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Abstract
Malignant catarrhal fever (MCF) is a lymphoproliferative and inflammatory disease
of cattle, deer and other ruminants. It is caused mainly by one of two herpesviruses,
alcelaphine herpesvirus 1 (A1HV-1) and ovine herpesvirus 2 (OvHV-2). A1HV-1 can
be grown in tissue culture; its complete genome has been sequenced and the virus
characterised as a gammaherpesvirus. OvHV-2 cannot be grown in tissue culture and
only a small amount of OvHV-2 genome sequence is known. Lymphoblastoid cell
lines can be propagated from the tissues of cattle, deer and experimentally infected
rabbits with MCF. Some of these cell lines transmit disease. The initial aim of this
project was to further characterise these cell lines and to use them as a source for
cloning the OvHV-2 viral genome.
The OvHV-2 infected cell lines were found to contain on average 50 copies
of viral genome per cell. Gardella gel analysis of OvHV-2 infected rabbit lines
showed evidence of substantial levels of viral replication, whilst analysis of an
OvHV-2 infected bovine cell line showed the virus genome to be predominantly in
the latent form. Analysis of RNA extracted from OvHV-2 infected rabbit cell lines
demonstrated evidence of early (ORF 57) and late (ORF 75) gene expression. This
prompted examination of cell lysates from OvHV-2 infected rabbit cells, resulting in
the first visualisation of an OvHV-2 capsid.
A cosmid library was constructed using genomic DNA extracted from the
OvHV-2 infected cattle cell line BJ/1035. Screening the cosmid library led to the
generation of overlapping cosmids spanning most of the viral genome. The virus
sequence was further extended using splinkerette PGR. Analysis of the viral
sequence revealed that the OvHV-2 genome is similar to that of A1HV-1 and the
unique "A"genes of A1HV-1 are conserved in OvHV-2. OvHV-2 also contains ORFs
not present in the A1HV-1 genome, including an IL-10 homologue. The sequence
derived is expected to be an invaluable resource for further study of OvHV-2
pathogenesis.
The OvHV-2 ORFs 07 and 08 were contained in the cosmid sequence. It
was hypothesised that the two sequences were spliced together to form a membrane
glycoprotein of similar function to gp350/220 of EBV. Evidence of splicing of the
07/08 sequence was found in 07/08 transfected tissue cultured cells, however this
iv
splicing appeared incomplete and it was hypothesised that viral factors might be
required for correct splicing. Immunofluorescence analysis of OvHV-2 infected
rabbit cells using anti-08 immune sera showed evidence that a high proportion of
OvHV-2 infected cells expressed 08. These studies provided a starting point for
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Herpesviruses are widely disseminated in nature, having been discovered throughout
the spectrum of vertebrates and in at least one invertebrate. In nature, each
herpesvirus is closely associated with a single host species. The most extensively
studied hosts are infected by several distinct herpesviruses. Approximately 130
herpesviruses have been identified to date (Minson, 2000), however this is thought to
be only a small proportion of the number in existence. Herpesviruses are well
adapted to their hosts and generally, severe infection is usually observed only in the
very young, the foetus, the immunosuppressed, or following infection of an
alternative host.
Once a host is infected with a herpesvirus, the virus persists in the host for
life as a latent infection. The ability to establish a latent infection is a property shared
by all herpesviruses. In the latent state the virus genome persists in the infected cell,
however no infectious virus particles are produced and a restricted pattern of virus
gene expression is displayed. Latent virus retains the ability to undergo reactivation,
at which point viral replication is resumed and infectious virions are produced. It is
thought that the establishment of latency allows the virus to avoid the host immune
system and therefore is an aid to persistence in the host.
The features of a herpesvirus infection can be illustrated using the
alphaherpesvirus bovine herpesvirus 1. This virus is the cause of respiratory disease
(infectious bovine rhinotracheitis) and genital disease (infectious vulvovaginitis and
balanoposthitis) in cattle. Following primary infection in epithilia of the respiratory
or genital tracts, lifelong latency is established in the either the sciatic or trigeminal
ganglia respectively. Reactivation of the virus, usually due to stress, leads to
asymptomatic shedding of virus. Shedding of virus due to reactivation in latently
infected cattle can cause serious outbreaks of disease in naive cattle; the disease
syndrome is often referred to as "shipping fever".
Similarly feline herpesvirus 1 is a common cause of respiratory disease in
cats. Although mortality is low in adult cats, the virus can cause fatal pneumonia in
kittens. Recovered animals can shed virus in the nasal secretions and lifelong latency
is established in the trigeminal ganglion. Inactivated and attenuated live vaccines are
commonly used to prevent both these diseases, however although the vaccines
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CHAPTER 1 INTRODUCTION
provide protection against clinical disease, they do not prevent infection or the
establishment of latency.
1.1.1 Biological Properties of Herpesviruses
All known herpesviruses share four biological properties (reviewed in Roizman,
2001c).
1. They specify a large array of enzymes involved in nucleic acid metabolism
(e.g. thymidine kinase, thymidylate synthase, dUTPase, ribonuclease
reductase), DNA synthesis (e.g. DNA polymerase, helicase, primase) and
protein processing (e.g. protein kinases).
2. The synthesis of viral DNAs and capsids occurs in the nucleus and capsids
are enveloped as they pass through the nuclear membrane.
3. Production of infectious progeny is accompanied by destruction of the
infected cell.
4. All herpesviruses studied to date are able to remain latent in their natural
hosts. In cells harbouring latent virus the viral genomes take the form of
closed circular molecules and only a small subset of viral genes are
expressed. Latent genomes retain the capacity to replicate and cause disease
upon reactivation.
The primary means of identifying members of the family Herpesviridae has been
that of virion structure. A typical herpesvirion consists of a core containing the linear
double stranded DNA genome and an icosahedral capsid approximately 100 to
llOnm in diameter containing 162 capsomeres. This is surrounded by a structure
known as the tegument and an envelope containing viral glycoprotein spikes on its
surface (Figure 1.1). The herpesviruses have been further classified into three
subfamilies initially on the basis of their biological properties, before the DNA
sequence of the virus genome were known. Herpesviruses have been classified into
genera, on the basis of DNA sequence homology and antigenic relatedness of viral
proteins. Examples of the herpesviruses and their hosts are shown on table 1.1.
3
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Figure 1.1 An Electron Microscopy Image of Herpes Simplex
Virus 2
The negatively stained image shows an icosahedral capsid (A)
made up of many capsomeres. This is surrounded by a
tegument (B) and a glycoprotein envelope (C).
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Table 1.1 - Examples of herpesviruses
Name Host Disease
Alphaherpesviruses
Herpes simplex-1 Human Cold sores, keratitis
Herpes simplex-2 Human Genital herpes
Varicella zoster virus Human Chicken pox and shingles
Bovine herpesvirus-1 Bovine Infectious bovine rhinotracheitis,
Genital disease, abortions
Feline herpesvirus-1 Cats Feline viral rhinotracheitis
Porcine herpesvirus-1 Pigs Pseudorabies (Aujzesky's disease)
Equine herpesvirus-1 Horses Abortion, neurological disease
Gallid herpesvirus-2 Chickens Marek's disease
Betaherpesviruses
Human cytomegalovirus Human Mononucleosis, multi-system disease
in immunocompromised patients
Porcine cytomegalovirus Pigs Rhinitis in piglets
Murine cytomegalovirus Mice




Epstein-Barr virus Human Infectious mononucleosis, Burkitt's
lymphoma, PTLD, nasopharyngeal
carcinoma,




Equine herpesvirus-2 Horses ? Respiratory disease in foals
Bovine herpesvirus-4 Cattle ? Conjunctivitis, metritis, mastitis
Herpesvirus saimiri Squirrel Fatal lymphoproliferations in
monkey cottontail rabbits & new world
monkeys e.g. marmosets
Herpesvirus ateles Spider monkey Lymphomas in new world primates
Rhesus rhadinovirus Rhesus monkey Lymphoproliferative disease in
immunosuppressed host




Alcelaphine herpesvirus-1 Wildebeest Malignant catarrhal fever in cattle,




Members of this subfamily have a variable host range, relatively short reproductive
cycle, rapid spread in culture, efficient destruction of infected cells and the capacity
to establish latent infections primarily in sensory ganglia. This subfamily contains
the genera Simplexvirus (e.g. Herpes simplex virus-1), Varicellovirus (e.g. Varicella
zoster virus), Marek's disease virus and Infectious laryngotracheitis virus.
1.1.3 The Betaherpesviruses
Members of this subfamily have a restricted host range, a long reproductive cycle
and grow slowly in culture. Infected cells frequently become enlarged, forming
cytomegalia. Latent infections can be established in secretory glands,
lymphoreticular cells, kidneys, and other tissues. This subfamily contains the genera
Cytomegalovirus (e.g. Human cytomegalovirus), Muromegalovirus (e.g. Murine
cytomegalovirus), and Roseolovirus (e.g. Human Herpesvirus-6).
1.1.4 The Gammaherpesviruses
Members of this subfamily have a narrow host range. The experimental host range is
generally limited to the family or order to which the natural host belongs. All
members of the family replicate in vivo in lymphoblastoid cells and some also cause
lytic infections in epithelial or fibroblast cells. The gammaherpesviruses establish
latency in lymphoid tissue. This sub-family contains the genera Lymphocryptovirus
(LCV), the prototype of which is Epstein-Barr Virus (EBV), and Rhadinovirus, the
prototypes of which are Ateline herpesvirus-2 (AtHV-2) and Herpesvirus saimiri
(HVS).
1.1.5 Herpesvirus Genomes
Herpesvirus DNA genomes are linear and double stranded. The length varies from
120bp to 250 kb and the base composition varies from 31% to 75% GC content. The
viral DNA circularises on release from the capsid into the nucleus of infected cells.
Herpesvirus genomes usually contain a number of reiterated sequences. The
arrangement of the repeated sequences either at the termini or internally, results in a
number of different genome structures (Figure 1.2).
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The sequence arrangements of the six classes of viral genomes of the herpesvirus
family are shown. In group A genomes, e.g. Channel catfish herpesvirus, sequence
from one terminus is directly repeated at the other terminus. In group B genomes,
such as herpesvirus saimiri, Alcelaphine herpesvirus-1, Kaposi's sarcoma
herpesvirus, the terminal sequence is directly repeated many times at both termini.
The number of reiterations at the termini may vary. In group C genomes, such as in
Epstein-Barr virus (EBV), the genome contains internal unrelated repeat sequences
greater than lOObp, named internal repeats (IR), as well as terminal repeats. In
group D viral genomes, such as Varicella zoster virus, the sequence at one terminus
(TR) is repeated in an inverted orientation internally (IR). This divides the unique
region into long unique (UL) and short unique (Us) regions. The short region can
invert giving two isomers of viral DNA. In group E genomes, such as in herpes
simplex virus and human cytomegalovirus, one terminus contains N repeats of
sequence A next to a longer sequence B. The other terminus has one directly
repeated sequence A next to a sequence C. The terminal sequences are inserted in
an inverted form internally ( B' A'N C' ). Both the long and short regions can
invert, forming four isomers. Repeat sequences have not been identified in group F
genomes (adapted from Roizman, 2001c).
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1.1.6 Herpesvirus Genes
The general features of herpesvirus genes are reviewed in Roizman, (2001c). Most
herpesvirus genes contain a promoter and other regulatory sequences spanning 50 to
200bp upstream of a TATA box, a transcriptional initiation site 20 to 25bp
downstream of the TATA box, a 5' non translated leader sequence of 30 to 300bp, a
single major ORF, with a translation initiation codon that meets the host
requirements for efficient initiation, 10 to 30bp of 3' non-translated sequence and a
polyadenylation signal. Exceptions are found, e.g. HSV-1 yi34.5 gene has no TATA
box and in some HSV late genes the promoter regulatory sequences may be located
3' to the TATA box. Gene overlaps are common and ORFs can be expressed that are
situated entirely antisense to each other. Most genes are transcribed by RNA
polymerase II, however EBV encodes a set of small non-polyadenylated RNAs or
EBERs that are not translated and are transcribed by RNA polymerase III. Most
herpesvirus genes are not spliced, however every herpesvirus encodes some spliced
genes and it is thought that splicing might enable differential regulation of a gene at
different parts of the virus life cycle.
1.1.7 Classification of Herpesviruses by Gene Relatedness and
Arrangement
Herpesvirus genomes contain between 70 and 200 ORFs. Among the viruses of
mammals and birds the genes are arranged into seven gene blocks. These gene
blocks have different orders and orientations in different herpesvirus subfamilies
(Figure 1.3), but genes within a block maintain order and transcriptional polarity. A
subset of 26 genes are conserved among the alpha, beta and gammaherpesviruses,
these genes are known as the herpesvirus core genes and include capsid proteins,
tegument proteins and components involved in DNA replication. Some genes are
conserved within subfamilies and some herpesviruses, especially the
gammaherpesviruses, encode homologues of cellular genes. It is hypothesised that
these genes might be acquired from the host. The cellular homologues are usually
located towards the viral termini between gene blocks. The complete genome
sequences for 26 herpesvirus species is now available and these sequences can be
used to construct phylogenetic trees illustrating the genetic relationships between the
8
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The gammaherpesvirus genes are arranged into seven blocks which
are colour coded as shown. The beta genes are found only in
betaherpesviruses. Gene blocks inverted relative to the
betaherpesviruses are marked with black arrowheads. Terminal
repeats (TR) are colour coded as shown, green arrowheads show the
direction of the terminal repeats. Internal repeats are marked IR.
(Adapted from Roizman, 2001c).
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herpesviruses (Davison, 2002). Virus sequence can be used along with criteria such
as host range and biological properties to classify viruses. Sequence data has been
used to classify viruses for which the complete sequence is not known, for example
porcine lymphotropic herpesvirus-1 (PLHV-l)(Goltz et al., 2002). The nucleotide
sequence of a 200bp polymerase chain reaction product, amplified from the
conserved herpesviral gene DNA polymerase gene by the use of degenerate primers,
is sufficient to establish the identity as a herpesvirus and classify it into the
appropriate subfamily. Sequences of genes such as glycoprotein B (gB), which is
conserved throughout the herpesviruses, have been used for comparison of
herpesviruses in order to classify them down to the genus level.
1.1.8 Herpesvirus Life Cycle and Replication
The life cycle of herpesviruses occurs in two different stages. The lytic stage
involves viral replication, production of new herpesvirus virions and release from the
cell, usually involving lysis of the infected cell. In the latent stage, the virus genome
persists in the cell as an episome, with no production of new virions and expression
of only a small subset of viral genes. The latent viral genome retains the ability to
undergo reactivation, whereby the virus returns to the lytic stage of the life cycle and
the full spectrum of viral genes is again expressed. It is thought that reactivation of
HSV can be triggered by a number of stimuli such as stress, tissue damage, or
immunosuppression, but the molecular mechanisms controlling latency and
reactivation are not fully understood (Wagner & Bloom, 1997).
1.1.9 Herpesvirus Lytic Replication
Much of the work on lytic replication of herpesviruses has been done on herpes
simplex virus and is reviewed in Roizman, (2001a) and Ward & Roizman, (1994).
Lytic replication is described here as it occurs in herpes simplex virus (Figure 1.4).
Since many replication genes are conserved between herpesviruses, the general
principles are relevant to any herpesvirus.
To initiate infection the virus must attach to the cell surface. This involves the
interaction of the viral envelope glycoproteins gC and gB with the





Figure 1.4 The diagram shows the lytic replication cycle of herpes simplex virus. To
initiate infection, the virus attaches to the cell surface by interaction of the viral
envelope glycoproteins gB and gC with cell surface heparin sulphate (1).
Glycoprotein D then interacts with one of several cellular co-receptors. This is
followed by fusion of the viral envelope with the host cell membrane (2).
After membrane fusion the viral capsid is released into the cytoplasm. Viral
capsids attach to microtubules and are transported to the nucleus (3). Certain
tegument proteins, e.g. VP16 which activates transcription of the viral genome, are
also transported to the nucleus. The viral DNA is released from the capsid into the
cell nucleus through the nuclear pores (4). Once in the nucleus the viral DNA
circularises (5). VP16 interacts with the host transcriptional components to stimulate
transcription of the immediate early or a genes (6).
The RNA transcripts are transported to the cytoplasm and translated (7). The
a proteins are transported to the nucleus, where they activate transcription of the
early or 8 genes (8). Early gene transcripts are transported into the cytoplasm and
translated (9). The 8 proteins function in viral DNA replication in the nucleus (10).
Late or y genes encode virion structural proteins and those needed for virus assembly
and particle egress. Some y proteins are required for formation of the viral envelope
and are synthesised on the rough ER (11). These membrane proteins are modified by
glycosylation.
Precursor viral membrane proteins are thought to be located on the inner and
outer nuclear membranes and on the membranes of the rough ER. These precursors
are transported to the Golgi apparatus for further modification and processing (12).
Mature glycoproteins are transported to the plasma membrane of the infected cell
(13). Newly replicated DNA is packaged into capsids (14). DNA containing capsids
bud from the inner nuclear membrane into the lumen of the ER (15), acquiring an
envelope containing precursors of viral envelope proteins.
Two possible mechanisms have been suggested for transport of enveloped
virus to the cell membrane. In the de-envelopment pathway (16), enveloped virus
fuses with the ER membrane and is released into the cytoplasm. The capsid buds into
a late Golgi component, where it acquires a membrane containing mature viral
envelope proteins. The enveloped virus is then transported to the cell membrane for
release by exocytosis. In the luminal pathway (17) enveloped virus is engulfed in a
vesicle and delivered to the Golgi, where the envelope proteins are modified by
Golgi enzymes. The enveloped virus is then transported to the cell membrane for
release by exocytosis (18). (Adapted from Flint et al., (2000)).
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the interaction of the viral glycoprotein gD with one of several cellular co-receptors.
The co-receptors include members of the tumour necrosis factor (TNF) receptor
family and members of the immunoglobulin superfamily. It is also thought that 3-0-
sulphated heparin sulphates may serve as receptors for viral entry (Shukla et al.,
1999). This is followed by fusion of the viral envelope with the host cell membrane,
requiring gB, gD and a gH-gL heterodimer. After fusion the capsid is transported to
the nuclear pore, whilst the tegument proteins are thought to modify cellular
metabolism.
After entry into the cell nucleus the viral DNA circularises. In cells
permissive for viral replication, entry of the virus genome into the nucleus is
followed by a highly regulated cascade of viral gene expression. Host RNA
polymerase II is responsible for transcription of all the viral genes (Costanzo et al.,
1977) and all viral proteins are synthesised in the cytoplasm. Immediate-early, or
alpha genes are defined by their transcription in the presence of inhibitors of protein
synthesis, such as cyclohexamide. The immediate early genes are distinct among
different subfamilies, and regulate subsequent gene expression by transcriptional and
post-transcriptional mechanisms. In HSV there are six alpha genes, which encode
viral proteins designated as ICPO, ICP4, ICP22, ICP27, ICP47 and Us1.5, whose
transcription unit lies within the coding sequence of the gene encoding ICP22. The
virion tegument protein VP 16 stimulates the transcription of the alpha genes
(Campbell et al., 1984).
The early or beta genes encode the DNA replication complex and a variety of
proteins and enzymes involved in modifying host cell metabolism, whilst the late or
gamma genes encode the structural proteins of the virus. HSV infection inhibits host
transcription, RNA splicing and transport, to change the cell from cellular to viral
gene expression. Viral DNA synthesis occurs by a rolling circle mechanism, from
one or more origins of replication (Garber et al., 1993). Replication of HSV-1 DNA
requires seven gene products, comprising an origin binding protein, a single stranded
DNA binding protein, a DNA polymerase composed of two subunits and a helicase-
primase complex composed of three gene products. Homologues of all but the origin
binding protein have been identified in all three herpesvirus subfamilies. Replication
of viral DNA results in concatemers of viral DNA, which are cleaved into
13
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monomers. This process is linked to the packaging of DNA into preformed mature
capsids within the nucleus (Deiss & Frenkel, 1986).
After packaging the virus matures and acquires infectivity by budding
through the inner lamella of the nuclear membrane, however it is not certain how
generation of the full enveloped particle is carried out (Roizman, 2001a). It is
thought that the virus may become de-enveloped by fusion with the nuclear
membrane and may then be re-enveloped in the Golgi apparatus. The alternative
theory is that the virion buds through the outer nuclear membrane, with the envelope
intact and then enters the Golgi already enveloped. Whilst in the Golgi, the
oligosaccarides of the virion glycoproteins are processed by Golgi enzymes. The
enveloped virions are transported through the Golgi to the cell surface in vesicles,
where they are released from the cell. Cells productively infected with herpes viruses
do not usually survive, as they suffer irreversible damage due to both viral
replication and cellular responses to infection.
1.1.10 Latency
Every herpesvirus studied to date establishes latent infection in a specific cell type
(Roizman, 2001c). The mechanisms of the establishment of latency vary from one
virus to the next and the genes expressed during latency are not generally conserved
between herpesviruses. Some viruses for example EBV, encode several proteins that
are expressed during the maintenance of latency. In other herpesviruses for example
HSV, gene expression during latency is more limited. Due to this variation, latency
in herpesvirus will be discussed in the context of specific viruses.
1.2 Gammaherpesviruses
The gammaherpesviruses include pathogens of animals and man and are associated
with lymphoproliferative diseases. EBV is the only human LCV and Kaposi's
sarcoma-associated herpesvirus (KSHV) is the only human rhadinovirus.
Lymphocryptoviruses have only been identified in primate species; many old world
and new world primates have their own endemic LCV. In contrast, the
rhadinoviruses are found in both primates and non-primate species.
Gammaherpesvirus genomes include genes that are shared by most herpesviruses,
14
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genes that are shared among gammaherpesviruses and genes conserved within
genera. Many gammaherpesviruses encode homologues of cellular genes, these are
located in the genome in the regions between blocks of conserved genes (Figure 1.4).
1.2.1 Epstein-Barr Virus
Epstein-Barr virus (EBV) was discovered in association with the malignancy
Burkitt's Lymphoma, and therefore EBV became the first candidate human tumour
virus discovered (reviewed in Kieff, 2001). EBV is also the prototype
gammaherpesvirus. EBV is a ubiquitous infectious agent; over 90% of the world's
population are infected. Primary infection usually occurs in early childhood and is
followed by a lifelong carrier state. If primary infection is delayed however, it can be
accompanied by the disease infectious mononucleosis (IM). EBV is also linked to the
human cancer nasopharyngeal carcinoma (Wolf et al., 1973) and is associated with
post transplantation lymphoproliferative disease (Tanner & Alfieri, 2001), Hodgkin's
disease and oral hairy leukoplakia.
1.2.1.1 The Structure of the EBV Genome
Due to the limited host range for EBV replication in vitro and the difficulty of
obtaining large amounts of viral DNA for molecular biological investigation, EBV
was the first herpesvirus whose genome fragments were cloned into E. coli (Arrand
et al., 1981) and was the first herpesvirus genome to be completely sequenced. The
EBV genome was sequenced from a BamHl library, therefore genes are often
referred to specific BatnHl fragments. The EBV genome is a linear double stranded
172 kbp DNA molecule, with a base composition of 60% GC. The genome contains
0.5kbp reiterated terminal direct repeats and reiterated 3kbp internal direct repeats.
These divide the genome into unique long and unique short regions. The unique long
and unique short regions contain imperfect tandem DNA repeats, mostly within
ORFs. The reiteration frequency of the EBV tandem repeats is variable during viral
DNA replication, with the average number of repeats being equal to that of the parent
genome. If cells are latently infected with episomal viral DNA, each EBV genome in
the progeny infected cells will have the same number of terminal repeat units as the
















































































































































Figure 1.5 Comparison of the genomic arrangement of gammaherpesviruses. The
genomes of herpesvirus saimiri (HVS), murine gammaherpesvirus-68 (MHV-68),
Kaposi's sarcoma herpesvirus (KSHV), equine herpesvirus 2 (EHV-2), and Epstein-
Barr virus (EBV) are shown. The EBV genome is shown inverted relative to its
conventional orientation. The conserved gene blocks 1 (Turquoise), II (green), III
(yellow) and IV (red). The numbers of open reading frames in the blocks are shown,
and relate to the HVS open reading frame numbering system.
Interspersed between these blocks are ORFs which are unique to each family
member; these areas contain homologues of cellular genes. Positional homologues to
HVS ORFs are marked with the prefix "p". Gammaherpesvirus genes with no
homologue in HVS are numbered separately: M, MHV-68 specific ORFs, K, KSHV
specific ORFs, A, A1HV-1 specific ORFs, E, EHV-2 specific ORFs. Other
abbreviations used are: STP - saimiri transforming protein, CRP - complement
regulatory protein, DHFR - dihydrofolate reductase, vIL - viral interleukin, TS -
thymidylate synthase, vFLIP - viral FLICE inhibitory protein, vMIP-la/B - viral
macrophage inhibitory factor a/6, vGPCR - viral G protein coupled receptor, sema -
semaphorin, vIRF - viral interferon responsive factor. Non-coding regions in the
genomes of A1HV-1 and EHV-1 are shown as diagonally striped blocks. (Adapted
from Simas & Efstathiou, (1998))
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cells arose as a result of clonal expansion from one progenitor cell, or from a number
of cells (Raab-Traub & Flynn, 1986). Two EBV types exist, designated type 1 and
type 2. Type 1 is more common in most populations; the main differences between
the two types lie in the genes encoding the EBV nuclear antigens (EBNA).
The EBV genome has large areas of collinear homology at the amino acid
level with other herpesviruses such as VZV and EISV. The relatively conserved
domains encode EBV genes functioning in lytic infection. The genes expressed in
latent EBV infection generally have no homology to other herpesviruses. It is
thought that some may have arisen partly from cellular DNA, particularly EBNA-I,
which contains repeat motifs found in host cell DNA (Heller et al., 1985). The
immediate early gene BZLF1 is closely related to the jun/fos family of transcriptional
activators (Farrell et al., 1989). EBV also has two bcl-2 homologues, encoded by the
BHRF1 gene and the BALF1 gene. EBV also contains a homologue of the cellular
gene IL-10 encoded by BCRF1. The BCRF1 gene shares 90% amino acid homology
to human IL10 sequence (Moore et al., 1990) (Hsu et al., 1990).
1.2.1.2 Epstein-Barr Virus Replication
EBV can infect primary B-lymphocytes in vitro, initiating a latent infection in
approximately 10% of cells. EBV infected B cells proliferate as immortalised or
transformed latently infected LCLs. These cell lines have been used to identify and
characterise the viral proteins expressed during this infection. Virus replication in
these LCLs is minimal or undetectable. There is no in vitro system that is fully
permissive for EBV replication, therefore studies of lytic infection have used semi-
permissive LCL or Burkitt's lymphoma (BL) cell lines, where replication can be
induced in a variable proportion of cells.
Lytic EBV infection is usually studied by inducing latently infected Burkitt's
lymphoma cells to become permissive for lytic virus infection. This can be done in a
number of ways. Treatment of cells with phorbol esters such as TPA results in
protein kinase C activation, resulting in jun-fos interaction with Apl sites upstream
of the immediate early genes of EBV (Baumann et al., 1998). The Akata EBV
infected cell line can be induced to 20 - 50% lytic infection by cross-linking surface
immunoglobulin. This causes a cascade of second messengers, which leads to the
mobilisation of calcium from intracellular stores and activation of protein kinase C.
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The latent EBV genome is extensively methylated (Falk & Ernberg, 1993). Extensive
methylation of lytic genes and their regulatory sequences is thought to help maintain
latency by inhibiting lytic gene expression. Treatment of latently infected cells with
drugs that reduce DNA methylation such as 5-aza-cytidine (Ben-Sasson & Klein,
1981), increases the frequency of spontaneous reactivation. Treatment of cells with
sodium butyrate inhibits histone deacetylase and this relieves transcriptional
repression resulting from condensed chromatin.
Entry of EBV into host B cells is initiated by interaction of the viral envelope
glycoprotein gp350/220 with the complement protein C3d receptor CD21 (Fingeroth
et al., 1984). It has also been shown that a complex of three glycoproteins, the gH
homologue gp85, the gL homologue gp25, and gp42, are required for penetration of
the virus into host cells (Molesworth et al., 2000). Gp42 binds HLA class II (Li et
al., 1997) and B cell lines which lack expression of HLA class II are not susceptible
to EBV infection. The mechanisms of infection of epithelial cells with EBV are
thought to be different from those of B cells. It is thought that a two part complex of
gp85 and gp25 are involved in infection of epithelial cells with EBV (Molesworth et
al., 2000) (Maruo et al., 2001), rather than the gp85/gp25/gp42 complex involved in
infection of B cells. Some epithelial cells do express small amounts of CD21 and
interaction of gp350 with CD21 has been shown to be of importance in infection of
epithelial cells (Fingeroth et al., 1999). Epithelial cells and B cells have been shown
to be infected independently of gp350 and CD21 (Janz et al., 2000) and it is thought
that other viral and cellular molecules are involved in the binding of EBV to its target
cells.
The immediate early gene products of EBV are BZLF1 or Zta, and BRLF1 or
replication and transcription activator (Rta). The proteins encoded by these genes are
key transactivators of a cascade of lytic EBV gene expression. BZLF1 and BRLF1
up regulate gene expression from early EBV gene promoters. Approximately 30
EBV genes have been classified as early genes. Many early genes are involved in
viral DNA replication, such as the viral DNA polymerase (BALF5) and ribonuclease
reductase (BORF2). The early genes BSMF1 and BMRF1 function as transcriptional
activators that can transactivate the expression of other EBV early genes. The EBV
bcl-2 homologues BHRF1 and BALF1 are both expressed in early lytic infection.
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BHRF1 is thought to be important in preventing apoptotic cell death during lytic
replication (Henderson et al., 1993), whilst BALF1 acts to negatively regulate the
antiapoptotic activity of BHRF1.
Many EBV late genes studied are glycoproteins and have potential
importance in antibody-mediated immunity to virus infection. Knowledge of non-
glycoprotein late genes is limited. One of the most abundant EBV late proteins is the
gB homologue gpl 10, encoded by BALF4. This protein is found in large amounts on
the inner nuclear membrane, however only small amounts are found in enveloped
extracellular virus. The gpl 10 protein is both N and O glycosylated. Due to its
distribution in the inner and outer nuclear membranes and cytoplasmic membranes
surrounding virus, but not in Golgi or plasma membrane, gpl 10 is thought to have a
role in initial envelopment of virus.
The late proteins gp85 and gp350/220 are found in the Golgi and on the
plasma membrane of infected cells. The glycoprotein gp350/220 is encoded by
BLLF1, which has a small region of distant homology to HSV-1 gC (Beisel et al.,
1985). The glycoproteins Gp350 and gp220 are encoded by the same gene and the
mRNA encoding gp220 is spliced in frame. Gp350/220 is the major external virus
glycoprotein, which mediates binding to the CD21 B lymphocyte receptor. Gp85 is
found in smaller amounts and is important in fusion of the virus envelope and the
host cell membrane. The glycoprotein gp85 has significant collinear homology with
HSV gH (Heineman et al., 1988) and complexes with the BKRF2 protein, which is
homologous to HSV gL. This complex is homologous to the gH/gL complex with is
found on the envelope of HSV.
Although gp350/220 is the most abundant viral protein in the lytically
infected cell membrane and virus envelope, only small amounts accumulate in the
lytically infected cell nuclear membrane. It is thought that the virus acquires the
initial envelope as it buds through the nuclear membrane, de-envelopment then
occurs in cytoplasmic vesicles, and nucleocapsids are released into the cytoplasm.
Re-envelopment then occurs at the plasma membrane, where the virus receives a
definitive envelope rich in gp350/220 and the gp85/BKRF2 complex.
The EBV IL-10 homologue BCRF1 is also expressed in early and late lytic
infection. Cellular IL-10 has anti-inflammatory activities mediated by inhibition of
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macrophage and monocyte synthesis of pro-inflammatory cytokines such as TNFa,
IFNy, IL-12 and IL-6 (Fiorentino et al., 1991). IL-10 inhibits MHC class II
expression on monocytes and inhibits proliferation of CD4+ T cells, but induces
proliferation and cytotoxic activity of CD8+ T cells (Groux et al., 1998). Cellular
IL-10 can also induce proliferation of thymocytes and mast cells and has been shown
to enhance the survival and differentiation of B cells (Moore et al., 2001). The EBV
viral IL-10 has 90% amino acid identity with human IL-10 (Hsu et al., 1990). The
main differences lie in the N terminal twenty amino acids. Despite the similarity with
cellular IL-10, the EBV IL-10 only retains a subset of the activity of cellular IL-10.
The EBV IL-10 retains the immunosuppressive activities such as inhibition of
antigen presentation by monocytes (de Waal Malefyt et al., 1991), inhibition of T
cell proliferation in response to antigen and inhibition of interferon y production by
activated lymphoid cells (Hsu et al., 1990). The immunostimulatory activities are
however, not retained. The ability to reduce inflammation and antigen presentation is
thought to aid viral persistence in the host by reducing the immune response to
infection.
1.2.1.3 EBV Latency
EBV latency is complex and has been studied mainly using in vitro cell lines. Using
these cell lines, latency has been classified into three types. The transformation
process in these cells is associated with an ordered sequence of virus gene expression
known as latency III. The features of latency III are;
• Expression of the EBV small non polyadenylated RNAs or EBERs
• Expression of the BamHI A RNAs, a family of spliced polyadenylated
transcripts whose protein products are not well characterised.
• Six differentially spliced transcripts, expressed either from the BamHI W
promoter or Wp, or more commonly from the adjacent BamHI C promoter or
Cp. The transcripts encode the viral nuclear antigens EBNAs 1, 2, 3A, 3B, 3C
and LP.




The other two forms of EBV latency, latency I and latency II, display a more
restricted pattern of EBV gene expression. These two forms of latency are thought to
represent two ends of a spectrum of viral gene expression, latency I and latency II
differ only with respect to the activity of the LMP promoters.
The features of latency I are;
• Expression of the EBERs
• Expression of the BamHIA RNAs.
• Silencing of the Cp/Wp promoters and activation of a downstream promoter
Qp, which initiates transcription of an EBNA I RNA with a unique splice
structure compared with expression from Cp/Wp.
• Silencing of the LMP promoters, making EBNA I the only virus-encoded
protein expressed in type I latency.
The features of Latency II are:
• Expression of the EBERs,
• Expression of the BamHI A RNAs
• Expression of EBNA I from the Qp promoter, as seen in latency I.
• Activation of one or more LMP promoters, leading to expression of the LMPI
and one or more of LMP2A and LMP2B mRNAs at levels varying from
borderline to easily detectable.
EBV infected cells displaying some of the features of in vitro latency have been
identified in vivo. Latency I was first identified in Burkitt's lymphoma cells, and
latency II is found in nasopharyngeal carcinomas (Young et al., 1988). RT-PCR
analysis of viral transcription of freshly isolated B cells from patients with infectious
mononucleosis has detected many of the RNAs characteristic of a latency III
infection (Tierney et al., 1994). Latency in vivo however remains difficult to study
because the cells isolated for analysis may differ with respect to viral gene
expression, therefore the results obtained will reflect a population of cells rather than
individual EBV infected cells.
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1.2.1.4 Functions of EBV Latency Associated Genes
The viral gene products expressed in latency maintain the latent infection and cause
previously resting B cells to continuously proliferate. EBV infected proliferating
lymphocytes display an activated phenotype similar to that seen in B lymphocytes
proliferating in response to antigen, mitogen or IL-4.
EBNAs
The promoter Wp promotes the transcription of the first EBV RNAs, which are
differentially spliced to encode EBNA-LP and EBNA-2. These two proteins up
regulate transcription from viral and cellular promoters, including Wp and Cp
(Harada & Kieff, 1997). EBNA-2 is required for in vitro growth transformation of
EBV (Cohen & Kieff, 1991). The EBNA-2 protein up regulates expression of the
cellular genes CD23, CD21, c-fgr and c-myc and bcl-2 and the viral genes LMP1,
LMP2, and EBNAs (Wang et al., 1990). EBNA-1 is present in all EBV infected
cells, regardless of the state of infection. It is essential for maintenance of viral
episomes in infection, as it mediates binding of EBV to chromosomes via the oriP or
latent origin of replication. The EBNA-1 gene contains a glycine and alanine
(Gly-Ala) repeat domain. This domain is thought to be involved in the inhibition of
presentation of EBNA-1 epitopes by interference with the antigen processing
pathways (Levitskaya et al., 1997). This is thought to prevent a CTL response to
EBV infected cells expressing EBNA-1.
The EBNA 3 genes are tandemly placed in the genome. EBNA-3A and 3C
are thought to be important for B lymphocyte growth transformation, however
EBNA-3B is not essential for any aspect of lymphocyte infection in vitro
(Tomkinson & Kieff, 1992). EBNA-LP is also thought to be important in host cell
transformation, as cells infected with EBNA-LP mutants have a reduced
transformation phenotype (Mannick et al., 1991).
LMP1
LMP1 is a membrane protein and has been shown to be essential for B lymphocyte
growth transformation by EBV (Kaye et al., 1993). LMP1 also has transforming
effects on non-lymphoid cells such as rodent fibroblasts (Wang et al., 1985). In B
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lymphocytes, LMP1 induces many of the phenotypic effects of EBV infection (Wang
et al., 1988), including induced expression of activation markers such as CD23,
CD39 and CD40, adhesion molecules such as LFA-1 and ICAM-1 and LFA-3, the
cell skeletal protein vimentin, HLA class II and the anti apoptotic genes bcl-2 and
A20. It has been shown a 200 amino acid carboxy terminal cytoplasmic domain of
LMP1 is important for the growth transforming properties of LMP1 (Kaye et al.,
1995). LMP1 acts as a constitutively active receptor. The first 44 amino acids of the
carboxy terminus interact with TNF associated cell cytoplasmic factors hTRAF3 and
hTRAFl, initiating a signalling pathway which results in activation of the
transcription factor NFkB.
LMP2
The FMP2 gene is expressed from a spliced mRNA that contains exons located at
both ends of the EBV genome. LMP2 can thus only be transcribed in latency when
the genome is circularised. Two forms of LMP2 are expressed; FMP2A and LMP2B.
These forms differ only in the first exons; the remaining exons are shared by both.
EMP2A has been shown to interfere with membrane signal transduction through
phosphorylation of its hydrophobic amino terminal domain and binding of the
cellular non-receptor tyrosine kinases Fyn and Lyn (Miller et al., 1994). This binding
blocks subsequent signal transduction from the immunoglobulin receptor and inhibits
B cell activation that would activate the lytic cycle.
1.2.1.5 Persistence of the EBV Genome During Latency
The EBV genome persists in latently infected cells as a circular episome. Stable
latently infected EBV cell lines contain multiple copies of EBV episomes (Adams &
Lindahl, 1975) and most LCLs have about 10 copies of the EBV genome per cell.
The Burkitt's lymphoma cell line Raji has 50 episomes per cell and has stably
maintained this number for over 30 years in culture (Adams, 1987). The initial
amplification of circular EBV DNA is at the start of latent infection and requires S
phase DNA synthesis, as prior to S phase each infected cell only has one episome
(Arvanitakis et al., 1995). EBV DNA can also integrate into chromosomal DNA and
both integrated and episomal DNA has been identified in some cell lines. Integration
occurs when BL cell lines are infected with EBV and extensively passaged, however
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it is not a regular feature of EBV infection. In latent infection, the EBV genome
undergoes extensive methylation and is associated with chromosomal proteins.
Regulatory domains involved in maintaining latent infection are undermethylated in
latently infected cells relative to genes that are expressed in lytic infection (Falk &
Ernberg, 1993).
1.2.1.6 Immune Response to EBV
Most of the information about antibody responses to EBV comes from the study of
infectious mononucleosis (IM) patients (reviewed in Rickinson, 2001). By the onset
of clinical symptoms, IM patients have IgM antibodies to the viral capsid antigen
(VCA) (composed of BCLF1, BFRF3, BLRF2 and gpllO) and a rising titre of IgG
antibody to VCA and early antigen (EA). EA is composed of a mixture of
immediate-early and early proteins including BZLF1, BALF2 and BHRF1. Virus
neutralising IgM and IgG antibodies develop to the major neutralisation target
antigen gp350, with IgG antibodies rising relatively late in disease. Antibodies to
gp350 also have the capacity to mediate antibody dependant cellular cytotoxicity
against cells in the late phase of virus replication (Pearson et al., 1979). IgG
Antibodies to EBNA-1 develop late in disease; healthy virus carriers maintain IgG
antibodies to VCA, gp350 and EBNA-1.
The virus neutralising antibodies are not sufficient to protect against infection
although they may prevent virus spread. It is thought that the cell mediated response
plays a more important role in protection against EBV, as illustrated by the incidence
of EBV associated lymphoproliferative disease in T cell immunosuppressed patients
(Nalesnik, 1998), (Beral et al., 1991). An EBV specific cytotoxic T lymphocyte cell
(CTL) response occurs in IM patients (reviewed in Rickinson & Moss, 1997) and
HLA class I restricted T cells can be detected specific to both latent and early lytic
cycle antigens. The initial expansion of latently infected growth-transformed B cells
seen in IM patients is eventually brought under control and it is thought that this is
brought about by the virus specific CTL response.
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1.2.1.7 Viral Persistence In Vivo
It is thought that the reservoir of EBV infection is contained in the B cell pool, as
bone marrow transplant patients receiving irradiation to destroy their lymphoid
system, but not other possible sites of persistence such as mucosal epithelium, were
cleared of their EBV infection (Gratama et al., 1988). Virus infected B lymphocytes
are thought to differentiate into memory B cells. EBV is thought to persist in the
memory B cell pool, exhibiting a restricted pattern of viral expression in order to
avoid CTL surveillance (Laichalk et al., 2002), (Babcock et al., 2000). Little is
known about how the pool of resting EBV infected B cells is maintained, however
latency type III cells must be continually generated, as antibody levels to type III
proteins are maintained at high levels for life.
1.2.1.8 Burkitt's Lymphoma
Burkitt's lymphoma (BL) is a B cell tumour originally identified in parts of Africa
and Papua New Guinea (Burkitt, 1963), but is now known to be found worldwide in
sporadic and endemic forms. BL is a disease of children and is rarely found in
patients over the age of 14 years. The endemic form of Burkitt's lymphoma occurs in
areas with high malaria infection, 97% of endemic BL tumours carry the EBV
genome, whilst only 12 - 25% of sporadic BL tumours are EBV positive (Ziegler et
al., 1976). The 3% of EBV negative BLs occurring in endemic areas are thought to
be sporadic cases of BL.
Tumours are found in a variety of sites but are most commonly found on the
mandible or maxilla. In the absence of treatment, BL tumours grow quickly and
death ensues within a few months. Chromosomal translocations are seen in BL cells
of both the sporadic and endemic form, in which the c-myc oncogene on
chromosome 8 is brought under the influence of an immunoglobulin gene promoter
on chromosome 14, 22 or 2. The deregulation of the c-myc gene is thought to be
responsible for the malignant change in the affected cell and the rapid outgrowth of a
clone of tumour cells. The role of EBV and malaria infection in the pathogenesis is
not clear, however it is thought to be a complex multistep process (Kieff, 2001). It
has been suggested that rapid proliferation of EBV infected cells occurs in the
presence of poor immunological control brought about by endemic malaria. This
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rapid proliferation is thought to increase the chances of a chromosomal translocation
occurring (Klein, 1987).
The Burkitt's lymphoma cell phenotype as determined by tumour biopsies, is
that of a non-activated B cell. Viral gene expression in these cells is a restricted type
I pattern with expression only of EBNA-1. In some tumours, however, a small
number of cells reactivate expression of additional latent or lytic cycle genes
(Niedobitek et al., 1995).
1.2.1.9 Infectious Mononucleosis (IM)
Infectious mononucleosis occurs as a result of delayed primary infection with EBV.
It is seen in teenagers and young adults of western societies and is sometimes known
as "the kissing disease" (Rickinson, 2001). Symptoms seen are sore throat, fever,
sweating, anorexia, headache and malaise. General lymphadenopathy occurs and is
particularly marked in the pharyngeal region. Splenomegaly and hepatomegaly are
also found. IM can sometimes resolve in days, but often continues for 1-2 weeks and
is followed by a period of lethargy before complete recovery. One of the key features
of IM is the presence of large numbers of "atypical mononuclear" cells in the blood.
These are predominantly CD8+ T lymphoblasts although some CD4+ cells and NK
like cells are found. There is expansion of a specific subset of CD8+ T cells with a
VB T cell receptor, which are thought to be proliferating in response to antigen
(Callan et al., 1996). The CD8+ T cells are specific for both latent and lytic EBV
antigens (Callan et al., 1998).
IM is thought to be an immunopathological disease whose symptoms are
caused by pro-inflammatory cytokines such as IL-1, IFN-y, and TNFa produced at
high levels by the reactive T cells seen infiltrating all tissues of the body
(Anagnostopoulos et al., 1995). It is not known why EBV causes IM in adolescence,
although it has been suggested that the cause could be the larger infectious dose of
virus transmitted than is found in childhood.
1.2.1.10 Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is a malignancy that develops in the squamus
epithelium of the nasopharynx (Raab-Traub, 1993). The disease is the major cause of
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death from cancer in southern China and also develops at high incidence in
Mediterranean Africa and in Eskimo populations. The tumour is found in two types,
70% are the undifferentiated type and the rest show squamus differentiation.
EBV is detected in all undifferentiated NPC (Niedobitek et al., 1991). Within
each tumour the EBV is clonal, suggesting the tumour arose from proliferation of a
single EBV infected cell (Raab-Traub & Flynn, 1986). Viral gene expression within
NPC cells follows a latency type II pattern of gene expression and EBNA-1 and
LMP1 expression is detected (Young et al., 1988). In addition to EBV infection,
there are other factors associated with development of NPC. It has been shown that
Chinese populations have a genetic predisposition to NPC (Chan, 1983).
Environmental factors also play a part; some traditional herbal remedies taken as
snuff have been found to contain tumour promoting phorbol esters (Hirayama & Ito,
1981) and traditional salt fish dishes contain carcinogenic nitrosamines (Ho et al.,
1978). Phorbol esters are activators of EBV replication as well as having tumour
promoting effects, therefore a higher number of EBV infected cells will be available
to progress to malignancy, possibly through a combination of the effects of EBV
LMP-I, with nitrosamine carcinogenicity and the tumour promoting effects of
phorbol esters.
1.2.1.11 Lymphomas in Immunosuppressed Patients
The lifelong infection with EBV is usually controlled by cell-mediated immunity.
The importance of control of EBV by the immune system is illustrated by the
incidence of malignancies in immunosuppressed patients, for example, post
transplantation, or suffering from acquired immunodeficiency syndrome (AIDS).
1.2.1.12 Post Transplantation Lymphoproliferative Disease (PTLD)
EBV is widely recognised as being associated with the development of lymphomas
in transplant patients (Nalesnik, 1998). The intensity of T cell suppressive therapy
given after transplantation is a major influence on the incidence of disease. After
renal and liver transplants the incidence is 1 - 2%, however after heart and lung
transplants the incidence is 3 - 8%, reflecting the higher amounts of
immunosuppression given to these patients. PTLD is also seen after bone marrow
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transplants (Nalesnik, 1998), especially when donor T cells are depleted from the
marrow graft. Another major influence on the development of PTLD is EBV status.
A higher incidence of PTLD is seen in EBV seronegative patients (Ho et al., 1985),
and therefore children are at a particularly high risk.
PTLD malignancies are found as a number of different types and 90% of the
lesions carry EBV. The tumour cells express EBNA-1, EBNA-2 and LMP1,
consistent with them being EBV transformed LCL-like foci proliferating in the
absence of CTL surveillance (Young et al., 1989). Many PTLD lesions, especially
early lesions, regress when immunosuppression is reduced. This is thought to be due
to the re-emergence of EBV specific cytotoxic T cells (Khatri et al., 1999).
Reduction of immunosuppression, however, carries with it the risk of rejection of the
transplanted organ. Cases of PTLD have also been treated successfully by adoptive
immunotherapy (Haque et al., 2002). In this approach, CTL lines specific for EBV
were established from healthy blood donors. The best available HLA matched CTLs
were used to treat EBV positive PTLD in patients who has failed to respond to other
forms of treatment.
1.2.1.13 Acquired Immunodeficiency Syndrome Lymphomas
HIV infected individuals are at particularly high risk of developing B cell
lymphomas. Approximately half of lymphomas seen in AIDS patients are EBV
associated; however association varies between different tumour types (Gaidano et
al., 1998). A major type of AIDS lymphoma is similar to PTLD lesions and appears
in end stage AIDS when the patient is profoundly immunosuppressed. EBV is
present in 80% of lesions, EBV positive tumours are largely composed of LMP1
positive, EBNA-2 positive B lymphoblasts typical of an EBV driven B cell
proliferation. Burkitt's lymphoma type tumours also arise at a higher incidence in
AIDS patients, though at an earlier time in disease than PTLD like lesions. These
tumours are EBV positive in 30 - 40% of cases and EBV expression in these lesions




1.2.2 Kaposi's Sarcoma Herpesvirus (KSHV)
The human rhadinovirus KSHV or Human Herpesvirus-8 (HHV-8), was first
identified in an AIDS related Kaposi's sarcoma (KS) biopsy, and was the second of
the human gammaherpesviruses to be identified. KSHV is also associated with the
malignancies primary effusion lymphoma (PEL) and Multicentric Castleman's
Disease (MCD).
1.2.2.1 Kaposi's Sarcoma
Kaposi's sarcoma is a vascular tumour consisting of bundles of spindle cells, an
inflammatory infiltrate and prominent angiogenesis (reviewed in Jenner & Boshoff,
2002). The characteristic spindle cells are thought to be the tumour cells. The
majority express lymphatic endothelial cell markers, however some express proteins
more characteristic of smooth muscle, macrophages and dendritic cells, therefore it is
thought that the spindle cells may be derived from a precursor cell whose progeny
gives rise to haematopoietic and endothelial cells.
Kaposi's sarcoma is found in a number of associations. Classic Kaposi's
sarcoma is described as an indolent tumour of elderly Mediterranean men. In central
Africa, endemic KS affects young children (Ziegler & Katongole-Mbidde, 1996),
and the occurrence of KS is increased among transplant recipients and chemotherapy
patients, especially those in high risk ethnic groups (Penn, 1979). With the onset of
the AIDS epidemic, AIDS-KS is now the most common form of KS.
KSHV DNA has consistently been detected in all forms of KS and is found
in the spindle cells of the lesions (Boshoff et al., 1995). It is not known if KS spindle
cell proliferation is caused by viral gene products or by external inflammatory
cytokines induced by infection. In the early stages of the disease only a small
proportion of spindle cells are KSHV positive, however in the later stages of the
disease, 90% of spindle cells contain KSHV, suggesting the virus provides a growth
advantage to infected cells. It is thought that KSHV is a polyclonal hyperplasia in the
early stages, which develops into a true clonal malignancy as the disease progresses.
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1.2.2.2 Primary Effusion Lymphoma (PEL)
Primary effusion lymphoma is a B cell lymphoma and occurs as effusions in visceral
cavities. The majority of PEL patients are HIV positive with advanced
immunosuppression and 80% of cases contain latent EBV. PEL is thought to
originate from post-germinal centre B cells, due to the presence of hypermutated
immunoglobulin genes and markers of late stage B cell differentiation in PEL cells
(Matolcsy et al., 1998) (Gaidano et al., 1997). Much of the research on KSHV has
been undertaken using latently infected cell lines established from PEL, for example
BCP-1 (Boshoff et al., 1998) and BC-3 (Arvanitakis et al., 1996).
1.2.2.3 Multicentric Castleman's Disease (MCD)
MCD is a lymphoproliferative disorder characterised by lymphadenopathy, episodes
of fever and splenic infiltration (Peterson & Frizzera, 1993). MCD is more common
in HIV infected individuals, where it is often an aggressive disease. KSHV is present
in almost all cases of MCD in AIDS patients, and in around half of cases in HIV
negative patients. KSHV positive MCD cases form a distinct class of MCD, named
plasmablastic MCD. In this form of MCD large plasmablastic cells, all containing
KSHV are found. Unlike PEL cells, coinfection with EBV has not been found in
MCD plasmablasts (Dupin et al., 2000).
1.2.2.4 KSHV Genome
Initial study of KSHV infected cell lines was hampered by lack of a replicative tissue
culture system for this virus (Renne et al., 1996b). TPA treatment of the KSHV
infected cell line BCBL-1 resulted in an increase in the number of lytically infected
cells and the first visualisation of the KSHV virus by electron microscopy. The
complete genome of KSHV was sequenced by mapping genomic phage and cosmid
libraries from the PEL cell line BC-1 (Russo et al., 1996). The genome consists of a
140.5 kb long unique coding region, flanked by approximately 800bp terminal repeat
sequences with a high GC content. In the long unique region, 81 open reading frames
have been identified, including 66 with sequence similarity to herpesvirus saimiri
(HVS) ORFs. The ORFs of KSHV are arranged in the seven gene blocks, similar to
other herpesviruses. It was initially thought that KSHV was most closely related to
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the prototype gammaherpesvirus HVS. The sequencing of strains of rhesus
rhadinoviruses (Searles et al., 1999), (Alexander et al., 2000) has revealed that these
viruses are also closely related to KSHV.
The KSHV genome contains a large number of genes encoding homologues
of host genes (Neipel et al., 1997), including those involved in induction of cellular
proliferation, such as v-cyclin (ORF 72), v-G protein-coupled receptor (ORF 74), v-
interferon regulatory factor (K9). Genes involved in inhibition of apoptosis include
v-bcl-2 (ORF 16) (Cheng et al., 1997), fas-associated death domain (FADD)
interleukin-IB-converting enzyme (FLICE) inhibitory protein (v-FLIP) (ORF 71),
and v-IL6. Homologues of the chemokines Macrophage inflammatory protein
(MIP)-I, II and III are encoded by K6, K4, and K4.1. ORF 4 is a complement binding
protein homologue, and K14 encodes a neural cell adhesion molecule (NCAM)-like
protein (v-adh), which is homologous to the rat and human OX-2 membrane
antigens. It is thought that these cellular homologues enable KSHV to control host
cellular responses and avoid anti-viral responses (Jenner & Boshoff, 2002).
1.2.2.5 KSHV Latency
KSHV is latent in the majority of in vitro KSHV infected cell lines, existing in the
nucleus as closed circular episomal DNA (Renne et al., 1996a). It is thought that the
latent viral DNA is replicated by the host cell DNA replication machinery during cell
division. During mitosis, KSHV DNA is tethered by the TR sequences to histone HI
on host chromatin via the KSHV latent nuclear antigen (LANA), encoded by ORF 73
(Ballestas et al., 1999). This is similar to the function of EBV EBNA-1. The cells
infected by KSHV are thought to be pre-germinal centre B cells in the case of MCD,
post germinal centre B cells in the case of PEL and endothelial cell precursors in the
case of KS. These cell types all have a high proliferative potential, which is thought
to help the virus propagate its genome within the host. The virus displays a restricted
pattern of gene expression in the cells it infects (Zhong et al., 1996). All infected
cells so far have been shown to express the latent nuclear antigen (LANA), encoded
by ORF 73, v-cyclin (ORF72) and v-FLIP (ORF 71). These genes are adjacent in the
genome and are co-transcribed on two polycistronic RNAs, LT1 (LANA, v-cyclin,
v-FLIP) and LT2 (v-cyclin/v-FLIP) (Talbot et al., 1999).
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LANA has been shown to have a number of functions, as well as tethering
viral episomes to host chromosomes in a similar way to EBV EBNA-1. LANA has
been shown to bind p53, repressing its transcriptional activity and its ability to
induce apoptosis, (Friborg et al., 1999) this therefore may function to promote viral
oncogenesis by enhancing survival of infected cells. LANA has been shown to up
regulate a number of promoter sequences, including telomerase and can also
transactivate expression from LT1 and LT2, maintaining latent gene expression. In
addition, LANA has been shown to interact with the cellular proteins mSin3A,
SAP30 and CIR, components of a corepressor complex that recruits histone
deactylases to promoters (Krithivas et al., 2000). Deacetylation of histones is
associated with repression of transcription, it has been suggested that LANA1 may
act to repress ORF 50 expression, thus maintaining latency. LANA also binds to
RING3, one of the five human homologues of fsh of Drosophila and is
phosphorylated as a consequence of this interaction (Piatt et al., 1999). LANA causes
RING3 to relocate to nuclear heterochromatin regions, where it is thought that
LANA and RING3 might have a role in regulation of chromatin structure (Mattsson
et al., 2002).
The viral encoded v-cyclin is most closely related to cyclin D2. It can interact
with cellular cyclin dependant kinase (CDK) 6 to mediate phosphorylation of the
retinoblastoma protein, leading to entry of the cell into S phase. The function of the
anti-apoptotic v-FLIP is thought to be to protect cells against CD95 and tumour
necrosis factor receptor 1 (TNFR1) - mediated apoptosis and possibly therefore
against an attack by cytotoxic T lymphocytes (CTLs) (Djerbi et al., 1999). The
v-FLIP is expressed from an internal ribosome entry site (Bieleski & Talbot, 2001),
this enables the mRNA to bypass the inhibition of cap-dependant translation in G2/M
phase cell cycle arrested cells and ensures expression of v-FLIP throughout the cell
cycle.
1.2.2.6 KSHV Lytic Replication
The majority of the KSHV genome remains silent during latency. This is thought to
be due to methylation of promoter sequences such as that of the ORF 50 gene, which
is highly methylated in latent PEL cell lines (Chen et al., 2001). Lytic replication can
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be induced by treatment with either phorbol esters such as 12-O-tetradecanoyl
phorbol-13-acetate (TPA), or with sodium butyrate. KSHV ORF 50 or Rta is
necessary and sufficient to activate the lytic cycle (Gradoville et al., 2000). KSHV
gene expression has been analysed in the TPA stimulated PEL derived cell line BC-3
by the use of microarrays (Paulose-Murphy et al., 2001) (Jenner et al., 2001). The
first group of genes to be expressed after induction are those thought to encode
regulators of gene expression such as ORF 50, K8, ORF 57 and ORF45. These are
followed by genes involved in replication of DNA such as DNA polymerase (ORF9).
Structural genes and genes involved in virus maturation are expressed as late genes.
The ORFK8.1 encodes a viral envelope glycoprotein which is expressed late in
infection (Raab et al., 1998). This position in the genome is comparable to that of the
EBV open reading frames BZLF2 or BLLF1, encoding the glycoproteins gp42 and
gp350/220. The fully glycosylated protein gp35-37 has been shown to be part of the
viral envelope (Li et al., 1999c) and the serum of KS patients contains antibodies
specific for the K8.1 protein product. The envelope glycoprotein K8.1 has been
shown to interact with cell surface heparin sulphate (Birkmann et al., 2001) and is
required for efficient infection by HHV-8. It is thought that K8.1 may have functions
in viral attachment comparable to the HSV glycoprotein gC, which has weak
homology with EBV gp350/220.
A small percentage of cells in KS, PEL and PEL cell lines express markers of
lytic replication (Parravicini et al., 2000), in contrast to MCD where more infected
cells express lytic genes. The presence of lytic gene transcripts in PEL, MCD and KS
suggests lytic gene expression may be important in the pathogenesis of these
diseases. The finding that the KSHV from KS, PEL and MCD has demethylated
ORF 50 promoters compared to that from PBMCs supports this theory (Chen et al.,
2001). Lytic gene expression has been analysed in KS lesions. Some of the genes
expressed have been identified as possibly important in the pathogenesis of KS.
These are ORFK1, which can activate immuno-receptor tyrosine kinase signalling
(Lee et al., 1998), v-IRF-1 (ORFK9), which interferes with interferon signalling
pathways (Gao et al., 1997), and v-GCR (ORF 74), which acts as a constitutively
active CXC chemokine receptor and induces the secretion of vascular endothelial
growth factor (Schulz, 2000). In addition, a few virally infected cells in KS lesions
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express viral chemokine homologues, the anti apoptotic bcl-2 homologue and the
viral IL-6 homologue (Staskus et al., 1999). Viral IL-6 is also expressed in lytically
infected cells in MCD and in PEL lesions and is thought to contribute to B cell
growth in these lesions.
1.3. Animal Gammaherpesviruses
Animal gammaherpesviruses are of interest both in their own right as causes of
disease, and as models to illustrate the variability and similarity of genome
arrangements in gammaherpesviruses and to illustrate the differences in disease
causing mechanisms.
1.3.1 Herpesvirus Saimiri
Herpesvirus saimiri (HVS) is the prototype rhadinovirus. The natural host of HVS is
the squirrel monkey (Saimiri sciureus) in which it produces no apparent disease. The
virus causes T cell lymphomas in new world primates other than its natural host and
in experimental rabbits. Lymphoblastoid cell lines can be established from tumour
tissues of marmosets and owl monkeys experimentally infected with HVS (Johnson
& Jondal, 1981). These cell lines initially produce virus in 1 - 10% of cells (Schirm
et al., 1984), however after long term culture the ability to produce virus is lost.
When the cells convert to non-producer status the virus persists as episomal DNA
(Werner et al., 1977). The cells in the cultures are T lymphocytes with the properties
of natural killer cells. HVS causes malignant lymphomas in New Zealand white
rabbits and lymphoblastoid cell lines can be propagated from the lymphomas
(Ablashi et al., 1985). A T cell line that grew in vitro in the presence of IL-2 was
propagated from the spleen of a rabbit inoculated with HVS. Expression of HVS
early antigens could be induced by addition of n-butyrate or TPA, however late
antigens could not be induced and infectious virus could not be rescued from the cell
line. On further analysis HVS DNA present in the cell line was found to contain a
deletion in the unique region of the genome.
HVS can also transform human T lymphocytes to continuous IL-2 dependant
growth (Mittrucker et al., 1992). The transformed human T cells have the phenotype
of activated mature T cells and possess the functional capabilities of normal T
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lymphocytes in terms of proliferative response, lymphokine secretion and induction
of IL-2 receptors. It is thought that the HVS transformed T cells grow via an
autocrine mechanism in response to activation signals given by their CD2 molecules
during mutual cell to cell contact.
The genome of herpesvirus saimiri has been completely sequenced (Albrecht
et al., 1992a) and consists of a 113kb low GC (34.5%) content unique region,
flanked by about 35 non-coding high GC (70.8%) repeats of 1.4kb. The genomes of
HVS and EBV are predominantly collinear and homologous genes are in
approximately equivalent locations and relative orientations. At the left hand end of
the L-DNA are seven U-RNA genes termed the herpesvirus saimiri U-RNAs
(HSURs), including promoters for cellular U-RNAs. The HSURs are only expressed
in productively infected cells and it is thought that these may contribute to cell
transformation by degradation of cellular mRNAs involved in T cell growth
regulation (Myer et al., 1992). HVS contains two copies of the putative viral
formylglycineamide ribotide amino transferase (v-FGARAT) at ORF 3 and ORF 75
in opposite orientations. FGARAT is a cellular enzyme involved in purine synthesis
(Barnes et al., 1994). A number of other gammaherpesviruses such as BoHV-4
(Zimmermann et al., 2001) and A1HV-1 (Ensser et al., 1997) encode two FGARAT
ORFs in this same arrangement at opposite ends of the genome.
Sequence divergence of HVS isolates is found at the left hand end of the
unique L-DNA and is the basis of classification of HVS into subgroups A, B and C
(Medveczky et al., 1984). Variation in this region is correlated with differences in
the ability of the viruses to immortalise T lymphocytes in vitro and to produce
lymphoma in non-human primates. Viruses of both subgroups A and C immortalise
common marmoset T lymphocytes to IL-2 independent proliferation (Szomolanyi et
al., 1987). Subgroup C strains also immortalise rabbit and rhesus monkey
lymphocytes and can produce lymphoma in rhesus monkeys, as well as in New
World primates. The sequence variation is in open reading frames at the left hand
end of the genome, which are essential for herpesvirus saimiri oncogenicity (Duboise
et al., 1998).
HVS subgroup A contains a single ORF, saimiri transforming protein A
(STP-A) (Jung et al., 1991), whereas sub group C contains two genes at this position,
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STP-C, a divergent form of the STP gene and the tyrosine kinase interacting protein
Tip. The protein Tip has been shown to physically interact with the protein tyrosine
kinase Lck in HVS transformed cells (Jung et al., 1995) inducing a constitutive
action of Lck. It is thought that constitutive activation of Lck by Tip positively
regulates the phosphorylation and activation of the signal inducer and activator of
transcription (STAT) 3 protein, inducing transcription of genes involved in T cell
growth (Isakov & Biesinger, 2000). STP-A interacts with a cellular src kinase (Lee et
al., 1997) whereas STP-C interacts with cellular ras (Jung & Desrosiers, 1995).
Other genes possibly contributing to stimulation of T cell proliferation by
herpesvirus saimiri include ORL72, a cyclin homologue (Nicholas et al., 1992) and
ORE 74, a G protein coupled receptor homologue with homology to the interleukin-8
receptor (Ahuja & Murphy, 1993). In addition to the genes required for stimulation
of cell proliferation, herpesvirus saimiri also encodes two potential inhibitors of
apoptosis. ORE 16 encodes a functional homologue of the bcl-2 oncogene (Nava et
al., 1997) in common with EBV and KSHV. ORE 71 encodes a viral FLICE
inhibitory protein (v-FLIP). This gene has been found to prevent apoptosis, but is
dispensable for viral transformation of T cells in vitro and for pathogenicity in
cottontop tamarins in vivo (Glykofrydes et al., 2000). Two other HVS genes
encoding cellular homologues are ORF4 (Albrecht & Fleckenstein, 1992) and ORF
15 (Albrecht et al., 1992b). These ORFs encode glycoproteins related to complement
control proteins, which down regulate complement activation.
1.3.2 Murine Gammaherpesvirus-68 (MHV-68)
MHV-68 was first isolated from a bank vole in Slovakia (Blaskovic et al., 1980) and
is used as a small animal model for the study of gammaherpesvirus pathogenesis. In
contrast to many other gammaherpesviruses, MHV-68 will undergo productive
replication in tissue culture, also the availability of transgenic "gene knockout" mice
enables manipulation of the host immune system. The in vivo function of viral genes
can also be studied by production of recombinant viruses for infection of mice.
Mice inoculated intranasally with MHV-68 establish productive infection in
the lung in alveolar epithelial cells, causing an interstitial and peri-bronchiolar
pneumonia (Sunil-Chandra et al., 1992a). The virus then spreads via lymph nodes to
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the spleen, where it establishes latency in germinal centre B cells (Sunil-Chandra et
al., 1992b). MHV-68 has also been shown to establish latency in macrophages and
dendritic cells (Flano et al., 2000). The virus has also been shown to persist in the
latent form in lung epithelial cells (Stewart et al., 1998). Establishment of latency in
the spleen is associated with splenomegaly and a mononucleosis similar to infectious
mononucleosis found in humans after primary infection with EBV (Tripp et al.,
1997). MHV-68 infection leads to the development of lymphomas in mice (Sunil-
Chandra et al., 1994). A mouse B cell lymphoma was used to propagate the MHV-68
infected B cell line Sll (Usherwood et al., 1996). This cell line carries MHV-68
predominantly in the latent form and is considered to be analogous to EBV positive
Burkitt's lymphoma cell lines and KSHV positive PEL cell lines. The Sll cell line
has been useful for studying MHV-68 latency in vitro.
The genome of MHV-68 has been completely sequenced (Virgin et al.,
1997), and displays the layout typical of a gammaherpesvirus with blocks of
conserved genes separated by virus specific genes. In common with other
gammaherpesviruses, MHV-68 has a number of genes of cellular origin and also
contains homologues of other viral genes which may be important in pathogenesis.
ORF4 has homology with various complement control proteins. MHV-68 encodes a
D-type cyclin homologue, in common with HVS and KSHV and an IL-8 homologue
(v-GPCR) as in KSHV. Mil has homology with bcl-2 and has been shown to be
functional (Roy et al., 2000). During lytic infection there is a conventional cascade
of gene expression, immediate early genes such as ORF 50 and ORF 73 (LANA),
early genes such as TK and late genes such as gpl50 have been identified.
The glycoprotein gpl50 is equivalent to gp350/220 of EBV (Stewart et al.,
1996). A virus glycoprotein has also been identified in this genomic position in all
gammaherpesviruses studied (bovine herpesvirus 4, HVS, equine herpesvirus-2,
KSHV). In common with gp350/220, antibodies to this protein neutralise virus
infectivity in the absence of complement. The glycoprotein gpl50 is translated from
an unspliced open reading frame in contrast to that of gp350/220, where splicing
occurs to generate gp220. Gpl50 is glycosylated and in infected cells is localised to
the nuclear margins, in the cytoplasm and on the cell surface. Gpl50 is also located
on the surface of the virion. At the left hand end of the viral genome is a group of
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genes unique to MHV-68; many of these genes are associated with MHV-68 latency.
These include four protein-coding genes named Ml to M4 and eight tRNA-like
sequences. The M3 gene encodes a secreted chemokine binding protein that is
expressed during acute infection and persistence (Bridgeman et al., 2001). Ml has
been shown to be non-essential for lytic replication in vitro and for latency in vivo
(Clambey et al., 2000). M2 is expressed during latency in vitro and in vivo (Husain et
al., 1999). The tRNA-like genes are expressed during productive infection in vivo
and are expressed in splenic germinal centres in latently infected mice (Bowden et
al., 1997). The tRNAs therefore are considered to be a marker for latent infection,
however their function is unknown. Study of the virus MHV-76, a deletion mutant of
MHV-68 lacking the M genes and all of the viral tRNA like genes emphasised this
region of the genome as important for viral pathogenesis (Macrae et al., 2001), as
this virus was less pathogenic in vivo and infected mice had lower levels of latency in
the spleen.
1.4 Gammaherpesviruses of Veterinary Relevance
1.4.1 Equine Herpesvirus-2 (EHV-2)
EHV-2 is one of the five recognised herpesviruses for which the horse is the natural
host. The biological properties of EHV-2 and 5 initially placed them as
cytomegaloviruses, however sequence analysis of random fragments of their
genomes led them to be re-classified as gammaherpesviruses. EHV-2 is widespread
and can be isolated from the leukocytes of most horses (Telford et al., 1993)
however it has been associated with immunosuppression in foals, respiratory tract
disease and poor performance (Browning et al., 1988). EHV-2 has also been
suggested to have a role in reactivation of latent EHV-1 and EHV-4 (Welch et al.,
1992).
Compared to what is known about EBV and KSHV, little is known about
EHV-2 infection in the natural host. EHV-2 can be grown in tissue culture however
and the genome has been fully sequenced (Telford et al., 1995). The genome of
EHV-2 is 184 kb in size and consists of a 149kb unique region and a 17.5 kb direct
repeat. The GC content of the genome is similar in the unique (58%), and repeat
(55%) regions of the genome. In contrast, the HVS genome has a GC content of 35%
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in the unique region and 71% in the terminal repeat region. The genome is collinear
with HVS and EBV, but shares more similarity with HVS. Genes which have no
counterparts in HVS are named El to E10. Eight proteins in the genome have
counterparts in HVS but not in EBV. Four of these have sequence homology (ORFs
10, 11, 70, and 74) and four have positional homology (ORFs 12, 13, 28 and 74).
HVS and EBV ORF 51 genes both encode predicted glycoproteins and are
positional homologues of gp350/220 of EBV. Only one protein of EHV-2 has a
homologue in EBV but not in HVS. This is the BCRF1 homologue ORF E7,
encoding an IL-10 like protein (Vieira et al., 1991). The amino acid sequence is
highly conserved between the human, EBV and EHV-2 proteins. EHV-2 encodes
three potential G-protein coupled receptors. One of these encoded by ORF 74, is
related to the mammalian chemokine receptor for IL-8 and to ORF 74 of HVS,
suggesting a similar function. ORF El has homology with the human 6 chemokine
receptor CKR1 and with the HCMV US28 protein, which also binds 8 chemokines
(Neote et al., 1993). EHV-2 encodes two proteins which are potentially involved in
the prevention of apoptosis of infected cells. ORF E4 encodes a bcl-2 homologue
similar to the BALF1 homologue of EBV. The EBV gene BALF1 has been shown to
not have any apoptotic activity of its own, however it acts as a negative regulator of
the bcl-2 homologue BHRF1 (Bellows et al., 2002). It is not known if the E4 gene of
EHV-2 is functional. The E8 ORF encodes v-FLIP that has been shown to bind to the
caspase-8 prodomain and block Fas and TNFR1 induced apoptosis (Bertin et al.,
1997).
An unusual feature of the EHV-2 genome is that approximately a third of the
sequence does not appear to encode proteins. This includes most of the terminal
repeat and adjacent sequences and regions containing the inverted repeat sequences
IR1 and IR2. Sequence analysis of these regions has revealed no homology to known
ORFs. It may be that the regions are transcribed into highly spliced mRNAs, which
are translated into proteins lacking cellular or viral homologues. It has also been
suggested that these regions may be transcribed into non-translated RNAs, similar to
the HVS HSURs or EBV EBERs, however these small RNAs are insufficiently
conserved to allow identification of counterparts in EHV-2 by sequence analysis.
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Clearly transcriptional analysis of these regions would be required to resolve the
question of their function.
1.4.2 Bovine Herpesvirus- 4 (BoHV- 4)
Bovine herpesvirus-4 was first isolated in Europe from cattle with respiratory and
ocular disease (Bartha et al., 1966). The virus has since been isolated from cattle
with abortion, metritis, pneumonia, diarrhoea and mammary pustular dermatitis,
however the role of BoHV-4 in the pathogenesis of these diseases is not clear and
BoHV-4 is not associated with any lymphoproliferative diseases. Bovine
herpesvirus-4, in common with EHV-2, was originally classified as a betaherpesvirus
due to its biological properties. It has now been reclassified as a gammaherpesvirus
as a result of sequence analysis of parts of the virus genome (Bublot et al., 1992).
BoHV-4 establishes persistent infections in its natural host (Osorio & Reed,
1983) and in experimentally infected rabbits (Osorio et al., 1982). It is thought that
the site of persistence is a cell of the macrophage/monocyte lineage, however little
else is known about persistence in the host. BoHV-4 has been demonstrated in the
cell fraction of milk from infected cattle and is thought that virus may be transmitted
to calves by this route (Donofrio et al., 2000). In contrast to other
gammaherpesviruses such as EBV, BoHV-4 replicates in tissue culture and cell lines
such as Georgia bovine kidney cells and baby hamster kidney cells can be used for
its growth.
The genome of BoHV-4 has been completely sequenced and established as
that of a gammaherpesvirus (Zimmermann et al., 2001). The genome is collinear
with other gammaherpesviruses and consists of a long unique region flanked by
terminal repeats. The unique region contains two regions of multiple direct repeats,
the number and length of these differing between isolates (Bermudez-Cruz et al.,
1997). The unique genes are named Bol to Bol7. In general the genome of BoHV-4
differs from other gammaherpesvirus genomes in a reduced number of potential
transforming genes or cellular homologues. No cytokine or cytokine receptor
encoding genes are present as are found in HVS, HHV-8 and EHV-2 and no
G protein-coupled receptor homologues are present.
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BoHV-4 contains two genes encoding potentially antiapoptotic proteins, a
bcl-2 homologue (ORF 16) and a death effector domain containing v-FLIP gene
(ORF 71). The v-FFIP gene has been shown to inhibit Fas and TNF 1 induced
apoptosis in common with other v-FFIPs such as ORF E8 of EHV-2 and the KSHV
v-FFIP. Also of interest is the fact that the virus contains two copies of the putative
viral formylglycineamide ribotide amino transferase (v-FGARAT) at ORF 3 and
ORF 75 in common with HVS and A1HV-1. Bol7 encodes a viral 6-1,6-N-
acetylglucosaminyltransferase (B-l,6GnT), which is transcribed during viral
replication and is functionally active (Vanderplasschen et al., 2000). No other virus
is known to encode this gene and it has been suggested to be necessary for
replication of the virus in mononuclear cells, or may be involved in viral immune
escape. The gene BolO encodes a glycoprotein and is predicted to be spliced. The
gene is positionally homologous to gp350/220 of EBV and the ORF 51 gene of HVS
and EHV-2. Fittle is known about latent gene expression of BoHV-4, however a
bovine macrophage cell line supporting persistent BoHV-4 infection has recently
been established in order to investigate latency in vitro (Donofrio & van Santen,
2001). Since the genome of BoHV-4 is less complex than other gammaherpesviruses,
and the virus can be grown in tissue culture, it has been suggested that BoHV-4 may
be of use as a gene therapy vector. The availability of the rabbit as a small animal
model has resulted in interest in using the genome to insert other gammaherpesvirus
genes in order to investigate their in vivo function.
1.4.3 Ovine Herpesvirus-2 and Alcelaphine Herpesvirus-1
These viruses cause the disease malignant catarrhal fever in ruminants worldwide
and will be discussed in detail in a later section.
1.5 Identification of New Gammaherpesviruses
The genes involved in gammaherpesvirus replication are highly conserved. This fact
has been used to develop a technique called consensus PCR (VanDevanter et al.,
1996). The method relies on using highly conserved amino acid motifs contained in
the DNA polymerase genes of herpesviruses as the basis for PCR amplification using
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degenerate primers. Consensus PCR has been used to partially sequence the
polymerase genes of several existing herpesvirus isolates and to characterise new
herpesviruses similar to KSHV in macaque species (Rose et al., 1997).
Recently several new ruminant gammaherpesviruses have been identified
using consensus PCR. Herpesviral DNA was amplified from the spleen and
peripheral blood leukocytes (pbl) of white tailed deer in an outbreak of malignant
catarrhal fever (Li et al., 2000). PCR amplification using primers specific for
OvHV-2 or A1HV-1 failed to amplify viral DNA, however viral DNA was amplified
using degenerate primers for a conserved region of a herpesviral DNA polymerase
gene. The new herpesvirus sequence exhibited 82% identity to OvHV-2 and 71% to
A1HV-1. The technique was used to detect a new bovine gammaherpesvirus bovine
lymphotropic herpesvirus-1 (BLHV-1) (Rovnak et al., 1998), which is thought to
have a possible role in the pathogenesis of enzootic bovine leucosis caused by bovine
leukaemia virus (BLV). A new herpesvirus of goats was identified using consensus
PCR and named caprine herpesvirus-1 (Li et al., 2001b), (Chmielewicz et al., 2001).
The virus is thought to be found worldwide. It is endemic in goats and has recently
found to be associated with the disease malignant catarrhal fever in sika deer
(Crawford et al., 2002).
1.5.1 Porcine Lymphotropic Herpesviruses
A search for new gammaherpesviruses of pigs was initiated due to concerns over the
use of porcine organs for xenotransplantation and the possible risk of transmission of
porcine pathogens to the transplant recipient. The use of consensus PCR using
primers designed against the herpesvirus DNA polymerase gene identified two novel
porcine herpesviruses, which were named porcine lymphotropic herpesvirus (PLHV)
1 and 2 (Ehlers et al., 1999). The viruses were identified from peripheral blood
mononuclear cells (PBMCs) and spleen of pigs. Initial analysis of the amino acid
sequence of the DNA polymerase genes of the two herpesviruses showed PLHV-1
shared 68% identity with alcelaphine herpesvirus-1 and ovine herpesvirus-2, and
67% identity with BLHV-1. PLHV-1 and PLHV-2 differ from each other by 8% at
the amino acid level. PLHV-1 and 2 have not been found to be associated with any
disease under natural conditions, however a porcine herpesvirus associated with
post-transplant lymphoproliferative disease in miniature swine following allogeneic
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haematopoietic stem cell transplantation (Huang et al., 2001) was found to be
identical to PLHV-1. In order to investigate the molecular mechanisms by which
PLHV-1 may cause PTLD, sequence of the genome was required. This was difficult
however, since neither a lytic cell culture system or a permanent cell line harbouring
PLHV-1 was available.
A 73kb section of the PLHV-1 genome PLHV-1 sequence was obtained by
PCR-based genome walking from the splenic DNA of a domestic pig that was PCR
positive for PLHV-1 but not for PLHV-2 (Goltz et al., 2002). The section of the
genome sequenced showed a genome arrangement typical of a gammaherpesvirus,
however a number of non-conserved genes were found. A homologue of EBV
BALL1 and EHV-2 E4 is present; this ORE has homology with bcl-2. The PLHV-1
ORE A5 is related to ORE A5 of A1HV-1 and BILF1 of EBV. This ORF is predicted
to encode a viral GPCR similar to ORF 74 of KSHV. The PLHV ORF A6 shows low
homology to the positional homologues of A1HV-1 ORF A6, EBV BZLF1 and
KSHV ORF K8. ORF A7 was most closely related to ORF A7 of A1HV-1 and ORF
BZLF2 of EBV, and ORFA8 was most closely related to ORF A8 of A1HV-1 and
BLLF1 of EBV.
ORF 3 of PLHV-1 encodes a homologue of the cellular enzyme FGARAT.
Homologues are found in the same position in A1HV-1, EHV-2, HVS and HVA. It is
not known if this virus also contains a FGARAT homologue at ORF 75 like HVS
A1HV-1 and BoHV-1 as the sequence of this region was not known. At the amino
acid level, almost all PLHV-1 genes were closely related to A1HV-1. The sequence
of PLHV-1 gB was contained in the new sequence. Phylogenetic analysis of gB
sequences confirmed the findings from analysis of the DNA polymerase sequence,
that PLHV1 was closest to A1HV-1, OvHV-2, BLHV and CprHV-2.
The genome of PLHV-1 was found to be transcriptionally active in the lymph
nodes of pigs with PTLD but not in normal pigs. This fact has been very useful in
terms of study of PTLD, as it has enabled transcriptional analysis of areas of the
PLHV-1 genome. Transcription of the PLHV-1 genes E4/BALF1, ORF 3
(v-FGARAT), ORF 8 (gB), ORF A5 (v-GPCR), ORF 29 (terminase), ORF 45 (IE
protein), ORF 50a & b (IE protein), A7 (glycoprotein) was found in PTLD pigs.




into 3 exons in the same way as has been shown for EBV ORF BZLFE PLHV-1 is
thought to infect B cells in pigs, although this has not been definitively proven. It is
thought that expression of ORFs such as the v-GPCR in PTLD may be involved in
the induction of cell proliferation in the same way as the KSHV v-GPCR.
It is hypothesised that PLHV-1 might be involved in the pathogenesis of
PTLD in miniature swine and therefore study of the sites of latency and transmission
are planned in order to further characterise natural infection among pigs. PLHV-1
infection in pigs may be a useful large animal model system for human PTLD. Since
the genome of PLHV-1 is closely related to that of A1HV-1 and OvHV-2, sequence
and transcriptional analysis provides valuable information for comparison of the
function and pathological mechanisms of these viruses.
1.6 Malignant Catarrhal Fever
Malignant catarrhal fever (MCF) is a disease of cattle, deer and other ruminants,
characterised by lymphoproliferation and tissue necrosis (Reid et al., 1984). The
disease is almost invariably fatal and is found worldwide.
MCF is mostly found in two forms, both of which involve an asymptomatic
carrier host acting as a reservoir of disease. In sub-Saharan Africa, the blue
wildebeest acts as a reservoir of infection (Plowright, 1960). This form of the disease
is referred to as wildebeest associated MCF (WA-MCF). In the rest of the world,
sheep are thought to be the main reservoir of infection, therefore this form is referred
to as non-wildebeest associated MCF (NWA-MCF) or sheep associated MCF (SA-
MCF). MCF affected animals are not infectious to other animals in natural conditions
and are thought be dead end hosts.
1.6.1 Importance and Incidence of MCF
Outbreaks of Wildebeest associated MCF in Africa frequently involve many cattle.
The disease also occurs in zoos and game farms worldwide where wildebeest
(Connochaetes taurinus) are kept. An outbreak of MCF in a Los Angeles zoological
park resulted in the deaths of four exotic ungulates over a 2 month period (Meteyer et
al., 1989). Two Chinese water deer (Hydropotes inermis), a gerenuk (Litocranius
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walleri) and a red flanked duiker (Cephalophus rufilatus) died. It was thought that
the source of infection was a newly purchased wildebeest bull.
Sheep associated MCF occurs worldwide wherever domestic sheep are kept.
The susceptibility of affected species is variable; European cattle are relatively
resistant and incidence is mainly sporadic, although infection can occur in outbreaks
over weeks, months or even years in which substantial losses may occur (Twomey et
al., 2002) (Otter et al., 2002). Other species such as Bali cattle are particularly
susceptible and must be kept separately from sheep if losses are to be avoided.
(Pierson et al., 1979, Taneichi et al., 1986). Bison are also particularly susceptible to
MCF and large outbreaks of SA-MCF have occurred in bison feedlots in North
America (OToole et al., 2002). The problem is such that MCF is the most important
acutely fatal infectious disease in the commercial bison industry. Similar problems
have occurred with SA-MCF in zoos where sheep have been kept with a range of
susceptible ruminants (Li et al., 1999b). MCF is also a problem in deer. When the
farming of red deer was first established in Europe and New Zealand, major
outbreaks occurred affecting up to 50% of the herd (Reid et al., 1979), however it
generally now occurs sporadically affecting individual animals. Pere David's deer
are particularly susceptible to MCF and attempts to farm this species of deer were
abandoned due to losses occurring from MCF (Reid, 2000). MCF has been seen in
numerous outbreaks in white-tailed deer (Brown & Bloss, 1992, Shulaw & Oglesbee,
1989), and substantial losses have occurred. MCF has also been reported affecting
pigs, but only in Scandinavian countries (Loken et al., 1998). MCF was first reported
in Japan in 1956 (Fujimoto, 1958). Enzootics of SA-MCF in beef cattle in Japan
killed 5 cattle, all of which had been housed adjacent to two ewes and their lambs
(Taneichi et al., 1986).
1.6.2 Clinical Signs of MCF
The incubation period of MCF in natural infection varies from 3 to 8 weeks and after
artificial infection averages 22 days. The clinical course of MCF varies from acute to
chronic (Reid et al., 1984) and is almost invariably fatal, although there have been
reports of recovered cases (O'Toole et al., 1997, Penny, 1998). Malignant catarrhal
fever is described as occurring in 2 forms; the "head and eye" form and the peracute
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alimentary tract form, although these are extremes of a range of clinical signs,
(Radostits et al., 1994).
In disease in cattle the "head and eye form" predominates (Figure 1.6). The
signs seen are anorexia, persistent pyrexia, lymphadenopathy, profuse mucopurulent
nasal discharge, dyspnoea due to obstruction of the nasal cavities with exudate,
ocular discharge and congestion of the scleral vessels, corneal opacity, necrosis of
the nasal mucosa and large patches of necrosis on the muzzle. Later nervous signs
such as incoordination can be seen and in longer duration forms of the disease
exudative discharge from the skin can be seen. Occasionally horns and hooves can be
shed. Typically the disease lasts 3 - 7 days and rarely to 14 days, however in cattle
there have been reports of the disease taking a more chronic course. A chronic case
of MCF was reported by O'Toole et al., (1997) which survived for 280 days until
euthanasia. Recovered cases remain persistently infected with OvHV-2 and are
usually left with corneal oedema and a chronic keratitis. In deer the more acute form
of the disease is often seen. The symptoms are those of acute gastrointestinal disease,
haemorrhagic diarrhoea, depression and anorexia. The affected animal deteriorates
rapidly over 12-24 hours and often animals will simply be found dead.
Unusual presentations of MCF can be seen. A case of MCF was reported in a
yearling bull in which the main sign observed was an exudative discharge from the
skin, along with pyrexia and anorexia (Holliman et al., 1994). The bull died 17 days
after the initial onset of symptoms and tested PCR positive for OvHV-2 DNA.
Histological findings in the skin were also typical of MCF, making a false positive
PCR result less likely.
1.6.3 Cause of MCF and Disease Transmission
WA-MCF is caused by the gammaherpesvirus Alcelaphine Herpesvirus 1 (A1HV-1)
(Plowright, 1960), which has been propagated in vitro in monolayered cells of
bovine origin (Plowright, 1963). All adult wildebeest tested have been shown to have
indirect immunofluorescence (IIF) and virus neutralising (VN) antibodies to A1HV-1
(Plowright, 1967). Most wildebeest calves are infected with A1HV-1 before 3 months
of age and virus is excreted in the nasal and lachrymal secretions (Mushi, 1980).
Virus has also been isolated from wildebeest foetuses, suggesting infection in utero
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Figure 1.6 The Clinical Signs ofMalignant Catarrhal Fever
A
B
The photographs illustrate some of the clinical signs of cattle
with the head and eye form of MCF. A shows catarrhal
inflammation and erosion of the nasal mucosa, whilst B shows
a purulent nasal discharge (Photographs kindly supplied by Dr
Hugh Reid, Moredun Research Institute).
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may be possible. It is thought that perinatal calves are the main source of infectious
A1HV-1 where WA-MCF is found. In Africa the seasonal occurrence of MCF
normally parallels the calving period of wildebeest. Wildebeest cows may also
excrete virus in late pregnancy (Plowright, 1965) or if stressed by confinement,
therefore these may also be a source of infection (Rweyemamu et al., 1974).
Sheep were long suspected to be associated with the incidence of NWA-
MCF, due to circumstantial evidence linking them with outbreaks of the disease
(Piercy, 1954). Sheep sera were later shown to have IIF antibodies to A1HV-1. The
pattern of immunofluorescence observed was similar to that detected from sera for
wildebeest, or from A1HV-1 infected cattle (Rossiter, 1981). The sheep sera were,
however not virus neutralising. It was also shown that cattle with non-wildebeest
associated MCF possessed IIF antibodies to A1HV-1 which were not virus
neutralising (Rossiter, 1983). Immunoblotting analysis of sera against the structural
proteins of A1HV-1 showed that wildebeest sera reacted with all proteins, but sheep
sera and sera from cattle with NWA-MCF only reacted with a subset of the proteins
(Herring et al., 1989). It was concluded from these studies that sheep carry a virus
antigenically related to A1HV-1. It has not been possible to culture a virus from the
tissues of animals with SA-MCF, however it has been possible to culture
lymphoblastoid cell lines from the tissues of MCF affected animals (Reid et al.,
1983). These cell lines transmit disease and viral DNA with homology to A1HV-1
has been detected in the cell lines (Bridgen & Reid, 1991). As a result of this finding
SA-MCF was proposed to be caused by a herpesvirus, which was named Ovine
herpesvirus-2 (OvHV-2).
A PCR test was developed from the limited sequence available (Baxter et al.,
1993). This has been useful in the diagnosis of MCF and also for testing of sheep for
the presence of OvHV-2 sequences. Use of the PCR test confirmed that most sheep
are infected with the virus and it is thought that most sheep worldwide are infected
with OvHV-2 (Baxter et al., 1997). Transmission of SA-MCF is associated with
lambing time (Selman et al., 1978). It is assumed that transmission of OvHV-2 to
susceptible animals from sheep occurs after close contact with sheep, however




Other ruminant gammaherpesviruses similar to A1HV-1 and OvHV-2 have
been identified, some of which have been associated with disease. MCF has been
recently found in sika deer infected with a recently identified gammaherpesvirus of
goats named caprine herpesvirus-2 (Section 1.5). A new gammaherpesvirus causing
MCF in white tailed deer has recently been identified (Li et al., 2000); the virus was
closely related to both A1HV-1 and OvHV-2. MCF killed 5 out of 6 white tailed deer
in a North American zoo and the sixth deer was euthanased. The herpesvirus was
identified in each deer by PCR, although the reservoir host for the virus was not
identified. Many other wild ruminants have been found to be carriers of
gammaherpesviruses and are resistant to clinical disease. A gammaherpesvirus has
been isolated from a roan antelope and named hippotragine herpesvirus-1 (HipHV-1)
(Reid & Bridgen, 1991). A virus Alcelaphine herpesvirus 2 has been isolated from
hartebeest (Reid & Rowe, 1973) and topi (Mushi et al., 1981). An outbreak of an
MCF like disease in Barbary Red deer was recently reported to be associated with a
herpesvirus closely related to A1HV-2, which was thought to have originated from
Jackson's hartebeest (Klieforth et al., 2002).
A recent study of ruminants in a wildlife park showed that antelope of the
genus Oryx were infected with a gammaherpesvirus. Scimitar-horned oryx and
gemsbok had antibodies which cross-reacted with A1HV-1 and a high prevalence of
gammaherpesvirus DNA was detected using primers against herpesvirus DNA
polymerase (Flach et al., 2002). A herpesvirus was isolated from a scimitar-horned
oryx which caused MCF when inoculated into rabbits. It is not known if this
herpesvirus causes natural MCF.
1.6.4 Control of MCF
At present no vaccine is available for MCF, therefore control is based around
separation of susceptible animals from wildebeest or sheep especially around
lambing or calving time. This is particularly difficult in zoos and wildlife parks,
where separation of susceptible animals from wildebeest or sheep may not be
practical. It is also becoming more difficult in Africa to remove cattle from areas
where wildebeest graze due to settlement and use of traditional grazing areas for
arable land. A vaccine to protect susceptible animals against SA-MCF and WA-MCF
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would therefore be useful, however so far attempts to develop an effective vaccine
have failed. In the case of SA-MCF cattle and sheep are often grazed together, yet
the incidence of disease is generally sporadic. Outbreaks can however, occur and in
these cases advice is to dispose of the whole sheep flock for slaughter (Reid, 2000).
Of particular concern is the new herpesvirus of white tailed deer (Li et al., 2000)
(Kleiboeker et al., 2002), as a reservoir host for this virus has not been identified thus
making planning of control measures difficult.
A number of different approaches to development of a vaccine have been
used. Initial attempts at vaccination of cattle against WA-MCF involved inoculation
of living or inactivated tissue culture grown A1HV-1, combined with Freund's
incomplete adjuvant on two occasions at 6-8 weeks apart. High levels of virus
neutralising antibody was detected in vaccinated animals, however no protection
against disease was observed after challenge with virulent A1HV-1. This indicated
that humoral immunity alone was not important in protection against A1HV-1
(Plowright et al., 1975). In addition, the avirulent WC11 strain of A1HV-1 did not
reliably protect cattle against virulent virus (Plowright, 1968). Rabbits were
vaccinated with the inactivated virulent C500 strain of A1HV-1 (Russell, 1980) and 4
out of 6 rabbits remained healthy up to 5 months after two challenges with C500
A1HV-1. This raised hopes that vaccination with inactivated C500 A1HV-1 may be of
use in protecting cattle. More recently a study by Mirangi (1991) showed that it was
possible to protect cattle against the virulent C500 strain of A1HV-1, by a vaccination
programme using a strain of A1HV-1 (707K) isolated from WA-MCF affected cattle
in America. Protection was not always achieved however, and multiple injections of
the 707K virus were required to induce protection which in itself risked induction of
an MCF-like disease.
1.6.5 Experimental Transmission of MCF
WA-MCF was first transmitted to cattle from blood of a normal wildebeest, thus
establishing wildebeest as a source of infectivity for cattle (Mettam, 1923).
WA-MCF can also be transmitted experimentally to cattle and to rabbits by
inoculation of intact cells or blood from infected animals (Plowright, 1968). This
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form of MCF has also been passed to hamsters, rats and guinea pigs (Jacoby et al.,
1988). Sheep associated MCF has also been passed to hamsters (Buxton et al., 1988).
Experimental transmission of SA-MCF proved more difficult and
transmission from affected cattle to healthy cattle is achieved only irregularly
(Selman et al., 1978). Experimental transmission of SA-MCF to rabbits was first
achieved by intraperitoneal injection of a suspension of spleen and mesenteric lymph
nodes from an MCF affected deer (Buxton & Reid, 1980). Transmission of SA-MCF
from cattle and deer to cattle, deer, rabbits and hamsters was later reported (Reid et
al., 1986). MCF in rabbits is similar in clinical course to the disease seen in cattle
and deer, therefore rabbits have proved very useful as an experimental model of
disease. Transmission of SA-MCF has been maintained continuously in rabbit to
rabbit passages with more than 100 serial transfers and infectivity demonstrated in
culture cells, but it has not been possible to identify the causal agent in these cells
(Reid et al., 1984). MCF has also been recently transmitted experimentally from
sheep to Japanese deer by housing in close contact with sheep (Imai et al., 2001).
1.6.6 Pathology of MCF and Post Mortem Findings
Malignant catarrhal fever is a multisystemic disease involving many tissues. Post
mortem findings vary between cases. In animals which die of acute MCF gross post
mortem changes may not be obvious, however generally the gross changes involve
extensive inflammation and necrosis of the mucosal surfaces (Jubb et al., 1993). The
nasal turbinates, larynx and trachea are hyperaemic and often have extensive
catarrhal exudates. There are often erosions and ulcerations of the mucosa of the
respiratory tract and the tongue may be ulcerated. The lungs are usually oedematous
and emphysaematous, but in peracute cases they may appear normal. Lymph nodes
are generally enlarged and oedematous. The liver and spleen are congested and
enlarged. Haemorrhage, hyperaemia and thickening of the bladder wall are seen. In a
study of Indonesian swamp buffalos with MCF, epicardial and pericardial
haemorrhages were consistently found, however this finding is not often reported in
domestic cattle (Floffmann et al., 1984). Small foci of interstitial nephritis are
sometimes seen in the kidneys. Erosions and ulcerations are also found in the
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intestinal mucosa. The intestinal lesions tend to be more severe and extensive in deer,
where they can extend from the duodenum to the rectum (Reid et al., 1984).
Histologically, lesions are characterised by proliferation of lymphoid tissues,
mononuclear cell infiltration of non-lymphoid tissues and inflammation including
vasculitis and necrosis (Figure 1.7). A detailed study of the vascular lesions of MCF
in calves was carried out (Liggitt & DeMartini, 1980a). Vascular lesions are found in
the small and medium arteries of many tissues. Commonly affected were vessels in
the gastrointestinal (Gl) tract, oral epithelium, eye, kidney, liver, lung and brain. The
principle lesion of the vasculitis was lymphoid cell infiltration of the adventitia, with
medial and intimal changes. The infiltrating mononuclear cells were mostly
lymphocytes and lymphoblasts and fewer monocytes and macrophages.
In epithelial tissues there were foci of lymphoid accumulation, epithelial cell
degeneration and necrosis (Liggitt & DeMartini, 1980b). The lesions were found in
the epithelia of the GI tract, biliary epithelium, conjunctiva, lachrymal, pancreatic
and salivary gland ducts, respiratory tract, urinary bladder and choroid plexus. The
infiltrating cells were mononuclear cells, mainly lymphocytes, lymphoblasts and
macrophages. In cattle that survive MCF for a prolonged period or appear to recover,
the vasculitis may progress to a proliferative arteritis, with proliferation of the
smooth muscle cells of the vessel wall (OToole et al., 1995). Severe ocular lesions
such as erosive keratoconjunctivitis, lymphocytic retinitis and anterior uveitis are
also typical of MCF (Whiteley et al., 1985).
Study of the pathology of rabbits infected with SA-MCF (Buxton et al.,
1984), described interstitial accumulations of lymphocytes occurring in the early
stages of disease, the proliferative response being hyperplastic rather than neoplastic
with retention of normal tissue architecture. Tissue destruction occurred only in the
later stages of disease. In general rabbits infected with SA-MCF have more severe
lesions in the mesenteric lymph nodes compared with rabbits infected with A1HV-1,
which have more severe lesions in the popliteal and submandibular lymph nodes.
The spleen was enlarged in all cases of MCF in rabbits. Treatment of the rabbits with
the T cell suppressor cyclosporin A did not affect the course of disease, showing the




Figure 1.7 Pathology of MCF
Necrotic hepatocytes
Lymphocytic infiltration
The photograph shows a haematoxylin and eosin stained section
of the liver of a cow with MCF. The section shows lymphocytic
inflitration and necrosis of hepatocytes.
54
CHAPTER 1 INTRODUCTION
1.6.7 Target Cells and Sites of Viral Replication
The tissues of rabbits infected with WA-MCF were tested for infectivity using calf
thyroid cell monolayers (Patel & Edington, 1980, Rurangirwa & Mushi, 1982). Most
infectivity was demonstrated in lymphocytes and it was therefore concluded that
lymphocytes are the major target cell for A1HV-1 in rabbits. A further study of
WA-MCF in rabbits found that the spleen was positive for virus antigen by indirect
immunofluorescence (IIF) at 2-3 days post infection. Virus was also recovered from
spleen, lymph nodes and thymus at 8 and 12 days post infection. This was taken to
suggest a primary cycle of virus replication in the spleen (Edington & Patel, 1981).
Tissue sections and cultured lymphocytes from rabbits infected with
WA-MCF were examined for presence of virus by in situ hybridisation (Bridgen et
al, 1992). Small numbers of virus infected cells were consistently detected in the
submandibular lymph nodes, whilst other tissues showed no evidence of viral DNA.
The virus from MCF infected rabbit tissues was titred and higher titres of virus were
found in lymph node, spleen and lung of infected animals, whilst only low titres were
found in kidney and peripheral blood lymphocytes (pbls). The number of
lymphocytes positive for A1HV-1 DNA by in situ hybridisation increased after 24
hours in culture, suggesting viral replication may be suppressed by the host.
1.6.8 Phenotypical Analysis of the Lymphoproliferative Lesions of MCF
The phenotype of the infiltrating cells in the vascular lesions of MCF has been
studied using monoclonal antibodies specific for bovine lymphocyte markers. In a
study by Ellis et al., (1992) frozen sections of choroid plexus, choroid rete and
choroid of the eye were examined from a case of SA-MCF in a 1-year-old heifer,
which was also infected with bovine viral diarrhoea virus (BVDV). The main
infiltrating cell was found to be CD8+ cytotoxic T lymphocytes. In a separate study
by Nakajima et al., (1992), frozen sections of the kidney, bladder, lymph nodes,
heart, brain and liver of a 2 year old cow with SA-MCF were examined and the cells
phenotyped. The study found that in agreement with Ellis et al., (1992), CD8+
lymphocytes were found infiltrating the blood vessels of the brain, heart and liver.
The lymphoproliferation in the lymph nodes was also found to consist of the same
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cell type, however the function of the CD8+ lymphocytes in the pathogenesis of the
disease is not clear and it is not known if these cells were infected with virus.
1.6.9 Culture of Cell Lines From MCF Affected Animals
Lymphoblastoid cell lines can be derived in culture from the tissue of cattle and
rabbits with both forms of MCF (Cook & Splitter, 1988, Reid et al., 1989, Reid et
al., 1983). The first reported cell line was cultured from the mesenteric lymph node
of a rabbit infected with SA-MCF (Reid et al., 1983). The cell lines required feeder
monolayers of foetal ovine kidney cells for their propagation and were cytotoxic to
both primary cell cultures and cell lines as shown by chromium release assays. The
cells had the morphology of large granular lymphocytes (LGL), which are often
cytotoxic. Although no viral particles could be identified in the cell line, as few as
100 cells transmitted disease to other rabbits.
Subsequently lymphoblastoid cell lines were propagated from the tissues of
cattle and red deer with SA-MCF (Reid et al., 1989). These cell lines were derived
from thymus, lymph node, spleen suspensions and also from cerebro-spinal fluid
cells and cultured cornea. A cell line was also derived from a Pere David's deer
affected by MCF. Sometimes the cell lines survived only for a short time, however
some cell lines could be maintained indefinitely as lymphoblastoid cell lines by
providing feeder cell monolayers and IL-2 and some cell lines became independent
of these factors. The cells had the morphology of large granular lymphocytes and
exhibited cytotoxicity characteristic of natural killer cells, which are morphologically
LGL (reviewed by Herberman & Ortaldo, 1981). In contrast to the cell lines derived
from rabbits, one cell line from a red deer transmitted disease however none of the
cell lines from cattle did. This has led to suggestions that in terminal stages of MCF
the viral genome may be only partially conserved (Reid et al., 1986).
Numerous speculations have been made as to the mechanisms involved in the
pathology of MCF. Since infiltrating mononuclear cells have been identified in the
lesions, the mechanisms have been suggested to be cell mediated immune responses
to virally infected vascular epithelium (Liggitt & DeMartini, 1980a), (Taneichi et al.,
1986) or an autoimmune mechanism of graft versus host reaction. It was suggested
by Plowright, (1968) that hypersensitivity to viral or viral antigens may be involved
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in pathogenesis. Given the propagation of LGL cell lines from MCF affected
animals, it has been proposed that the LGL may be a target cell for the disease (Reid
et al., 1984) and the pathology may result from dysregulation of the function of this
cell type. This could cause the non-specific polyclonal T cell proliferation by loss of
suppressor T cell activity of the LGLs, whilst the tissue necrosis might be caused by
extension of the natural killer cell activity of the LGLs to normal tissues.
1.6.10 Further Characterisation of OvHV-2 Infected Cell Lines
The phenotype of a number of OvHV-2 infected cell lines is variable. OvHV-2
infected cell lines cultured from the tissues of cattle and deer with MCF were
examined by Burrells & Reid, (1991). Cell lines from three out of four cattle were
identified as CD4- CD8+, whilst the other cell line was CD4+ CD8-. Two cell lines
were derived from deer and were CD4-CD8-. Bovine Cell lines of mixed CD4+ and
CD8+ phenotype were identified by Schock et al., (1998). All cell lines examined
expressed a CD2 T cell marker. The pathology of MCF has been described as similar
to the pathology induced by the viruses HVS and HVA (Hunt & Billups, 1979; Patel
& Edington, 1980) and it has been suggested that similar pathological mechanisms
may be involved. This view is reinforced by the fact that OvHV-2 infected LCLs
have been observed to be similar to HVS and HVA infected T cell lines. In common
with OvHV-2 infected cell lines, HVS and HVA infected cell lines expressed a T cell
receptor, NK antigens and exhibited NK function (Kiyotaki et al., 1988; Kiyotaki et
al., 1986). In addition, some HVS transformed cells do not shed infectious virus even
after stimulation (Meinl et al., 1997). HVS infected cell lines from rhesus monkeys
were CD4+ CD8+ (Meinl et al., 1997). HVS transformed human T cells had an
activated T cell phenotype and both CD4+ and CD8+ cell lines were identified
(Mittrucker et al., 1992).
Infection of human T cell clones with HVS was reported to modify the
cytokine secretion profile (De Carli et al., 1993). All infected cell lines were induced
to express IFNy and IL-2, and some cell lines were induced to express TNF-13 and
IL-4. The cytokine transcription of OvHV-2 infected T cell lines was studied for
comparison (Schock et al., 1998). All cells transcribed IFNy, TNFa, IL-4 and IL-10.
No mRNA for IL-2 was detected. It was observed that the secretion profile shares
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similarities with HVS infected cell lines and with anergic T cells (reviewed by
Schwartz, 1997). As a result of these observations, it was proposed that
OvHV-2 infected T cell lines are activated anergic T cells and that the maintenance
of anergy of peripheral T cells is altered by the virus during MCF (Schock et al.,
1998). The secretion of IL-10 was observed to be of interest as both EBV and
EHV-2 encode IL-10 homologues and it was proposed that the IL-10 might be of
viral origin.
Since both HVS and EBV express viral proteins which interfere with cell
signal transduction molecules, particularly the non-receptor protein tyrosine kinases,
these mechanisms were investigated in relation to the behaviour of A1HV-1 and
OvHV-2 infected lymphocytes. It was shown that the src kinases Lck and Fyn were
constitutively active in OvHV-2 and A1HV-1 infected LCLs and not in non-infected
lymphocytes (Swa et al., 2001). Lck and Fyn are src kinases involved in the initiation
of T cell activation via the T cell receptor (TCR) or other structures such as CD2,
CD4, CD8 and the IL-2 receptor (Qian & Weiss, 1997; van Leeuwen & Samelson,
1999). They are the first known signalling molecules to be recruited to the TCR after
antigen or other stimulation of the TCR. The kinases become activated themselves by
phosphorylation of their activation motifs and go on to phosphorylate
iinmunoreceptor tyrosine-base activation motifs (ITAMs) on TCR CD3 and £, chains.
This then leads to a series of signalling events leading to T cell gene transcription
and expression of an activated T cell phenotype. It is thought that viral proteins are
responsible for the changes in Lck and Fyn in infected cells, however an amino acid
homology search for putative binding factors for host signalling molecules failed to
reveal any candidates in the A1HV-1 genome.
1.6.11 Sequence Analysis of AIHV-1
Since the pathology and lymphoproliferative syndromes found in rabbits or
marmosets infected with HVS are similar to those found in MCF, the AIHV-1
genome was completely sequenced in order to identify and compare the pathogenesis
associated genes (Ensser et al., 1997) (Figure 1.8).
The strain of AIHV-1 sequenced was the virulent C500 strain. The virus was
confirmed to be a gammaherpesvirus of the genus rhadinoviridae. The genome is
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essentially collinear with other rhadinoviruses such as HVS, KSHV and MHV-68,
although differences were found in the regions between the blocks of conserved
genes. There were no homologues of known cytokine related or transformation
associated genes of KSHV and HVS. Since the A1HV-1 genome was fully
sequenced, sequencing of a large part of the porcine gammaherpesvirus PLHV-1 has
also been achieved (Goltz et al., 2002) (Section 1.5.1). This herpesvirus is most
similar to A1HV-1 and OvHV-2 and it has been suggested that in future a new genus
may contain all three of these gammaherpesviruses, along with BLHV-1 and the new
gammaherpesvirus of goats, CprHV-2.
The genes of A1HV-1 were numbered according to the counterpart in HVS,
whilst the open reading frames (ORFs) with no homology to HVS genes were named
Al to A10. The conserved genes are arranged in four blocks collinear to HVS, whilst
the non-conserved ORFs are found in between these blocks. The putative viral
transactivators encoded by ORF 50 (BLRF1 of EBV) and ORF 57 (BMLF1 of EBV)
are only weakly conserved, however they have been shown to be functional
transactivators (Frame, 2001; Devi, 2001). ORF 73 shares structural similarity to
ORF 73 of HVS and KSHV. A fusion protein derived from this cDNA is recognised
by antisera from A1HV-1 infected animals (Lahijani et al., 1995). Recently
antibodies to OvHV-2 ORF 73 have been identified in sheep by screening an
expression library from OvHV-2 infected cattle LCLs with sheep sera (Coulter &
Reid, 2002). The ORF 75 gene is homologous to formylglycineamide ribotide amino
transferase (FGARAT). This gene and its homologue ORF 3 at the left hand end of
the genome are conserved in other gammaherpesviruses as described in section 1.3.1.
A1HV-1 does not have a homologue or a positional homologue of ORF28. The only
other gammaherpesvirus sequenced so far that shares this property is PLHV-1. An
ORF 49 homologue is also absent, however this is present in
PLHV-1.
The ORFs Al to A4 are located at the left-hand end of the genome between
the terminal repeats and the conserved gene ORF 3, which is at the left end of the
first gene block. This position is equivalent to the transformation-associated proteins
of HVS, STP and Tip (Duboise et al., 1998), however none of the genes Al to A4



































































































































Figure 1.8 The Genome Organisation of Alcelaphine Herpesvirus 1. The diagram
shows the linearised genome of A1HV-1. The open reading frames are represented as
block arrows, which are coloured according to the conservation of the open reading
frame among the three subfamilies (a, B and y) of herpesviruses. Major repetitive
regions of the genome are marked R1 to R7. The genome length is shown in Kbp
(Adapted from Ensser et al., (1997)).
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protein. A1 has a TATA box-like sequence upstream and polyadenylation site
downstream, providing further evidence that A1 is a real ORF. The A2 protein is
encoded by a spliced transcript. It has a motif similar to nuclear localisation signals
and the basic domain of the stress-induced transcription factor ATF3 (Chen et al.,
1996). ORF A3 is homologous to the semaphorin gene family (Ensser &
Fleckenstein, 1995). Semophorins were originally described as a family of related
transmembrane and secreted proteins, acting as repulsive signals for growth cone
guidance in embryonic development (Kolodkin et al., 1993). Truncated genes of
similar structure are found in poxviruses (Comeau et al., 1998) but not in any other
herpesviruses. It has been proposed that poxvirus semophorins play a role in the
immune system as natural immunosuppressants that are secreted from virus infected
cells, therefore would have a role in reducing the host immune response to infection.
ORF A4 encodes a protein of 121 aa with a putative signal peptide cleavage
site, indicating the protein may be secreted. ORF A5 is a homologue of the EBV
gene BILF1 and EHV-2 E6. This gene is however, missing in HVS and KSHV. This
might suggest that the gene may have been present in an ancestral
gammaherpesvirus, but has been lost in primate rhadinoviruses. It may encode for a
protein with the characteristics of a G protein coupled receptor, as sequence analysis
shows seven putative transmembrane domains. The A5 gene may therefore be
involved in the induction of cell proliferation in the same way as the v-GPCR of
KSHV (Arvanitakis et al., 1997).
The region of the genome including ORFs A6, A7 and A8 is similar in its
arrangement of genes to EBV. A6 may therefore encode a regulatory protein like the
BZLF-1 gene of EBV (Packham et al., 1990). ORF A7 shows a weak amino acid
similarity to ORF 51 of HVS and EHV-2, including a potential signal peptide
cleavage site between the arginine and leucine residues at positions 19 and 20. ORF
A8 is predicted to encode a glycoprotein of 683 aa. It is positionally equivalent to
gp350/220 of EBV and therefore may be a candidate for interaction with a host cell
receptor for A1HV-1. ORF A9 encodes a protein of 168 aa with homology to the
bcl-2 family. Despite being located at a different genomic position to bcl-2
homologues of HVS, EBV and KSHV, A9 is similar in size to the other viral bcl-2
homologues. It contains a well conserved BH1 region and a conserved hydrophobic
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carboxy terminus. A1HV-1 ORF A4.5 encodes an additional bcl-2 homologue which
was not identified in the original sequence. This ORF is homologous to the BAFF1
ORF of EBV, which encodes a second bcl-2 homologue in EBV. The BAFF1 protein
has been found to negatively regulate the antiapoptotic activity of BHRF1 (Bellows
et al., 2002), therefore it is possible that the A4.5 protein of A1HV-1 may negatively
regulate the activity of A9 in a similar way. Orf A10 has the potential to encode a
472 aa glycoprotein.
Despite similarities of MCF to HVS induced pathology and
lymphoproliferative syndromes, A1HV1 contains no homologues of the HVS
transforming proteins STP and Tip. This suggests that though the phenotype of
AFHV-1 infected cell is similar to those infected with HVS, different viral effector
molecules act to achieve this similar phenotype. The complete sequence of A1HV-1
is a considerable aid to the study of A1HV-1 pathogenesis, as it will enable the
functions of possible pathogenesis associated genes to be examined, as well as the
production of recombinant viruses and antibodies, to study the expression of viral
proteins.
1.6.12 Identification of AIHV-1 Virulence Genes In Vivo
When AIHV-1 is passaged through bovine cell cultures the C500 isolate loses its
ability to cause MCF in the laboratory model, the rabbit. This attenuation is
associated with an alteration in the genome (Handley et al., 1995) affecting ORF 50,
A7 and A3. It has been shown that ORF 50 is not expressed in the attenuated form of
AIHV-1 (Wright et al., 1997), and ORF A6 and A7/8 are deleted. ORF 50 has
homology to EBV transcriptional transactivator (Rta) and HVS ORF 50
transcriptional transactivator. It has been demonstrated that AHV ORF 50 is a
functional transactivator acting on the AFHV-1 immediate early (ORF 57) and
delayed early (ORF 6) promoters (Frame, 2001) and may be an important control
element in AIHV-1 gene expression. As described, ORF A3 encodes a semaphorin
homologue (Ensser & Fleckenstein, 1995), which may be important in immune
evasion. ORF A7 and A8 are in an equivalent position in the genome to BFFF1 of
EBV, which encodes a glycoprotein gp350 mediating attachment of EBV to the B
cell receptor CD21. A8 therefore may be a candidate for interaction with a host cell
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receptor for A1HV1. It is not known which ORFs are responsible for the attenuated in
vivo phenotype of passaged A1HV-1, however each ORF involved in the
rearrangement has potential importance in disease pathogenesis.
1.6.13 Molecular Studies of OvHV-2
The lack of a tissue culture system for OvHV-2 has made working with the virus
difficult and attempts to identify a virus in cultured cell lines have failed. The first
OvHV-2 sequence to be identified was a DNA clone derived by hybridisation of
A1HV-1 probes to a genomic OvHV-2 phage X library (Bridgen & Reid, 1991).
OvHV-2 virus has been difficult to detect by hybridisation analysis, however
development of a PCR test (Baxter et al., 1993) has now enabled sites of OvHV2
infection in sheep to be studied and is also used for diagnosis of clinical cases of
MCF. The PCR test was designed from sequence from a clone with homology to
A1HV-1 ORF 75 and to EBV ORF 75 or BNRF1. The primers used amplify a 238bp
fragment of OvHV-2 viral DNA. Other methods of diagnosis of OvHV-2 infection
have been developed, such as a competitive-inhibition ELISA (Li et al., 1994).
However PCR was found to be the most sensitive test available and has made
diagnosis of cases in the incubation period possible (Muller-Doblies et al., 1998).
The use of ELISA was not successful in diagnosing acute cases of SA-MCF,
possibly due to the animal having insufficient time to mount an immune response (Li
et al., 1995).
Studies regarding the acquisition of OvHV-2 infection by lambs are
conflicting. In a study by Baxter et al., (1997) OvHV-2 DNA was detected in nasal
secretions and epithelial tissues from all lambs tested during the first 2 months
following birth. However Li et al., (1995), found that only a small percentage of the
pbls of lambs were OvHV-2 positive by ELISA and by PCR up to 12 weeks old. At
3.5 months old however, the percentage of lambs PCR positive rose sharply to 87%.
Antibody and viral DNA were not found in samples from pre-suckling lambs,
suggesting that transplacental transmission of viral is a rare event if it does occur.
Suckling lambs were found to acquire high levels of antibody by passive transfer in
colostrum. Virus DNA was detected in colostrums and milk by PCR testing and it is
thought that virus may be transmitted by this route. It was found that removing lambs
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from the flock at 2.5 months old prevented OvHV-2 infection, therefore it was
suggested that the positive PCR signals sometimes seen before this point resulted
from passive transfer of maternal leukocytes which are then eliminated.
The production of OvHV-2 free sheep by separating lambs from the ewes by
two months old has enabled the transmission of OvHV-2 between adult sheep to be
studied (Li et al., 1999a). Here it was found that adult sheep that have been
maintained OvHV-2 free are just as susceptible to OvHV-2 infection as are lambs.
Development of quantitative methods of PCR such as competitive PCR and
fluorogenic PCR have enabled quantitation of viral DNA in samples from
asymptomatic sheep and from animals with SA-MCF (Hua et al., 1999; Hussy et al.,
2001). In one 7 month old OvHV-2 infected sheep, higher levels of virus DNA were
found in the nasal secretions than in pbls. This suggested enhanced viral replication
in the nasal, pharyngeal or possibly ocular epithelium. A study of OvHV-2 in the
nasal secretions of sheep found that levels of shedding of OvHV-2 DNA were
undetectable until 5 months old. Shedding peaked at 7 months old and then remained
relatively stable. This was taken to suggest that the main source of transmission of
OvHV-2 to susceptible species was adult sheep rather than neonatal lambs (Li et al.,
2001a). In one study adult sheep pbl were separated into different cell types and
analysed for the presence of OvHV-2 DNA (Baxter et al., 1997). The OvHV-2 DNA
was detected in the B lymphocyte fraction of the cells and OvHV-2 DNA was not
detected in the T lymphocyte or macrophage fractions. In contrast, the culture of
OvHV-2 infected cell lines of the LGL phenotype from cattle, deer and rabbits with
MCF has led to suggestions that LGLs are the target cell for OvHV-2 in these species
(Reid et al., 1983) (Reid et al., 1989). Evidently more in vivo studies are required to
identify the sites of replication and latency of OvHV-2 in its natural host and in MCF
affected animals.
1.7 Project Outline
Little is known about Ovine herpesvirus-2 infection due to the lack of a replicative
tissue culture system for growing virus. The resources available for the study of
ovine herpesvirus-2 are; the rabbit as a model system and the lymphoblastoid cell
lines cultured from virus infected animals. Since at least rabbit cell lines transmit
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disease, it may be that whole virus is present in this cell line, however little is known
about the mechanisms of virus persistence in these cell lines. The availability of
sequence of OvHV-2 would be a huge step in the study of this virus, as this would
enable the production of antibodies and probes with which to study expression of
viral genes in the in vivo rabbit model. This would enable the identification of viral
virulence genes and the testing of their function in vivo using recombinant viruses.
The aims of this project were:
1. To characterise the state of the viral genome in OvHV-2 infected cell lines.
2. To generate OvHV-2 viral sequence by construction of a cosmid library using
DNA extracted from OvHV-2 infected cell lines, which could be probed with
walking probes in order to generate a series of overlapping cosmids spanning
the viral genome.
3. To study in detail an area of viral sequence of interest resulting from the
cosmid sequence. This is likely to come from the left hand end of the virus,
where the genes involved in virulence were expected to be located, by
analogy with other gammaherpesviruses.
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2.4 Polymerase Chain Reaction
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2.1 Molecular Cloning
Molecular cloning methods were based on the protocols described in Sambrook et
al., (1989). All common buffers and stock solutions are described in appendix 1,
located at the end of materials & methods.
2.1.1 Digestion of DNA with Restriction Enzymes
Restriction enzymes were obtained from either Invitrogen or New England Biolabs
and were used with the supplied buffers according to the manufacturer's instructions.
Restriction enzyme digests were typically carried out for 2 hours at 37°C in a
20-200/il volume, using 10 units enzyme per 1 - 10/xg of DNA.
2.1.2 Purification of DNA
DNA was purified after enzyme reactions by extraction with phenol : chloroform. A
mixture of phenol (equilibrated to pH 7.8 with TE), chloroform and iso-amyl alcohol
in the ratio 25:24:1 was added to an equal volume of DNA solution and mixed by
vortexing. After centrifuging for 5 minutes at 10,000 x g, the aqueous phase was
removed into a clean tube and the process repeated until no protein debris remained
at the interphase between the aqueous and organic phases (usually just once). The
sample was then extracted once with chloroform in order to remove any remaining
phenol and the sample concentrated by ethanol precipitation.
2.1.3 Ethanol Precipitation of Nucleic Acids
DNA (or RNA) was precipitated by addition of 0.3 volumes 7.5M ammonium
acetate or 0.1 volume 3M sodium acetate (pH 5.2), and 2.5-3 volumes of ice cold
96% (v/v) ethanol (VWR). The solution was mixed and incubated at -20°C for 1
hour. The precipitated DNA was then recovered by centrifugation at 12,000 x g for 5
minutes. The DNA was washed in 70% ethanol, air dried for 10 minutes and
resuspended in the appropriate volume of TE or dH20.
2.1.4 Agarose Gel Electrophoresis
DNA or RNA were analysed by gel electrophoresis on 0.5-1% agarose gels
containing 0.5/xg/ml (w/v) ethidium bromide (Sigma), in TAE or TBE buffer.
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Samples were made up to a 10-20 /r 1 volume with TE, and mixed with 1/10 volume
loading buffer (15% (w/v) Ficoll type 400, 0.25% (w/v) bromophenol blue and
0.25% (w/v) xylene cyanol) or 0.25% (w/v) Orange G (Sigma) in dH20).
Electrophoresis was carried out at 70V in a horizontal tank (Bio-Rad) containing
TAE or TBE buffer. The size of DNA bands was estimated by comparison with
molecular weight standards (1Kb plus DNA ladder or 0.24 - 9.5Kb RNA ladder,
Invitrogen). Bands were visualised under ultraviolet (UV) light using a short wave
UV transilluminator (UVP).
2.1.5 Purification of DNA from Agarose Gels by Electro-Elution
DNA bands were excised from agarose gels using a sterile scalpel blade under UV
light. The gel slice was then inserted into clean sterile dialysis tubing (Visking size 2-
18/32", Medicell) and 300/xl TAE added. Any air bubbles were removed and the
tubing sealed at both ends. The dialysis tubing was then immersed in TAE in a mini
gel tank and electrophoresis carried out for 1 hour at 70V. The current was then
reversed for 30s to remove any DNA attached to the tubing, and the TAE solution
containing the DNA removed into a clean microfuge tube. The DNA was then
phenol : chloroform extracted and concentrated by ethanol precipitation.
2.1.6 Purification of DNA from Agarose Gels Using a QIAquick Gel
Extraction Kit (QIAGEN)
This was done according to the manufacturer's instructions. The gel slice containing
DNA was weighed, and 3 volumes buffer QG added to 1 volume of gel
(100mg~100/Tl). The sample was then incubated for 10 minutes at 50°C, vortexing
every 2 minutes, until the gel slice had completely dissolved. One gel volume of
isopropanol was then added and the sample added to the QIAquick column, before
centrifuging for 1 minute at 10,000 x g to bind the DNA to the membrane. The DNA
was then washed once with buffer QG (0.5ml) and once with buffer PE, before
eluting the DNA by adding 50/zl of buffer EB, incubating for 1 minute and
centrifuging for 1 minute at 10,000 x g.
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2.1.7 Quantification of DNA
DNA concentration was assessed using a fluorometer (DyNAQUANT 200, Hoefer,
Amersham Biosciences). DNA was diluted 1 : 1000 in 0.2M HC1, lOmM Tris
(pH7.4), ImM EDTA containing 0.1/rg/ml bisbenzimide (Hoechst H33258,
Amersham Pharmacia). Binding of the Hoechst dye to DNA results in a shift in the
emission spectrum of the dye that can be measured using a photodetector. The DNA
concentration is calculated by comparing the signal to that obtained with a lOOng/ml
DNA standard.
2.1.8 De-Phosphorylation of Linearised DNA
In order to prevent re-circularisation during ligation reactions, the 5' phosphate
group on each end of linearised vector DNA was removed using calf intestinal
alkaline phosphatase (CIAP, Roche). Following restriction enzyme digest, the DNA
was incubated with 20U CIAP for 20 minutes at 37°C and the DNA purified by
either phenol : chloroform extraction and ethanol precipitation, or using the
CONCERT rapid PCR purification system (Invitrogen).
2.1.9 Ligation of DNA
Ligations were set up with using approximately 50ng linearised plasmid DNA
(cloning vectors used are shown in appendix 5) and variable amounts of fragment
DNA depending on the size, such that the ratio of plasmid : insert was 1 : 4. The
reaction contained 1 x T4 DNA ligase buffer (50mM Tris-HCl, lOmM MgCh,
lOmM DTT, ImM ATP, 25/xg/ml BSA, New England Biolabs), and 6 Weiss units
T4 DNA ligase in a reaction volume of 20/tl. All ligations included negative controls
whereby the fragment was omitted from the reaction in order to check for
self-ligation of the plasmid. Ligation was performed overnight at 14°C.
2.1.10 Transformation of Competent Bacteria with Plasmid DNA
Eschericia coli bacteria (Epicurian coli XL-1 Blue competent cells, Stratagene) were
transformed according to the manufacturer's protocol. Competent cells were thawed
on ice and a 50/rl aliquot transferred to a pre chilled 15ml falcon polypropylene tube.
B-mercaptoethanol was added to a concentration of 25mM and the tubes incubated
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on ice for 10 minutes with regular agitation. A 1/rl aliquot of the ligation reaction
was then added and the cells mixed before incubation on ice for 30 minutes. The
cells were then heat pulsed at 42°C for 45 seconds, and the tubes incubated on ice for
a further 2 minutes, before 0.9ml of pre-warmed SOC medium was added. The tubes
were then incubated at 37°C for 1 hour with shaking. A 100/xl sample of the mixture
was then spread on LB agar plates containing antibiotic (100/xg/ml ampicillin or
50jUg/ml kanamycin, Sigma). The remaining mixture was centrifuged for 2 minutes
at 4,000 x g, and the pellet resuspended in 150/xl medium before spreading on an
agar plate. The plates were incubated overnight at 37°C, after which the plates were
stored at 4°C for up to 4 weeks.
2.1.11 Small Scale Preparation of Plasmid DNA (Mini-Preps)
Mini-preps were usually performed using the alkaline lysis method. A bacterial
colony was picked from the plate using a flamed loop and grown up in 10ml Luria-
Bertani (LB) medium, with the appropriate antibiotic, overnight at 37°C in an orbital
shaker. A sample of the culture was then streaked onto an LB-agar plate with the
appropriate antibiotic and this was stored at 4°C after growing overnight at 37°C.
The bacteria were then centrifuged to a pellet at 4,000 x g for 10 minutes. The pellet
was resuspended in 200|il of solution I (50mM glucose, 25mM Tris.HCl pH 8.0,
100|ug/ml RNase; (Invitrogen) and 1 mg/ml lysozyme; (Sigma)), and transferred to a
microfuge tube. A 400|il volume of solution II (0.2N NaOH, 1% (w/v) sodium
dodecyl sulphate; (SDS)) was then added and the solution mixed by inverting, before
incubating for 5 minutes on ice. A 300pl volume of solution III (5M potassium
acetate, 12% (v/v) glacial acetic acid pH 4.8) was then added and the solution mixed
by inversion before incubating for 5 minutes on ice.
The solution was then centrifuged for 5 minutes at 10,000 x g, and the
resulting supernatant transferred to a new microfuge tube before adding 500pl of
isopropanol alcohol (IPA, VWR). The tube was then incubated for 15 minutes on ice
and then centrifuged for 5 minutes at 10,000 x g. The resulting pellet was dried and
resuspended in 200p.l TE. A 1 OOjliI volume of 7.5M potassium acetate was then
added and the solution incubated for 15 minutes on ice before centrifuging at
10,000 x g for 5 minutes. The supernatant was then transferred to a new tube and
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600jli1 95% ethanol (VWR) added and the solution mixed before incubating for 1
hour at -20°C. The solution was then centrifuged for 5 minutes at 10,000 x g and the
pellet of plasmid DNA washed in 70% ethanol, before centrifuging at 10,000 x g for
10 minutes. The supernatant was then removed and the pellet air dried before
resuspending in 20|il TE pH 8.0. The samples were stored at 4.0°C and analysed by
restriction enzyme digestion.
2.1.12 Preparation of DNA for Sequencing
Preparation of plasmid DNA for sequencing and small scale preparation of cosmid
DNA was done using a QIAprep spin mini prep kit (QIAGEN) according to the
manufacturer's instructions. A single colony was used to inoculate 10ml LB medium
containing the appropriate antibiotic and grown overnight at 37°C with shaking. The
bacteria were then pelleted at 1,500 x g for 5 minutes, before resuspension in 250/xl
buffer PI. Buffer P2 (250/rl) was then added and the sample mixed by inversion and
incubated for 5 minutes at room temperature. Buffer P3 (350/rl) was then added and
the sample mixed before centrifuging for 10 minutes at 10,000 x g. The resulting
supernatant was decanted into a QIAprep spin column and the DNA bound to the
membrane by centrifugation at 10,000 x g for 1 minute. The membrane was then
washed in 500/zl buffer PB, and 750/rl buffer PE before elution of the DNA in 50jid
Tris pH 8.5. For elution of cosmid DNA, the elution buffer was heated to 70°C
before use.
2.1.13 Concentration of Cosmid DNA For Sequencing
The concentration of cosmid DNA purified using the QIAGEN miniprep kit was
usually low. In preparation for sequencing, cosmid DNA was concentrated using
YM-100 centrifugal filter devices (Millipore) according to the manufacturer's
instructions. The cosmid DNA was made up to a volume of 150-200/xl with diHEO
and loaded into the filter device, before centrifuging for 12 mins at 500 x g. The filter
device was then inverted and the concentrate eluted by centrifugation for 3 mins at
1,000 x g.
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2.1.14 Large Scale Preparations of DNA (Maxi-Prep)
Large scale preparations of plasmid DNA were performed using anion exchange
columns (Endofree Plasmid Maxi Kit, QIAGEN) according to the manufacturer's
instructions. An overnight bacterial culture (250ml) was centrifuged at 6,000 x g for
15 minutes at 4°C and the pellet resuspended in 10ml of buffer PI (50mM Tris
pH8.0, lOmM EDTA, 100jUg/ml RNase A). A 10ml volume of buffer P2 (200mM
NaOH, 1% (w/v) SDS) was then added and the solution mixed by gentle inversion,
before incubation for 5 minutes at room temperature. A 10ml volume of ice-cold
buffer P3 (3M potassium acetate pH5.5) was then added and the sample mixed
gently by inversion before incubation for 10 minutes on ice. The mixture was then
filtered using a QIAfilter cartridge, after which 2.5ml endotoxin removal buffer
(buffer ER) was added and the sample mixed before incubation for 30 minutes on
ice. A QIAGEN-tip 500 anion exchange column was equilibrated using 10ml buffer
QBT (750mM NaCl, 50mM MOPS pH7.0, 15% isopropanol, 0.15% Triton X-100),
and the filtered lysate added to the equilibrated column. The column was then
washed twice with 30ml buffer QC (1M NaCI, 50mM MOPS pH7.0, 15%
isopropanol) and the DNA eluted in 15ml buffer QN (1.6M NaCl, 50mM MOPS
pH7.0, 15% isopropanol). The DNA was precipitated by adding 0.7 volumes
isopropanol and pelleted by centrifugation at 15,000 x g for 30 minutes at 4°C. The
pellet was washed with 70% ethanol before air drying and resuspending in 200/xl TE.
2.1.15 Preparation of Plasmid DNA by Caesium Chloride Density
Gradients
A bacterial colony was grown in 10ml LB broth supplemented with the appropriate
antibiotic for 8 hours then inoculated into 400ml LB with antibiotic and grown
overnight. The bacteria were then pelleted by centrifugation at 6,000 x g for 5
minutes, before resuspension in 20ml glucose solution (50mM glucose, 25mM
Tris.CI, lOmM EDTA) with 5mg/ml lysozyme (Sigma). The suspension was
incubated for 10 minutes at room temperature, then 40ml mini preps solution II
(Section 2.1.11) added. The mixture was incubated for 5 minutes on ice, before the
addition of 20 ml ice cold mini preps solution III (Section 2.1.11). After mixing by
inversion, the sample was then centrifuged for 5 minutes at 6,000 x g and the
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resulting supernatant passed through 4 sheets of gauze to remove any particulate
matter. The solution was precipitated by the addition of 0.6 volumes of isopropanol
followed by incubation on ice for 30 minutes and the precipitate then pelleted by
centrifugation at 6,000 x g for 5 minutes.
The pellet was air dried and resuspended in 6ml TE pH 8, after which 3ml
7.5M ammonium acetate was then added and the solution incubated on ice for 30
minutes. The sample was centrifuged for 10 minutes at 8,000 x g and the resulting
supernatant transferred to a new tube. The sample was then precipitated by the
addition of 18ml ice cold 95% (v/v) ethanol and incubation at -20°C for one hour.
The precipitated DNA was pelleted by centrifugation at 8,000 x g for 10 minutes.
The DNA was resuspended in 500/xl TE pH 8 and transferred to an Ultraclear
disposable ultracentrifuge tube (Beckman). A 200/xl volume of lOmg/ml ethidium
bromide solution was added and the tube filled to the top with a 100% (w/v) solution
of caesium chloride in TE. The tube was weighed and a balance tube made to the
same weight. The two tubes were then heat-sealed. The tubes were then loaded into
the Vti70 rotor and centrifuged overnight at 260,000 x g. After centrifugation the
tubes were carefully removed from the rotor and fixed over a UV light box. The
thick band of plasmid DNA was then removed using an 18G needle and syringe.
2.1.16 Removal of Ethidium Bromide and Caesium Chloride from The
DNA Preparation
An equal volume of isoamyl alcohol was added to the DNA solution and mixed by
vortexing. The sample was then left to stand until it separated into a pink organic
upper phase and a colourless aqueous phase. The organic phase was removed and the
procedure repeated until no pink colour was visible in the organic phase (4-6
times), indicating removal of the ethidium bromide. The caesium chloride was then
diluted by the addition of 3 volumes of TE pH 8 and 8 volumes of 95% (v/v) ethanol.
The solution was stored overnight at 4°C and the solution precipitated by
centrifugation at 10,000 x g for 15 minutes at 4°C. The precipitated DNA was then
washed in 70% ethanol before resuspending in TE pH 8.
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2.1.17 Storing Bacterial Cultures as Glycerol Stocks
Glycerol stocks were made by growing bacterial cultures to log phase and adding
glycerol to 20% (v/v), before mixing and storing at -80°C.
2.1.18 Large Scale Preparation of Cosmid DNA
Large-scale purification of cosmid DNA was carried out using a QIAGEN large
construct kit according to the manufacturer's instructions. This protocol was similar
to the maxi prep kit but involved an exonuclease digestion step whereby
contaminating genomic DNA and damaged cosmid DNA were removed from
supercoiled cosmid DNA. Buffers were the same as those used in the EndoFree
plasmid maxi kit unless stated. A 500ml overnight bacterial culture was pelleted by
centrifugation at 6,000 x g for 15 minutes at 4°C and the bacterial pellet resuspended
in 20ml buffer PI. Buffer P2 (20ml) was added and the sample mixed gently before
incubation at room temperature for 5 minutes. Buffer P3 (20ml) was then added and
the sample mixed before incubation on ice for 10 minutes. The sample was then
centrifuged at 20,000 x g for 30 minutes at 4°C and the supernatant filtered to remove
any particulate matter. The DNA was then precipitated by addition of 0.6 volumes
isopropanol and pelleted by centrifugation at 15,000 x g for 30 minutes at 4°C. The
DNA pellet was washed with 70% (v/v) ethanol, air dried and redissolved in 9.5ml
buffer EX (50mMTris pH8.5, lOmM MgCE). ATP-dependant exonuclease (200/xl)
and lOOmM ATP (300/xl) were then added and the solution incubated at 37°C for 1
hour. A 10ml volume of buffer QS (1.5M NaCl, lOOmM MOPS pH7.0, 15%
isopropanol) was added to the solution and the solution added to an equilibrated
QIAGEN-tip 500 ion exchange column. The column was washed twice with buffer
QC and the DNA eluted with 15ml buffer QF (1.25M NaCl, 50mM Tris pH8.5, 15%
isopropanol) at 65°C. The DNA was precipitated with 0.7 volumes of isopropanol
before pelleting by centrifugation at 15,000 x g for 30 minutes at 4°C. The DNA
pellet was washed in 70% ethanol before drying in air and resuspending in 200/xl TE.
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2.2 Southern Analysis of DNA (Southern Blotting)
2.2.1 Extraction of High Molecular Weight DNA from OvHV-2 Infected
Cells
OvHV-2 infected cells were centrifuged for 5 minutes at 4,000 x g and washed twice
in PBS before resuspension at 5xl07 cells/ml in TE. Extraction buffer (0.5% (w/v)
SDS, 0.1M EDTA, 0.2M Tris.HCl pH8.0) (10 volumes) was then added and RNase
(Sigma) added to a final concentration of 20|Ug/ml before incubation at 37°C for 1
hour. Proteinase K (Roche Molecular Biochemicals) was added to a final
concentration of 100|ag/ml and the solution incubated overnight at 56°C. After
incubation overnight, the DNA solution was transferred to a polypropylene tube and
extracted twice with phenol : chloroform and once with chloroform as described
(Section 2.1.2). Since high molecular weight DNA is easily sheared, modifications to
the phenol : chloroform extraction protocol were made. The DNA solution was
mixed with the phenol : chloroform gently on a rotating wheel instead of vortexing
and wide bore pipette tips were used. The solution was precipitated by adding 0.3
volumes 7.5M ammonium acetate and 3 volumes 95% ethanol. The resulting
precipitate of DNA was spooled using a Pasteur pipette and washed twice with 70%
(v/v) ethanol before drying in air and resuspending in TE pH 8.0 at 1ml per 5 x 106
cell equivalents. If necessary, the sample was incubated at 37°C to aid dissolving the
DNA into solution. The DNA was then quantified using the fluorometer as described
and a sample analysed by electrophoresis on a 0.7% (w/v) TAE agarose gel.
2.2.2 Electrophoresis and Southern Transfer of DNA
A 1% agarose gel was loaded with 5-10/xg of DNA /lane and electrophoresis carried
out at 80V until the dye front had migrated 8-10 cm down the gel. The gel was then
photographed under UV light and rinsed in distilled water. The DNA was denatured
by soaking the gel twice in 0.5M NaOH, 1M NaCl for 20 minutes on a rotary
platform, before neutralising in 0.5M Tris.HCl pH 7.5, 1.5M NaCl for 2 washes of
20 minutes. The DNA was then transferred overnight to a nylon membrane
(Magnagraph Nylon Transfer Membrane, Osmonics) by capillary transfer using 10 x
76
CHAPTER 2 MATERIALS & METHODS
SSC. After transfer, the DNA was UV cross-linked to the membrane using the
Stratalinker (Stratagene) on the "auto crosslink" setting and either stored at -20°C or
pre-hybridised.
2.2.3 Pre-Hybridisation
Before pre-hybridising the lkb DNA ladder was cut off the membrane and stained,
by soaking in 1M acetic acid for 10 minutes, then in staining solution (0.2%
methylene blue, 0.4M acetic acid, 0.4M sodium acetate). Excess stain was removed
by washing in distilled water and the DNA ladder air dried. The membrane was
pre-hybridised for at least 2 hours at 65°C, in 20ml 6 x SSC, 0.05 x BLOTTO (5%
non-fat dried milk) or in 100ml of a solution containing 5 x Denhardt's solution, 4 x
SSC, 200jUg/ml denatured sheared salmon sperm DNA (Sigma), 0.1% SDS) in a
hybridisation oven (Techne Hybridiser HB-1).
2.2.4 Radiolabelling of DNA Probes
DNA probes for hybridisation were labelled using a Random Primed DNA labelling
kit (Roche) according to the manufacturer's instructions. The DNA probe (25ng) was
denatured by heating to 100°C for 10 minutes, cooled on ice and added to a solution
containing 25/xM dATP, dCTP, dTTP, dGTP, 5/xg hexanucleotide primer, 50^Ci
a32PdCTP (Amersham Biosciences) and 2U Klenow DNA polymerase in a 20/xl total
volume. The reaction was incubated at 37°C for 40 minutes. Unincorporated
nucleotides were then removed from the probe using a Nick sephadex G-50 column
(Amersham Biosciences) and the labelled DNA eluted in 400/xl TE pH7.5. The
radiolabelled probe was denatured in 0.1 volumes 3N NaOH for 5 minutes at room
temperature, then neutralised in 0.05 volumes 1M Tris pH 7.5 and 0.1 volumes 3N
HC1. Then probe was then added to enough pre-hybridisation buffer to cover the
membrane (10-20ml) and the membrane hybridised overnight at 65°C.
2.2.5 Membrane Washes
After hybridisation in order to minimise non-specifically bound probe, the membrane
was washed in 5 x SSC, 0.5% SDS for 2x15 minutes at room temperature, then in 1
x SSC, 0.5% SDS for 2 x 15 minutes at 37°C, finally in 0.1 x SSC, 1% SDS for 3 x
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15 minutes at 65°C. The membrane was then covered in Saran wrap and exposed to
x-ray film (Kodak X-Omat AR, Sigma) at -70°C.
2.2.6 Use of Ultrahyb Hybridisation Buffer
In some situations, Ultrahyb sensitive hybridisation buffer (Ambion) containing 50%
formamide was used for pre-hybridisation and hybridisation. A 10-12 ml volume was
used depending on the size of the membrane. Pre-hybridisation and hybridisation
carried was carried out using the same buffer at 42°C. Due to the increased
sensitivity of this buffer, 1/10 of the radiolabelled probe was used. Membranes
hybridised in Ultrahyb were washed at 42°C twice for 5 minutes in 2 x SSC, 0.1%
SDS and twice for 15 minutes in 0.1 x SSC, 0.1% SDS before exposing to X-ray film
as before.
2.2.7 Stripping of Radioactive Probe from Nylon Membranes
To remove radioactive probe from nylon membranes, boiled distilled water was
poured on the membrane and the membrane soaked for 5 minutes. This procedure
was usually repeated three times.
2.3 Gardella Gel Analysis
2.3.1 Preparation of Gardella Gels
Gardella gels were run as described by (Gardella et ai, 1984). The gel consisted of
non-denaturing gel portion composed of 0.75% (w/v) agarose in TBE, forming the
main body of the gel. A space was left for the denaturing part of the gel, which
contained the wells. This gel contained 0.75% (w/v) agarose in TBE, 2% SDS, and
lmg/ml proteinase K (Roche) and was poured just before loading the gel.
2.3.2 Gardella Gel Loading and Electrophoresis
The cells used were fresh OvHV-2 infected LCLs obtained from Dr Hugh Reid
(Moredun Research Institute) (Section 2.10.1). Positive controls used were fresh Sll
cells (a B cell line infected containing MHV-68 in both latent and lytic forms)
(Usherwood et al., 1996) or fresh BCP-1 cells (KSHY infected B cells containing
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both the lytic and latent forms of KSHV) (Boshoff et ai, 1998). Cells for analysis
(2 x 106of each type) were washed once in PBS before resuspending in 50pl loading
buffer (15% Ficoll, 2 units RNase /ml (Sigma), 0.01% bromophenol blue in TBE). A
small sample of lp.g Cosmid A8 (Supercosl-MW containing the left-hand end of
MHV-68) was also loaded onto the gel as a control. After loading the cells were then
overlain with denaturing gel and electrophoresis was then carried out at 4°C, at
0.3V/cm (20V) for 3 hours, then at 7.5V/cm (110V) for 17 hours.
After electrophoresis the gel was rinsed in TBE and stained by soaking in a
solution of 0.5/xg/ml ethidium bromide in TBE for 30 minutes at room temperature.
Unbound ethidium bromide was then removed by soaking the gel in distilled water
for 20 minutes. The stained gel was then visualised under UV light and
photographed. The position of the DNA on the gel was then identified by Southern
blotting as described (Section 2.2).
2.4 Polymerase Chain Reaction (PCR)
2.4.1 Components of PCR Reactions
PCR reactions were typically made up to a 100/xl total volume containing 1 x PCR
reaction buffer (20mM Tris pH8.4, 50mM KC1, Invitrogen), 1.5mM MgCE, 250jttM
of each of dATP, dGTP, dCTP, dTTP (Ultrapure dNTP set, Amersham Biosciences)
0.2pmol of each primer, 100-500ng DNA template and 1U Taq DNA polymerase
(Invitrogen). Samples were made up to the correct volume using RNase free water
(Sigma). PCR primers were obtained from MWG-Biotech and primers used are
shown in appendices 2 and 3. Negative control reactions contained distilled water
instead of template. PCR reactions were carried out in thin walled 0.5ml tubes
(ThermoHybaid) in an Omnigene thermal cycler (ThermoHybaid). A modified "hot
start" cycle was used to increase specificity of products. Reactions were heated to
94°C for 5 minutes, then held at the annealing temperature until the Taq enzyme was
added. The PCR program then consisted of 30-40 cycles of 1 min annealing at
temperature specific to primer, extension at 72°C for 1 min/Kb of product and 30s
denaturing at 94°C. The reactions were then incubated at 72°C for a further 8 minutes
before cooling to room temperature.
79
CHAPTER 2 MATERIALS & METHODS
DNA for cloning or sequencing was amplified using PfuTurbo DNA
polymerase (Stratagene). PCR reactions contained PfuTurbo DNA polymerase
reaction buffer (20mM Tris pH8.8, lOmM KC1, lOmM (NH4LSO4, 0.1% Triton X-
100, O.lmg/ml BSA), 0.2pmol of each primer, 100-500ng DNA template, 250juM
each of dATP, dGTP, dCTP and dTTP (Ultrapure dNTP set, Amersham Biosciences)
in a final volume of 100/xl. Reaction conditions were similar to those used for PCR
amplification with Taq DNA polymerase.
2.4.2 PCR Amplification of Long or Difficult Templates
PCR of long or difficult templates was performed using Expand Long Template PCR
System (Roche) according to the manufacturer's instructions. This involves use of an
enzyme mix containing thermostable Taq DNA polymerase and a proof reading
polymerase. Reactions contained PCR buffer 3 (1 x PCR buffer with 2.25mM MgCL
and detergents), supplemented with 1.5/xl 50mM MgCL (Invitrogen) and final
concentrations of 500/rM dTTP, dGTP, dATP, and dCTP (Ultrapure dNTP set,
Amersham Biosciences), 0.2pmol of each primer, 100-500ng template and 2.6U
DNA polymerase mix in a 50/rl total volume. The reactions were made up using two
master mixes, one containing dNTP's, primer and template, the other containing
DNA polymerase mix, buffer, and MgCL. The two components were mixed
immediately before cycling and the reactions overlain with mineral oil. The enzyme
was used to amplify cDNA where the product was expected to be over lkb in length
using a cycle of 2 mins at 94°C, followed by 40 cycles of denaturation at 94°C for
10s, annealing at the temperature determined by the primers for 30s, elongation 68°C
for 45s/kb product and finally elongation at 68°C for a further 7 minutes.
PCR amplification of long templates was also performed using TaqPlus Lung
DNA polymerase (Stratagene). This was a mixture of a proof reading DNA
polymerase (Pfu DNA polymerase, Stratagene) and Taq polymerase (Taq 2000,
Stratagene). The concentrations of nucleotides, primer and template used were the
same as for Taq DNA polymerase. Reactions also contained either 1 x TaqPlus Long
low salt buffer (20mM Tris-HCl pH8.75, lOmM KC1, lOmM (NH4LSO4, 2mM
MgS04, 1% Triton X-100, O.lmg/ml BSA) or 1 x TaqPlus Long high salt buffer
(20mM Tris-HCl pH9.2, 60mM KC1, 2mM MgCL)- Low salt buffer was used to
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amplify templates up to 5kb and high salt buffer was used to amplify templates over
5kb in length. Cycling conditions were similar to those used for amplification using
Taq DNA polymerase, except an extension time of 30s to lmin/kb was used.
2.4.3 Use of Expand Long Template PCR System to Amplify Genomic
DNA
The enzyme was used to amplify DNA extracted from OvHV-2 infected cells using a
cycle of denaturation for 2 minutes at 92°C, followed by 10 cycles of denaturation at
92°C for 10s, annealing at 62-65°C for 30s and elongation for 20-25mins at 68°C.
This was followed by 10-15 cycles of denaturation at 92°C for 10s, annealing at
62-65°C for 30s and elongation at 68°C for 20-25 mins plus an additional elongation
time of 20s for each cycle.
2.4.4 Genome Walking by Splinkerette PCR
Splinkerette PCR is a method of extending from known to unknown sequence by
amplification of DNA sequences which lie between a single known primer and a
nearby restriction site (Devon et al., 1995).
2.4.5 Generation of Linker Molecules for Splinkerette PCR
Linker molecules were generated as described in (Devon et al., 1995).
Oligonucleotides used are shown in appendix 4. The splinktop and enzyme specific
bottom oligonucleotides were resuspended in Tris pH 7.4 and 5mM MgCL at
300/tM, then lOjul of each oligonucleotide (one splinktop oligo and one splink
bottom oligo) was mixed and heated to 90°C, before cooling at room temperature for
10-20 minutes.
2.4.6 Generation of Ligated Splinkerette Molecules
DNA extracted from OvHV-2 infected cell lines (2jttg) was digested with the
restriction enzyme required, in a 100/xl reaction. The digested DNA was purified
using a CONCERT Rapid PCR purification kit (Invitrogen) as described, resulting in
a 50/zl end volume. The digested DNA (4/rl) was then ligated to annealed splinker
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molecules (6pil) in a 20/xl reaction at 15°C overnight. The ligated molecules were
then used as a template for PCR reactions.
2.4.7 Splinkerette PCR Program
The program used involved combined hotstart and touchdown components to
increase specificity of the reaction. The program comprised one cycle of heating at
45°C for 8 minutes, denaturation at 95°C for 5 minutes followed by cooling to the
first annealing temperature of 71°C. The temperature was held at this point until Taq
polymerase enzyme was added. This was followed by elongation at 72°C for 2
minutes, denaturation at 94°C for 1 minute and annealing at 69°C for 1 minute. This
cycle was repeated 5 times, decreasing the annealing temperature by 2 degrees each
cycle until the annealing temperature was 61°C. The cycle was then repeated 5 times
with the annealing temperature at 61°C, 10 times with the elongation time increased
to 4 minutes and 20 times with the extension time increased to 6 minutes. This was
followed by elongation at 72°C for 8 minutes. This PCR program was then repeated
using internal primers and the primary product as template. Any PCR products
generated were cloned and sequenced as described (Section 2.4.9).
2.4.8 Purification of PCR Products
PCR products were purified using the CONCERT Rapid PCR Purification System
(Invitrogen). The reaction was mixed with 400/xl binding solution HI before loading
onto a spin cartridge. The DNA was bound to the membrane by centrifugation at
12,000 x g for 1 minute and the cartridge washed with wash buffer H2. A 50/xl
volume of TE heated to 65°C was then added, followed by incubation of the cartridge
at room temperature for 1 minute. The DNA was then eluted by centrifugation at
12,000 x g for 2 minutes.
2.4.9 Cloning PCR Products
PCR amplification products produced using primers with restriction enzyme sites at
the 5' end were digested with the appropriate restriction enzymes and then cloned
into sequencing vectors such as pBluescribe KS II (Stratagene) (Appendix 5). PCR
products without restriction sites were cloned using TA cloning vectors.
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2.4.10 Cloning PCR Products using a pCR 2.1 TOPO TA Cloning Kit
PCR products were cloned using a pCR 2.1-TOPO TA cloning kit (Invitrogen)
(Appendix 5) according to the manufacturer's instructions. This kit contains a
linearised plasmid vector with single 3' - thymidine (T) overhangs and
Topoisomerase I covalently bound. The TOPO cloning reaction contained a final
concentration of 200mM NaCl, lOmM MgCh, 2/xl fresh purified PCR product and
lOng plasmid. The reaction was mixed gently and incubated for 5-15 minutes at
room temperature, before transforming One Shot TOP 10 chemically competent
cells.
2.4.11 Transformation of One Shot TOP 10 Chemically Competent
Escherichia coli
One Shot TOP 10 chemically competent cells (Invitrogen) were transformed
according to the manufacturer's instructions. A 50/rl aliquot of the cells was thawed
on ice and 2jul of the TOPO cloning reaction was added. The sample was gently
mixed and incubated on ice for 5 minutes, before heat shocking for 30s at 42°C. The
tubes were then transferred to ice and 250/rl SOC medium added before incubation at
37°C with shaking for 1 hour. Aliquots of 20/zl, 50/xl and the remainder of the sample
were then spread onto LB-Amp plates to which 20yu.l 200mM isopropyl B-D
thiogalactoside (IPTG) and 40jul 2% (w/v) 5-bromo-4-chloro-3-indoyl-B-D-
galactoside (X-Gal) were added for blue/white selection of positive colonies. The
plates were then incubated overnight at 37°C. Pure white colonies were picked and
analysed by "mini prepping" and restriction enzyme digestion of the plasmid DNA.
2.4.12 TA Cloning using pGEM-T Easy Vector
PCR products were cloned using pGEM-T Easy vector (Promega)
(Appendix 5) according to the manufacturer's instructions. A ligation mix was
prepared containing 2 x Rapid Ligation Buffer, 50ng pGEM-T Easy Vector, 3jiil PCR
product and 6 Weiss units T4 DNA ligase, in a total volume of 10/rl. The mixture
was incubated at room temperature for 1 hour and a 2[xl aliquot used to transform the
XL-1 Blue strain of E. coli. After transformation the bacteria were plated out onto
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LB-Amp plates to which IPTG and X-Gal had been added as described (Section
2.4.11) for blue/white selection of positive colonies.
2.5 Construction of a Cosmid Library
All restriction enzymes and buffers were from Invitrogen or New England Biolabs
unless stated otherwise.
2.5.1 Cosmid Vector
Supercosl (Stratagene) DNA, modified as described by (Cunningham & Davison,
1993) was provided by Dr A. Davison (University of Glasgow). SuperCos 1 contains
genes conferring resistance to ampicillin and neomycin and two adjacent cos sites
separated by an Xbal site. The region for inserting foreign DNA contains a single
BamUl site flanked by bacteriophage T7 and T3 transcriptional promoters and Notl
and EcoRI sites in the configuration EcoRI-Notl-Tl promoter-5«wzHl-T3 promoter-
Notl-EcoRI. Supercosl was modified by replacing the Notl fragment with a single
synthetic oligonucleotide to give SuperCos 1MW, containing a cloning region with
the configuration EcoRI-Notl-Ascl-Pacl-BamHl-Ascl-Pacl-Notl-EcoRI.
2.5.2 Preparation of Cosmid DNA for Cloning
Cosmid DNA at lpg/pl was digested in a number of steps as directed in the
SuperCos 1 kit instructions provided by Stratagene. SuperCos 1MW DNA (25/ig)
was linearised by digestion with Xbal and digested cosmid DNA dephosphorylated
using calf intestinal alkaline phosphatase (CIAP) (Roche) in 1 x dephosphorylation
buffer in a lOOjil reaction for 30 minutes at 37°C. The enzyme was then inactivated
by adjusting the reaction to 15mM EDTA and heating at 68°C for 10 minutes. The
sample was then extracted once with phenol : chloroform and once with chloroform
before ethanol precipitating and resuspending in 25pl of TE pH8.0. The Xbal and
CIAP-treated DNA was then digested with BamHl to give 2 cosmid arms of size 1.1
and 6.5kb. The DNA was then extracted once with phenol : chloroform and once
with chloroform before ethanol precipitating and resuspending in 25pl distilled water
(lBg/jUl).
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2.5.3 Partial Digestion of High Molecular Weight DNA for Cosmid
Cloning
High molecular weight DNA extracted from OvHV-2 infected cells was partially
digested with Mbol such that the products were on average 40kb in size. This was
done by preparing dilutions of Mbol of 1/125, 1/250, 1/500, 1/1000 and 1/2000 in
reaction buffer, lpd of each dilution was used to digest 10pg of high molecular
weight DNA in a 200pl reaction for 1 hour at 37°C. Samples were checked for
digestion by electrophoresis of an aliquot alongside a 40kb size marker (Linearised
SuperCos 1MW containing 40kb of the left-hand end of MHV-68), kindly provided
by Dr A. MacRae. Samples which digested to produce DNA of the required size of
approximately 40kb were extracted once with phenol : chloroform and once with
chloroform, taking care not to vortex the samples, before dephosphorylating with calf
intestinal alkaline phosphatase (CIAP, Roche) in a 100/rl reaction containing 20U
CIAP. The dephosphorylation reaction was stopped by heating to 68°C for 10
minutes in the presence of 15mM EDTA. The sample was then phenol : Chloroform
extracted and ethanol precipitated before resuspending at l/xg//xl.
2.5.4 Ligation of Partially Digested OvHV-2 DNA to Cosmid Arms
A 2.5pg sample of partially digested genomic DNA was ligated to lpg SuperCos
1MW DNA (Digested with Xbal, CIAP and BamYLl) in a 20/zl reaction as described.
New England Biolabs DNA ligase was used, as the ligase buffer does not contain
polyethylene glycol, which can inhibit packaging.
2.5.5 Packaging the Ligated DNA
The ligated DNA was packaged into recombinant X phage using a Gigapack III XL
packaging kit (Stratagene) according to the manufacturer's instructions. The
packaging extract (in a 25/xl volume) was thawed on ice and the ligated DNA added
immediately (1 - 4pl containing 0.1 - lpg of ligated DNA). The tube was then stirred
with a pipette to mix, before incubating for 2 hours at 22°C in a water bath. A 500pil
volume of SM buffer (0.1M NaCl, 50mM Tris.HCl, 0.01% (w/v) gelatine (VWR))
was then added to the tube, followed by 20pl of chloroform. The sample was then
spun briefly to sediment the debris and stored at 4°C for titration. A positive control
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packaging reaction was also prepared using the packaging protocol as described but
packaging lfil of the X cl857 wild-type X control DNA provided with the packaging
kit. This reaction was stopped using 1ml SM buffer.
2.5.6 Preparation of Bacteria For Titration of Packaging Reactions
The E. coli strain XL 1-Blue MR (Stratagene) was used for titration of cosmid
packaging reactions and the VCS257 strain provided with the packaging kit was used
to titre the positive control packaging reaction. A single colony of the required
bacteria was grown overnight in LB medium supplemented with lOmM MgS04 and
0.2% (w/v) maltose at 37°C with shaking. A 10pl sample of bacteria was inoculated
into 10ml LB medium supplemented with lOmM MgS04 and 0.2% (w/v) maltose
and grown for 4 - 6 hours at 37°C with shaking, to an OD600 of less than 1.0. The
bacteria were then pelleted by centrifuging at 500 x g for 10 minutes and
resuspended in half the original volume with sterile lOmM MgS04. The bacterial
cells were then diluted to an OD600 of 0.5 in lOmM MgS04 and stored on ice until
used.
2.5.7 Titration of the Positive Control Packaging Reaction
Serial dilutions of the control packaging reactions from 10"' to 10~4 were prepared in
SM buffer. A 1 Ojul sample of the 10~4 dilution was then added to 200(0.1 of the
VCS257 host strain, diluted to an OD6oo of 0.5 in lOmM MgS04. The mixture was
incubated at 37°C for 15 minutes, before adding 3ml of LB top agar (LB medium
with 0.7% agarose; Seakem), melted and cooled to 48°C. The dilution was then
poured onto dry, pre warmed LB agar plates and the plates incubated overnight at
37°C. After incubation the plaques were counted, approximately 400 plaques being
expected in the 10~4 dilution plate when the reaction was stopped with 1ml SM
buffer.
2.5.8 Titration of the Cosmid Packaging Reaction
A 1:10 and a 1:50 dilution of the cosmid packaging reaction was prepared in SM
buffer. A 25jlx1 sample of each dilution was then mixed with 25(xl XLl-Blue MR cells
diluted to an ODgoo of 0.5 in lOmM MgSQ4, and incubated at room temperature for
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30 minutes. LB broth (200pl) was then added to each sample and the samples
incubated for 1 hour at 37°C with shaking. The cells were then pelleted by
centrifugation for 5 minutes at 5,000 x g, and the pellet resuspended in 50|il of fresh
LB broth. The cells were then plated onto LB-Amp agar plates using a sterile
spreader and the plates incubated overnight at 37°C. The colonies grown were
counted and the titre calculated in colony forming units (cfu)/ml.
2.5.9 Amplification of Cosmid Libraries
Packaged cosmid DNA (i.e., the remainder of the packaging reaction after titration)
was mixed with an equal volume of XL 1-Blue MR cells diluted to an ODgoo of 0.5 in
lOmM MgSCL, and the mixture incubated at room temperature for 30 minutes. LB
broth (4 volumes) was added and the tube incubated at 37°C for 1 hour with shaking.
The cells were then harvested by centrifuging for 10 minutes at 500 x g and
resuspended in 500p.l LB broth, before spreading onto a 150mm LB-Amp agar plate.
After incubating the plate overnight at 37°C, 3ml LB broth was poured onto the plate
and the colonies scraped into the liquid using a sterile spreader. The broth was
pipetted into a fresh tube and the plate washed with another 3 ml LB broth. Sterile
glycerol was then added to a final concentration of 20%(v/v) and ampicillin (Sigma)
to 50|ig/ml. The amplified library was then mixed and aliquoted into several
samples, which were stored at -80°C.
2.5.10 Titration of The Amplified Cosmid Library
Serial dilutions of the amplified cosmid library were made from 10"1 down to 10"6 in
LB broth. A 50)0.1 sample of each dilution was plated onto LB-Amp plates, and
incubated overnight at 37°C. The titre in cfu/ml was then calculated.
2.5.11 Screening Amplified Cosmid Libraries
The amplified cosmid library was plated onto a 150mm LB-Amp plate to give
individual colonies (approximately 4,000 colonies). After incubation overnight at
37°C the colonies were transferred to a nylon membrane (Magnalift, Osmonics). The
position of the membrane on the plate was marked, by pushing a needle through the
membrane to the bottom of the plate and marking the position on the bottom of the
87
CHAPTER 2 MATERIALS & METHODS
agar plate. The membrane was then lifted off and placed colony side up on a fresh
150mm LB-Amp agar plate. This plate and the original plate were incubated for 4
hours at 37°C. The membrane was then treated for 2 minutes in denaturation solution
(0.5M NaOH), followed by neutralising solution (lMTris.HCl pH 7.4). The
membrane was then soaked in neutralising solution and agitated in order to remove
the bacterial debris, before UV crosslinking using the Stratalinker (Stratagene).
2.5.12 Generation of Probes For Library Screening
Probes were generated by PCR of known OvHV-2 sequence using either DNA
extracted from OvHV-2 infected cell lines, or cosmid DNA as a template. Probes
were generally 300-500bp in size. The PCR products were purified using the
CONCERT PCR purification system as described (Section 2.4.8), before random
primed labelling with a32P dCTP.
2.5.13 Probing The Amplified Cosmid Library
cx32Colonies of interest were detected by probing the membrane using P dCTP
labelled DNA probes. Membranes were pre-hybridised for 24h in 6 x SSC, 5 x
Denhardt's reagent, 0.5% SDS, 100p.g/ml denatured fragmented salmon sperm DNA
at 65°C, before hybridising overnight at 65°C. Membranes were then washed as
described for Southern blotting, covered in Saran wrap and exposed to x-ray film
(Kodak X-Omat) at -70°C for 24 - 48 hours.
2.5.14 Low Stringency Hybridisation
The library was probed by low stringency hybridisation using Ultrahyb sensitive
hybridisation buffer (Ambion) as described (Section 2.2.6), using a hybridisation and
washing temperature of 37°C. Hybridisation probes were uj2PdCTP labelled as
before.
2.5.15 Identification of Colonies of Interest
The needle holes on the membranes were marked on the overlying x-ray film using
waterproof pen and the correct orientation of the x-ray film on the plate determined
by aligning marks on the developed x-ray film to those on the original plate. Positive
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colonies were then identified by the position of the x-ray film spots on the plate.
Since a there were a large number of colonies on the original plate, it was not usually
possible to identify individual positive colonies on the first screen, therefore the
colonies round the positive area were scraped off the plate and resuspended in LB-
Amp before re-plating to single colonies and re-screening to identify positive
colonies. The positive colonies were picked and grown overnight at 37°C in 10ml
LB-Amp broth and cosmid DNA for sequencing prepared from the samples using a
QIA-spin mini prep kit (QIAGEN) as directed. Samples were then analysed by
restriction enzyme digestion and agarose gel electrophoresis. Samples containing
inserted DNA were then sequenced at each end of the insert. The sequence was then
compared with sequence in the Genbank database.
2.5.16 DNA Sequencing
DNA sequencing was performed using the di-deoxy chain termination sequencing
method by Mr Ian Bennet (Dept of Veterinary Pathology, University of Edinburgh).
Reactions were performed using a SequiTherm EXCEL II DNA Sequencing kit
(cycle sequencing protocol) on a 4000L automated sequencing machine (MWG-
Biotech).
2.6 Sequence Analysis
2.6.1 Nucleotide Sequence Analysis
Analysis of sequenced DNA by comparison to database sequences was done using
the basic alignment search tool (BLAST) programs on the NCBI web site
http://www.ncbi.nIm.nih.gov/BLAST/ (Altschul et al., 1990). Nucleotide sequences
were compared to each other using the "pairwise blast" program. Analysis of
sequence for the presence of open reading frames was performed using the NCBI
ORF finder. Analysis of restriction sites and other features was done using the
European Molecular Biology Open Software Suite (EMBOSS), provided by the UK
Human Genome Mapping Project computer services, UK HGMP Resource Centre,
Hinxton, Cambridge, CB10 1SB (http://www.hgmp.mrc.ac.uk/). Sequence was
analysed for splice donor and acceptor sites using the program NetGene2 (Brunak et
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al., 1991) and translational start and stop sites were predicted using HMMgene
(Krogh, 1997). These tools were found at the Centre for Biological Sequence
Analysis (CBS) prediction servers at http://www.cbs.dtu.dk.
2.6.2 Protein Sequence Analysis
Protein sequence database comparisons were done using the protein-protein BLAST
(blastp) program at http://www.ncbi.nlm.nih.gov/blast/. Alignment of protein
sequences for comparison was carried out using the ClustalW multiple sequence
alignment program (Thompson et al., 1994) and shaded diagrams of the sequence
alignments carried out using the BOXSHADE program, both tools can be found at
http://www.ch.embnet.org. Hydrophobicity plots of proteins were performed using
the method of (Kyte & Doolittle, 1982), using the program ProtScale of the Expert
Protein Analysis System (ExPaSy) web site at http://www.expasv.ch. Analysis of
protein sequence for antigenic sites was carried out using the program ANTIGENIC,
found on the JEMBOSS suite at http://www.hgmp.mrc.ac.uk/. This predicts antigenic
sites using the method of (Kolaskar & Tongaonkar, 1990). Analysis of the sequence
for transmembrane regions was done using the program TMHMM 2.0 (Sonnhammer
et al., 1998). Prediction of signal cleavage sites was done using the program SignalP
(Nielsen et al., 1997), analysis of the sequence for N-glycosylation sites was done
using the program NetNGlyc 1.0, (Gupta et al., 2002) and prediction of O-
glycosylation sites was done using the NetOGlyc program (Hansen et al., 1995).
These tools were available at the Centre for Biological Sequence Analysis (CBS)
prediction servers at http://www.cbs.dtu.dk. Analysis of the protein for features such
as proline and serine rich regions was done using the ProSite tool, which scans a
protein against the PROSITE database of protein families and domains (Falquet et
al., 2002), this was found at the Expert Protein Analysis System (ExPaSy) molecular





2.7.1 Extraction of Cytoplasmic RNA from Cells
Cells (105 - 5 x 107) were washed twice in PBS before resuspension in 1ml ice cold
Tris saline (25mM Tris pH 7.4, 130mM NaCl, 5mM KC1). The suspension was then
centrifuged for 30s at 1000 x g and the pellet resuspended in 400/xl Tris saline. A
100/rl volume of Igepal buffer (1% Igepal (Sigma), 0.5% sodium deoxycholate,
0.01% dextran sulphate in Tris saline) was added and the sample mixed by gentle
inversion. This resulted in lysis of the plasma membranes but not the nuclear
membranes. The lysate was centrifuged at 2,000 x g for 1 minute and the nuclear
pellet discarded. The supernatant was transferred to a new tube containing 500/xl
phenol : chloroform : iso-amyl alcohol (v/v), 25/rl 20% SDS and 15/rl 5M NaCl. The
sample was then mixed by vortexing, followed by centrifugation at 10,000 x g for 2
minutes. This was repeated until the interface was clear (2-3 times) and the RNA
was then extracted with chloroform : iso-amyl alcohol in order to remove any
remaining phenol. The RNA was then precipitated by the addition of 1ml 96% (v/v)
ethanol to the aqueous phase and incubation at -20 °C for 1 hour. The precipitate was
then recovered by centrifugation at 4°C for 20 minutes at 10,000 x g. The sample was
then washed in 80% ethanol, air dried and resuspended in 50/xl sterile water. RNA
was quantified using a Cecil spectrophotometer and the concentration calculated
using the equation,
RNA concentration = Absorption at 260nm (A260) x 40 x dilution factor
Where an A260 of 1.0 is equivalent to 40mg/ml of RNA. The RNA was also analysed
by gel electrophoresis on a 0.8% agarose gel in 1 x TBE. RNA samples were
concentrated if necessary by adding 1/10 volume of 3M Sodium Acetate pH5.2, 3
volumes of 95% Ethanol and 20mg glycogen (Ambion) and incubating at -20°C for
at least one hour. The samples were then centrifuged at 10,000 x g at 4°C to pellet the
RNA and resuspended in the appropriate volume of RNase free water.
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2.7.2 Extraction of Total RNA From Cells
Total RNA was extracted from cultured cells using an RNeasy kit (QIAGEN). The
cells (5 x 10 ~ 107) were harvested and pelleted by centrifugation for 5 minutes at
500 x g. The cells were then lysed by addition of 600|il of buffer RLT and the lysate
homogenised by passing 10 times through a 20G needle attached to a 2ml syringe. A
600pl volume of 70% ethanol was then added and the sample added to an RNeasy
spin column. After centrifugation the column was washed once in buffer RW1 and
twice in buffer RPE and the RNA was eluted in 30-50pl RNase free water.
2.7.3 Extraction of Poly A RNA From Cells
This was performed using an Oligotex Direct mRNA purification kit (QIAGEN)
according to the manufacturer's instructions. Cells (5 x 106 - 2 x 107) were harvested
and pelleted by centrifugation for 5 minutes at 500 x g. The cells were lysed by
addition of buffer OL1 (0.6ml) to which B-mercaptoethanol had been added to a final
concentration of 4.3M. The lysate was homogenised by passing 10 times through a
19G needle attached to a 2ml syringe. Buffer ODB (1.2ml) was then added and the
sample mixed before the cell debris was removed by centrifuging for 3 minutes at
10,000 x g. The supernatant was transferred to a new tube and llO^tl oligotex
suspension added before vortexing and incubating at room temperature for 10 min.
The oligotex was then pelleted by centrifugation for 5 minutes at 10,000 x g and the
supernatant removed before resuspension of the oligotex and mRNA pellet in 100/rl
buffer OL1 by vortexing.
In order to further reduce ribosomal RNA, buffer ODB (400/xl) was added
and the sample incubated at 70°C for 3 minutes, followed by incubation for 10
minutes at room temperature. The oligotex and mRNA complex was then pelleted by
centrifugation for 5 minutes at 10,000 x g and the pellet resuspended in 350^1 buffer
OW1 by vortexing. The sample was then pipetted onto a small spin column and
centrifuged for 1 minute at 12,000 x g. The membrane was washed twice in 600yU.l
buffer OW2 (lOmM Tris-Cl pH7.5, 150mM NaCl, ImM EDTA) and the column
transferred to a new collection tube. A 100/r.l volume of buffer OEB (5mM Tris-Cl,
pH 7.5) heated to 70°C was pipetted onto the spin column and the sample pipetted 3
or 4 times to resuspend the resin. The RNA was then eluted by centrifugation for 1
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minute at 10,000 x g and the process repeated once. The mRNA was quantitated by
spectrophotometry and concentrated by ethanol precipitation before resuspension in
the appropriate volume of diH20.
2.7.4 Northern Analysis of RNA
Electrophoresis of RNA was carried out on 1.2% agarose gels containing 1 x MOPS
buffer and 2.2M formaldehyde. Generally 5 - 10 pg of total RNA or 1 - 10 jag of
polyadenylated RNA was loaded onto the gel alongside 5pg of an RNA molecular
weight marker (0.24 - 9.5Kb RNA ladder, Invitrogen). RNA samples were suspended
in 0.5 x MOPS, containing 50% formamide and 17.5% formaldehyde in a 20pl
volume. Samples were then denatured by heating to 65°C for 15 minutes, followed
by cooling on ice. A 2pl volume of formaldehyde gel loading buffer (50% glycerol,
ImM EDTA (pH8.0), 0.25% bromophenol blue) was added before loading.
Electrophoresis was carried out overnight in 1 x MOPS buffer (20mM MOPS (pH
7.0), 8mM Sodium Acetate, ImM EDTA (pH 8.0)) at 35V, during which the buffer
re-circulated using a peristaltic pump. The gel was rinsed in distilled water and
photographed before blotting overnight. Northern blots were set up in the same way
as Southern blots except that transfer was carried out in 10 x SSPE. After transfer,
the position of the wells was marked on the membrane and the RNA fixed by UV
cross-linking using the Stratalinker (Stratagene). The lane containing the RNA
marker was cut off and stained in the same way as for DNA ladders (Section 2.2.3).
2.7.5 Reverse Transcription of RNA
For reverse transcription 1-2 pg total RNA or 0.5-lpg polyadenylated RNA was
used. RNA was first incubated in a lOpl total volume with 1U amplification grade
DNasel (Invitrogen) in 1 x DNasel reaction buffer for 15 minutes at room
temperature. The DNasel was inactivated by adding 1 jal of 25mM EDTA and heating
for 10 minutes at 65°C. Whilst still hot, 0.5pg oligo dT primer or 250ng random
primer (Invitrogen) and 1 pM each dATP, dGTP, dCTP, dTTP were added and the
reaction mixed then cooled on ice. The reaction was then made up to a final
concentration of 1 x first strand buffer (Invitrogen) and 0.2pM DTT and 40U
recombinant ribonuclease inhibitor (RNase OUT, Invitrogen) was added before
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incubation at 42°C for 2 minutes. Reverse transcriptase (200U) (Superscript II,
Invitrogen) was then added, before incubation at 42°C for 50 minutes (if random
primers were used, a 10 minute incubation at 25°C was required before the 50 minute
incubation at 42°C). The enzyme was then inactivated by heating to 70°C for 10
minutes. A 2pl volume of the reaction was used as a template for PCR reactions.
2.8 Protein Analysis
Methods of protein analysis were performed based on methods described by Harlow
& Lane, (1988).
2.8.1 Sodium Dodecyl Sulphate - Polyacrylamide Gel Electrophoresis
(SDS-PAGE)
SDS-PAGE analysis of proteins was performed using an Atto AE-6400 Dual Mini
slab kit by the method of Laemmli, (1970). The glass plates were cleaned with 70%
ethanol and the apparatus assembled as per the manufacturers instructions. The
resolving gels were 12% (w/v) acrylamide (Ultra Pure Proto Gel, 30% (w/v)
acrylamide:0.8% (w/v) bis-acrylamide, National diagnostics) 0.1% (w/v) SDS,
375mM Tris pH8.8, 0.04% N,N,N' Tetraethylmethylenediamine (TEMED, Sigma),
and 0.1% (w/v) Ammonium persulphate (APS, Sigma). The resolving gel was
poured and overlain with a small amount of overlay buffer (375mM Tris, pH8.8, 1%
SDS (w/v)), then left to set. After the overlay buffer was removed from the surface of
the solidified resolving gel, the stacking gel (125mM Tris, pH6.8, 0.1% (w/v) SDS,
5% (w/v) acrylamide, 0.1% (w/v) APS, 0.1% (v/v) TEMED) was poured over the top
and a plastic comb inserted to form the wells. When set, the gels were assembled in
the tank and SDS-PAGE running buffer (24mM Tris, 250mM glycine, 0.1% (w/v)
SDS) added to the reservoirs. Samples for analysis were diluted 1:1 in 2 x
SDS-PAGE sample buffer (lOOmM Tris (pH6.8), 4% (w/v) SDS, 4% (v/v) (3-
Mercaptoethanol, 20% (v/v) glycerol, 0.1% (v/v) bromophenol blue) and heated in a
boiling water bath for 10 minutes before loading onto the gel. Samples of cells for
analysis were usually resuspended in lOO^tl SDS-PAGE sample buffer per 106 cells.
A sample of 10 - 20/rl was then loaded onto the SDS-PAGE gel. The samples
included a 5pl sample of broad range pre-stained SDS-PAGE standards (BioRad) in
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order to estimate protein molecular weight relative to the standards. Electrophoresis
was started at 80V until the dye front had reached the resolving gel then continued at
180V until the dye front had reached the bottom of the gel.
2.8.2 Coomassie Staining of SDS-PAGE Gels
SDS-PAGE gels were stained in Coomassie blue stain (0.25% (w/v) Coomassie blue,
Sigma) 10% (v/v) glacial acetic acid, 50% (v/v) methanol) overnight with gentle
shaking and de-stained over a period of 4 - 8 hours in a few volumes of Coomassie
de-stain (50% (v/v) methanol, 10% (v/v) acetic acid) until excess stain had been
removed. The gel was then dried onto 3MM paper using a model 583 gel dryer and
HydroTech vacuum pump (BioRad).
2.8.3 Transfer of Proteins to Nylon Membranes (Western Blotting)
After SDS-PAGE, proteins were transferred to a PVDF membrane (Immobilon-P,
Millipore) by the tank wet transfer system using a Mini Trans Blot Cell (BioRad).
The apparatus was assembled according to the manufacturer's instructions and the
tank filled with transfer buffer (25mM Tris, 250mM Glycine, 20% (v/v) methanol)
and transfer carried out at 250mA for 1-1/2 hours.
2.8.4 Immunoblotting
Membranes were incubated in blocking buffer (5% (w/v) non-fat skimmed milk in
TBS) overnight at 4°C in order to minimise non-specific antibody binding. When
sheep serum was used as a primary antibody, 5% (v/v) donkey or horse serum was
included in the blocking buffer. Membranes were then incubated with primary
antibody diluted in blocking buffer (antibodies used and concentrations are shown in
table 2.1) for 2 hours with gentle agitation. The membrane was then washed 4 times
in TBS with 0.2% (v/v) Tween-20 before incubation with the secondary antibody
diluted in blocking buffer for 1 hour with gentle agitation. The membrane was then
washed 4 times in TBS with 0.2% (v/v) Tween-20 as before. If necessary, this was
followed by incubation with a tertiary streptavidin conjugate for 1 hour. The
membrane was then washed 5 times in TBS with 0.2% (v/v) Tween-20 and once in
TBS before detection of antibody binding.
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Antigen Primary Secondary Tertiary







































1: 500 to 1: 2,000
Table 2.1 Antibodies used in immunoblotting analysis. Concentrations used are
shown in blue and suppliers are shown in red.
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The tertiary streptavidin was conjugated to either alkaline phosphatase (AP) or
horseradish peroxidase (HRP). In both cases, detection of the enzyme activity was
used to detect antibody binding. Alkaline phosphatase activity was detected
by incubation of the membrane with BCIP/NBT solution
(Sigma FAST 5-bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolium).
Horseradish peroxidase activity was detected using the ECL Western Blotting
Analysis System (Amersham Biosciences) according to the manufacturer's
instructions. An equal volume of detection solution 1 was mixed with detection
solution 2 and the membrane incubated with the mixture for 1 minute. Excess
solution was then drained from the membrane. The membrane was then wrapped in
Saran wrap and exposed to autoradiography film (Hyperfilm ECL, Amersham
Biosciences) at room temperature for 15s to one hour, depending on the strength of
the signal.
2.9 Antibody production
2.9.1 Production of a GST Fusion Protein
A 621 bp fragment of A8 was amplified by PCR of DNA extracted from OvHV-2
infected cell lines using the PCR primers 08pGEX-5' and 08pGEX-3'
(Appendix 2). The PCR product was then purified and digested using BamHl and
EcoKl. After purification using the CONCERT PCR purification system the PCR
product was ligated into the vector pGEX-3X (Amersham Biosciences) in frame with
the Schistosoma japonicum glutathione S-transferase gene (GST), using the EcoRI
and BamHl sites. The construct was transformed into XL-1 Blue strain of E. coli
(Stratagene) as previously described. Bacterial colonies were checked for the 08
construct inserted into pGEX-3X by "mini prepping" and restriction analysis of the
plasmid DNA with EcoRl and BamHl. Positive samples were tested for expression of
the GST fusion protein. Individual colonies were picked and grown overnight at
37°C in 10ml LB broth with lOOjig/ml ampicillin. The culture was then diluted 1 in
10 in fresh LB and ampicillin and grown to an OD595 of 0.6. Protein expression was
then induced by addition of isopropyl-(3-D-thiogalactopyranoside (IPTG, Invitrogen)
to a final concentration of 0.1mM and the culture grown for a further 3 hours. A
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E5ml sample of the culture was then pelleted at 500 x g for 5 minutes and the pellet
resuspended in 300pl PBS containing 1% Triton-X 100 and 1% Apoprotinin. The
bacteria were then lysed by sonication on ice and the insoluble material pelleted by
centrifugation at 2,000 x g for 5 minutes. The soluble fraction was then incubated
with 50pl of a 50% suspension of equilibrated glutathione-sepharose beads for 5
minutes at room temperature and the beads then washed in PBS containing 1%
Triton X-100 before pelleting at 2,000 x g for 30 seconds. The beads were then
washed twice in PBS before pelleting and resuspending in SDS-PAGE sample
buffer. The insoluble and soluble fractions of the bacteria were then tested for protein
expression by SDS-PAGE analysis.
2.9.2 Isolation of Bacterial Proteins by Inclusion Body Preparation
Bacterial colonies were grown overnight and induced with IPTG as described
(Section 2.9.1). The bacteria were then pelleted at 7,000 x g for 5 minutes and
resuspended in inclusion body solution (lOOmM NaCl, ImM EDTA, 50mM Tris
(pH8.0)) to a final concentration of 10% (v/v). Lysozyme was added to lOmg/ml and
the solution incubated at room temperature for 20 minutes. The sample was then
centrifuged at 5,000 x g for 10 minutes, the supernatant discarded and the pellet
transferred to ice. The pellet was then resuspended in inclusion body solution with
0.1% (w/v) sodium deoxycholate and incubated on ice for 10 minutes. Magnesium
chloride was added to a final concentration of 8mM and DNasel (Roche) to a final
concentration of 10pg/ml and the sample was incubated at 4°C for 1 hour with
occasional mixing. The inclusion bodies were then removed from solution by
centrifuging at 6,000 x g for 10 minutes and the pellet washed once in inclusion body
solution in 1% (v/v) NP40 and once in inclusion body prep solution before
resuspension in 2 x SDS-PAGE sample buffer. The soluble and insoluble fractions
were analysed by SDS-PAGE.
2.9.3 Immunisation of Rabbits For Antibody Production
Two three month old New Zealand White rabbits were injected subcutaneously
between 4 sites with a total of 250/rl of a 50% (v/v) solution of inclusion body
preparation diluted in PBS, emulsified with an equal volume of Freund's complete
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adjuvant (Difco). This was then repeated in two months time, except that inclusion
body preparation was this time emulsified with Freund's incomplete adjuvant. Blood
samples were taken before immunisation and 2 weeks after the second injection. The
serum was then analysed for the presence of specific antibodies.
2.10 Analysis of Eukaryotic Cells
2.10.1 OvHV-2 Infected Cell Lines
All OvHV-2 infected cell lines for analysis were cultured at the Moredun Research
Institute by Dr Hugh Reid and Ms Irene Pow. The bovine cell line BJ/1035 was
cultured from the tissues of a natural case of MCF (Reid et al., 1989). The OvHV-2
infected rabbit cell lines BJ/2222, BJ/2223, BJ/880 and BJ/2476 were cultured from
the tissues of rabbits experimentally infected with SA-MCF (Reid et al., 1983).
2.10.2 Fixation of Cells
Cells were harvested and resuspended in PBS at 1 x 106/ml. The cells were applied to
glass microscope slides (Twinfrost slides, VWR) by cytocentrifuging using a
cytospin 2 (ThermoShandon). The cells were then air dried before fixing either in 4%
(w/v) paraformaldehyde in PBS for 10 minutes at room temperature, or for 5 minutes
in 100% acetone at -20°C. Acetone fixed slides were air dried and stored at -20°C.
After fixing in paraformaldehyde the slides were washed twice in PBS, then
permeablised by incubation for 5-10 minutes in PBS containing 0.2% (v/v)
Triton X-100. The slides were then washed four times with PBS, air dried and stored
at -20°C.
2.10.3 Immunostaining of Fixed Cells
Fixed cells on slides were incubated in PBS with 5% (v/v) normal goat or pig serum
(the serum used was from the species of animal that the secondary antibody was
raised in) for 30 minutes at room temperature in order to minimise non-specific
binding of the antibodies used. The slides were then incubated with the primary
antibody diluted in PBS with 5% (v/v) normal serum for 2 hours at 37°C (antibodies
used and concentrations are shown in table 2.2). Negative control slides were
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Antigen Primary Secondary
OvHV-2 08
Rabbit sera 1: 50 to 1: 250 Porcine anti rabbit FITC
conjugate 1: 50 DAKO
HA
Rat monoclonal anti HA
(3F10) 1: 250
Roche
Goat polyclonal anti rat Ig
FITC conjugate 1: 250
Pharmingen
Table 2.2 Antibodies used in immunostaining. Concentrations used are shown in
blue, and suppliers are shown in red.
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incubated for 2 hours in PBS with 5% (v/v) normal serum. The slides were then
washed 4 times in PBS containing 0.05% (v/v) Tween-20, before incubation with the
secondary antibody diluted in PBS containing 5% (v/v) normal goat serum for 45
minutes at 37°C. The cells were then washed four times in PBS containing 0.05%
(v/v) Tween-20, before drying in air and mounting in fluorescent mounting medium.
2.10.4 Fluorescent Microscopy
Samples for fluorescent microscopy were mounted in fluorescent mounting medium.
(DAKO) and examined using a Nikon Diaphot 200 Ultraviolet Microscope.
2.10.5 Separation of Lymphocytes From Whole Blood
Heparinised rabbit blood was obtained from the Moredun Research Institute and the
lymphocytes separated by Ficoll density centrifugation using Lymphoprep Solution
(Nycomed). The blood was very slowly and gently pipetted onto an equal volume of
Lymphoprep solution, so that the layers did not mix. The blood and Lymphoprep was
then centrifuged for 20 minutes at 400 x g. The lymphocytes were then carefully
removed from the interface between the serum and the Lymphoprep using a Pasteur
pipette and were washed three times in Roswell Park Memorial Institute 1640 (RPMI
1640, Invitrogen) complete medium (RPMI 1640 with 10% FCS, 2mM L-glutamine,
70/rg/ml penicillin, 10/zg/ml streptomycin, 50/rM B-mercaptoethanol). The
lymphocytes were then counted using a haemocytometer and resuspended at the
required concentration.
2.10.6 Stimulation of Lymphocytes Into Activated Lymphoblasts Using
Phytohaemagglutinin (PHA)
Lymphocytes were separated from blood using Lymphoprep as described (Section
2.10.4). The lymphocytes were then resuspended in RPMI complete medium at 2 x
106/ml and phytohaemagglutinin was then added to 7.5/rg/ml. The lymphocytes were
then incubated in a well of a 6 well plate such that the lymphocytes had adequate
contact with each other, at 37°C in a humidified atmosphere containing 5% CCF
After 48 hours, the lymphoblasts were harvested.
101
CHAPTER 2 MATERIALS & METHODS
2.10.7 Mammalian Cell Culture
All cell lines were cultured in sterile plastic ware (Nunc) and incubated at 37°C in a
humidified atmosphere containing 5% CO2. HEK 293 cells (Graham et al., 1977) and
MDBK cells (Madin, 1958) were cultured in Dulbecco's Modified Eagle's Medium
(DMEM, Invitrogen) supplemented with 10% (v/v) foetal calf serum (FCS, Sigma),
70pig/ml penicillin (VWR), 10/xg/ml streptomycin (Sigma) and 2mM L-Glutamine
(VWR). A20 cells (Kim et al., 1979) were grown in RPMI 1640 supplemented with
5% FCS, 70/rg/ml penicillin, 10/rg/ml streptomycin, 50juM G-mercaptoethanol
(Sigma) and 2mM L-glutamine.
2.10.8 Harvesting Cultured Cells
Adherent cells were harvested and passaged by removing the monolayer with
trypsin. The medium was poured off and the monolayer washed in 0.02% versene
(Invitrogen) before incubation with 0.25% trypsin (Invitrogen) until the monolayer
could be removed by tapping the flask. The trypsin was then diluted with an equal
volume of medium and the cells centrifuged for 5 minutes at 450 x g. The cell pellet
was resuspended in medium and a 50/xl aliquot mixed with an equal volume of 0.1%
(w/v) trypan blue (Sigma). The cells were then counted and non-viable cells
identified using a haemocytometer.
2.10.9 Transfection of Cultured Cells by Electroporation
Cells at 50% confluency were harvested, counted and resuspended at 2.5 x 106/ml.
An 800/xl sample of the cells was added to a 4mm electroporation cuvette (Equibio),
5 - 20 fxg DNA added and the sample mixed. The cells were then electroporated
using an Easyject electroporator (Equibio). HEK293 and A20 cells were
electroporated using a double pulse protocol (600V, 25pF, 99mQ followed by 0.1s
delay then 250V, 1050pF, 99mQ). MDBK cells were transfected using a single pulse
protocol (270V, 2500/rF, infinite resistance). A20 cells were transfected using either
the double pulse protocol described, or a single pulse protocol (260V, 1800/xF,
infinite resistance). Immediately after electroporation, the cell suspension was
removed from the cuvette into 10ml fresh medium and the medium divided between
2 wells of a 6 well plate. Transiently transfected cells were harvested 48 hours post
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transfection. The transfection efficiency was estimated by transfecting the control
plasmid pEGFPCl (Clontech), which expresses GFP and examining cells under UV
light.
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Appendix 1 - Buffer and Stock solutions
TE buffer Tris-HCl (pH8.0)
ImMEDTA
TAE buffer 0.04M Tris-Acetate
ImM EDTA
TBE buffer 450mM Tris-Borate
ImM EDTA
Luria-Bertani (LB) medium 1 % (w/v) tryptone
0.5% (w/v) yeast extract
1% (w/v) NaCl
LB agar LB containing 1.5% (w/v) bacto-agar
SOC medium LB containing 20mM glucose, 20mM
MgCl2
20 x SSC 3M NaCl, 300mM Na Citrate, pH7.0
20 x SSPE 3M NaCl, 0.2M NaH2P04.H20
20mM EDTA pH7.4
Tris-buffered saline (TBS) 50mM Tris-HCl, 150mM NaCl, pH7.6
Phosphate-buffered saline (PBS) 150mM NaCl, 2.5mM KC1, lOmM
Na2H2P04, ImM KH2P04, pH 7.4
50 x Denhardt's solution 1% (w/v) Ficoll 400,
l%(w/v) Polyvinylpyrrolidone,
1% (w/v) BSA (Fraction V)
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Appendix 2 - PCR Primers





5' - GCTTCAGCTTACTCCCTTTAC - 3'






5' - CAGCCTTTTGCTCACTGG - 3'






5' - CTATTCTCCATCACACAC - 3'







5'- TAGGCAAATATGGCCACTAG - 3'






5' - CATCACTACCCTGGTGCTTG - 3'






5' - GGGCCTTTATCTAACGTATGAGA - 3'






5' - GGACGTACAGGTCTTATTAC - 3'









5' - GGGATCCCC TCTAAGTCCTCCATCTTTCTG - 3'
£coRI







5' - GCGAATTCTTACTCGGTTAAACACAGGAC - 3'
BamHl










5' - GCGCGGCCGCTCTTCTCTCCCAGTCACCAT G - 3'
BamHl Stop Triple HA epitope
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Primer Primer sequence Annealing temp AmplifiedRegion
07-3' 5' - GGTAGCTGAACTCCACAC - 3'
55°C 07 - used
with 07/8-5'
228bp
07/8spl 5' - CACTAGCTGTAGGTGGTG - 3'
55°C 07 - 08 used
with 07/8-5'
702bp
08end-5' 5' - GCTGAGACACTCACTCAGC - 3'






5' - GTTGTGGTCGTGGTTGTTATG - 3'






5' - CCTTCATTGACCTCAACTACAT - 3'






5' - CGGCTCTCACGGAAAGAACTAGAAG - 3'






5' - GGGGATTGGAAAGTAAACGTCG - 3'






5' - TGGATATTGTTGCCATCAATGACC - 3'
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Appendix 3 - Primers Used In Splinkerette PCR
In first round PCR, the primer pair was the splinkerette primer (splink primer) with a
gene specific primer (GSP). In the second round of PCR, the primer pair was the
internal splinkerette primer (splink.Int) with an internal gene specific primer (GSP.
Int).
PRIMER PRIMER SEQUENCE Ann Temp
Splink
primer
5' - CGAATCGTAACCGTTCGTACGAGAA - 3'
69°C
02.GSP 5' - TCAAGAAGAGGTTACAGGAGCACGAG - 3'
73°C
Spl2.GSP 5' - GATGCTGAACACCATTAGGTGAGTG - 3'
69°C
Spl3.GSP 5' - AGTAGCACTGAGGTTTAACACGCTC - 3'
69°C
C75R.GSP 5' - TGGGTGTGTGATGGAGAATAGTCTG - 3'
69°C
C75R2.GSP
5' - GCCGAGAGTGCCTTTCTTGATCTTC - 3' 71°C
Splink.Int 5' - TTCGTACGAGAATCGCTGTCCT - 3'
61°C
02.GSP.Int 5' - GCAGCAGCAAGAACGAGTAAG - 3'
59°C
Spl2.GSP.Int 5' - TCATCAGTGTTGAAGGGGATGC - 3'
61°C




5' - GAGAATAGTCTGAATATACTGACC - 3' 61°C
C75R2.
GSP.Int
5' - CCCCTAACCTTTCATTTGCAGC - 3' 61°C
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Appendix 4 - Oligonucleotides Used For Construction of Splinkerette
Linkers
The splink Top oligo was used as the top strand in all linker molecules except the




Splink HindlW 5' - AGCTTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink AcoRI 5' - AATTTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink Xbal 5' - CTAGTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink Xma\ 5' - CCGGTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink Sail 5' - TCGATCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink BglII 5' - GATCTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink .ftssHII 5' - CGCGTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink Nhel 5' - CTAGTCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
Splink Top BamHl 5CGAATCGTAACCGTTCGTACGAGAATTCGTACG
AGAATCGCTGTCCTCTCCAACGAGCCAAGG - 3'
Splink BamHl 5' - GATCCCTTGGCTCGTTTTTTTTTGCAAAAA - 3'
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Appendix 5 - Cloning Vectors
JjcZOATG
CAO OAA ACA OCT ATQ AqC
gtc err rciT oav. tac via
III
I
Kfiflt I £irHI SQ4 I
I I T
ATO ATT ACQ CCA AOC TTO OTA CCO AOC TCO OAT CCA CTA
[OTAC TAA TOO OJuT TOG AAC CAT OHX TOG AGt CTA GOT OAT
awo eoc^i
i i
orA A03 OCC OCC Aor oro CTO OAA TTC OOC TT












CDC 0*A TTC TGC
T 003 CTT aAO ACQ
**v»l
I
ACiA TAT CCA TCA CAC too con COO CTC OO cat oca tct AO* o» CCC AAT TCOlOCC TaT
tct ata o3t aot ora aoc one c*x ctc gta con" a-^ tct ooc gas tta Aonlaaa ata
t—
T,? Pi ift QHi MI3 F(« w.,hII-| |->Vi Pnn>ri Ml 3 F(«»-jnrl I-4Q| Rinfti
or OAC- TOO OAA AAC
CTG ACC CTT TTG
Otbe* comment*:
The sequence above represents it**
cCR*l' 1 va^ic* v»nha PCR product
inaenedby TA Ctomftj* Note that the
inserted PCR product r? llantedcn eejh
sdeby fioR isiies
The atiom >:ii loJoates me = ian oi
ii arrscnpion lc« me T7 RNA poVerase
0-1*0*15
The vector pCR2.1 was obtained from Invitrogen
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" Tne Aps i site is
fsOuixJant in
vision A only.
the Xbs I silo is
ledurriant In
veislon B only.
Plasmid pcDNAS. l/A/Zyc-His, obtained from Invitrogen.
Plasmid pEGFP-Cl, obtained from Clontech
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Xmn I 2009























The vector pGEM - T Easy was obtained from Promega
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Sal I
The control plasmids pSG5/Jic-ELA and pSG5/IRF7-HA were
composed of either the Jk-HA sequence or the IRF7-HA sequence
cloned into the vector pSG5, and were provided by Dr Jeff Sample,
St. Jude Children's Research Hospital, Memphis.
The cosmid vector SuperCos 1 was modified by the replacement of
the Notl fragment of the vector cloning site with a cloning region
with the sequence EcoKl - Notl - Ascl - Pacl - BamlAl - AscI -
Pad - Notl - EcoRl to make SuperCos 1MW. The cosmid was
kindly provided by Dr Andrew Davison, MRC Virology Unit,
Glasgow.
112
CHAFFER 2 MATERIALS & METHODS
PGEX-3X (27-4803-01)
Factor Xa
I lie Glu Gly Argi'dy lie Pro Gly Asn Ser Ser
ATC GAA GGT CGT G.GG ATC.C.CC GGff.AAT TQA TCGIGA CTG ACT GAG
BamH I Sma j EcoR I Stop codons
The vector pGEX-3X was obtained from Amersham Biosciences
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The plasmid pVR1255 was obtained under license from Vical
Incorporated.
The vector pTrxFus is obtained from Invitrogen. The OvHV-2
ORF 59 sequence was cloned into the vector pTrxFus using the
Pstl and Xbal sites, resulting in the construct pTrxFus/ORF59
(Obtained from the Moredun Research Institute).
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The vector pBluescript IIKS was obtained from Stratagene
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Appendix 6 - Commercial Suppliers
Ambion Inc, Ambion (Europe) Ltd, Ermine Business Park, Spitfire Close,
Huntingdon, Cambridgeshire PE29 6XY
www.ambion.com
Amersham Biosciences UK Ltd, Amersham Place, Little Chalfont,
Buckinghamshire HP7 9NA HP7 9NA
www.amershambiosciences.com
Bio-Rad Laboratories Ltd, Bio-Rad House, Maylands Avenue, Hemel Hempstead,
Hertfordshire HP2 7TD
www.bio-rad.com
Clontech - BD biosciences Clontech UK, 21 In Between Towns Road, Cowley,
Oxford 0X4 3LY
www.clontech.co.uk
DakoCytomaton Ltd, Denmark House, Angel Drove, Ely, Cambridgeshire CB7
4ET
www.dakocvtomaton.com
EquiBio, Action Court, Ashford Rd, Middlesex. TW15 1XB
www.equibio.com
Flowgen, Findel House, Excelsior Rd, Ashby Park, Ashby de la Zouch,
Leicestershire LE65 1NG
www.flowgen.co.uk
Invitrogen Ltd, 3 Fountain Dr, Inchinnan Business Park, Paisley PA4 9RF
www.invitrogen.com
Millipore, 80 Ashby Rd, Bedford, Massachusetts, USA.
www.millipore.com
MWG Biotech (UK) Ltd, Mill Court, Featherstone Rd, Wolverton Mill South,
Milton Keynes MK12 5RD
www.mwgbiotech.com
Nalgenunc International, 75 Panorama Creek Drive, Rochester, NY 14625
www.nalgenunc.com
National diagnostics (UK) Ltd, Unit 4, Fleet Business Park, Itlings Lane, Hessle,
East Riding of Yorkshire HU13 9LX
www.nationaldiagnostics.com
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New England Biolabs (UK) Ltd 73 Knowl Piece, Wilbury Way, Hitchin,
Hertfordshire, SG4 OTY
www.neb.com
Nycomed, Langebjergl P.O. Box 88 DK- 4000 Roskilde, Denmark
www.nvcomed.com
Pharmingen - BD biosciences Pharmingen, 21 In Between Towns Road, Cowley,
Oxford 0X4 3LY
www.bdbiosciences.com/pharmingen/
Promega UK Ltd, Delta House, Chilworth Research Centre, Southampton SO 16
7NS
www.promega.com
Roche Diagnostics Ltd, Bell lane, Lewes, East Sussex, BN7 1LG
www.roche.com
QIAGEN Ltd, Boundary Court, Gatwick Rd, Crawley, West Sussex RH10 9AX
www.QIAGEN.com
Sigma-Aldrich Company Ltd, Dorset, England
www.sigmaaldrich.com
Stratagene Europe, Gebouw California, Hogehilweg 15, 1101 CB Amsterdam,
Zuidoost, The Netherlands
www.stratagene.com
ThermoHybaid, Action Court, Ashford Road, Ashford, Middlesex, TW15 1XB
www.thermohvbaid.com
ThermoShandon, 171 Industry Drive, Pittsburgh, PA 15275 USA
www.shandon.com
Vical Incorporated, 9373 Towne Centre Drive, Suite 100, San Diego, California
92121-3088
www.vical.com
VWR international Ltd, Merck House, Poole, Dorset BH15 1TD
www.vwr.ltd.uk
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3.1 Replication of Ovine Herpesvirus 2
Little is known about OvHV-2 viral gene expression in animals with SA-MCF,
largely due to the fact that the lack of available sequence has meant that there are few
reagents available for the study of OvHV-2 pathogenesis. From animals infected
with Malignant Catarrhal Fever, Lymphoblastoid Cell Lines (LCL) can be
propagated, some of which transmit disease (Reid et al., 1989) (Reid et al., 1983).
Until this point, no evidence of virus particles or viral products have been found in
the cell lines, although viral DNA homologous to that of A1HV-1 has been identified
by hybridisation with A1HV-1 DNA (Bridgen & Reid, 1991). Since the OvHV-2
infected cell lines transmit disease, it is hypothesised that the complete OvHV-2
virus genome persists in the cell lines. The mode of viral persistence in the OvHV-2
infected cell lines is however, unknown.
The aim of this work was to further characterise the OvHV-2 infected cell
lines, with respect to the mode of viral persistence in the cell lines and to quantify the
amount of virus persisting in the cell lines. The ultimate aim of the work was to
establish if there was evidence of viral replication in OvHV-2 infected cell lines and
if possible, identify viral particles. This work was performed as a starting point to
determine if the OvHV-2 infected cell lines were a suitable source of viral DNA
from which the full OvHV-2 viral genome could be obtained.
3.1.1 Determination of the OvHV-2 Genome Copy Number
Initially it was decided to establish on average, how many viral genomes were
present in each cell. The genome copy number was determined by a Southern
blotting method. Serial dilutions of an OvHV-2 sequence (ORF59) were
electrophoresed alongside digested DNA from 1.6 x 106 OvHV-2 infected LCLs. The
intensity of any bands seen in the plasmid lanes of the blot was compared with that
seen in the digested OvHV-2 DNA lanes after probing with an OvHV-2 specific
probe.
In order to construct an OvHV-2 specific probe a clone containing OvHV-2
ORF 59 sequence (Coulter & Reid, 2002) cloned into the vector pTrxFus
(Invitrogen) (Appendix 5) was obtained from the Moredun Research Institute. This
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was named pTrxFus/ORF59. The OvHV-2 ORF 59 sequence was excised from this
vector by digestion with Xbal and Pstl. The fragment was then gel purified by
32electroelution as described and labelled with a ~PdCTP.
3.1.1.1 Preparation of Dilutions of Plasmid DNA For Southern Blotting
The plasmid TrxFus/ORF59 was 4.6kb in size, lkb of DNA has an approximate
molecular weight of 6.60 x 105 (Sambrook et al., 1989) therefore a plasmid of 4.6kb
has a molecular weight of 3.04 x 106. The weight of one mole of plasmid was
therefore 3.04 x 106g. This meant that 1/rg of plasmid contained 1.97 x
101 'molecules.
The aim was to make a dilution of plasmid DNA such that 5/rl of the sample
contained 109 molecules. Serial dilutions of this sample could then be made down to
105 molecules/5(il. A 5/zl aliquot of each sample would then be linearised in
preparation for electrophoresis. The pTrxFus/ORF59 plasmid stock was at 100ng//d,
therefore 5/rl contained 500ng of DNA and 1 x 10"molecules. In order to make a
stock of 109 molecules/5/rl, the plasmid stock was needed to be diluted 1/100 in TE
pH8.0, however due to a mistake in the original calculations the plasmid dilution
made was 1/175. Serial dilutions of this stock were then made in TE pH8.0, which
O A
were now from 5.7 x 10 molecules/5jal down to 5.7 x 10 molecules/5/il in 1 in 10
serial dilutions. A 5/xl sample of each dilution was then digested in a 20/xl reaction
with Pstl, in order to linearise the plasmid. Gel loading buffer (4/xl) was then added
to each digested plasmid sample, before loading onto the gel.
3.1.1.2 Southern Analysis of the OvHV-2 DNA and ORF59 Plasmid
Dilutions
DNA was extracted from the OvHV-2 infected bovine cell line BJ/1035 as described
(Section 2.2.1). Genomic DNA extracted from OvHV-2 infected cell lines was
termed OvHV-2 DNA. OvHV-2 DNA (10/xg) was digested with BamHl or 7/mdIII
in a 200/rl reaction at 37°C. These enzymes were chosen because the GC content of
OvHV-2 DNA was not known. Since the BamHl restriction site is relatively GC rich,
whereas the Hindlll site is relatively AT rich, it was predicted that the DNA should
digest well with one of these enzymes. After digestion, the samples were ethanol
precipitated and resuspended in a 20/i\ volume of TE pH8.0. The OvHV-2 DNA
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Figure 3.1.1 Southern Blot for Estimation of the Copy






X X X X X
I—- 1—; i—; I—; |—
LO LO 10 to LO
4.5kb-
1.0kb— -
OvHV-2 DNA (10pg) extracted from the OvHV-2 bovine cell line
BJ/1035 was digested with Barrii II and lOpg digested with Hindlll.
The digests were electrophoresed alongside serial dilutions of
OvHV-2 ORF 59 DNA from 5.7 x 108 to 5.7 x 104. The
electrophoresed DNA was analysed by Southern blotting using an
OvHV-2 ORF 59 probe. The blot was exposed to film overnight and
any bands compared to a lkb DNA ladder.
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samples were loaded onto a 1% agarose gel alongside the linearised plasmid samples
and electrophoresed until the loading buffer dye front had migrated 10cm down the
gel. The gel was then photographed to check for even loading and the DNA
transferred to a nylon membrane (Magnagraph, Osmonics) by Southern blotting as
described (Section 2.2). The membrane was probed using the a32P labelled OvHV-2
ORF59 probe. After exposure of the blot to X-ray film the intensity of the resulting
bands from the known copy numbers of plasmid DNA was compared with that of the
two lanes of digested OvHV-2 DNA.
The BamHl digest of the OvHV-2 DNA resulted in 2 bands at lkb and 4kb
approximately. This showed that there is a BamHl site in the ORF59 DNA
(Figure 3.1.1). The Hindlll digest resulted in just one band at 4.5kb. The intensity if
the bands of digested OvHV-2 DNA was similar to both the 5.7 x 107 and the 5.7 x
108 copies of plasmid lanes. The 10p.g of genomic DNA was from 1.6 x 106 cells,
therefore the OvHV-2 infected cells contain between 356 and 36 copies of viral
genome. Since the intensity of the bands was more similar to the 108 copies of
plasmid lane, it was estimated that the cells contain approximately 50 copies of viral
DNA per cell.
3.1.2 Analysis of OvHV-2 Infected Cells by Gardella Gel Electrophoresis
It was not known in what form the viral DNA persisted in OvHV-2 infected cell
lines. If the viral genomes were predominantly in the latent state, persistence was
likely to be as a circular episome. If viral DNA replication was taking place, this
would result in the production of linear viral DNA. In order to address this problem,
Gardella gel electrophoresis was performed on OvHV-2 infected LCLs. A Gardella
gel is a denaturing agarose gel whereby whole cells to be analysed are loaded onto
wells in the denaturing section of the gel and gently lysed in situ, whilst undergoing
slow electrophoresis (Gardella et al., 1984). After lysis, the current applied to the gel
is increased and the products of cell lysis are electrophoresed overnight. Circular
DNA is retarded compared to linear DNA, therefore when the DNA is transferred to
a nylon membrane and hybridised with an OvHV-2 specific probe, the presence of
linear or circular viral DNA can be determined by comparison to controls.
Fresh OvHV-2 infected LCLs (2 x 106) were loaded onto the denaturing
portion of the gel containing SDS and proteinase K as described (Section 2.3.2). Two
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control cell lines were also analysed; the BCP-1 cell line is a KSHV infected B cell
line (Boshoff et al., 1998) in which approximately 1% of cells are lytically infected
(Dr S.J.Talbot, Personal communication), whilst the remaining cells are latently
infected. The Sll cell line is an MHV-68 infected B cell line (Usherwood et al.,
1996) in which up to 20-30% of cells can undergo productive cycle replication. The
cells were subjected to electrophoresis slowly at 30V for 3 hours at 4°C though the
denaturing gel, so that any episomal DNA would remain intact. Electrophoresis was
then continued overnight at 110V.
After electrophoresis the DNA was transferred to a nylon membrane
(Section 2.2), The position of the viral DNA on the gel was then determined by
Southern blotting. OvHV-2 viral DNA was detected using a 32P labelled OvHV-2
specific probe. This was made by PCR amplification of DNA extracted from the
OvHV-2 infected cell line BJ/1350 using the primers 075-5' and 075-3'
(Appendix 2). These primers were designed to amplify a 540bp region of OvHV-2
ORF 75. KSHV DNA was detected using a probe specific for the KSHV K1 gene
(obtained from Dr. S.J. Talbot) and MHV-68 DNA was detected using a probe
specific for the MHV-68 M2 gene (obtained from Dr A. MacRae). The OvHV-2
infected cell lines analysed were the bovine cell line BJ/1035 and the rabbit cell lines
BJ/2222 and BJ/2223.
Hybridisation was initially carried out using 0.05 x BLOTTO in 6 x SSC,
however no signal was detected. It was suspected that transfer of DNA onto the
nylon membrane may not be optimal, therefore the Gardella gel was repeated and a
control for DNA transfer was electrophoresed. This was 0.5/xg cosmid A8 DNA
(SuperCos 1MW containing the left-hand end of MHV-68, obtained from Dr A.
MacRae). Hybridisation of the M2 probe to this DNA was detected by Southern
blotting, however hybridisation of the virus specific probes to any of the viral DNA
samples was not detected. The amount of DNA in the A8 control DNA sample,
however, may have been quite large compared to the amount of viral DNA present in
a latently infected cell line, therefore it was decided that a more sensitive detection
system might be useful.
In order to increase sensitivity, Ultrahyb sensitive hybridisation buffer
(Ambion) was used. This buffer contains 50% formamide and when detecting a high
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copy number target, only a 1-2 hour hybridisation is required. Lower abundancy
targets such as the viral DNAs resolved by Gardella gel electrophoresis required
overnight hybridisation. Hybridisation and washes were carried out at 42°C as
described (Section 2.2.6). The blot was initially exposed to X-ray film for 2 days,
after which a low intensity signal was detected for all samples. The membrane was
therefore exposed for a further 2 weeks to increase the intensity of the signal (Figure
3.1.2). The Sll cell control showed an obvious upper band indicating episomal
circular DNA and a heavy lower smeared band indicating linear viral DNA produced
in viral DNA replication. The BCP-1 control cell line also showed two bands of viral
DNA, indicating the presence of both linear and episomal DNA. The OvHV-2
infected rabbit cell lines (BJ/2222 and BJ/2223) both showed an obvious lower
smeared band indicative of linear DNA, as would be produced in viral DNA
replication. A faint upper band was also seen, indicating the presence of episomal
circular viral DNA found in latently infected cells. In the OvHV-2 infected bovine
cell line BJ/1035, the lower linear viral DNA band was of low intensity compared to
that observed in the rabbit cell lines, whilst there was a strong upper band indicating
episomal viral DNA.
The presence of retarded upper bands of viral DNA in the rabbit OvHV-2
infected cell lines and in the cattle cell lines was clear evidence that as suspected, all
cell lines contained circular OvHV-2 viral DNA. This suggested that some cells in
each cell line were latently infected with OvHV-2. The smeared high intensity lower
bands seen in the rabbit cell lines were indicative of production of linear viral DNA,
and therefore were evidence that the cell lines contained replicating viral DNA. The
cattle cell line showed a barely detectable lower linear DNA band, which would
seem to suggest that this cell line contained lower levels of viral DNA replication.
3.1.3 Analysis of RNA Extracted from OvHV-2 Infected Rabbit Cell Lines
Gardella gel analysis of OvHV-2 infected cells demonstrated evidence of viral DNA
replication in rabbit cell lines. Since viral DNA replication and production of linear
viral DNA is generally seen in the viral lytic cycle, the OvHV-2 infected cell lines
were investigated for further evidence of lytic viral replication. The cell lines were
124
CHAPTER 3 RESULTS









X co CO O
cn X 01 O
n^
CM CO uo
T_ CM CM CO
■ CM CM o
Q_ CM CM •*—
O —) —3 -o
CO CD CD CQ
Linear-
Two OvHV-2 infected rabbit cell lines (BJ/2222 and BJ/2223) and
one OvHV-2 infected bovine cell line (BJ/1035) were analysed by
Gardella Gel Electrophoresis. The KSHV infected B-cell line
BCP-1 and the MHV-86 infected B-cell line Sll were analysed as
control cell lines. The gel was analysed by southern blotting and
probed using 32P labelled probes specific for OvHV-2 (ORF 75),
KSHV (Kl) and MHV-68 (M2). The position of covalently closed
circular (CCC) and linear DNA are marked on the left side of the
image. The stars mark bands which were visible on the x-ray film
but did not reproduce well photographically.
125
CHAPTER 3 RESULTS
therefore analysed for evidence of expression of productive cycle genes by northern
analysis and RT-PCR.
3.1.3.1 Northern Analysis of OvHV-2 Infected Rabbit Cell Lines
Treatment of cell lines latently infected with EBV or KSHV with the phorbol ester
TPA increases the proportion of cells lytically infected, therefore a sample of
BJ/2222 OvHV-2 infected rabbit cells was incubated overnight with TPA at a
concentration of 20ng/ml. Cytoplasmic RNA was extracted from the TPA treated
OvHV-2 infected rabbit cells and from untreated cells as described (Section 2.7.1). A
5/xg sample of total RNA was then analysed by northern blotting (Section 2.7.4). The
blot was probed using an OvHV-2 ORF 57 probe. This was made by PCR
amplification of OvHV-2 infected cell DNA using the primers 057-5' and
057-3' (Appendix 2). These primers amplified a 483bp region of OvHV-2 ORF 57.
ORF 57 is an immediate early lytic gene and is thought to be involved in regulation
of viral gene expression (Goodwin et al., 2000). No signal was detected after
exposure to film for 14 days therefore the ORF 57 probe was removed from the blot.
Hybridisation of the blot was then repeated using an OvHV-2 ORF 75 probe. ORF
75 is a late gene encoding a putative tegument protein and it was thought that
expression of this gene might be higher than that of ORF 57. No signal was detected
however after a 14 day exposure to film, therefore it was concluded that levels of
OvHV-2 mRNA in the BJ/2222 cells were low and treatment of the cells with TPA
did not increase expression of viral genes to the level of detection. In order to
increase the likelihood of detecting viral transcripts by northern blotting, analysis of
poly A RNA would have been necessary however, at the time this was not possible
due to the low availability of OvHV-2 infected cells.
3.1.3.2 RT-PCR analysis of OvHV-2 infected rabbit cell lines
Northern analysis of RNA extracted from the OvHV-2 infected rabbit cell lines
demonstrated that expression of viral transcripts was low, therefore in order to
increase sensitivity of detection, samples of the same batch of RNA were analysed
by RT-PCR. Two samples of RNA (1/xg/reaction) were incubated with DNasel as
described and reverse transcribed using random primers (Section 2.7.5). For each
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reaction a control sample was included, omitting reverse transcriptase enzyme from
the reaction. This was to ensure any products were as a result of amplification of
cDNA and not from amplification of contaminating genomic DNA.
Initially PCR amplification of the cDNA was performed using the primers
Rgap-5' and Rgap-3' (Appendix 2), which were designed to amplify a 400bp region
of the rabbit glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. This is a
housekeeping gene that is expressed at substantial levels in all cells. In initial
analyses, failure of the GAPDH PCR reaction indicated that the RT reactions had not
worked. Phenol contamination of RNA is sometimes found in RNA samples
extracted using methods involving the use of phenol. This can inhibit the action of
reverse transcriptase enzymes, therefore a different method of RNA extraction was
used. Total RNA was extracted from the BJ/2222 OvHV-2 infected rabbit cell line
using a QIAGEN RNeasy kit (Section 2.7.2), as this does not involve the use of
phenol.
PCR amplification of the new sample of total RNA using the GAPDH
primers, resulted in product of the correct size of 400bp (Figure 3.1.3), therefore this
confirmed that the reverse transcriptase reaction had worked. The cDNA was then
used for PCR amplification reactions using the OvHV-2 ORF 75 primers 075-5' and
075-3' (Appendix 2) and using the OvHV-2 ORF 57 primers 057-5' and 057-3'
(Appendix 2). The PCR products were analysed by gel electrophoresis. Products
were detected from reactions using both the ORF 57 primer pair and the ORF 75
primer pair (Figure 3.1.3). This showed expression of both the OvHV-2 immediate-
early gene ORF 57 and the OvHV-2 late gene ORF 75 in the rabbit OvHV-2 infected
cell line BJ/2222. By comparison to other gammaherpesvirus genes, both ORF 57
and ORF 75 are expressed in the viral lytic cycle, therefore transcription of these
genes in OvHV-2 infected rabbit cell lines provides evidence of early and late lytic
viral gene expression in the cell lines.
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Total RNA was extracted from the OvHV-2 infected rabbit cell line
BJ/2222. The RNA was used in reverse transcription reactions using
random primers. The products of the RT reactions were amplified by
PCR using the primers against rabbit GAPDH (Rgap-5' and Rgap-3'),
OvHV-2 ORF75 (075-5' and 3') and OvHV-2 ORF57 (057-5' and 3')
as indicated above the gel images. The products were analysed by
agarose gel electrophoresis alongside a lkb+ DNA ladder.
+C = PCR Positive control using OvHV-2 genomic DNA as template
for ORF 75 and ORF 57 primers and MHV-68 cDNA template for
GAPDH primers. -C = PCR negative control with dHzO template.




3.1.4 Electron Microscopy of Rabbit Cell Line BJ/2222
Evidence of OvHV-2 viral DNA replication in the OvHV-2 infected rabbit cell lines
was demonstrated by Gardella gel analysis and viral transcripts of the productive
cycle genes ORF 57 and ORF 75 were detected by RT-PCR. To this point viral
particles had not been observed in the OvHV-2 infected cell lines, however as a
result of the evidence that viral replication occurred in these cell lines, the OvHV-2
infected cells were examined for the presence of viral particles. Sodium Butyrate
treated and non-treated OvHV-2 infected rabbit cells were fixed in glutaraldehyde
and examined by transmission electron microscopy, however no particles were
visible after examination of a few hundred cells. An alternative method was therefore
adopted based on that used by Arvanitakis et al., (1996). Cells were lysed by freeze-
thawing and the lysates pelleted by ultracentrifugation. The pellets were examined by
transmission electron microscopy at Lasswade Veterinary Laboratory by Dr Martin
Jeffrey and Ms Gillian McGovan. A herpesvirus particle was visualised (Figure
3.1.4), the icosahedral capsid typical of a herpesvirus was visible, however it was not
obvious if the capsid was surrounded by a viral envelope.
In summary, it has been shown that there is evidence of productive cycle
replication of OvHV-2 in infected rabbit cell lines, as shown by production of linear
DNA as shown by Gardella gel analysis, production of mRNA for lytic cycle genes,
and production of viral capsids, however the presence of fully enveloped viral
capsids has not yet been shown.
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Figure 3.1.4 An Electron Micrograph Obtained From
Examination of Lysates of OvHV-2 infected Rabbit Cell line
BJ/2222
Cells of the OvHV-2 infected rabbit cell line BJ/2222 were
lysed by freeze thawing and concentrated by centrifugation as
described in (Arvanitakis et al., 1996). The fixed cell pellet




3.2 Generation of OvHV-2 Genome Sequence
3.2.1 Construction of a Cosmid Library
The study of OvHV-2 has been limited by lack of a tissue culture system supporting
replication of OvHV-2. At the beginning of this work therefore, only a small amount
of the genome sequence of OvHV-2 was known. A phage X library had previously
been constructed using genomic DNA from OvHV-2 infected LCL and from this a
DNA clone corresponding to ORF 75 had been derived by homology to A1HV-1
(Bridgen & Reid, 1991). Recently the sequence of OvHV-2 ORF48, 49 and 73 has
been derived by screening an expression library constructed using cDNA from
OvHV-2 infected bovine cell lines with sheep sera (Coulter & Reid, 2002). It had
been assumed that the full viral genome is present in OvHV-2 infected cell lines due
to the fact that the cell lines transmit disease to cattle, sheep and deer (Reid et al.,
1983).
The aim of this work was to derive the complete genome sequence of
OvHV-2. In the absence of a tissue culture system for production of virus, in order to
derive the complete DNA sequence of OvHV-2 we were limited to using total
cellular DNA from OvHV-2 infected cells instead of purified viral DNA. A cosmid
library was constructed using DNA extracted from OvHV-2 infected cattle cell lines
(Figure 3.2.1.1). The aim of the cosmid cloning was to produce a series of
overlapping clones spanning the OvHV-2 genome. The library was predicted to
contain a mixture of recombinant cosmids, some containing inserted OvHV-2 viral
DNA and some containing inserted bovine LGL DNA. The aim was to identify virus
containing clones by screening the cosmid library with a probe of known OvHV-2
viral sequence. The cosmid SuperCos 1 was 7.9kb in size. Since recombinant
molecules of 38 - 52kb can be packaged into phage used in cosmid cloning, foreign
DNA of size 30 - 44kb can be cloned using this vector. From sequence at each end of
the cosmid insert, probes were generated and used to identify additional clones
containing viral sequence. Since Gardella gel analysis showed that the genome is
present in bovine OvHV-2 infected cell lines predominantly in the episomal or
circular form (section 3.1.2), it was expected that cosmid clones spanning the viral
terminal repeats might be obtained from the library.
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Figure 3.2.1.1 Cosmid Cloning




















The diagram shows the strategy that was used in cosmid cloning.
Genomic DNA to be cloned was digested into fragments of average
size 40kb by partial restriction digestion using Mbol. These DNA
fragments were then dephosphorylated and ligated to compatible
cosmid arms. The ligated cosmid construct was packaged in vitro
into bacteriophage heads. The recombinant bacteriophage were then
used to infect E.coli. Once in E.coli, the recombinant cosmid
molecule circularises and replicates like a large plasmid. The E.coli




Assuming an average size of cosmid insert of 40kb, the number of
transformants necessary to have a reasonable chance of identifying any given clone
of interest can be calculated, using the formula
N = ln( 1-P )/ln( 1-f)
Where P is the desired probability of identifying any given clone, f is the fractional
proportion of the genome in a single recombinant and N is the necessary number of
recombinants. Therefore assuming the bovine genome to contain 3 x 109 bp DNA, in
order to have a 99% probability of identifying a clone of interest in the library, the
number of clones required would be
N = ln( 1-0.99 )/ln( 1-(40000/3 x 109)
N = 345,459 clones.
However since it has been estimated that the average viral copy number per cell is
50, each viral sequence will be present in a 25 fold excess compared to unique
cellular sequences, assuming 2 copies of each sequence, therefore 1/25 of this
number of clones will be required. A library containing 13,818 clones would
therefore be theoretically sufficient.
3.2.1.1 Preparation of Eukaryotic DNA For Cosmid Cloning
The aim was to produce eukaryotic DNA fragments of average size 40kb, as this was
the correct size for ligation to cosmid DNA and in vitro packaging. The cosmid
vector SuperCos 1MW used to clone the OvHV-2 genome contained two cos sites.
These vectors are an improvement on cosmid vectors containing just one cos site, as
the partially digested genomic DNA used does not need to be size fractionated
(Reilly & Silva, 1993b). This means that reduced quantities of genomic DNA can be
used, as DNA loss in the size fractionation step which is required using vectors with
just one cos site is avoided. High molecular weight DNA was extracted from an
OvHV-2 infected bovine cell line (BJ1035, cultured at the Moredun Research
Institute) as described (Section 2.2.1). The extraction of high molecular weight DNA
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of good quality is one of the most important steps in the construction of a cosmid
library; therefore care was taken to handle the DNA solutions gently to avoid
shearing the DNA. The DNA solution was mixed gently during phenol : chloroform
extraction, rather than vortexing and the solution was pipetted using wide bore
pipette tips.
A number of dilutions of Mbol (IOU//1I) from 1/250 to 1/4000 were made. A
1/xl aliquot of each dilution was used to digest a 10/xg sample of OvHV-2 DNA to
give a series of partial digests (Figure 3.2.1.2). An aliquot of the Mbol digested DNA
was then analysed by gel electrophoresis alongside a 40kb standard (Sail linearised
Cosmid A8). The restriction enzyme Mbol recognises a 4bp sequence and generates
a cohesive terminus, which can be ligated to DNA digested with BamHl. DNA
digested to a suitable size of product was then dephosphorylated in preparation for
cloning into cosmids.
3.2.1.2 Generation of a Cosmid Library Using OvHV-2 DNA
In order to prepare cosmid DNA for cloning, cosmid DNA was linearised by
restriction enzyme digestion with Xbal and dephosphorylated using CIAP to prevent
self-ligation of the cosmid. The cosmid DNA was then digested with BamHl to
produce 2 cosmid arms (Figure 3.2.1.3). Partially digested dephosphorylated
OvHV-2 DNA was ligated to cosmid arms produced as described. The product of the
ligation reaction was expected to be a population of concatemers comprising
OvHV-2 DNA ligated to two different cosmid arms. The ligation reaction was
packaged into recombinant X phage and the products of the packaging reaction were
then used to infect the XLl-Blue MR strain of E. coli. SuperCos 1MW contains an
ampicillin resistance gene; this was therefore used for selection of cosmid containing
clones.
Before packaging ligated OvHV-2 DNA, the packaging efficiency was tested
using the wild type X control phage DNA. A number of trials were necessary to
obtain acceptable efficiency of 400 plaques in the 10"4 dilution. Having established
that the packaging protocol was working with acceptable efficiency using the control
X DNA, packaging was attempted using ligated OvHV-2 DNA. A number of
ligations of OvHV-2 and cosmid DNA were packaged and plated in order to obtain a
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Figure 3.2.1.2 Mbol Partial Digests of DNA Extracted From an
OvHV-2 Infected Cattle Cell Line
40kb
High molecular weight DNA was extracted from the OvHV-2
infected cattle LCL BJ/1035. Partial restriction digests of the DNA
were then performed using dilutions of Mbol (lOU/pl) from 1/250 to
1/4,000 as labelled. A sample of each digest was analysed by
electrophoresis on a 0.5% agarose gel alongside a 40kb size marker
and undigested OvHV-2 DNA.
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Digestion and ligation of cosmid DNA in preparation for packaging
into phage X. Cosmid DNA was digested with Xbal and
dephosphorylated, producing linearised cosmid vector. This was then
digested with BamHI to produce 2 cosmid arms. The cosmid arms
were then ligated to dephosphorylated Mbol digested genomic DNA.
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library with an acceptable titre for screening. A 2/xl sample of OvHV-2 DNA
digested with a 1/250 dilution of M&ol and ligated to SuperCos 1MW was packaged.
The packaging reaction diluted 1/10 and then plated resulted in 80 colonies, whilst a
dilution of 1/50 resulted in 16 colonies. The sample was therefore titred at 32,000
cfu/ml. Since the library was contained in a volume of 500/U.l, this meant that it
contained 15,000 transformants. This library was amplified and plated onto a 150mm
LB amp agar plate, such that it contained many small individual colonies 0.5-1mm
diameter (approximately 4,000 colonies).
3.2.1.3 Cosmid Library Screening Using an OvHV-2 ORF 75 Specific
Probe
In order to identify cosmid clones containing OvHV-2 DNA, the library was
screened by colony hybridisation as described (Section 2.5.11). All probes used to
screen the cosmid library are shown in figure 3.2.1.4. The probe used initially was
generated by PCR amplification of a 540bp area of OvHV-2 ORF 75 using the
primers 075-3' and 075-5,' and genomic DNA from OvHV-2 infected cells as a
template. The PCR product was purified to remove primer and labelled with ~P
(Section 2.2.4). This initial screen resulted in 8 positive clones (named C75-1 to 8).
These clones were colony purified by re-plating to single well-spaced colonies and
re-screening. Individual positive colonies were identified, which aligned exactly with
spots on the x-ray film at re-screening. These colonies were selected and cosmid
DNA purified by "mini prepping". Cosmid DNA purified from these colonies was
analysed by restriction enzyme digestion with PacI, as this site flanked the insert at
each side. Inserted DNA was found in 5 clones, C75-1.1.1, 6.1, 7.2, 1.1.2, and 7.1.
Restriction digests from clones C75-1.1.1, 6.1, 7.1 and 7.2 produced a band of
excised cosmid DNA at 7.9kb and bands of approximately llkb, 25kb and 2kb. The
total size of the insert was estimated to be approximately 40kb (Figure 3.2.1.5).
Digestion of clone 1.1.2 resulted in a single band of approximately 12kb.
3.2.1.4 Sequencing of Positive Cosmid Clones
Modifications made to the vector SuperCos 1 to make SuperCos 1MW meant that the
T7 and T3 RNA polymerase promoters had been removed (Section 2.5.1). This
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Figure 3.2.1.4 PCR Primers and Library Probes Used to
Identify OvHV-2 Viral Sequence
1 - ORF 75, 2 - C75R, 3 - ORF57, 4 - ORF33, 5 - ORF11,6- ORF8,
7 - C249, 8 - ORF 02 A - C75R.GSP B - C75R2.GSP, C - Spl3.GSP,
D - Spl2.GSP, E-02.GSP
The OvHV-2 genome is represented circularised at the terminal
repeats (TR). The position of some open reading frames are shown in
coloured block arrows. The library screening probes are shown in blue
and numbered, whilst the PCR primers are shown as block arrows and
labelled with letters. The library probes and PCR primers were, when
possible, named according to the OvHV-2 ORF sequence from which
they were derived. Probe C75R and C75R.GSP were derived from
sequence at the right hand end of cosmid C75. Probe C249 was
derived from the A1HV-1 clone C249 (Figure 3.2.1.9) which extended
from A1HV-1 ORF A3 to ORF 6. Spl2.GSP was from sequence
derived by splinkerette PCR using 02.GSP, and spB.GSP was from
sequence derived by splinkerette PCR using spl2.GSP. C75R2.GSP




Figure 3.2.1.5 Pacl Digests of C75 Cosmid DNA
A cosmid library was constructed using OvHV-2 infected bovine
cell DNA. The library was screened with an OvHV-2 ORF75 probe.
Positive areas were selected and re-plated so that individual positive
colonies could be picked. Cosmid DNA was prepared from positive
colonies using a Q1AGEN mini prep kit. The cosmid DNA was
digested with Pacl and analysed by electrophoresis on a 0.8%
agarose gel alongside a lkb DNA ladder. Digested DNA from
colonies identified by re-screening of positive areas C75-1, 6 & 7 is
shown. The numbers given to each cosmid DNA sample represent
the colony number given at each screen. The position of excised
cosmid DNA is indicated.
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meant that sequencing primers designed specifically against the T7 or T3
bacteriophage promoter regions could not be used for sequencing cosmid inserts,
therefore new sequencing primers were designed and 5' end-labelled with the dye
IRD800. These were named primer 7850 and primer 181 due to the coordinates on
the cosmid vector at which they originated (Figure 3.2.1.6). DNA prepared from
these colonies using a QIAGEN miniprep kit was sequenced. Sequence was then
analysed using the program blastx, which compares the translated query sequence
with the protein database nr. Sequencing using the cosmid sequencing primers 7850
and 181 generally resulted in 400-500bp of sequence from each end of the cosmid
insert. Analysis of the sequence obtained from C75-1.1.1 and C75-7.1 using the
sequencing primer 7850 showed the cosmids contained viral DNA homologous to
A1HV-1 ORF 57.
Sequencing clones C75-1.1.1 and 7.1 using the sequencing primer 181
initially produced insufficient sequence for analysis. This could have been due to the
fact that the cosmid DNA samples for sequencing were of very low concentration
(usually approximately 100ng//rl), or because the sequencing primer used in the
reactions was not working very well, resulting in sub-optimal sequencing reactions.
The cosmid clones grew slowly in overnight culture and overnight mini cultures for
preparation of cosmid DNA always resulted in cosmid DNA samples of low
concentration. This may have been because the cosmids are replicated at a low copy
number compared to smaller plasmids. In addition because they are large molecules,
cosmids have a relatively long replication time. The long replication time would
result in slower growth of the host bacteria. It is also possible that the viral DNA was
toxic to the bacterial hosts, resulting in slower bacterial growth.
In order to make a more concentrated cosmid DNA preparation, cosmid DNA
was purified by making a large cosmid DNA preparation using a QIAGEN large
construct kit as described (Section 2.1.18). The left hand end of this DNA was
sequenced using primer 181 and this time sufficient sequence was obtained for
analysis. Comparison of this sequence with the database revealed no similarity to
database protein sequences, but due to the fact that the probe used to identify this
cosmid was ORF 75, it was assumed to be in the area beyond ORF 75, possibly

























































































40kb in size and spanned 17 ORFs. Sub-optimal sequencing reactions when using
primer 181 might have been due to inefficient binding of the sequencing primer to
the target sequence. It was suspected that this could have been because the
sequencing primer was too short. In order to rectify this problem, a new longer
sequencing primer was designed from the SuperCos 1MW sequence and was named
primer 175 (Figure 3.2.1.6). This replaced primer 181 in all subsequent sequencing
reactions, however sequence obtained from this primer continued to be weak and
difficult to read compared with sequence obtained using primer 7850. It was
concluded that there may be secondary structure in this region of the cosmid which
made primer binding difficult.
Increasing the concentration of the DNA preparation used for sequencing
usually improved the sequence yield. The protocol of isolation of cosmid DNA using
the QIAGEN large construct kit was time consuming and the yields of DNA were
disappointing. It was found that cosmid DNA concentrated using Microcon
centrifugal filter units (Section 2.1.13) resulted in cosmid DNA of sufficient
concentration for sequencing, therefore this method was used to concentrate all
cosmid samples before sequencing.
3.2.1.5 Screening The Cosmid Library Using OvHV-2 ORF 57
In order to extend the viral genome sequence to the left of the known virus sequence
from clone C75-1.1.1, a new "walking" probe was made by PCR amplification of the
ORF 57 sequence at the left hand end of clone C75-1.1.1 in order to re-screen the
library. PCR primers were designed using the ORF 57 sequence at the end of cosmid
C75-1.1.1 to amplify a sequence spanning 50bp to 533bp from the left hand end of
cosmid C75-1.1.1, resulting in a product of 483bp (Appendix 2). The probe was
made by PCR using C75-1.1.1 DNA as a template. This probe was used to screen the
cosmid library and 1 large plate with 4,000 colonies was probed as before. From this
first screen, 10 positives were re-plated and re-screened. Cosmid DNA purified from
these was analysed by restriction digestion using Pad. All positive colonies digested
to the same 2 products of approximate size 20kb and 30kb (Figure 3.2.1.7) in
addition to the 7.9 kb product of cosmid DNA. Digestion of clones such as C57-2.6
and 2.7 with Pad resulted in a cosmid band of disproportionally high intensity
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The cosmid library was probed using an OvHV-2 ORF 57 probe.
Positive areas were re-plated so that single positive colonies could be
selected. Cosmid DNA was prepared from individual positive colonies
using a QIAGEN mini prep kit. The cosmid DNA was digested using
Pacl and the products analysed by electrophoresis on a 0.8% agarose gel
alongside a lkb DNA ladder and C75-1.1.1 DNA. The cosmid DNA
shown resulted from re-plating of positive area C57-2. The numbers
given to each cosmid DNA sample represent the colony number at each
screen. The position of excised cosmid DNA is indicated.
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compared to the other bands produced on digestion. This suggested that the clones
used to isolate the cosmid DNA might have contained two different types of cosmid
sequence. This could have resulted from selecting more than one clone when picking
colonies, however this was unlikely as the colonies selected were well spaced on the
culture plate. It is possible that during growth in culture the cosmid DNA in some
clones was rearranged and the insert lost. This would result in a mixed culture of
bacteria, with some clones containing cosmid DNA without insert. These bacteria
were likely to have a selective advantage over the bacteria containing cosmids with
inserted DNA, resulting in quicker growth of these bacteria. This therefore was
evidence that some cosmid containing clones were unstable and it was hypothesised
that instability of cosmid inserts may be a cause of failure to isolate some viral
sequences if this problem were to occur.
The ends of a number of these clones were sequenced. Sequence obtained
from clone C57-2.10 using cosmid sequencing primer 175 showed homology with
A1HV-1 ORF 33. Sequence obtained using primer 7850 was homologous to A1HV-1
ORF63. This meant that by analogy with the ORF layout of A1HV-1, the cosmid
spanned an area of 33 open reading frames and had a size of approximately 40kb.
The overlap with cosmid C75-1.1.1 was seven ORFs and approximately lOkb,
therefore the screen resulted in a cosmid containing 30kb of new sequence.
3.2.1.6 Screening The Cosmid Library Using a C75R Probe
In order to extend the virus sequence towards the viral terminal repeats to the right of
ORF 75, the library was re-screened using a probe designed from sequence at the
right hand end of cosmid C75. PCR primers were designed from sequence of the
right hand end of clone C75-1.1.1 and were named C75R-5' and C75R-3'. These
primers amplified a 435bp region spanning 25bp to 461 bp from the right hand end of
cosmid C75-1.1.1 (Appendix 2). A probe was made by PCR amplification using
C75-1.1.1 cosmid DNA as a template. This probe was named C75R and was used to
screen one plate of 4,000 colonies. Four positive spots were re-plated and screened,
initially analysis of sequence obtained using primer 7850 revealed weak homology
with A1HV-1 ORF 33. It was therefore envisaged that this clone might span the
terminal repeats and this cosmid was named cosmid C75R-1. Some of the C75R-1
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sequence was ambiguous, therefore area was re-sequenced and the ambiguous areas
checked. Re-analysis revealed no significant homology with viral sequences.
Despite analysis of the sequence at the right hand end of cosmid C75R
revealing no homology to virus sequence, it was still suspected that this clone might
span the viral terminal repeats and therefore might contain the potential OvHV-2
virulence genes at the left hand end of the virus genome. In order to further
characterise the clone, it was decided to analyse C75R-1 by restriction mapping. The
first step undertaken was to try to identify the sequence overlapping with the left
hand end of clone C75-1.1.1.
In order to analyse cosmid C75R-1 by restriction mapping, cosmid DNA
from the clone was restriction enzyme digested using a series of enzyme digests;
SalVBamHl, BamHl Notl/BamHl, Hindlll, Notl/HindUl, EcoRl, NotMEcoRl, Sail,
Notl/Sall, Norl. The products of the digests were electrophoresed on a 1% agarose
gel and analysed by Southern blotting for hybridisation with the hybridisation probe
C75R (from sequence at the right hand end of the genome beyond ORF 75), in order
to establish a section of cosmid overlapping with the end of cosmid C75-1.1.1 from
where the probe originated.
On the first hybridisation the probe annealed to many bands on the gel,
including the bands of SuperCos 1MW DNA excised from the cosmid clones, which
should not have cross hybridised with the C75R probe. It was suspected that this
might have been caused by contamination of the probe with template, which in this
case was cosmid C75-1.1.1. The probe was re-synthesised by PCR amplification,
using OvHV-2 DNA as a template and the blot re-probed. On this probing no
hybridisation was detected, therefore there seemed to be no areas of overlap with
C75-1.1.1. This confirmed the suspicion from re-sequencing that the clone was not of
viral origin, therefore likely to be a clone of bovine cellular DNA.
Southern analysis using the probe C75R made by PCR amplification using
cosmid as a template PCR resulted in hybridisation to all DNA containing cosmid
sequence. It was thought that screening of the library using this probe might have
resulted in the false positive clone C75R-1 in the same way. This would be due to
contamination of the PCR product with template, in this case cosmid C75-1.1.1 and
labelling of this cosmid in the labelling reaction. Labelled cosmid would cross-
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hybridise with any cosmid clones, whatever the insert. To avoid this problem in
future, it was decided that all probes used should be produced by PCR amplification
of OvHV-2 genomic DNA rather than cosmid and the products gel purified in order
to remove PCR product from template. The probe C75R was re-made by PCR
amplification using DNA from OvHV-2 infected cell lines as a template. The
resulting PCR product was electrophoresed on an agarose gel and the PCR product
purified from the gel (Section 2.1.6). This was carried out to ensure that the DNA
used as a probe was not contaminated with the template used for PCR. The gel
purified C75R probe was labelled with P32 and was used to screen the library. All
resulting positive clones had the same restriction profile as C75-1.1.1 when digested
with Pad. This meant that the screen did not identify a new cosmid clone.
3.2.1.7 Screening the Cosmid Library Using an OvHV-2 ORF 33 Probe
In order to extend sequence at the right hand end of the genome, PCR primers were
designed against the ORF 33 sequence. The primers were from 13bp to 398bp from
the left hand end of cosmid C57 and amplified a product 385bp in length
(Appendix 2). The probe was made by PCR amplification using OvHV-2 DNA as a
template. The ORF 33 PCR proved difficult to optimise. The PCR was optimised
such that a single band was produced, however this was of low intensity and
purification of the product resulted in a probe of low DNA concentration (8ng//xl).
This probe was used to probe the library, (4 large plates, 16,000 colonies) and no
positives found on this screen.
The PCR was further optimised such that a band of the correct size with more
product was produced, however this also resulted in the production of spurious
bands, therefore the whole PCR product was electrophoresed and band of the correct
size was excised from the gel. The DNA was then purified from the gel as described
32
(Section 2.1.6) and labelled with " P. The new probe was then used to re-probe the
library and a further 9 large plates screened (36,000 colonies). From this screen, 15
positives were re-plated and re-screened and 25 colonies from this screen were
selected. Cosmid DNA was purified from these clones and analysed by restriction
enzyme digestion with Pad and with EcoRI. The products of the digests were
analysed by agarose gel electrophoresis and 4 new clones identified (Figure 3.2.1.8).
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The cosmid library was probed using an OvHV-2 ORF33 probe.
Positive colonies (numbered C33.9, 14, 16, 17 & 21) were picked
and re-plated so that single colonies could be identified. Some
colonies were re-plated a third time. Cosmid DNA was prepared
from single bacterial colonies using a QIAGEN mini prep kit. The
cosmid DNA was digested with EcoRX and the products analysed by
electrophoresis on a 0.8% agarose gel alongside a lkb+ DNA ladder.
The numbers given to each cosmid DNA sample represent the
colony number on each screen.
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These clones were named C33-9, 14, 16, 17 and 21 according to the colony number
given at the first library screen. Digestion of cosmid DNA extracted from the clones
C33-9, 14 and 21 with £coRI resulted in the same restriction pattern, suggesting the
sequence of these clones was the same. The cosmid ends of clones C33-16, 17 and
21 were sequenced and two clones contained viral DNA with homology to the
A1HV-1 genome. The sequence obtained from C33-17 was not similar to any known
viral sequence therefore the clone was assumed to contain non-viral DNA. The
sequence obtained from clone C33-21 using primer 7850 was homologous to
A1HV-1 ORF22, however there was insufficient sequence from the reaction with
primer 175 for analysis. The sequence from this primer was likely to be in the region
to the right of ORF 33, towards ORF 57. This cosmid therefore contained
approximately 15kb of new sequence, spanning 10 new OvHV-2 open reading
frames. The sequence obtained from C33-16 using primer 7850 was homologous to
A1HV-1 ORF 11, whilst the sequence obtained using primer 175 was homologous to
A1HV-1 ORF40. This meant that by analogy with the ORF layout of A1HV-1, the
cosmid was approximately 40kb in length and spanned 27 open reading frames. The
overlap of the new C33 cosmid sequence with cosmid C57 was 12 open reading
frames and approximately lOkb; therefore the screen generated 30kb of new OvHV-2
sequence.
3.2.1.8 Screening the Cosmid Library Using OvHV-2 ORF 11
In order to extend sequence further at the right hand end, a probe was made from the
sequence of OvHV-2 ORF 11. The primers 011-5' and OH-3' (Appendix 2) were
designed to amplify a product extending from 67bp to 374bp from the left hand end
of cosmid C33. The probe was made by PCR amplification using OvHV-2 DNA as a
template. The PCR product was electrophoresed and the required band excised from
the gel. The PCR product was then purified from the gel. This probe was used to
screen the library; 6 large plates containing approximately 24,000 colonies were
screened. From this screen, 9 positives were re-plated and 17 positives selected on
the second screen. From the 5 samples sequenced, CI 1-9 and CI 1-12 both contained
viral DNA of the same clone. The sequence obtained using primer 175 had
homology to A1HV-1 ORF 10 and the sequence obtained using primer 850 had
homology with ORF42. Assuming the layout of the genome to be similar to that of
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A1HV-1, the screen had only advanced 1 open reading frame. This was a distance of
approximately lkb.
3.2.1.9 Screening The Cosmid Library With The AIHV-1 Clone C249
The aim was to extend sequence further into the left hand end of the genome and if
possible over the terminal repeats, however probing with ORF 11 had resulted in
further sequence of just one ORF distance. A probe whose sequence was located
closer to the terminal repeats was therefore needed. Analysis of cosmid sequence so
far revealed significant amino acid homology of much of the OvHV-2 sequence with
that of AIHV-1, therefore it was hypothesised that there may be sufficient homology
at the nucleotide level to screen the library using a probe containing AIHV-1
sequence. A clone containing sequence from the left hand end of AIHV-1 was
obtained (C249N). This extended from ORF A3 to ORF 3 and was 7kb in size
(Figure 3.2.1.9). The clone consisted of C249N cloned into the plasmid pBluescribe
M13+. The C249 fragment was excised from the vector by digestion with Sac\ and
Sphl. The products of the digest were then electrophoresed and the band of interest
excised. The C249N DNA was then purified from the gel and labelled with 32P for
use as a library screening probe.
The library was plated onto 6 large plates (24,000 colonies approximately).
These were probed using colony hybridisation as before, but blots were hybridised at
low stringency (37°C) using Ultrahyb hybridisation buffer (Section 2.2.6). Low
stringency hybridisation was used because the probe was likely to have lower
homology with the OvHV-2 sequence than the screening probes used so far. This
was due to the fact that the probe sequence was AIHV-1 DNA and not OvHV-2.
From this screen, 21 positives were re-plated and re-screened. Screens generally
resulted in a large number of possible positives of varying intensities on the x-ray
film. A sample of 25 possible positives was selected and the colonies re-plated onto 2
identical plates. Since the aim was to identify a clone which extended from ORF 11
over to C75R spanning the viral terminal repeats, one plate was probed by colony
hybridisation using the OvHV-2 C75R probe, and the other plate probed using the
OvHV-2 ORF 11 probe. Hybridisation was performed using Ultrahyb hybridisation
buffer at the normal stringency hybridisation temperature of 42°C. There were no
convincing positives on this screen. Although a new clone may not have necessarily
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The clone C249N was isolated from molecular cloning of the
A1HV-1 genome (Ensser et al, 1997). The diagram represents part of
the genome of A1HV-1, with the open reading frames shown in solid
blocks. The open reading frames in the clone C249N are shown in
red. The clone was approximately 7kb in size, and extended from
A1HV-1 ORF A3 to ORF6.
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overlapped with either C75R or C33, it was concluded low stringency hybridisation
was resulting in the identification of false positive clones.
3.2.1.10 Screening The Cosmid Library With OvHV-2 ORF8
Screening the library using the A1HV-1 C249 probe failed to result in the
identification of new virus containing clones. This was probably due to insufficient
similarity between the clone and the target DNA. New OvHV-2 ORF8 PCR primer
sequences published by Dunowska et al., (2001) made it possible to produce an
OvHV-2 ORF8 screening probe, in order to try to identify sequence to the left hand
end of ORF 10. The PCR primers were designed to amplify a region between -116
and +91 relative to the ORF8 sequence, producing a product of length approximately
2.8kb. This probe was used to screen 24,000 colonies on 6 large plates. From the
second screen cosmid DNA from 19 colonies was analysed by restriction enzyme
digestion with Pacl and EcoRI. On analysis sequence obtained from sample C8-5.2
using primer 7850 had high homology to A1HV-1 ORF6. Sequence obtained from
C8-18.4 using primer 7850 had homology with A1HV-1 ORF A2. By analogy with
the ORF layout of A1HV-1 the screen had produced sequence of 9 open reading
frames of new OvHV-2 sequence (approximately 20kb) extending to the left hand
end of ORF 10. Sequence of the right hand end of these cosmids using sequencing
primer 175 did not produce enough sequence for database comparisons, however
restriction enzyme analysis and gel electrophoresis showed cosmids C8-5.2 and C8-
18.4 to be approximately 40kb in size.
3.2.1.11 Screening The Cosmid Library With OvHV-2 ORF 02
It was expected that screening the library with an OvHV-2 02 probe could result in
the identification of a clone that either extended into, or spanned the viral terminal
repeat sequences. A PCR probe was made from the sequence of ORF 02, this was
designed to amplify sequence from 3bp to 400bp from the left hand end of cosmid
C8-18.4, resulting in a product of 387bp (Appendix 2). The probe was made by PCR
amplification using OvHV-2 DNA as a template. The PCR product was
electrophoresed and the PCR product purified from the gel as described. The library
was probed using the 32P labelled 02 probe and 6 large plates (24,000 colonies) were
screened. The second screen resulted in 7 positive colonies and cosmid DNA was
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purified from these. On restriction analysis with EcoRI, 6 out of the 7 cosmid DNA
samples resulted in the same restriction pattern as cosmid C8-18.4 and the remaining
sample contained no insert. This screen had therefore not resulted in the
identification of any new virus containing cosmids.
3.2.2 Extension of Known Sequence Using PCR
Screening the library with probes to extend the sequence at both the right hand end
(C75R probe) and the left hand end (02 probe), of the virus genome resulted in no
new sequence. This was possibly because the cosmid library did not contain clones
with inserts of viral terminal repeat DNA. It is possible that these clones do not grow
well in culture and were not amplified in sufficient numbers when the cosmid library
was amplified.
Although it was not possible to identify all parts of the virus genome in
cosmid clones, it was still hypothesised that DNA extracted from the OvHV-2
infected bovine cell line BJ/880 contained complete circular viral genomes. It was
therefore decided to use the known OvHV-2 sequence obtained from cosmid cloning,
to extend the viral sequence using a PCR based walking method on BJ/1035 OvHV-2
DNA. The technique of splinkerette PCR was chosen as a suitable method. This
method enables the application of PCR amplification to stretches of DNA where the
sequence information is only available at one end. Splinkerette PCR is a modification
of vectorette PCR; both methods have been used for PCR walking (Devon et al.,
1995) and in the isolation of end fragments from YAC recombinants.
The aim was to extend the sequence to the terminal repeats at both ends of the
genome in order to obtain the complete OvHV-2 viral sequence. Although
splinkerette PCR does not generally result in as large walking "steps" as in cosmid
cloning, if the genome layout of OvHV-2 is similar to that of A1HV-1, the distance to
the viral terminal repeats was expected to be only 2 - 3kb. Splinkerette PCR involves
restriction enzyme digestion of the DNA of interest and ligation of this DNA to a
"splinkerette linker molecule". The steps used in the generation of ligated splinkers
are shown diagrammatically in figure 3.2.2.1. PCR amplification is then performed
using primers specific for the known genomic DNA sequence (gene specific primers
or GSPs), and for the splinkerette sequence (Figure 3.2.2.2). The splinkerette primer
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Figure 3.2.2.1 Splinkerette PCR- Formation of Ligated Splinker
Molecules
1. Digestion of OvHV-2 DNA with the required restriction
enzyme
2. Formation of splinkerette linker molecules by heating a
mixture of splink top and splink bottom molecules and








Step 1: DNA (shown in blue) was extracted from OvHV-2 infected
cattle cell line BJ/1035 was digested with the required restriction
enzyme. Step 2: Splinkerette linker molecules were made by mixing
equimolar amounts of top strand oligonucleotide and bottom strand
oligonucleotide (shown in green), heating to 90°C and cooling at
room temperature. This created a linker molecule with the required
compatible overhang for ligation. The 3' end of the bottom strand of
the linker molecule was designed so that it formed a hairpin structure
and was not complementary to the 5' end of the top strand. Step 3:
Splinkerette linker molecules were ligated to the digested OvHV-2




Figure 3.2.2.2 Splinkerette PCR
PCR round 1 - Primer extension from OvHV-2 specific primer. The




No primer annealing from bottom
strand - lost from reaction.
PCR round 2 - primer extension from Splink GSP due to
annealing to product from OvHV-2 GSP
OvHV-2 GSP product
< . < .
Splink GSP
PCR round 3 - Primer extension from splink primer and GSP
PCR amplification was performed using the ligated splinkerette
molecule as template. The primers used were a gene specific primer
(GSP)(blue arrow) of choice and a splinkerette GSP (splink
GSP)(green arrow) which was designed to anneal to the known
splinkerette sequence. PCR round 1 - Primer extension proceeds
from the OvHV-2 GSP. The splinkerette primer cannot anneal due to
the mismatch in the bottom strand of the splinkerette linker. Primer
extension can therefore only occur from splinkerette molecules
ligated to target DNA. PCR round 2 - the splinkerette GSP anneals
to the product from round 1 and primer extension occurs.
PCR round 3 - primer extension proceeds from both primers.
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is the same sequence as the top strand of the splinkerette molecule, however the
bottom strand of each linker molecule forms a hairpin like structure at the 3'end.
This means that the splinkerette primer cannot anneal to the splinkerette bottom
strand, as this strand is mismatched. The bottom splinkerette strand is therefore
removed from the reaction. PCR extension using the splinkerette primer can only
occur when a bottom strand has been synthesised by chain extension from a digested
genomic DNA ligated to a splinkerette linker. This design prevents non-specific PCR
products occurring due to amplification of unligated splinkerette molecules. The
PCR is then repeated using internal primers. Any resulting PCR product is then
cloned and sequenced.
3.2.2.1 Splinkerette PCR using OvHV-2 02 Primers
OvHV-2 DNA was digested initially with EcoRl, BamHl, Xbal or Hindlll. The
digested DNA was then ligated to "linker molecules". Linker molecules were
constructed by annealing oligonucleotides as described (Section 2.4.5). The linker
molecules required a unique bottom strand, depending on the sticky end that was
required. Linker molecules for ZscoRI, BamHl and Xbal all used the same top strand
(Splink Top), whilst the top strand used for the BamHl linker (Splink Top Bam HI)
differed by one base pair from the Splink Top sequence (Appendix 4).
The ligated DNA samples were used as a template for PCR using a primer
against the known linker sequence and a gene specific primer (Appendix 3). The
positions of all splinkerette primers on the OvHV-2 genome are shown on figure
3.2.1.4. The primer used in the initial PCR was the gene specific primer 02. This
primer was designed to amplify sequence of 02 towards the left hand end of the viral
genome and was designed to the complement of the 02 sequence. The 5' end located
70 bp downstream of the BamHl site at left hand end of cosmid 02, and the 5' end of
the internal primer was located 47bp from the BamHl site.
PCR was performed using the 02.GSP primer and the splinkerette primer
(splink primer), using a combined "hotstart" and "touchdown" program (Section
2.4.7) to increase specificity of the reaction. In this reaction, the initial annealing
temperature used was above the expected annealing temperature of the primers. The
annealing temperature was then reduced in each cycle of PCR. The PCR was
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repeated using the splinkerette and 02 internal primers using the same PCR program
as was used in the first round. PCR using the ligated Hindlll OvHV-2 digest as a
template resulted in a product of approximately 1.2kb using the internal primers
(Figure 3.2.2.3). This product was cloned into a pCR 2.1-TOPO TA vector and
sequenced. The sequence was analysed using the "pairwise blast" program, in which
two sequences are compared with each other (Section 2.6.1). The sequence was
found to overlap with known sequence of 02. The sequence was therefore concluded
to be viral; therefore this round of PCR had resulted in 1.2kb of new OvHV-2 viral
sequence at the left hand end of the genome beyond 02. This clone was named
splinkl. Comparison of the sequence with the Genbank database using the program
blastx showed the sequence was composed partly of sequence with homology to
A1HV-1 A2, however no sequence homologous to A1 was identified, therefore it was
assumed that the left hand end of the new clone was in sequence beyond 02.
3.2.2.2 Splinkerette PCR Using Spl2 Primers
In order to extend the known virus sequence further towards the left hand end of the
genome beyond the splinkl sequence, PCR primers were designed using the splinkl
sequence and named spl2.GSP and spl2.GSP.Int (Appendix 3) (Figure 3.2.2.4). The
spl2.GSP primer 5'end was 69bp from the ligation point of the splinkl sequence to
the splinkerette linker. The 5' end of the spl2.GSP.Int primer was 23bp from the
splinkerette ligation point. PCR amplification using the gene specific primer
spl2.GSP and the splinkerette primer, using the BamHl digested and ligated OvHV-2
DNA as a template, resulted in a 900bp product (Figure 3.2.2.3).
The PCR was repeated using the internal primers and the product was cloned
and sequenced. The sequence was compared to the splinkl sequence using the
pairwise blast program as before. The new sequence shared overlap with splinkl
sequence against which the spl2.GSP primers were designed; therefore the sequence
was assumed to be specific OvHV-2 viral sequence and was named splink2.
Comparison of the splink2 sequence with the Genbank database using the program
blastx did not show any homology of sequence with known viral sequence. This
sequence was therefore assumed to be new OvHV-2 sequence to the left of ORF 02
in between open reading frames.
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OvHV-2 DNA was digested with a number of enzymes and ligated to
splinkerette linker molecules. The ligated DNA was then used as a
template for PCR amplification. The products were analysed by
electrophoresis on a 1% agarose gel.
A - Products of PCR amplification of ligated HindlW digested
OvHV-2 DNA using the splink primer and the 02.GSP.
B - Products of PCR amplification of BamWi digested and ligated
OvHV-2 DNA. C75R - PCR Product using the splink primer and
C75R.GSP. C75R.Int - Product from amplification of C75R with
internal primers splink.Int and C75R.GSP.Int. Spl2 - PCR product
using the splink primer and spl2.GSP. Spl2.Int - Product from
amplification of spl2 using internal primers splink.Int and
spl2.GSP.Int. -C - PCR negative control for each primer pair using
distilled water as a template.
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3.2.2.3 Splinkerette PCR Using C75R Primers
In order to extend the known virus genome sequence to the right hand end of the
viral genome beyond the right hand end of cosmid C75-1.1.1 towards the viral
terminal repeats, gene specific primers were designed against the sequence at the
right hand end of cosmid C75-1.1.1 beyond ORF 75, and were named C75R.GSP
and C75R.GSP.Int. The 5' end of primer C75R.GSP was located 45bp downstream
of the BamHl site at the right hand end of cosmid C75-1.1.1, and the 5' end of the
C75R.GSP.lnt primer was 32bp downstream of the BamHl site. PCR amplification
using the C75R.GSP primer and the splinkerette primer, using the BamHl digested
and ligated OvHV-2 DNA as a template resulted in a 200bp product (Figure 3.2.2.3).
The PCR was repeated using the internal primers and the product cloned and
sequenced. The sequence was compared with the C75R sequence and was found to
overlap with the right hand end of the C75R sequence. Comparison of the sequence
with that of the Genbank database did not reveal any homology with known viral
sequence. The sequence was therefore assumed to be new OvHV-2 sequence
between open reading frames beyond the C75R sequence and was named
splinkC75R. The genome of A1HV-1 contains an area beyond ORF 75, between A9
and A10, which does not contain any identified open reading frames. It was assumed
that the C75R sequence and the splinkC75R sequence were located in this region.
3.2.2.4 Splinkerette PCR Using Spl3 Primers
Gene specific primers were designed against the splink2 sequence and named
spB.GSP and spl3.GSP.Int (Appendix 3) (Figure 3.2.2.4). The 5' end of the
spl3.GSP primer was located 96bp from the ligation point to the splinkerette linker,
and the 5' end of the spB.GSP.Int primer was located 64bp from the splinkerette
ligation point. The primers were designed to extend the viral sequence towards the
terminal repeats beyond the spl2 sequence. PCR using the spB.GSP primer and the
splinkerette primer and each of the 4 ligated OvHV-2 digests (Hindlll, BamHl, Xbal,
TscoRI) as templates, did not result in any product either on the first round of PCR, or
on the second round using internal primers.
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i * 1 C75R
Splinkerette I I SplinkC75R
linker 29 78 sequence
GSP - gene specific primer, Int - internal primer
A - Spl2.GSP B-Spl2.GSP.lnt C-Spl3.GSP
D - Spl3.GSP.lnt E - C75R2.GSP F - C75R2.GSP.lnt
The splinkerette PCR products are shown, and the QSP used to produce each
product is indicated above each diagram. The splinkerette linker sequence
(purple) is shown at the left hand end of all products. The position of the
splinkerette ligation point is shown and the coordinates of primers are shown as
distances in base pairs of the 5' end of each primer from the splinkerette ligation
point. The spl2 primers were designed from sequence obtained by splinkerette
PCR using the 02.GSP. The new splinkl sequence is shown in blue, with 02
sequence (green) to the right of the splinkl sequence. The spl3 primers were
designed from sequence obtained by PCR amplification using the spl2 primers.
The new splink2 sequence is shown in dark green, with the splinkl sequence
(blue) at the right hand end. The C75R.2 primers were designed from sequence
obtained by PCR amplification using the C75R.GSP primers. The new
splinkC75R sequence is shown in turquoise and the C75R sequence in green.
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3.2.2.5 Splinkerette PCR Using C75R2 Primers
In order to extend the sequence to the right of the splinkC75R sequence towards the
terminal repeats, gene specific primers were designed against the splinkC75R
sequence. These were named C75R2.GSP and C75R2.GSP.Int (Appendix 3)(Figure
3.2.2.4). The 5' end of the C75R2.GSP.Int primer was located 29bp to the right of
the splinkerette ligation point and the 5' end of the C75R2.GSP primer was located
78bp to the right of the splinkerette ligation point. PCR amplification was performed
using the C75R2.GSP primer and the splinkerette primer. The templates used were
the 4 ligated OvHV-2 digests (Hindlll, BamHl, Xbal, CcoRI) as were used for PCR
with the spl3 primers. PCR using this primer pair and repeating the first product as a
template, using the internal primers, did not result in any product.
3.2.2.6 Design of New Splinkerette Linkers
Splinkerette PCR using the C75R2.GSP and Spl3.GSP primer resulted in no new
products. It was thought that this could be due to the fact that the sequence at the
terminal repeats was likely to be GC rich and the there were not many of the
restriction sites required in this area. New splinkerette linkers were therefore
designed requiring the digestion of OvHV-2 DNA restriction enzymes that recognise
GC rich sites. These enzymes were Xmal, Sail, NheI, 5i\vHII and Bglll. OvHV-2
DNA was digested with these enzymes and ligated to splinker molecules as before.
PCR amplification was performed using the splinkerette primer with the C75R2.GSP
primer, and with the SpB.GSP primer. The 5 new ligated OvHV-2 DNA samples
were used as templates. The products of the initial amplification reaction were used
as templates for PCR using the internal primers. Small products of approximately
150bp resulted from PCR amplification with C75R2.GSP internal primers using the
Nhel and Sail digested DNA as template, and product of a similar size resulted from
PCR with Spl3 internal primers using the Xmal digested DNA as template. The Spl3
primer product was lost on PCR purification and repeat of the PCR failed to
reproduce this product. The product from PCR of the Nhel and Sail digested and
ligated DNA was cloned into the TA vector. Positive colonies were selected and
plasmid DNA purified. This plasmid DNA was analysed by restriction enzyme
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digestion, however all plasmids were found to contain no insert. It was therefore
assumed that all 3 products were primer dimers.
3.2.2.7 PCR Amplification Across the Viral Terminal Repeats
The last round of splinkerette PCR failed to result in new virus sequence, however, it
was estimated that by comparison with the layout of the A1HV-1 genome, the
distance to the terminal repeat sequences may be as little as lkb at each end of the
genome. Gammaherpesviruses contain variable numbers of copies of terminal
repeats, therefore it was decided to try obtain the remaining OvHV-2 genome
sequence by PCR amplification across the viral terminal repeat sequence using
primers designed against the known sequence at the left and right hand ends of the
genome.
It was hypothesised that the distance across may be up to 20 - 30kb, therefore
an enzyme designed for long distance PCR was used. Expand long template PCR
system uses an enzyme mix containing thermostable Taq DNA polymerase and a
proofreading polymerase. It is designed to give a high yield of product from
episomal and genomic DNA. Denaturation times were kept short (10s) and
temperatures low (92°C) to avoid damage to the template DNA. Primers used (Figure
3.2.1.4 and Appendix 2) were longer than standard to permit the use of higher
annealing temperatures which would enhance specificity.
The primers used were designed against the sequence derived by the second
round of splinkerette PCR and were named C75R21ong and spl31ong. The primer
spl3 long was the same primer as spl3 primer. The primer C75R21ong was designed
against the same coordinates as the primer splC75R2, however the sequence was the
complement of splC75R2. The template used was genomic DNA extracted from the
bovine OvHV-2 infected cell line BJ/1035. This cell line had been shown by
Gardella gel analysis to contain OvHV-2 DNA in the circular episomal form. This
DNA was therefore this was considered to be a suitable template as the terminal
repeats would be fused, allowing PCR amplification across the repeats.
The PCR reaction was performed initially as described (Section 2.4.3). The
enzyme used was the Expand Long Template PCR System (Roche). The reaction
mix contained Expand PCR buffer 3 which resulted in a final magnesium
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concentration of 2.25mM in each reaction. The annealing temperature used was 65°C
and the elongation temperature used was 68°C as was recommended for the Expand
enzyme. The initial extension time used was 20 minutes. This was increased by 20s
each cycle until the extension time was 25 minutes, however the reaction did not
result in any product. The PCR amplification reaction was repeated with a reduced
annealing temperature of 62°C, and an extension time of 25 minutes extending by
20s each cycle to 30 minutes. Each reaction mix contained either an additional 1.5jul
50mM MgCE, to give a final concentration of 3.75mM, or an additional 2.5/xl 50mM
MgCb, to give a final reaction concentration of 5mM. These reactions did not result
in the generation of any product.
Amplification of the first PCR product using internal primers, a magnesium
concentration of 3.75mM and the longer extension time and reduced annealing
temperature protocol, produced a high molecular weight smear. The PCR was again
repeated using the high molecular weight product as template and internal primers.
The products of this PCR reaction were a number of bands, the largest of which was
approximately 1.3kb. A band of size 1.3kb and a band of size 650bp band were
cloned using the pCR2.1 TOPO TA cloning kit. The clones were sequenced,
however sequence analysis showed that the clones did not overlap with the right or
left hand ends of the virus genome and had homology to cellular DNA sequences. It
was concluded therefore, that the sequence was amplified from bovine cellular DNA,
by mis-priming of the primers.
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3.2.3 Sequence Analysis of the OvHV-2 Genome
3.2.3.1 General Sequence Analysis
Cosmid cloning of the OvHV-2 genome resulted in the cloning of the majority of the
OvHV-2 genome into five overlapping cosmids (Figure 3.2.3.1). Extending of the
sequence by splinkerette PCR walking resulted in two new clones containing virus
sequence at the left hand end of the genome and one new clone at the right hand end
of the genome. The OvHV-2 genome sequenced so far is approximately 125kb in
size. Sequencing of the cosmids was performed by Mathias Ackermann and co¬
workers at the University of Zurich, Switzerland. Sequence analysis of the genome
was performed and the open reading frames identified using the NCBI ORF finder
(Section 2.6.1). Potential protein coding open reading frames were defined by criteria
similar to those applied to other herpesvirus genomes, these were:
1. ORF size larger than 60 amino acids
2. The presence of potential transcriptional start sites and polyadenylation sites
3. Homology to previously described genes in herpesviruses or other genes
The predicted open reading frames identified are listed in table 3.1. The translated
sequences were analysed by comparison with the NCBI protein database using the
program blastp. The amino acid identity with A1HV-1 ranges from 28% (ORF 06) to
83% (capsid protein vp23 encoded by ORF 26 and the minor capsid protein, encoded
by ORF 43). The amino acid identity with herpesvirus saimiri ranges from 21%
(ORF 10) to 58% (terminase exon 1, encoded by ORF 29a). The genome
arrangement is very similar to that of A1HV-1, however there are notable differences.
The layout of the predicted OvHV-2 open reading frames is shown in figure 3.2.3.2.
Open reading frames with homologues in HVS have been numbered according to the
HVS homologue. The genes without homologues in HVS have been named the "O"
genes. The A1HV-1 "unique" genes A2, A3, A5, A6, A7, A8 and A9 have
homologues in OvHV-2. The block of ORFs from ORF6 to 9 are all highly
conserved and encode genes involved in viral DNA replication. The 02 ORF is
predicted to be spliced, as is A2 of A1HV-1. This ORF contains leucine zipper motifs















































































































































Table 3.1 OvHV-2 ORFs
OvHV- Strand Start Stop Length AlHV-1 HVS Possible
2 Codon Codon (aa) % identity % identity Function
ORF (similarity) (similarity)
02b - 1990 1841
02a - 1746 1336 186 56(71) Leucine zipper motifs
02.5a + 2753 2938 182 11-10 homologue
02.5b + 3021 3080 Signal sequence
cleavage 26-27 aa
02.5c + 3162 3314 51% identity/69% sim.
to Equine IL-10
02.5d + 3406 3471
02.5e + 3552 3632
03 + 3978 5354 458 50(63) Semaphorin (NB
shorter by 200aa than
A3 at C-terminus)
03.5 + 6088 6579 163 Signal peptide: secreted
3 + 6831 10916 1361 52(57) 28(46) FGARAT
04.5 + 10972 11610 212 50(73) Bcl-2 homologue ? viral
Bcl-2 antagonist similar
toEBVBALFl
6 + 11752 15141 1129 79(88) 50(69) Single-stranded DNA
binding protein
7 + 15216 17264 682 65(79) 41(60) Transport protein
8 + 17248 19839 863 76(84) 44(62) Glycoprotein B
9 + 20034 23030 998 75(86) 56(70) DNA polymerase
05 + 23312 24565 417 49(72) GPCR. NB has much
longer C-terminal
intracellular tail than A5
10 + 24285 25505 406 56(72) 21(40)
11 + 25507 26739 410 56(75) 30(49)
17 - 37734 36076 552 50(61) 34(47) Capsid Protein
18 + 37691 38521 276 68(79) 45(65)
19 - 40174 38495 559 74(85) 41(58) Tegument protein
20 - 40715 39963 250 61(72) 41(58) Fusion protein
21 + 40714 42423 569 47(63) 29(47) Thymidine kinase
22 + 42444 44696 750 63(78) 27(47) Glycoprotein H
23 - 45891 44689 400 58(71) 34(53)
24 - 48086 45897 729 70(80) 41(59)
25 + 48085 52188 1367 81(91) 57(74) Major capsid protein
26 + 52254 53168 304 83(92) 48(67) Capsid protein vp23
27 + 53174 54055 293 51(69) 28(41)
29b - 55287 54142 352 82(90) 58(78) Terminase exon 2
30 + 55305 55556 83 57(73) 33(50)
31 + 55478 56152 224 67(75) 41(59)
32 + 56101 57531 476 48(61) 25(44)
33 + 57521 58540 339 52(67) 37(54)
29a - 59447 58530 328 76(85) 53(67) Terminase exon 1
34 + 59446 60459 337 63(75) 37(58)
35 + 60437 60898 153 59(76) 29(52)
36 + 60792 62114 440 55(70) 33(52) Phosphotransferase
37 + 62098 63555 485 79(88) 42(63) Alkaline exonuclease
38 +
63510 63695
61 49(67) 47(64) Myristylated tegument
protein
39 - 64967 63741 408 80(92) 44(67) GlycoproteinM
40 + 65011 67038 675 48(64) 26(40) Helicase-primase
42 - 67808 67035 257 64(78) 36(59)
43 - 69468 67780 562 83(92) 54(70) Minor capsid protein
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OvHV- Strand Start Stop Length AlHV-1 HVS Possible
2 Codon Codon (aa) % identity % identity Function
ORF (similarity) (similarity)
44 + 69323 71815 830 78(88) 55(72) Helicase
45 - 72656 71871 261 37(47) 22(38)
46 - 73552 72689 287 71(87) 56(71) Uracil DNA glycosylase
47 - 73883 73428 151 45(57) 28(48) Glycoprotein L
48 - 75278 73938 446 41(57) 25(49)
50a +
75449 75505
573 36(51) 22(39) Transcriptional control -
RTA exon 1
49 - 76520 75544 324 N/A 23(41)
50b + Transcriptional control -
76556 78220 RTA exon 2
06a +
78532 79056
256 28(46) N/A Viral Transactivator
BZLF1 homologue
06b + 79166 79270
06c + 79366 79503
07 +
80078 80302
556 60(79) N/A Virion Glycoprotein
exonl
08a 80691 81933 41(56) N/A Exon2
08b 82881 83080 Exon3
52 - 83552 83142 136 45(68) 26(44)
53 - 83942 83634 102 51(72) 35(59) Glycoprotein N
54 + 84011 84892 293 57(75) 36(54) dUTPase
55 - 85592 84936 218 74(86) 43(67)
56 +
85591 88104




433 51(67) 23(39) Transcriptional control
MTA exon 1
57b + Transcriptional control
88391 89640 MTA exon 2
58 - 91147 90092 351 60(77) 26(46)
59 _
92323 91154
389 63(72) 33(50) Processivity factor of
DNA pol









335 63(79) 32(52) Capsid assembly and
maturation
63 + 96818 99661 947 61(77) 27(47) Tegument protein
64 + 99666 107540 2624 50(66) 24(40) Large tegument protein
65 - 108240 107605 211 41(49) Capsid protein
66 - 109604 108297 435 60(73) 36(54)
67 - 110299 109523 258 68(79) 51(74) Virion tegument protein
67a - 110561 110307 84 69(86) 48(72)
68 +
110781 112199
472 61(76) 39(54) Probable major envelope
glycoprotein
69 + 112206 113060 284 74(88) 44(61)
08.5 + 116954 118126 390
73 _ 119710 118223 495 43(48) LANA homologue;
episomal maintenance
75 - 124231 120281 1316 58(76) 29(46) FGARAT
09 + 124613 125233 206 50(69) Bcl-2 homologue
Key: Red. Homologous to A1HV-1 unique A gene
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Figure 3.2.3.2 The Genome Organisation of OvHV-2. The diagram shows the
linearised genome sequence of OvHV-2 that was cloned into cosmids. The open
reading frames are represented as block arrows, which are coloured according to the
conservation of the ORF among the three subfamilies (a, 6 and y) of herpesviruses.
The ORFs unique to OvHV-2 and A1HV-1 are shown in red, whilst the ORFs unique
to OvHV-2 only are shown in pink. The genome length is shown in kbp. ORF 49,
shown in orange, is missing in A1HV-1 but is present in HVS, PLHV-1 and other
gammaherpesviruses. The sequence not yet cloned, but predicted to be present by
comparison with the A1HV-1 genome sequence, is shown in semi-transparent colour.




homologue, and contains a highly conserved "sema" domain. 05 is predicted to be a
G protein-coupled receptor (GPCR), with homology to A5 of A1HV-1, A5 of
PLHV-1 and to the EHV-2 gene E6. This is the only GPCR homologue as, in
common with A1HV-1, OvHV-2 does not encode an ORF 74 homologue. The ORFs
06, 07, and 08 have homologues in A1HV-1 and in the porcine gammaherpesvirus
PLHV-1. The 06 ORF is predicted to be spliced into 3 exons and is positionally
equivalent to the EBV transactivator BZLF1. Transcriptional analysis of the PLHV-1
A6 gene has shown that the transcript is spliced into 3 exons in the same way as is
predicted for the homologue in OvHV-2. 07 and 08 are predicted to form two exons
of a putative glycoprotein similar in function to gp350 of EBV. The 08 ORF is also
predicted to be spliced. The 09 ORF is predicted to encode a bcl-2 homologue and
has 50% amino acid identity to the bcl-2 homologue A9 of A1HV-1.
OvHV-2 contains two copies of the putative viral tegument protein with
homology to the purine biosynthetic enzyme formylglycineamide ribotide amino
transferase (FGARAT) in different orientations, located at each end of the genome at
ORF 3 and ORF 75. These conserved genes are also present in A1HV-1, HVS, and
BoHV-4, however only one copy of the FGARAT gene is found in KSHV and EBV.
ORF 3 of PLHV-1 is also a FGARAT homologue (Goltz et al., 2002), however the
area of ORF 75 has not yet been sequenced.
The ORF 04.5 encodes a 212 aa protein with homology to bcl-2.
Homologues of this protein are found in EHV-2 (E4), PLHV-1, in EBV (BALF1)
and in A1HV-1. This means that OvHV-2 has two putative bcl-2 homologues
(located at 04.5 and at 09), as does EBV (BALF1 and BHRF1) and A1HV-1.
Analysis of the translated sequence using the blastp program showed the 04.5
sequence had 46% amino acid identity with the BALF1 homologue of A1HV-1. The
sequence also had 32% amino acid identity to the PLHV-1 BALF1 homologue and
22% identity to the E4 sequence of EHV-2. This method of sequence analysis did not
reveal homology with any bcl-2 protein sequences.
The translated ORF 04.5 sequence was compared to other viral and cellular
bcl-2 homologues by ClustalW analysis (Figure 3.2.3.3). The conserved BH domains
were located on the sequence by comparison with the location in other bcl-2
sequences. The analysis showed that although 04.5 was most similar to the A1HV-1
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Figure 3.2.3.3 Alignment of viral and cellular bcl-2 sequences. The amino acid
sequences of viral and cellular bcl-2 homologues (A1HV-1 BALF1, OvHV-2 04.5,
EBV BALF1, Pongine herpesvirus 1 (PoHV-1) BALF 1, herpesvirus papio (HVP)
BALF1, rhesus lymphocryptovirus (RhLCV) BALF1, PLHV-1 BALF1, EHV-2 E4,
human bcl-2, EBV BHRF1) were aligned using the Blosum scoring matrix with the
"ClustalW" program (see 2.6.2), and displayed using the "BOXSHADE" program.
Identical residues are highlighted in black, whilst similar residues are highlighted in
grey. The position of the bcl-2 homology (BH) domains and C terminal
transmembrane hydrophobic region (TM) are marked above the alignment in red.
171
CHAPTER 3 RESULTS
BALF1 homologue, there were amino acids conserved in all the sequences,
especially in the areas of the predicted BH domains. The OvHV-2 BALF1
homologue appeared to encode all four bcl-2 homology (BH) domains, although the
BH4 domain was less well conserved than the other domains. The BALF1
homologous sequences from the primate gammaherpesviruses were highly
conserved, probably reflecting similarity in the host species. All BALF1 homologous
sequences were more highly related to each other than to the BHRF1 or bcl-2
sequences, suggesting that these proteins are a separate group of bcl-2 like proteins.
3.2.3.2 Open Reading Frames Present in OvHV-2 But Not in AIHV-1
The open reading frames present in OvHV-2 but not in AIHV-1 are of great interest
as they confirm OvHV-2 as a gammaherpesvirus that is distinct from AIHV-1. The
open reading frame ORF49 is present in OvHV-2 but is missing from AIHV-1. This
ORF is not OvHV-2 specific, however as it is present in other gammaherpesviruses
including HVS and also in the closely related PLHV-1. The open reading frame 03.5
is in the same position as A4 of AIHV-1. It is predicted to encode a 163 aa secreted
protein and contains a predicted signal peptide sequence, however the ORF is not
homologous to A4 of AIHV-1. The 02.5 open reading frame does not have a
positional homologue in AIHV-1; this ORF encodes a 182 aa protein with homology
to IL-10. IL-10 homologues are also present in EBV (BCRF1) and in EHV-2 (ORF
E7) sequence. Analysis of the OvHV-2 ORF 02.5 translated sequence shows that the
sequence is highly homologous to a large number of IL-10 sequences (Table 3.2).
The OvHV-2 IL-10 homologue is different from E7 and BCRF1 in that it contains
potential splice donor and acceptor sites such that it is predicted to be spliced into 5
exons. ClustalW analysis of the translated IL-10 sequence (Figure 3.2.3.4) illustrated
the similarity of both viral and cellular IL-10 sequences to each other. The OvHV-2
IL-10 sequence seemed to be more distantly related to the cellular IL-10 sequences
than the ORF virus IL-10 or the EBV IL-10. Comparison of the predicted splice sites
with the splice sites found in the human IL-10 sequence revealed that the predicted
splice sites in the OvHV-2 sequence were at equivalent sites, as shown on the
ClustalW diagram. This suggests that the splice sites predicted might to be used in
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vivo. The 08.5 ORF encodes a 390 amino acid protein that has no homologues in
other herpesviruses. The possible function of this sequence is not known.
Table 3.2 Results from blastp analysis of the translated sequence ofOvHV-2
ORF 02.5.
IL-10 Source % Identity % Similarity
Equine 45 60
EHV-2 44 60





Red Deer 45 60
Ovine 44 59
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The amino acid sequences of viral and cellular IL-10 amino acid sequences (Ovine,
bovine, ORF virus (ORFv), equine, mouse, human, Epstein-Barr virus (EBV), Ovine
herpesvirus-2 (OvHV-2), human cytomegalovirus (CMV)) were aligned using the
Blosum scoring matrix with the "ClustalW" program, and displayed using the
"BOXSHADE" program (see 2.6.2). Residues that were identical are highlighted in
black, whilst similar residues are highlighted in grey. The positions of the five exons




3.3 Characterisation of OvHV-2 07 and 08
RESULTS
Cosmid cloning of the OvHV-2 genome resulted in cloning of a large proportion of
the virus genome, therefore the aim was to study an area of the genome in more
detail. A non-sequence conserved glycoprotein gene is located in the centre of the
genome of all gammaherpesvirus genomes sequenced so far (Birkmann et al., 2001).
In EBV this is the major envelope glycoprotein gp350/220, which mediates binding
of the virus to the B lymphocyte receptor CD21. Virus neutralising antibodies can be
raised against gp350/220; therefore the protein has been used in vaccine studies. An
equivalent protein, gpl50 of MHV-68, has been shown to bind specifically to
lymphocytes (I. Atkin, unpublished). OvHV-2 equivalent ORFs are 07 and 08 and
are located near the centre of the linearised genome map, along with 06 (Figure
3.2.3.1). It was decided to study the predicted open reading frames 07 and 08, which
were contained in the cosmid C57 sequence. By analogy with gp350, 07 and 08
may function as a viral glycoprotein involved in viral entry into target cells. The aim
of this study was to further characterise 07 and 08, in order to gain some insight into
the possible function of this protein in viral pathogenesis.
3.3.1 Initial Characterisation of 07 and 08
The predicted 07 and 08 amino acid sequences were initially analysed by
comparison with the protein database using the translated BLAST search tblastx, as
described (Section 2.6.1). 07 and 08 have the highest homology with the A1HV-1
sequence. 07 shares 60% amino acid identity with A7 of A1HV-1. The similarity is
located in one distinct region from nucleotides 1-212, relative to the ATG start
codon at the beginning of the 07 ORF (Figure 3.3.1.1). The predicted 07 open
reading frame is 121 aa in length. This is considerably shorter than the 07 of
A1HV-1 (243 aa) or PLHV-1 (234 aa). 08 shares on average 56% amino acid
identity with A8 of A1HV-1. The homologous areas of 08 are located in two distinct
blocks, from nucleotides 643 -1863, and from 2892 - 3002. 08 also displays
homology with sequence of PLHV-1, with 20% amino acid identity. The translated




Figure 3.3.1.1 Sequence Analysis - Areas of 07/08
Homologous to A7/A8
353bp 619bp 3009bp
The 07 and 08 sequence was analysed using the translated blast search
tblastx. The diagram shows the region encoding the 07 and 08 open
reading frames. The predicted 07 open reading frame is shown in lilac,
and the predicted 08 open reading frame is shown in green. The region
between the 07 and 08 sequences is shown in yellow. The regions of
the translated 07 and 08 sequence homologous to A1HV-1 are shown as
turquoise blocks below the 07 and 08 sequence.
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AIHV-1 229 BAPT JALaPAPVHG
PLHV-1 215 hRS0^NCQ§KKYCLCAGYSH
The A7 amino acid sequences of OvHV-2, AIHV-1 and PLHV-1 were aligned using
the Blosum scoring matrix with the "ClustalW" program, and displayed using the
"BOXSHADE" program. Identical residues in two or more sequences were
highlighted in black, while similar residues were highlighted in grey.
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Figure 3.3.1.3 Alignment of A8 homologous amino acid sequences. The amino acid
sequences of the A8 homologues of A1HV-1, PLHV-1 and OvHV-2 were aligned
using the Blosum scoring matrix with the "ClustalW" program (Section 2.6.2), and
displayed using the "BOXSHADE" program. Identical residues are highlighted in
black, whilst similar residues are highlighted in grey.
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program (Section 2.6.2) and diagrams of the similarities for both 07 and 08 made
using the boxshade program (Figure 3.3.1.2 & 3). It can be seen that the greatest
similarity is between the OvHV-2 and the A1HV-1 sequences, however some amino
acids are conserved between all three proteins. Possible promoter sequences for
07/08 can be seen at -74 (TATATTG) and at -55 (TATTTAAA) relative to the
translational start site of 07. A putative poly A signal (AATTAAA) can be seen
45bp downstream of the 08 stop codon. This work was based on an initial hypothesis
that 07 and 08 encode separate domains of the same glycoprotein. The 07 and 08
sequence was therefore translated into a continuous 844 aa sequence encoding both
07 and 08 using identified splice sites that it was considered were the most likely to
be used in translation of an 07 and 08 protein (discussed later). This sequence was
was used for subsequent protein sequence analysis.
Virion membrane glycoproteins such as gp350 and gpl50 are type I
membrane glycoproteins that contain N and O linked glycosylation, an N terminal
hydrophobic signal sequence and a C terminal hydrophobic membrane anchor.
Sequence analysis of 07/08 was performed to identify predicted features in common
with other virion membrane glycoproteins. Initial analysis revealed the presence of
N-linked glycosylation motifs in both the predicted 07 and 08 open reading frames.
Asparagine N-glycosylation sites were predicted using the NetNGlyc program
(Gupta et al., 2002) and possible serine and threonine O-linked glycosylation sites
were predicted using the NetOglyc2.0 program (Hansen et al., 1995). 07/08 has 22
potential sites for N-glycosylation, shown diagrammatically on figure 3.3.1.4. 07/08
has 51 potential serine O linked glycosylation sites, and 43 potential threonine O-
linked glycosylation sites, all are shown diagrammatically on figure 3.3.1.5. The area
from amino acids 500 - 770 is predicted to be highly
O-glycosylated.
Hydropathicity analysis of the translated 07/08 sequence was performed,
using the method of (Kyte & Doolittle, 1982) (Section 2.6.2). This shows that the
areas of the highest hydropathicity were located at the N terminus of the predicted
07 sequence and at the C terminus of the predicted 08 sequence. The sequence was
also analysed using the program TMHMM2.0 (Sonnhammer et al., 1998). This
predicted that the N terminal hydrophobic region of 07 and C terminal hydrophobic
180
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Figure 3.3.1.4 Potential O-Glycosylation sites in the 07/08 sequence as
predicted using the NetOGlyc program. The translated 07/08 sequence is shown
linearised on the horizonal axis with amino acids numbered from 0 - 844. The
threshold for glycosylation is shown in red, and potential O-glycosylation sites
in the sequence are shown as vertical blue lines extending above the height of the
threshold line.
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Figure 3.3.1.5 Potential N-Glycosylation sites in the 07/08 sequence as
predicted using the NetNGlyc program. The translated 07/08 sequence is
shown linearised on the horizontal axis, with the amino acids numbered from
0 - 844. The threshold for N-Glycosylation is shown as a horizontal blue line,
and potential N-Glycosylation sites are shown as vertical green lines extending
above the height of the threshold line.
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region of 08 were likely to be transmembrane regions of the protein. The N terminal
predicted transmembrane region extended from amino acid 7 to 29, with amino acid
1 to 6 predicted to be inside the membrane. The C terminal transmembrane region
extended from amino acid 818 to 840 and could form a membrane anchor, with
amino acids 841 - 844 being back inside the membrane (Figure 3.3.1.7).
It was suspected that the N terminal hydrophobic region of the protein might
encode a signal peptide, therefore the program SignalP (Nielsen et al., 1997) was
used to predict the probability of the presence of a signal sequence in 07/08, and the
location of a possible signal cleavage site. The program predicted that the sequence
from amino acids 1-32 was a signal peptide, with the signal cleavage site being
between amino acids 32 and 33. The signalP program used the C-score (raw cleavage
site score), the S-score (signal peptide score) and the Y score (combined cleavage
site score) at each location of the sequence, to predict the location of the signal
cleavage site. The C-score is high at position +1 after the cleavage site, and low at all
other positions, the S-score is high at all positions before the cleavage site, and low at
30 positions after the cleavage site and in the N terminal regions of non-secretory
proteins. The prediction of cleavage site location is optimised by observing where the
C-score is high, and the S-score changes from a high to a low value. The Y score
shows this by combining the height of the C-score with the slope of the
S-score. A diagram of the C, S and Y scores for the 07/08 sequence is shown on
figure 3.3.1.8.
The fact that the predicted 07 amino acid sequence contained a hydrophobic
signal sequence but no membrane anchor, and the 08 sequence was predicted to
contain a hydrophobic membrane anchor but no signal sequence strongly suggested
that these two ORFs might form one gene and be spliced together to produce one
protein product. This was further suggested by the lack of any good TATA box
sequence upstream of 08 and the lack of a poly A signal downstream of 07.
The nucleotide sequence from 07-08 was analysed for the presence of
predicted splice donor and acceptor sites using the NetGene2 program (Brunak et al.,
1991, Hebsgaard et al., 1996). The location of the splice donor and acceptor sites is
shown in figure 3.3.1.9. The 07 open reading frame runs continuously from
nucleotides O - 363, with respect to the 07 translational start site and the 08 open
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ProtScale output for user sequence
Figure 3.3.1.6 A hydropathicity plot of the 07/08 translated sequence
performed using the method of Kyte & Doolittle (1982). The translated
07/08 sequence is shown linearised on the horizontal axis. Hydropathicity
of each amino acid is shown plotted on the vertical axis. Hydrophobic
regions of the sequence have positive values, whilst hydrophilic regions
have negative values.
TMHMM posterior probabilities for 0708
1.2 . . . . — r
0 100 200 300 400 500 600 700 800
transmembrane inside outside
Figure 3.3.1.7 The diagram shows transmembrane helices in 07/08,
predicted using the program TMHMM2.0. The 07/08 translated
sequence is shown linearised on the horizontal axis. Transmembrane
regions are shown in red, whilst areas on the outside of the membrane
are shown in pink, and areas inside the membrane in blue. The program
uses an algorithm called N-best to predict the most probable location of
transmembrane helices in the sequence. In the area of probability
between 1 and 1.2 the N-best prediction of the location of
transmembrane helices is shown.
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Figure 3.3.1.8 Prediction of Signal Cleavage sites in 07/08
SignalP prediction (euk networks): 0708
0 10 20 30 40 50 60 70 80 90
Position
The diagram shows a graphical representation of the scores used in
prediction of signal cleavage sites in the 07 sequence, using the
program signal P. The first 90 amino acids of the translated 07/08
are shown linearised on the horizontal axis. The C-score, S-score
and Y-score as predicted by the program, are plotted for each amino
acid on the vertical axis. The C-score is high at position +1 after the
cleavage site, and low at all positions, the S-score is high at all
positions before the cleavage site, and the Y score combines the
height of the C-score with the slope of the S-score to predict the




Figure 3.3.1.9 Prediction of Splice Donor And Acceptor Sites In
07/08 Sequence Using The NetGene2 Programme
ATG
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The diagram shows the location of splice donor and acceptor sites in
the sequence encoding the 07 and 08 ORFs. Splice donor and
acceptor sites in the sequence were predicted using the NetGene 2
programme. The predicted 07 open reading frame is shown in blue
and the predicted 08 open reading frame is shown in green. The area
between the open reading frames is shown in yellow. Translational
start sites (ATG) and stop sites (TAA) are shown. The coordinates
shown are nucleotide numbers relative to the 07 start site. The splice
donor and acceptor sites are shown as vertical lines extending from
the position of the site. The height of the line is proportional to the
confidence value with with the programme predicted the site. Splice
donors are shown in purple and splice acceptors are shown in red.
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reading frame runs from 637 - 2720 (08a), where a splice acceptor splices into a
different frame to 2802. 08 then ends at 3002 (08b). There are a number of
predicted splice donor and acceptor sites in the two open reading frames, raising the
possibility of alternative splicing of the sequence.
Analysis of the sequence using the ScanProsite program (Section 2.6.2)
revealed a proline rich domain in the putative ectodomain region towards the
membrane anchor (509 - 768), this feature is found in other herpesvirus
glycoproteins such as gpl50 of MHV-68 and gp350/220 of EBV (Stewart et al.,
1996). The sequence also contained a serine rich domain from amino acids 530 -
712, and a threonine rich domain from amino acids 557 - 816. The sequence was
analysed for possible antigenic sites using the program ANTIGENIC, found on the
EMBOSS web site (Section 2.6.1). Analysis identified 34 possible antigenic regions,
which are shown in figure 3.3.1.10.
In summary, sequence analysis resulted in the hypothesis that 07 and 08 are
spliced together to form a membrane glycoprotein. The signal peptide of the
glycoprotein was predicted to be encoded by 07, whilst the C terminal region of 08
was predicted to form a membrane anchoring region. The sequence was predicted to
be highly glycosylated and multiple splice variants were possible. These findings
form a basis for experimental investigation of the properties and likely function of
the 07/08 region.
3.3.2 Analysis of The Expression of 07/08 In OvHV-2 Infected Cell Lines
3.3.2.1 Northern Analysis
Analysis of the sequence of 07 and 08 predicted that the sequences were spliced
together to form a glycoprotein. In order to confirm this, the expression of mRNA
encoding 07 and 08 in rabbit cell lines was studied. Northern analysis for ORF 75
showed that expression of productive cycle genes in OvHV-2 infected rabbit cell
lines is low, therefore efforts were made to increase the expression of productive
cycle genes of OvHV-2. Treatment of KSHV infected BCP-1 cell lines with sodium
butyrate has been shown to increase expression of productive cycle genes (Dr S.J
Talbot, personal communication) therefore this approach was used for the OvHV-2
infected rabbit cell line BJ/880.
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Figure 3.3.1.10 Antigenic sites of 07/08
10 20 30 40 50 60
. | . | . ! . | . | . ,
MRFPHKLLLLEILCVLAALNICITSFTLGCFALYROLVHISIGNLSFPHRDGDEVVRLMY
07
70 80 90 100 110 120
. | . | . | . | . | . |
IPPLNDSVEFSYPPTPSPDAPPSMDNATLSLNCNYTTYSYTHYVYSTLSYLVFVGNGPAY
130 140 150 160 170 180
. | . | . | . | . | . |
PNCPDCVYDVTFNSSSLHNLNSSYIRISNATSDIKSFNESSGEGGPPVTLSVVGGOSPWV
190 200 210 220 230 240
. | . | . | . | . | . |
IWAAVNISSDNMTLDSEGQDALALMRVVDPFNISWCTVYNARPVPATEPEONEDCADISD
250 260 270 280 290 300
. | . | . | . | . | . |
ELPVLDSKSSIFLQDYSANSSINFTVFLALNSSNSYSOCSANVSIPNPNRLTNVOIACPT
310 320 330 340 350 360
. | . | . | . | . j . |
LPLTVNMKMIPANNTEGDTLSATLDIGWLLAHEDGVSLTVKTTOTSPPRSNCSRFQNISS
370 380 390 400 410 420
. | . | . | . | . | . |
RRESLPENNRYSLTHIPTPVNRNKSFSLSWNPVLLNFSOPPOSFOLVVYNQREPSCVLER
430 440 450 460 470 480
. | . | . | . | . | . |
LDNVSDAVLVSLACPHLEASFTPGGPITVTVSENYSSNAN FS LAFLSSLGTF,YAGVLLLI"'
490 500 510 520 530 540
. | . | . | . | . | . |
VSSPLEASPGTVASTSLYASKTSLSSSSPAPPPSAAPTTTQPPTPLSLEPETGRPSDSSF
550 560 570 580 590 600
. , | . | . | . | . |
SFRSSSSNLSSTDPTAGPTSDSRTSTPVTPLLSDANSSPPSPSPGGSSSSGVVTPSPVSS
610 620 630 640 650 660
. , . | . | . | . | . |
PTEAETPLYSPSPSSTPRPALSTOALPPSTPSTPSSMVPRTEFSPTOHPGDKSSAPTTSN
670 680 690 700 710 720
. | . | . | . | . | . |
SPPSTTFTTORATGASSISPTPPVPETAFLISEAGPTPDRPPTLSPEPSPNTARPDQPAP
730 740 750 760 770 780
. | . | | . | . | . |
SPSAETLTOPTEASFVGPILTTPIPPSTTKKIHPEOPEVAPSAPTNPPNITTTTTTAGHH
790 800 810 820 830 840
. | . j . , : | : | : |
HHHRSHSTRRLIITPHDLFPPEDLTTPPVVEHHERMKIWLLPIVGTIFAIVMVVIINIVL
850 860 870 880 890 900




Figure 3.3.1.10 Possible antigenic sites of the translated 07/08 sequence were
predicted using the ANTIGENIC program. The translated 07/08 sequence is shown
with numbers shown above the amino acids for orientation. The 07 sequence is
shown with a blue dashed overline and the remaining sequence is 08 sequence.
Antigenic sites are underlined in red, with the maximum score amino acid also
shown in red. Sequence used in generation of the anti-08 antibody is shown in green.
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An aliquot of 2 x 106 BJ/880 OvHV-2 infected rabbit cells was incubated with 3mM
sodium butyrate overnight at 37°C. Total RNA was then extracted from these cells
and from untreated BJ/880 cells using a QIAGEN RNeasy kit as described (Section
2.7.2). The RNA was quantified by spectrometry and 5/xg RNA from two samples of
BJ/880 cells, 1 and 2 and from the sodium butyrate treated BJ/880 cells, was
analysed by northern blotting as described (Section 2.7.4). The blot was probed using
a 32P labelled OvHV-2 08 probe. This was synthesised by PCR amplification of
OvHV-2 DNA using the primers 08pGEX-5' and 08pGEX-3' (Appendix 2). These
primers amplified a 621bp region of OvHV-2 08 (Figure 3.3.2.1). The membrane
was exposed to x-ray film overnight, however no signal was detected. The membrane
was then exposed to film for a further 2 weeks, however no signal was detected. In
order to check for the presence of RNA on the membrane, it was
re-probed using a ~P labelled probe for the housekeeping gene glyceradehyde-3-
phosphate dehydrogense (GAPDH). This was made by PCR amplification of a 400bp
region of the rabbit GAPDH gene using the PCR primers Rgap-5' and Rgap-3'
(Appendix 2). Exposure of the membrane to film overnight showed the presence of
GAPDH mRNA at 1.5kb (Figure 3.3.2.2). It was concluded that the lack of signal on
the northern blots for OvHV-2 08 was due to low expression of the mRNA rather
than to lack of mRNA on the membrane. This experiment therefore showed that
levels of 08 transcripts in the cell line were low and treatment of the cells with
sodium butyrate did not increase expression of 08 to the level of detection.
In an effort to increase sensitivity of the detection of 08 expression, poly A
RNA was extracted from the OvHV-2 infected rabbit cell line BJ/2476 using an
Oligotex Direct mRNA purification kit (Section 2.7.3) and quantified by
spectrometry. RNA (10/xg) was analysed by northern blotting as described (Section
2.7.4). Total RNA (10/rg) extracted from MDBK cells, which had been previously
transfected with an 07/08 expression construct and had been shown by RT-PCR to
express 08 (Section 3.3.3.7), was used as a positive control. The blot was probed
using the 32P labelled 08 probe. After exposure of the membrane to film overnight, a
band corresponding to an RNA species of 2.2kb was detected in the transfected
MDBK RNA lane (Figure 3.3.2.3), however no expression of OvHV-2 08 RNA was


















































































































































Figure 3.3.2.2 Northern Analysis of RNA Extracted











RNA (5pg per sample) extracted from samples of the OvHV-2
infected rabbit cell line BJ/880 (1 & 2), and from BJ/880 cells
incubated overnight with sodium butyrate, was analysed by
northern blotting using an OvHV-2 08 probe. No visible bands
were observed after a 2 week exposure of the blot to film,
therefore the blot was re-probed using a rabbit GAPDH probe.
The membrane was exposed to x-ray film overnight. The size of




Figure 3.3.2.3 Northern Analysis of Poly A RNA Extracted










Poly A RNA (10pg) was extracted from the OvHV-2 infected
rabbit cell line BJ/2476 and analysed by northern blotting using an
OvHV-2 08 probe. The positive control (+C) was RNA extracted
from MDBK cells transfected with an 07/08 expression construct
(section 3.3.3.6 ). The size of any bands was determined by




08 transcripts in 0vHV-2 infected rabbit cell lines were low and were below the
level of detection that could be achieved by northern analysis of either total RNA or
poly A RNA.
3.3.2.2 RT-PCR Analysis of The Expression of 07/08 In OvHV-2 Infected
Rabbit Cell Lines
Due to low levels of expression of 07/08 as demonstrated by northern analysis, the
expression of 07/08 was analysed by RT-PCR as this technique is more sensitive
than northern analysis. The 07/08 transcript was predicted by sequence analysis to
contain both the 07 and 08 open reading frames. The aim was to amplify the
predicted cDNA transcript of 07/08 by PCR and to clone this PCR product into a
suitable vector for sequencing, so that the RNA structure and possible splice variants
could be examined. PCR primers were therefore designed to amplify the 07/08
transcript. The 5' end of the primer 07/8-5' was located at - 11 with respect to the
translational start site of 07 and the primer contained a BamRl restriction site at the
5' end (Appendix 2). The 5' end of the primer 07/8-3' was located at +3003 with
respect to the 07 translational start site and the primer contained an £coRI restriction
site at the 5' end (Appendix 2). The primers were designed to amplify a 3kb product
from genomic DNA that spanned both the 07 and 08 open reading frames (Figure
3.3.2.1). The restriction sites were designed to facilitate cloning of any RT-PCR
products into the vector pBluescript KS for sequencing.
Total RNA (1/tg of each sample) extracted from the sodium butyrate treated
BJ/880 rabbit cell line and from non-butyrate treated BJ/880 cells was reverse
transcribed into cDNA using superscript II RT enzyme (Section 2.7.5) and random
primers. For each RT reaction a negative control reaction was included, which
contained ljtig RNA but no reverse transcriptase (RT) enzyme. This was to check
that any PCR product from the RT reactions was produced by amplification of cDNA
and not from amplification of contaminating DNA in the RNA samples. The BJ/880
cDNA was used as a template for PCR amplification, initially using the GAPDH
primers Rgap-5' and Rgap-3' (Appendix 2), in order to establish that the reverse
transcription reaction had worked. In order to check that 08 was expressed in the
BJ/880 cell line PCR amplification of BJ/880 cDNA was performed using the
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primers 08pGEX-5' and 08pGEX-3' (Appendix 2), which amplify a 621bp section
of 08 (Figure 3.3.2.1). It was possible to amplify the 621bp section of 08 in all
cDNA samples (Figure 3.3.2.4). This demonstrated that there was expression of
OvHV-2 viral genes in the samples, therefore PCR amplification of the 07/08
cDNA product was attempted.
The aim was for resulting PCR products to be cloned and sequenced;
therefore the most accurate PCR amplification possible was required. The PCR
reaction was initially optimised with BJ/1035 genomic DNA as a template, using the
proof-reading DNA polymerase pfu turbo (Stratagene). Extension times from 3 - 4
minutes were tested, and annealing temperatures from 50°C to 53°C, using 40 cycles
of PCR, however the PCR reaction proved unreliable and difficult to optimise.
Optimisation was repeated using Taq DNA polymerase, as this enzyme often
produces more consistent amplification. This polymerase however, does not have
proof-reading properties, therefore any products would have to be re-amplified and
re-sequenced to confirm that the results were accurate. The optimal conditions for
PCR amplification of the 3kb product using Taq DNA polymerase were an annealing
temperature of 52°C and an extension time of 3 minutes 30 seconds. After
optimisation, the same conditions were used for PCR amplification of the BJ/880
cDNA, however no product was produced. It was thought that the possible reason for
the lack of 07/08 PCR product were that possibly the full length cDNA template
was not being produced using the random primers. It is also known that longer
products amplify less efficiently than shorter products. The RT reaction was repeated
using superscript II RT enzyme and oligo dT primers, in order to improve the yield
of cDNAs containing the 3' end of the sequence. PCR amplification was again
performed using the 07/8-5' and 07/8-3' primers, however no product was seen.
Due to the difficulty in obtaining the 07/08 RT-PCR product from BJ/880
RNA, it was decided to study the transcription pattern of 07/08 by RT-PCR
amplification of selected smaller areas of the sequence. In order to do this, PCR
primers were designed to amplify selected areas of 07 and 08, some of which
spanned predicted splice sites. The primer pairs used are shown on Figure 3.3.2.1.
PCR amplification of BJ/880 cDNA was performed using the primer pair 07/8-5'
and 07-3' to show 07 was expressed. The primer pair 07/8-5' and 07/8spl were
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Figure 3.3.2.4 RT-PCR Analysis of RNA Extracted From OvHV-2
Infected Cell Line BJ/880 Using Primers to Amplify 08
Total RNA was extracted from the OvHV-2 infected cell line BJ/880
and from BJ/880 cells after a 24 hour incubation with sodium
butyrate (but). The RNA was reverse transcribed using random
primers and the products used as a template for PCR amplification
using the primers 08pGEX-5' and 08pGEX-3'. The PCR products
were then analysed by agarose gel electrophoresis alongside a lkb+
DNA ladder.
+C = PCR Positive control using OvHV-2 genomic DNA template.
-C = PCR negative control using dH20 template. RT+ = RT-PCR




designed to amplify sequence across the region from 07 to 08, in order to show that
a cDNA encoding both 07 and 08 was produced. 08mid-5' and 08mid-3' were
designed to amplify the middle region of 08. 08end-5' and 07/8-3' spanned the
putative splice site across from the 08a ORF to 08b ORF, therefore PCR
amplification using these primers would confirm if this splice occurs. PCR
amplification was performed using these primer pairs with BJ/880 cDNA as template
and OvHV-2 DNA as positive control template. Product was identified from all the
PCR reactions; therefore this showed that there was expression of the 07/08 region
in the areas of 07/08 tested (Figure 3.3.2.5).
The primers 07/8-5' and 07/8 spl produced a 702bp product when used for
PCR amplification of genomic DNA (Figure 3.3.2.6). The 07 and 08 open reading
frames are predicted to be spliced together to produce the 07/08 glycoprotein
mRNA, therefore a smaller PCR product than that produced by amplification of the
control genomic DNA was expected. Only small amount of product was generated in
the RT-PCR and was not easily visualised on examination of the agarose gel under
UV light. The product appeared the same size as that produced by PCR amplification
of genomic DNA.
In order to determine if the PCR product was 07/08 DNA the RT-PCR
product was analysed by Southern blotting. The RT-PCR product produced from
PCR amplification of BJ/880 cDNA with the primers 07/8-5' and 07/8 spl was
electrophoresed and the DNA transferred to Magnagraph nylon transfer membrane
(Section 2.2). The membrane was then probed using 32P labelled cosmid C57, as this
cosmid contained the 07/08 sequence. After exposure to x-ray film overnight, bands
were clearly visible in both the positive control and the RT lane with no product in
the negative control lanes (Figure 3.3.2.6). The positive control lane showed a
number of spurious bands as well as the required product at 702bp. Two bands were
also present in the RT lane; one at 700bp approximately and one seen at
approximately 480 bp. Both the bands observed in the RT+ lane were present in the
positive control lane, therefore it was concluded that there was no evidence of
splicing occurring between the 07 and 08 open reading frames. The fact that a
product resulted from this amplification reaction was evidence that 07 and 08 were
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Figure 3.3.2.5 RT-PCR Analysis of RNA Extracted From the
OvHV-2 Infected Cell Line BJ/880
881 bp
Total RNA was extracted from OvHV-2 infected cells and reverse
transcribed using random primers. The RT product was used as a
template for PCR amplification. The PCR products were analysed by
agarose gel electrophoresis alongside a lkb+ DNA ladder. The sizes
of the products are indicated.
A — Products of PCR amplification of the cDNA using primers
08mid-5' and 08mid-3' which amplify the middle region of 08.
B - Products of PCR amplification of cDNA using primers 07/8-3'
and 08end-5' which amplify sequence at the 3' end of 08 (labelled
08end) or the primers 07/8-5' and 07-3' which amplify 07 sequence
(labelled 07).
+C = PCR Positive control using OvHV-2 genomic DNA template.
-C = PCR negative control using dH20 template. RT+ = RT-PCR




Figure 3.3.2.6 Southern Analysis of the Products From RT-PCR
Analysis of RNA Extracted From the OvHV-2 Infected Cell Line
BJ/880
? 9 £ £
700bp—
500bp—
Total RNA was extracted from the OvHV-2 infected cell line
BJ/880 and reverse transcribed using random primers. The product
was then used for PCR amplification using the primers 07/8-5' and
07/8spl, which amplify sequence extending from 07 to 08. The
PCR products were electrophoresed on a 1% agarose gel and
analysed by Southern blotting using a cosmid C57 probe. The blot
was exposed to x-ray film overnight and the sizes of the bands
determined by comparison with a 1 kb+ DNA ladder.
+C = PCR Positive control using OvHV-2 genomic DNA template.
-C = PCR negative control using dH20 template. RT+ = RT-PCR




expressed in the same transcript. In order to confirm that the RT-PCR products were
unspliced 07 and 08, it would have been necessary to clone the RT-PCR products
into a suitable vector for sequencing, however this was not carried out due to the
small amount of PCR product present.
3.3.2.3 RT-PCR Analysis of Poly A RNA Extracted From OvHV-2 Infected
Rabbit Cell Lines
Until this point, RT-PCR analysis had only been carried out using total RNA.
RT-PCR analysis of poly A RNA would increase the chances of detection of viral
transcripts, however this had not been carried out due to insufficient numbers of
OvHV-2 infected cells for analysis. The availability of a new OvHV-2 infected cell
line named BJ/2476, meant that extraction of poly A RNA was now possible. Poly A
RNA was extracted from the OvHV-2 infected rabbit cell line BJ/2476 using an
oligotex direct mRNA kit as described (Section 2.7.3). Poly A RNA (ljUg) was the
reverse transcribed using superscript II RT enzyme and oligo dT primers. A sample
of RNA was prepared for the reverse transcription reaction omitting the reverse
transcriptase enzyme, as a negative control (RT-) to ensure that any amplification
from the samples was not due to amplification of contaminating genomic DNA. The
reverse transcribed samples, both with RT enzyme and without RT enzyme, were
used as templates for PCR amplification.
Initially PCR amplification was performed using the GAPDH primers
Rgap-5' and Rgap-3' (Appendix 2). This confirmed that the RT reactions had
worked and PCR amplification was then performed using the 07/8-5' and 07/8-3'
primers (Appendix 2), designed to amplify the full length 07/08 cDNA product
(Figure 3.3.2.1). The PCR enzyme Expand Long Template PCR system (Roche) was
used. This was because the enzyme had proved very efficient for the amplification of
relatively long templates when little template was present as was likely in this case.
PCR amplification of the BJ/2476 cDNA resulted in a product approximately 3kb in
length, which appeared the same size as that produced by PCR amplification of
positive control genomic DNA (Figure 3.3.2.7). In order to sequence this RT-PCR




Figure 3.3.2.7 RT-PCR Analysis of Poly A RNA Extracted
From the OvHV-2 Infected Rabbit Cell Line BJ/2476
Poly A RNA was extracted from the OvHV-2 infected rabbit cell
line BJ/2476. RNA (1 |Lig) was reverse transcribed using oligo dT
primers. The RT product was amplified by PCR using the primers
07/8-5' and 07/8-3', which amplify the 07/08 sequence. The PCR
products were then analysed by agarose gel electrophoresis
alongside a lkb+ DNA ladder.
+C = PCR Positive control using OvHV-2 genomic DNA template.
-C = PCR negative control using dH20 template. RT+ = RT-PCR




The production of this full length 07/08 PCR product by amplification of cDNA
from the OvHV-2 rabbit cell line BJ/2476 provides further evidence that 07 and 08
are expressed on the same transcript, however there was no evidence of splicing of
the transcript. In conclusion therefore, analysis of OvHV-2 infected rabbit cell lines
has provided evidence that as predicted, the 07 and 08 open reading frames are
expressed on the same transcript, in agreement with the prediction that they both
form functional domains of a putative viral glycoprotein. There was no evidence that
the OvHV-2 07/08 transcripts expressed in OvHV-2 infected rabbit cell lines are
spliced.
3.3.3 Analysis of 07/08 Expression In Transfected Cells
3.3.3.1 Cloning 07 and 08 Into pVR1255
Analysis of the expression of 07/08 in OvHV-2 infected cell lines was difficult due
to the low levels of expression of viral genes in these cells and due to the short life of
OvHV-2 infected cell lines restricting availability of cells for analysis. In order to
further analyse the splicing and expression pattern of 07/08 and to avoid the
problem of low expression of these genes in virus infected cell lines, the region of
the genome containing 07 and 08 was cloned into the expression vector pVR1255 in
preparation for transfection into eukaryotic cells.
A 3' influenza haemagglutinin (HA) epitope tagged 07/08 construct was
made (Figure 3.3.3.1), as this would enable protein expression of the construct to be
studied using commercially available anti-HA antibodies. The vector pVR1255 was
obtained under licence from Vical Inc. (Hartikka et al., 1996). This vector was
chosen as it contained a CMV promoter sequence for high level of expression of
cloned genes. The vector also contained the CMV intron A sequence. This sequence
is thought to increase gene expression due to an enhanced rate of polyadenylation
and nuclear transport associated with RNA splicing (Huang & Gorman, 1990). It is
also thought that this element may be a positive element for the high efficiency of the
CMV promoter/enhancer (Xu et al., 2001). PCR primers were designed to amplify
the 07/08 sequence such that PCR amplification of OvHV-2 DNA template would
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Figure 3.3.3.1 Expression Constructs Used for Transfection of the
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To make the constructs the region spanning the 07 and 08 open
reading frames was amplified by PCR using the primers 07/8HA-5'
and 07/8HA-3'. The PCR product was digested with Notl and
BamHI and ligated into the vector pVR1255 to make 07/8VR-HA,
or into the vector pcDNA3.1 myc His (-) to make the construct
07/8pcDNA-ElA. Each construct contained the predicted 07 and 08
open reading frames and the region between 07 and 08 followed by
three haemagglutinin epitopes (YPYDVPDYA) and a stop codon.
The construct 07/8VR-HA contained a CMV intron A sequence
(CMV int A) downstream of the CMV promoter/enhancer sequence
(CMV pro/enh). In the construct 07/8pcDNA-HA the 07/08
sequence was driven by the CMV promoter only (CMVpro).
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produce a haemagglutinin tagged 07/08 construct, which could then be cloned into
the vector PVR1255 using the Notl and BamHl sites in this vector. The 5' end of
PCR primer 07/8HA-5' was at -18 with respect to the 07 translation start site and
contained a Notl site at the 5'end (Appendix 2). The 5' end of the primer 07/8HA-3'
was located at the 3' end of the 08 open reading frame (+3002) and contained three
copies of the haemagglutinin epitope sequence (YPYDVPDYA) followed by an
ATG stop codon and a BamHl restriction site (Appendix 2).
PCR amplification of BJ/1035 OvHV-2 DNA was performed using the
primers 07/8HA-5' and 07/8HA-3' using Taqplus Long DNA polymerase enzyme
(Stratagene). This PCR enzyme was designed for better results on amplification of
long PCR products and also had proof-reading properties. The conditions that
produced the PCR product of the required length of 3 kb were an extension time of 3
mins 30 s and an annealing temperature of 57°C. This was repeated for 30 cycles.
The PCR product was termed 07/8-HA and was purified before restriction digestion
with BamHl and Notl. The digested PCR product was then ligated to BamHl and
Notl digested pVR1255. The products of the ligation were transfected into the XL-1
Blue strain of E. coli and transformants containing the construct were selected by
restriction analysis of mini preparations of plasmid DNA from selected colonies. A
positive clone containing an insert of the correct size was selected and named
07/8VR-HA. In order to prepare pure DNA for transfection, a large scale preparation
of 07/8VR-HA was carried out using an endo-free maxi prep kit as described
(Section 2.1.14).
3.3.3.2 Northern Analysis of RNA Extracted From Transfected HEK293
Cells
07/8VR-HA DNA (20/xg) was transfected into HEK293 cells by electroporation,
using a double pulse protocol (Section 2.10.8). Negative control cells were also
subjected to electroporation, but with no plasmid DNA (mock tranfections). After 48
hours the transfected cells were harvested and total RNA extracted from the cells
using a QIAGEN RNeasy kit. The RNA extracted was used for northern analysis and
the blot probed using the 08 probe. Exposure of the blot to film for 7 days produced
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Figure 3.3.3.2 Northern Analysis of Poly A RNA Extracted




HEK293 cells were transfected with the construct
07/8VR-HA and the cells harvested after 48 hours. Poly A
RNA was extracted from transfected (+) and untransfected (-)
cells and analysed by northern blotting using an OvHV-2 08
probe. The blot was exposed to x-ray film for 7 days and the




3 bands representative of RNA species of approximately 2.2kb, 2.4kb and 3.0kb.
Since the size of the genomic 07/08 sequence was 3.0kb, this was evidence that the
07/08 construct was being spliced in HEK293 cells. It was suspected that the three
different sizes of RNA observed were due to different stages of splicing of immature
transcripts. In order to test this, the transfection was repeated as before and poly A
RNA extracted from the harvested cells using an oligotex direct mRNA kit (Section
2.7.3). The poly A RNA (2/xg of each sample) was analysed by northern blotting and
the blot probed using the 08 probe. Exposure of the blot to film for 7 days produced
the same 3 RNA species seen on analysis of total RNA of approximately 2.2kb,
2.4kb and 3.0kb (Figure 3.3.3.2). The fact that bands representing three RNA species
of the same size were identified on analysis of total RNA and poly A RNA suggested
that all bands seen represented mature polyadenylated transcripts. The 3kb RNA
species was the correct size to represent an unspliced 07/08 transcript, and the
smaller sized RNA species were evidence that the 07/08 construct was spliced in
HEK293 cells.
3.3.3.3 RT-PCR Analysis of RNA Extracted From 07/08 Transfected
HEK293 Cells
In order to analyse the sequence of the 07/08 transcripts seen after transfection of
HEK293 cells with the 07/8VR-HA plasmid, RNA extracted from the cells was
analysed by RT-PCR and the PCR products cloned into the vector PKS for
sequencing. Total RNA (1/tg) extracted from 07/8VR-HA transfected 293 cells was
reverse transcribed using Superscript II RT enzyme and oligo dT primers as
described (Section 2.7.5). For all RNA samples a control reverse transcriptase
reaction was set up omitting RT enzyme in order to show that any RT-PCR products
resulted from amplification of cDNA and not from contaminating DNA in the RNA
samples. The products of the RT reactions were used initially as a template for PCR
amplification using the primers Hgap-5' and Hgap-3' (Appendix 2) (Obtained from
Dr S.J. Talbot), which were designed to amplify the human GAPDH gene. A product
of the correct size of 400bp was produced in all RT samples suggesting that the RT
reactions had worked (Figure 3.3.3.3B). PCR amplification of the cDNA was then
performed using the primers 08pGEX-5' and 08pGEX-3,' to check for expression
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Figure 3.3.3.3 RT-PCR Analysis of RNA Extracted From 07/08
Transfected HEK293 Cells using Primers to Amplify 08
<5
Ig A - Q8pGEX primers
< l 1 l ~
Q R dT R dT
HEK293 cells were transfected with the construct 07/8VR-HA.
Total RNA was extracted from transfected (+) and untransfected (-)
cells after 48 hours and used in reverse transcriptase reactions using
random primers (R) or oligo dT primers (dT). The RT products
were then amplified by PCR. A - Products of PCR amplification
using the primers 08pGEX-5' and 08pGEX-3', which amplify 08.
B - Products of PCR amplification using the primers Hgap-5' and
Hgap-3' (obtained from Dr S.J. Talbot), which amplify a 400bp
section of the human GAPDH gene. The PCR products were
analysed by agarose gel electrophoresis alongside a lkb+ DNA
ladder.
+C = PCR Positive control using OvHV-2 genomic DNA template
with 08pGEX primers and MHV-68 cDNA template with GAPDH
primers. -C = PCR negative control using dH20 template.




of 08 in the transfected cells before attempting amplification of the full length
07/08 product. A product of the correct size of 621 bp was amplified from all the
07/08 transfected cells, but not from the mock-transfected cells (Figure 3.3.3.3A),
suggesting that the expression of 08 in the cells was as a result of the transfection
with the 07/08 construct. Finally amplification of the cDNA was performed using
the using the 07/8-5' and 07/8-3' primers (Appendix 2). The PCR products were
analysed by gel electrophoresis (Figure 3.3.3.4) and were seen to contain a major
product of size approximately 2.2kb and minor products of various sizes. The PCR
product was purified using the CONCERT PCR purification system (Invitrogen) and
digested using BamHl and FcoRI. The digested PCR product was then ligated to
BamHl and FcoRI digested pBluescribe KS II vector (Stratagene) (Appendix 5) and
the ligated DNA transfected into the XL-1 Blue strain of E. coli. Colonies were
selected and analysed for the presence of inserted DNA by restriction digestion and
electrophoresis of plasmid DNA purified from bacterial colonies. Positive colonies
with inserted DNA of various sizes were found and samples with inserted DNA of
size approximately 2.2kb, 1.9kb and 1.6kb were sequenced.
Three different spliced cDNAs were found (Figure 3.3.3.5). 07/8-293.11
contained just one large splice of size 943bp in 08. The area spliced out extended
from 1857 to 2800 with respect to the translational start of 07. The splice sites used
were exactly as predicted by analysis using the NetGene2 program; the 5' splice
donor site in 08 with a confidence value of 0.37 and the splice acceptor site at 2800
with a confidence level of 0.94 (confidence values are given relative to the cutoff
values used to find nearly all true splice donor or acceptor sites). The area spliced out
of the 08 corresponded closely with the area of 08 not homologous to A8 of
A1HV-1. The lack of splicing in 07 meant that in transcribing from 07 to 08 several
stop signals were found, therefore it was unlikely that an 07/08 protein would be
translated from this transcript.
07/8-293.6 also contained a large splice from 08, however the splice donor
site in 08 was at 1896 and the splice acceptor back into 08 was located at 2800 as
before. The splice donor site at 1896 was predicted by NetGene, with a confidence
value of 0.70 and produced an in frame 08. This cDNA also contained one small
splice from within the predicted 07 ORF (from 42 -149) and one small splice in the
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Figure 3.3.3.4 RT-PCR Analysis of RNA Extracted From 07/08





HEK293 cells were transfected with the 07/8VR-HA construct and
the cells harvested after 48 hours. Total RNA was extracted from the
cells and used in reverse transcriptase reactions with oligo dT primers.
The RT products were amplified by PCR using the primers 07/8-5'
and 07/8-3'. The products were then analysed by agarose gel
electrophoresis alongside a lkb+ DNA ladder.
+C = PCR Positive control using OvHV-2 genomic DNA template.
-C = PCR negative control using dH20 template. RT+ = RT-PCR














































































































































































region between 07 and 08 (350 - 466). The splice donor site at 42 was not predicted
by analysis using the NetGene program, however the splice acceptor site was a
consensus GT motif. The acceptor site at 149 was predicted with a confidence level
of 0.96. The donor site at 350 was predicted with a confidence level of 0.55 and the
acceptor site at 466 with a confidence level of 0.72. The splice in the 07 ORF meant
that stop codons were introduced into the sequence, also following the second splice
the sequence was not in frame with the predicted 08 ORF. This RNA was therefore
unlikely to be translated into an 07/08 protein. 07/8-293.5 extended from 466, a
location 5' to the beginning of the 08 open reading frame, to the end of 08. The
sequence contained the large 943bp splice in 08, using the same splice donor and
acceptor sites that were used in 07/8-293.11. This PCR product was possibly
generated by mis-priming of the 07/8-5' primer.
3.3.3.4 Cloning of 07 and 08 Into pcDNA 3.1//WyoHis (-)
The plasmid pVR1255 contained the CMV intron A sequence (Figure 3.3.3.1), which
was designed to improve expression of the inserted sequence. It was suspected that
this sequence could potentially interfere with efficient splicing of the 07/08
construct, therefore the 07/8-HA tagged construct was cloned into pcDNA3.1/myc-
His (-) (Invitrogen) (Appendix 5). This vector was designed for high expression of
inserted DNA under the control of the CMV promoter and since the construct
contained a stop signal 3' to the triple HA tag, the ATyc-His tag in the vector would
not be expressed. Vector DNA was digested with Noil and BamHl before
desphosphorylating using the CIAP enzyme. The pcDNA vector was then ligated to
Notl and BamWl digested 07/8-HA DNA and the construct transfected into the XL-1
Blue strain of E. coli. Colonies were selected and analysed for the presence of
plasmid DNA containing an insert of the correct size of 3kb, by digestion of
minipreparations of plasmid DNA with BamWl and Notl. A positive colony was
selected and a large-scale preparation of plasmid DNA prepared using a QIAGEN
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3.3.3.5 Transfection of The 07/08 Sequence Into A20 Cells
The splicing patterns found in the cDNAs from transfection of HEK293 cells with
the 07/08 construct were such that the open reading frames were not maintained in
any of the cDNAs. It was thought that this was possibly because cell type or species
specific factors were involved in splicing, or that correct splicing required viral
factors. Since OvHV-2 is suspected to infect lymphocytes in cattle and sheep (Baxter
et al., 1993), it was possible that lymphocyte specific factors were involved in
splicing. In order to address this, the 07/8pcDNA-HA construct (10/rg) was
transfected into A20 cells (Kim et al., 1979). These cells are a mouse B cell
lymphoma line and were known to transfect efficiently. The A20 cells were
transfected using a double pulse protocol as described (Section 2.10.8) and 20/rg
DNA was used for each transfection. A control plasmid containing the green
fluorescent protein (GFP) gene (pEGFPCl, Clontech), was transfected to assess
transfection efficiency. The optimum efficiency obtained in these cells was
approximately 50% and the electroporation protocol used resulted in a high
percentage of cell death.
After 48 hours the cells were harvested and total RNA extracted from the
cells using a QIAGEN RNeasy kit as described previously (Section 2.7.2). The RNA
was quantified by fluorometry. The yield of RNA from A20 cells was low, possibly
because of the high percentage of cell death resulting from electroporation. The RNA
was analysed by RT-PCR in the same way as for the HEK293 cells using the 07/8-5'
and 07/8-3' primers. The PCR products were then analysed by gel electrophoresis.
The major product of the RT-PCRs was approximately 2.2kb in length (Figure
3.3.3.6). This was the same size of RT-PCR product as that resulting from the same
experiment in HEK293 cells. RNA extracted from A20 cells was not analysed by
northern blotting, as the amount of RNA extracted from the cells was not sufficient
for this method. It was concluded therefore, that there were no differences in the
splicing pattern of the 07/08 construct in A20 cells as compared to those found in
HEK293 cells. This suggested that B lymphocyte cell specific factors were not
required for splicing of the 07/08 construct.
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Figure 3.3.3.6 RT-PCR Analysis of RNA Extracted From 07/08






A20 cells and MDBK cells were transfected with the construct
07/8pcDNA-HA by electroporation and total RNA extracted after
48 hours. RNA from transfected (+) and non-transfected (-) cells
was used in reverse transcription reactions with oligo dT primers.
PCR amplification of the RT products was performed using the
primers 07/8-5' and 07/8-3' which amplify 07/08 sequence. The
PCR products were analysed by electrophoresis on a 1% agarose
gel and are shown compared to a lkb+ DNA ladder.
+C = PCR Positive control using OvHV-2 genomic DNA template.
-C = PCR negative control using dH20 template. RT+ = RT-PCR




3.3.3.6 Northern Analysis of Transfected MDBK Cells
To determine if splicing was affected by species-specific factors the
07/8pcDNA-HA construct was transfected into Madin-Darby Bovine Kidney
(MDBK) cells (Madin, 1958) obtained from the Moredun Research Institute. This
cell type was chosen because OvHV-2 naturally infects cattle and MDBK cells were
known to transfect efficiently. Transfection efficiency in MDBK cells by
electroporation was optimised, by testing a number of different single and double
pulse protocols using the GFP expressing plasmid pEGFPCl. A single pulse protocol
as described (Section 2.10.8) was found to give the optimal efficiency of
approximately 70%. MDBK cells were transfected with the 07/8pcDNA-HA
construct (ICtytg) using the single pulse electroporation protocol. Transfected cells
were harvested after 48 hours and total RNA extracted using a QIAGEN RNeasy kit.
RNA extracted from 07/8pcDNA-HA transfected MDBK cells was subjected to
northern analysis using the 08 probe. This resulted in just one band at approximately
2.4kb after a two day exposure of the membrane to film (Figure 3.3.3.7).
3.3.3.7 RT-PCR Analysis of Transfected MDBK Cells
In order to analyse the sequence of 07/08 RNAs extracted from transfected MDBK
cells, the RNA was analysed by RT-PCR using the 07/8-5' and 07/8-3' primers. Gel
electrophoresis of the RT-PCR products showed that the same main product of 2.2kb
was found in 07/8pcDNA-HA transfected MDBK cells (Figure 3.3.3.6). A product
of size 3kb was found in the RT- control indicating that there was some
07/8pcDNA-HA plasmid DNA contamination in the RNA sample. The 2.2kb
RT-PCR product from RT-PCR analysis of RNA extracted from transfected MDBK
cells and associated products close to it, was excised from an agarose gel and
purified using a QIAGEN Gel extraction kit as described. The PCR product was then
ligated to the vector pKS using the BamHl and EcoRl sites and the products of the
ligation transfected into E. coli. A selection of 24 possible transformants was
checked and all colonies proved negative for the presence of plasmids containing
inserted DNA. The failure to clone the PCR products into pKS may have been due
inefficient ligation, since the number of colonies obtained in the negative control
ligations (plasmid without insert), was similar to the number obtained from the
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MDBK cells were transfected by electroporalion with the
construct 07/8pcDNA-HA. Transfected (+) and untransfected
(-) cells were harvested after 48 hours and total RNA extracted.
The RNA was analysed by northern blotting using an OvHV-2
08 specific probe. The hybridised blot was exposed to film
overnight, and the size of any RNA bands determined by
comparison to an RNA size marker.
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positive samples. The inefficient ligation reaction might have been due to the fact
that restriction sites located at the end of DNA fragments such as PCR products
sometimes digest poorly. The lack of properly digested PCR product as a substrate
for ligation would result in a lower than optimum amount of ligated DNA. In order to
solve this problem, the PCR amplification of the RNA extracted from transfected
MDBK cells was repeated and the product excised from the gel and purified as
before. The product was then ligated to the TA vector pGEM-T Easy
(Promega)(Appendix 5) using the quick-ligation buffer supplied, as described
(Section 2.4.12). The ligation reaction was then used to transform the XL-1 Blue
strain of E. coli. Positive colonies were then identified by blue/white selection
(Section 2.4.11). Plasmid DNA purified from positive colonies was analysed by
restriction digestion with EcoRI, however none of the colonies analysed contained
the correct inserted DNA and the plasmid DNA purified from these colonies did not
digest with EcoRI.
Due to the unsatisfactory progress made by cloning using the pGEM-T Easy
TA cloning vector, the 07/08 PCR amplification was repeated and the product was
cloned using a pCR 2.1 TOPO TA cloning kit, as this method had been successful in
the past. The TOPO cloning reaction was set up as described (Section 2.4.10) and the
products transfected into One Shot TOP 10 competent E. coli. Positive colonies were
again identified by blue/white selection and plasmid DNA purified from the colonies
analysed by restriction enzyme digestion with EcoRl. Gel electrophoresis of the
EcoKl digests showed that there were three samples with inserted DNA
approximately 2.2kb in size (MDBK4, 6 and 12) and one sample with inserted DNA
of size just over 1.6kb (MDBK3). These samples were sequenced and two different
cDNA clones were observed (Figure 3.3.3.8). MDBK4, 6 and 12 were the same
sequence; all contained a large splice within the 08 ORF at the same coordinates as
seen in cDNAs from transfected HEK293 cells (1857 - 2800). MDBK3 contained a
large splice in the 08 ORF from 1857 - 2800 in the same way as in MDBK 4, 6 and
12 and also a large splice from 07 from 42 - 466. The splice donor located at 42 was
within the 07 ORF, whilst the splice acceptor at 466 was located in the region
between the predicted 07 and 08 open reading frames. The splice acceptor at 466





































































































































































frame as the 08 ORF. This RNA was therefore unlikely to be translated to a
complete 07/08 protein.
3.3.3.8 Western Blotting Analysis of 07/08 Transfected HEK293 Cells
Western blotting analysis of the 07/08 transfected HEK293 cells was carried out in
order to determine the apparent molecular weight of the putative 07/08 protein. Due
to the presence of glycosylation, the molecular weight was expected to be higher
than that predicted. Since the 07/08 expression construct contained three HA
epitopes at the 3' end, it was possible to use an anti-HA antibody to detect the
protein. Initially untransfected HEK293 cells and cells transfected with 10, 15 or
20ixg of the 07/8VR-HA plasmid were resuspended in western sample buffer at a
concentration of 106/100/xl. A 10 and 20/xl aliquot of each cell lysate was analysed
by SDS-PAGE as described (Section 2.8.1). After electrophoresis, samples of each
cell lysate were analysed by Coomassie staining to ensure that cell lysis had been
adequate. Samples were also transferred to a PVDF membrane by western blotting
(Section 2.8.3). The western blot was incubated with the rat monoclonal anti-HA
antibody, followed by a secondary biotinylated anti-rat IgG and a tertiary
streptavidin-AP conjugate as described in Section 2.8.4. Antibody binding was
detected by incubation of the membrane with Sigma FAST BC1P/NBT solution. A
number of protein bands were identified on the membrane after incubation with the
detection reagent, however all bands were present on the untransfected cells;
therefore it was suspected that these were caused by non-specific binding of the
antibodies.
It was suggested that the use of ECL might be required in order to detect the
HA epitope (Alastair MacRae, personal communication). The western blot was
repeated and HEK293 cells transfected with the control HA tagged plasmid
PSG5/JkHA were used as a positive control. This plasmid was a triple HA tagged
version of the signalling protein Jk, inserted into the pSG5 expression vector
(Stratagene) (Appendix 5) (Zhao et al., 1996) and was obtained from Dr Jeff Sample,
St Jude Children's Research Hospital, Memphis. Streptavidin-POD was used as a
tertiary antibody as described (Section 2.8.4) and the ECL kit was used to detect
antibody binding. No strong bands could be visualised in ECL analysis, therefore
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optimisation of the protocol in terms of the concentrations of the antibodies used was
required. Due to the time constraints, this was not pursued.
3.3.3.9 Immunofluorescence Analysis of 07/08 Transfected MDBK Cells
It was not known if transfection of MDBK cells resulted in protein expression from
the 07/08 construct. Although the cDNAs sequenced seemed to have sequence
containing stop codons, it was not known if protein translation occurred from these
or other undetected transcripts. In order to investigate this, 07/8pcDNA-HA
transfected MDBK cells were analysed by immunofluorescence using an anti-HA
antibody (Section 2.10.2). This was possible because the 07/08 expression construct
contained three HA epitopes at the 3' end of the 08 open reading frame. Expression
of the haemagglutinin epitopes therefore depended on translation of the construct
right to the 3' end.
Two positive control constructs were used for transfection, both containing
three haemagglutinin epitopes at the 3' end. The plasmid pSG5/jk-HA was a triple
HA tagged version of the signalling protein Jk, inserted into the pSG5 expression
vector (Stratagene) (Appendix 5) (Zhao et al., 1996). Plasmid pSG5/IRF7-HA was
the pSG5 vector containing the inserted triple haemagglutinin tagged interferon
regulatory factor 7 (IRF7) (Zhang & Pagano, 1997). Both plasmids were obtained
from Dr Jeff Sample, St Jude Children's Research Hospital, Memphis. MDBK cells
were transfected with the HA tagged constructs (10/xg of each) using the single pulse
electroporation protocol as described, and harvested after 48 hours. Transfection
efficiency was checked using the pEGFPCl plasmid and found to be approximately
60 - 70%. Harvested cells were resuspended in PBS at 106/ml, and "cytospun" onto
Twinfrost slides (VWR) as described (Section 2.10.1). The "cytospun" cells were
fixed with either 100% acetone or 4% paraformaldehyde (Section 2.10.1).
Paraformaldehyde fixed cells were permeablised by incubation in PBS containing
0.2% Triton-X 100 for 5-10 minutes.
The fixed cells were subjected to immunostaining using the rat anti-HA
antibody as described (Section 2.10.2). Both the primary anti-HA antibody and the
secondary goat anti-rat-Ig antibody were used at a concentration of 1/250. The
immunostained cells were examined by UV microscopy, however no fluorescence
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was observed in either the positive control samples or the 07/08 transfected
samples. The transfection efficiency using the GFP expressing control plasmid was
high, however the same efficiency may not have been attained using the HA epitope
tagged plasmids. Although the plasmid DNA was prepared using an endo-free maxi
kit, it was still well known that higher transfection efficiencies could be obtained
using DNA prepared using Caesium Chloride (CsCl) gradients. In order to ensure
that the transfected DNA was of the highest quality possible, large scale preparations
of the HA tagged plasmid DNA were prepared using CsCl gradients (Section 2.1.15).
The transfections were repeated using the CsCl gradient prepared DNA samples and
the cells cytospun and fixed as before. The paraformaldehyde fixed cells were
permeablised for 5 minutes in 0.2% Triton-X 100 instead of 10 minutes as before, as
overpermeablisation can destroy the protein epitopes used for antibody recognition.
The fixed cells were immunostained using the rat anti-HA antibody in the same way
as was done previously. On examination under the UV microscope, the positive
control HA tagged proteins were visible in the paraformaldehyde fixed samples
(Figure 3.3.3.9), but not in the 100% acetone fixed samples. The Jk-HA protein
localised in the cell nucleus and the IRF7-HA protein localised in the cytoplasm. No
fluorescence was observed on the 07/8pcDNA-HA transfected cells, indicating that
HA tagged proteins were not expressed from this construct in MDBK cells at levels
detectable using the anti-HA antibody.
3.3.4 Production of An Antibody Against 08
Until this point, no evidence of expression of OvHV-2 proteins had been seen in
OvHV-2 infected cell lines, therefore in order to detect the expression and
subcellular location of the 08 protein in OvHV-2 infected cell lines, rabbits were
immunised against a section of 08.
In order to raise an antibody to 08 a region of 08 was selected and amplified
by PCR before cloning into the expression vector pGEX-3X. The vector pGEX-3X
(Appendix 5) was constructed to direct the synthesis of foreign polypeptides in
E. coli as fusion proteins with the C terminus of Sj26, a 26kDa glutathione
S-transferase (GST) (Smith & Johnson, 1988). The plasmid directs the synthesis of
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Figure 3.3.3.9 Immunofluorescence Analysis of MDBK Cells
Transfected With Haemagglutinin Tagged Expression Constructs
IRF7-HA JkHA
The haemagglutinin tagged 07/08 construct 07/8pcDNA-HA, the
positive control haemagglutinin tagged constructs IRF7 and JkHA and
the positive control plasmid pEGFPCl were transfected into MDBK
cells by electroporation. The pEGFP transfected cells were examined
in the wells under UV light after 48 hours. The 07/8pcDNA, IRF7 and
JkHA transfected cells were harvested after 48 hours and fixed to glass
slides. The fixed cells were then subjected to immunostaining using a
primary rat monoclonal anti-HA antibody followed by a secondary
anti-rat FITC conjugate. The cells were then examined under UV light.
220
CHAPTKR 3 RESULTS
the fusion protein under the control of the 1PTG inducible tac promoter. This is a
strong promoter, which can result in high levels of expression of the fusion protein.
The GST fusion protein is then purified by affinity chromatography on immobilised
glutathione followed by competitive elution with excess reduced glutathione. On
purification, the GST fusion protein can then be injected into rabbits in order to raise
an antibody response.
3.3.4.1 Expression of An 08-GST Fusion Protein
Primers were designed to amplify a 621 bp (207 amino acids) (aa 292-549) region of
08 (Figure 3.3.1.9) between +1125 and +1746 with respect to the translational start
site of 07 and were named 08pGEX-5' and 08pGEX-3'. This region was chosen as
it contained a number of possible of antigenic sites and avoided most of the proline
rich area of the protein (aa 509 - 768), as proline rich proteins are often not well
tolerated in bacterial expression systems. The area used also included a number of
hydrophilic regions as shown by the hydrophobicity plot (Figure 3.3.1.6).
Additionally the fact that the region contained a number of putative N and O
glycosylation sites (Figure 3.3.1.4 & 5) indicated that this region might be the
ectodomain region of 08. 07 was not chosen to raise an antibody, as it was predicted
to encode a signal peptide, which would be cleaved away from the rest of the protein.
The region of interest was amplified by PCR using OvHV-2 genomic DNA
as a template. The amplified region was ligated into pGEX-3X in frame with the
GST sequence using the BamWl and EcoRl sites to make the construct
08pGEX (Figure 3.3.4.1). The construct was transformed into E. coli bacteria and
transformants checked for presence of the inserted 08 DNA by restriction analysis of
small-scale preparations of plasmid DNA with EcoRI and BamWl. Transformants
containing the inserted 08 DNA were then tested for expression of the 08-GST
fusion protein.
Four samples positive for the 08 insert were analysed for expression of the
GST fusion protein. Expression of the GST fusion protein was induced by addition
of IPTG to 0.1mM during the exponential growth phase of the culture. The bacteria
were harvested 3 hours after induction and lysed by sonication. Both the supernatant
and the cell pellet were then analysed by electrophoresis on a 12% SDS-PAGE gel.
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Figure 3.3.4.1 08pGEX Construct Used for Expression of





A 600bp section of 08 was amplified by PCR using the primers
08pGEX-5' and 08pGEX-3'. The PCR product was digested
using BamHl and EcoRI and ligated to the vector pGEX-3X. The
vector encodes the Schistosoma japonicum Glutathione S-
Transferase (GST) protein sj26. The vector is designed so that the
sequence of interest (08) is expressed as a GST fusion protein
under the control of the tac promoter (ptac). The Cloning site is
followed by translational STOP signals in all three open reading
frames. Under normal conditions, expression is repressed by the
product of the Laclq gene, however repression is removed by the
addition of the inducer isopropyl (3-D thiogalactosidase (IPTG), a
lactose analogue. The plasmid contains the ampicillin resistance
gene (AmpR) for selection of plasmid containing colonies and a
pBR322 origin of replication (Ori).
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A 621 bp sequence of 08 was cloned into the vector pGEX-3X and
transfected into the XL-1 blue strain of E.coli. Transfected bacteria
were grown overnight and induced with 0.1 mM IPTG for 3 hours.
The bacteria were lysed by sonication on ice and pellet and
supernatant fractions were analysed on a 12% SDS-PAGE gel.
Proteins were visualised by Coomassie blue staining. The molecular
weights of protein standards are indicated, and the position of the








The electrophoresed proteins were identified by Coomassie staining of the gel
(Section 2.8.2). All samples contained a major product of approximate size 52 KDa
predominantly in the pellet fraction (Figure 3.3.4.2). The expected size of the 08
protein was approximately 23 KDa and the GST protein was 30Kda, therefore the
52kDa band was the right size to be the 08-GST fusion protein. The fact that the
GST fusion protein was found in the bacterial pellet meant that this protein was
insoluble. It was thought that this effect could have possibly been observed due to
insufficient sonication of the bacteria, however on repeating this, the GST fusion
protein still appeared insoluble (Figure 3.3.4.3A).
3.3.4.2 Purification of The GST Fusion Protein By Inclusion Body
Preparation
Foreign proteins that are overexpressed in E. coli and found to be insoluble often
form insoluble aggregates called inclusion bodies (Marston, 1986). These are readily
isolated by low speed centrifugation and often consist of almost pure aggregations of
the denatured form of the foreign protein. The GST fusion protein was therefore
purified by means of an inclusion body preparation (Section 2.9.2).
Clone 3 containing the 08pGEX construct was induced with 0. ImM IPTG
and incubated for 3 hours at 37°C before harvesting. The cells were then resuspended
in inclusion body prep solution and subjected to gentle lysis with lysozyme.
Contaminating nucleic acids were removed from the lysate by incubation with
DNasel and the inclusion bodies were removed from suspension by centrifugation at
10,000 x g. The inclusion bodies were then washed in inclusion body prep solution
containing NP40, to remove contaminating bacterial proteins, before resuspension
into a 50% (v/v) solution in PBS. Samples of the supernatant and pellet fractions
from the inclusion body preparation were then analysed on a 12% SDS-PAGE gel to
determine presence of the 08-GST fusion protein. A protein sample from an induced
bacterial strain containing the vector pGEX-3X without an insert was also
electrophoresed to show the size of the GST protein.
The 08-GST fusion protein was present in the insoluble inclusion body
preparation and not in the supernatant fraction (Figure 3.3.4.3A). A sample of the
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Figure 3.3.4.3 Analysis of 08-GST Fusion Proteins
Prepared Using Different Methods
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A - 08-GST Fusion proteins were analysed on a 12% SDS-PAGE gel
and visualised by Coomassie blue Staining
B - The same samples were analysed by western blotting using a goat
anti-GST antibody, followed by a secondary biotinylated anti-sheep Ig,
and a tertiary streptavidin-AP. Antibody binding was detected by
incubation with Sigma FAST BCIP/NBT solution. The molecular
weights of protein standards are indicated.
GST : Glutathione S-transferase P: Pellet s/n: Supernatant
08pGEX : Products from lysis of bacteria transfected with 08pGEX.
08pGEX2: Products of lysis of 08pGEX transfected bacteria, prepared




inclusion body preparation was transferred to a PVDF membrane by western blotting
(Section 2.8.3) and the membrane incubated with a goat anti-GST antibody at a
concentration of 1/1,000, followed by incubation with an anti-sheep Ig conjugated to
biotin. The tertiary detection reagent used was a streptavidin conjugated to alkaline
phosphatase (streptavidin-AP). Antibody binding was then visualised by use of
Sigma FAST BCIP/NBT solution. The positive band was seen in at approximately 52
KDa and smaller bands were also seen at approximately 40KDa and at 30KDa, the
same size as the GST band, possibly indicating some breakdown of the protein
(Figure 3.3.4.3B). Since particulate antigens are suitable for injection, the inclusion
body preparation was used to immunise two New Zealand White rabbits as described
(Section 2.9.3).
3.3.4.3 Analysis of Immune Rabbit Sera For The Presence Of Antibodies
To The 08-GST Fusion Protein
In order to check that immunisation of the rabbits had been successful, normal rabbit
sera (pre-bleed) and post immunisation rabbit sera were tested at different
concentrations for the presence of antibodies to the 08-GST fusion protein. A sample
of the inclusion body preparation was resuspended in SDS-PAGE buffer and loaded
onto a 12% SDS-PAGE gel with only two lanes. The lane of standard width was
loaded with the protein molecular weight standard, whilst the wide lane was loaded
with the 08-GST inclusion body preparation. The 08-GST fusion protein was
therefore electrophoresed in one wide band down the gel.
After electrophoresis the proteins were transferred to a PVDF membrane by
western blotting and the membrane was cut into narrow strips. This was to enable
incubation of the proteins with different concentrations of primary and secondary
antibodies to determine an optimal combination, which showed specific antibody
binding, but with minimum non-specific antibody binding. Antibody binding
observed using both the normal rabbit serum and in the immune serum was
interpreted as non-specific binding. The rabbit serum was used at concentrations
ranging from 1/1,000 to 1/10,000. The secondary antibody was a porcine anti-rabbit
Ig conjugated to alkaline phosphatase. This was used at concentrations from 1/1,000
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to 1/10,000. In each membrane one strip was probed with a polyclonal rabbit
anti-GST antibody used at a concentration of 1/500. The secondary antibody used
was the porcine anti-rabbit Ig at 1/1,000 concentration. Alkaline phosphatase activity
on the membrane was detected by incubation of the strips in Sigma FAST
BCIP/NBT solution. All immune serum concentrations demonstrated a specific
antibody response to the 52KDa band, (Figure 3.3.4.4). The rabbits had also
developed a strong antibody response to a protein of size approximately 24KDa,
which the anti-GST antibody did not specifically recognise. It is possible that this
protein was a breakdown product of the GST fusion protein. The optimum
concentration of primary and secondary antibody for minimising non-specific
antibody binding was a serum concentration of 1/2,000 and a secondary antibody
concentration of 1/2,000. On the basis of the antibody response shown by western
blotting, both rabbits were euthanased and the serum separated from the blood. The
sera were aliquoted and frozen at -20°C.
3.3.4.4 Immunofluorescence Analysis of 08 Expression in OvHV-2
Infected Cell Lines Using The Immune Rabbit Serum
In order to attempt to detect expression of the 08 protein in BJ/880 OvHV-2 infected
rabbit cells, serum from rabbit B was used in immunofluorescence on acetone fixed
cytocentrifuge preparations of the OvHV-2 infected rabbit cell line BJ/880 (obtained
from the Moredun Research Institute). The immune rabbit serum was used as the
primary antibody. The secondary antibody was a porcine anti-rabbit Ig conjugated to
FITC and was used at a concentration of 1/50. Pre-immune rabbit serum was used as
a control at the same concentrations as the immune serum using the same secondary
antibody. As a control to check for binding of the secondary antibody to the cell,
some samples were incubated with PBS as the primary reagent followed by the anti-
rabbit FITC as the secondary reagent.
Immunofluorescence analysis using the immune rabbit serum at a
concentration of 1/100 showed positive fluorescence in a large proportion of cells
(Figure 3.3.4.5). The localisation of the staining appeared to be around the cell
surface and in the cytoplasm. Some fluorescence was observed on the cells incubated
with normal rabbit serum, however this was not of the same intensity as the
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fluorescence seen following incubation with the immune serum. The cells incubated
with PBS followed by FITC exhibited only low levels of fluorescence, this suggested
that the secondary anti-rabbit FITC was not binding to the BJ/880 OvHV-2 infected
rabbit cells. Immunofluorescence staining was performed on paraformaldehyde fixed
cytocentrifuged cells, obtained from the Moredun Research Institute, as
paraformaldehyde fixing of cells generally preserves the cellular architecture better
than acetone fixation. No positive fluorescence was seen in these samples. This
might have been because paraformadehyde treatment can destroy some protein
epitopes, therefore the optimum method of fixing has to be determined for the
antigen to be detected. The positive fluorescence observed in the OvHV-2 cells
incubated with immune serum as compared to samples incubated with pre-immune
serum suggested that a high proportion of cells were expressing the 08 protein. The
use of control non-infected cells was considered to be necessary to reinforce the
validity of this result.
3.3.4.5 Immunofluorescence Analysis of PHA Treated Control Rabbit
Lymphocytes
The OvHV-2 infected rabbit lymphocytes are a lymphoblastoid phenotype (Reid et
al., 1983). It was considered important to try to make a non OvHV-2 infected
negative control for immunofluorescence analysis using the immune rabbit serum.
The most appropriate control for use was considered to be activated normal rabbit
lymphocytes. Lymphocytes were separated from rabbit blood by Ficoll density
centrifugation using Lymphoprep (Section 2.10.4). The lymphocytes were then
incubated for 48 hours with 7.5ju.g/ml PHA. This resulted in the cells displaying an
activated phenotype, as shown by the cells adhering to each other and forming
irregular shapes (Section 2.10.5). The cells were harvested and washed in PBS, after
which they were cytospun onto slides as described (Section 2.10.1). The cytospun
activated lymphoblasts were then fixed in 100% (v/v) acetone and were incubated
with the immune rabbit serum followed by the anti-rabbit FITC in the same way as
was carried out in the BJ/880 OvHV-2 infected lymphocytes.
The PHA treated control rabbit lymphocytes showed generally low levels of
fluorescence in both the immune serum incubated and pre-immune serum incubated
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samples (Figure 3.3.4.5). A small number of cells in the immune serum treated
samples did, however exhibit fluorescence of a similar staining pattern and intensity
to the OvHV-2 infected rabbit cells. The samples incubated with PBS followed by
anti-rabbit FITC exhibited cell surface and intracellular fluorescence in a small
number of cells. This staining was of higher intensity than that seen on PBS and
anti-rabbit FITC staining of OvHV-2 infected lymphoblastoid cell lines. The
fluorescence seen on PBS/anti-rabbit FITC incubated control rabbit lymphocytes
suggests that some of the fluorescence seen after incubation of these fixed cells using
immune and pre-immune serum may have been caused by binding of the secondary
anti-rabbit FITC antibody to the cells. It was also observed that whilst the OvHV-2
infected LCLs were known to be only T lymphocytes, PHA treated rabbit
lymphocytes would also contain B lymphocytes, and binding of the primary antibody
to Fc receptors on these cells may cause problems with background fluorescence.
3.3.4.6 Western Blotting Analysis Using Anti-08 Immune Rabbit Serum
OvHV-2 infected BJ/880 rabbit cells were analysed by western blotting to determine
the size of the 07/08 protein. BJ/880 cells were lysed in sample buffer and
electrophoresed on a 12% SDS-PAGE gel. The electrophoresed proteins were
transferred to a PVDF membrane and the membrane was cut into strips. The strips
were incubated with varying concentrations of the primary antibody, which was
immune rabbit serum, or pre-immune rabbit serum. Concentrations varying from
1/100 to 1/5,000 were used. The strips were then incubated with the secondary anti-
rabbit-AP conjugate at a concentration of 1/5,000 and antibody binding was detected
by incubation with Sigma FAST BCIP/NBT solution. After incubation with the
detection reagent a number of bands were detectable, a 53KDa band and two smaller
bands of size approximately 37KDa and 38KDa seemed to be recognised by the
immune serum but not the pre-immune serum at concentrations of 1/100 down to
1/1,000 (Figure 3.3.4.6).
Western blotting was repeated using PHA treated rabbit lymphocytes as
negative control cells (Section 2.10.5). A number of bands were observed from
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Figure 3.3.4.6 Western Blotting Analysis of OvHV-2 Infected
Rabbit Cells Using the Anti-08 Immune Serum
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Cell lysate of the OvHV-2 infected rabbit cell line BJ/880 was
electrophoresed on a 12% SDS-PAGE gel and the proteins
transferred to a PVDF membrane. The membrane was cut into strips
and the strips incubated with different concentrations of immune (I)
or pre-immune (P) rabbit serum. The strips were then incubated with
a secondary anti-rabbit alkaline phosphatase conjugate and antibody
binding was visualised using Sigma FAST BCIP/NBT solution. The
concentrations of sera used are shown above the strips and the
molecular weight of protein standards indicated. The position of
bands of interest described in the text are marked with stars.
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analysis of lysates from infected cells but not in the control rabbit lymphocyte cell
lysates. Electrophoresed cell lysate from equal numbers of the control lymphocytes
and BJ/880 was analysed by Coomassie staining. This showed that the amount of
protein in the BJ/880 cells was far greater than the amount in the same number of
control lymphocytes, therefore it was concluded that the differences on western
blotting analysis were be due to different amounts of protein on the SDS-PAGE gel.
This experiment was not repeated due to time constraints and the lack of rabbit blood
for isolation of lymphocytes. The initial western blotting analysis of cell lysates from
OvHV-2 infected rabbit cells showed that the anti-08 antiserum was recognising
three proteins of 53KDa, 37KDa and 38KDa that were not recognised by the pre-
immune rabbit serum. This suggested that the binding of the serum to these protein
species was specific and that these proteins might represent different forms of the 08
protein.
3.3.4.7 Analysis of Ovine And Bovine Sera For The Presence of Anti-08
Antibodies
Sheep are considered to be the natural host of OvHV-2 and since sheep have been
shown to transmit disease to other susceptible animals, it is thought that the full cycle
of viral replication with production of viral particles must occur in sheep. It has been
shown that adult sheep have antibodies that cross-react with A1HV-1 proteins
(Herring et al., 1989), therefore these antibodies are expected to react with OvHV-2
proteins. Since a major part of the antibody response to EBV is generated against the
envelope glycoprotein gp350 (Thorley-Lawson & Poodry, 1982) and 08 is a
predicted to encode a similar envelope glycoprotein, it was hypothesised that sheep
might develop an antibody response to 08.
In order to test sheep sera for antibodies to 08, the 08 inclusion body prep
was electrophoresed on a 12% PAGE gel with a wide lane in the same way as was
carried out to test rabbit sera for the presence of antibodies (Section 3.3.4.3). The
proteins were then transferred to a PVDF membrane by western blotting. Since sheep
antibodies often display a high degree of non-specific binding, the membrane was
incubated in a blocking solution containing 5% (w/v) non-fat dried milk and 5%
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(v/v) equine serum. This solution was also used for dilution of antibodies. The
membrane was cut into strips and the strips incubated with sera at a concentration of
1/50. The serum samples were taken from three adult sheep (A, B and C), two cattle
that had recovered from malignant catarrhal fever and one normal cow (presumed
not to have antibodies to OvHV-2). As a positive control, one strip was incubated
with a polyclonal rabbit anti-GST antibody.
The strips were incubated with the sera for two hours and with the secondary
and tertiary reagents as described (Section 2.8.4). A band was detected in all samples
at the position of the GST fusion protein, as shown by binding of the anti-GST
antibody (Figure 3.3.4.7), however, since binding was also seen on the sample from
the non-infected cow, this binding was considered to be non-specific. In order to
decrease non-specific antibody binding, a protocol involving the use of Tween 80 to
a concentration of 0.5% and a "high salt" hybridisation and blocking solution as
described in (Section 2.8.4), however this had no effect on the amount of non¬
specific binding. It was hypothesised that sheep may be exposed to only small
amounts of the 08 protein during infection, therefore the antibodies may be of low
titre. Increasing the serum concentration to 1/20 and 1/10 did not however, result in
positive bands on western analysis. It was concluded, therefore that there was no




Figure 3.3.4.7 Western Blotting Analysis of the 08-GST Fusion






















A sample of 08-GST inclusion body preparation electrophoresed
on a 12% SDS-PAGE gel. The proteins were then transferred to a
PVDF membrane by western blotting and the blot cut into strips.
The strips were incubated with primary antibodies, which were
rabbit anti-GST antibody (Anti-GST), serum from three normal
sheep (A, B and C), serum from cow A (recovered MCF case), cow
B (recovered MCF case) and cow C (OvHV-2 negative cow). The
secondary antibody to the bovine or ovine serum was a biotinylated
anti-sheep antibody, whilst the secondary for the anti-GST was an
anti-rabbit-AP antibody. Strips incubated with bovine or ovine sera
were then incubated with a tertiary streptavidin-AP and antibody
binding in all strips was detected using BCIP/NBT solution. The






4.2 Generation of Sequence of the OvHV-2 Genome
4.3 Sequence Analysis of the OvHV-2 Genome





Research into the pathogenesis of OvHV-2 has been hampered by the lack of a tissue
culture system supporting productive replication of the virus. Compared to A1HV-1,
relatively little is known about OvHV-2. At the start of the work the only available
virus sequence was the OvHV-2 ORF49 sequence, derived from screening of an
OvHV-2 expression library (Coulter & Reid, 2002) and the OvHV-2 ORF 75
sequence, which was the first OvHV-2 sequence identified (Bridgen & Reid, 1991).
OvHV-2 infected rabbit and cattle cell lines were available and these had been the
source of all the virus sequence to date. Some OvHV-2 infected cell lines transmitted
disease, however the mechanism of viral persistence in these cell lines was unknown.
The aims of the project were initially to further characterise the OvHV-2 infected cell
lines in terms of viral persistence. This was to be performed as a starting point before
construction of a cosmid library from OvHV-2 infected cell lines, in order to derive
more viral sequence. It was then envisaged that having derived more OvHV-2 viral
sequence, a selected area of the genome of interest would be studied in greater detail.
4.1 OvHV-2 Replication
Cell lines propagated from the tissues of cases of SA-MCF have been shown to
transmit disease and viral DNA with homology to that of A1HV-1 has been identified
in the cell lines. This led to the hypothesis that the cell lines carry the virus OvHV-2.
This work was performed in order to further characterise OvHV-2 infected cell lines
in terms of the amount of virus in the cell lines and the mode of viral persistence.
The copy number of viral genomes in the OvHV-2 infected cells was
determined by Southern blotting and the results show that the cells contain on
average 50 copies of viral genome per cell. This finding was similar to the amount of
virus found in other gammaherpesvirus infected cell lines, as the EBV infected
Burkitt's Fymphoma cell line Raji contains 50 copies of latent viral genome per cell
(Adams & Findahl, 1975) and the MHV-68 infected Sll cell lines contain on
average 40 copies of virus per cell (Usherwood et al., 1996). This work was carried
out in preparation for the construction of a cosmid library from DNA extracted from
OvHV-2 infected cell lines. The finding of an average of 50 copies of viral genomes
per cell meant that the cell lines contained sufficient virus DNA to enable
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construction of a cosmid library, as this had been performed using the DNA of
Turkey Herpesvirus cell lines, which contain similar numbers of viral genomes
(Reilly & Silva, 1993a).
Until this point, little was known about the state of the OvHV-2 viral genome
in OvHV-2 infected cell lines. Although some OvHV-2 infected cell lines transmit
disease (Reid et al., 1983), infectious virus had not been identified in the cell lines,
and the mechanism of viral persistence in the cell lines was not known. It was of
interest to determine if there was evidence of viral replication in the OvHV-2
infected cell lines, as this would suggest that viral particles might be produced.
Gardella gel analysis was used to determine the state of the viral genome in OvHV-2
infected bovine and rabbit cell lines. Gardella gel analysis is an established technique
for the analysis of herpesviral DNA. It has been used for detection of the latent form
of EBV DNA in the peripheral blood cells of healthy individuals (Decker et al.,
1996a) and for detection of KSHV DNA in infected tissues (Decker et al., 1996b).
On analysis of the OvHV-2 infected rabbit cell lines, an obvious smear of
linear DNA was detected, whilst the upper band indicating circular viral DNA was of
lower intensity. On analysis of the OvHV-2 infected bovine cell line BJ/1035, the
upper band of circular DNA was of higher intensity than that seen on analysis of
rabbit cell lines. A lower smear of linear DNA was present but was of very low
intensity. The presence of circular DNA is evidence of episomal viral DNA as is
found in latently infected cells, whereas the presence of linear viral DNA is evidence
of viral DNA replication. The results suggested that a substantial amount of linear
DNA was present in OvHV-2 infected rabbit cells as compared to bovine cells. This
suggested that a sizeable proportion of the OvHV-2 infected rabbit cells analysed
contain replicating viral DNA, although some cells are latently infected. In the
bovine cell line, evidence suggests that cells are predominantly latently infected with
low levels of viral DNA replication.
Once optimised Gardella gel analysis of OvHV-2 infected cell lines was
simple and the results were consistent and reproducible. Use of the control
rhadinovirus infected cell lines SI 1 and BCP-1 reinforced the relevance of the results
from analysis of OvHV-2 infected cell lines. Episomal DNA identified on analysis of
the rabbit and cattle cell lines migrated in a similar manner to episomal DNA from
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the S11 and BCP-1 cell lines. The smear of linear viral DNA found on analysis of the
OvHV-2 rabbit cell lines was similar to that seen on analysis of the MHV-68 infected
cell line Sll, therefore it was concluded that the lower and upper bands seen on
analysis of OvHV-2 infected rabbit cells did represent the linear and circular forms
of the viral genome.
The easily visible smear of linear DNA identified on analysis of OvHV-2
infected rabbit cells is suggestive of a substantial amount of viral replication,
however it gives no indication of the number of cells in which DNA replication is
taking place. The Sll cell line contains up to 20-30% of cells productively infected,
whilst the remainder are latently infected (Usherwood et al., 1996). It is tempting to
suggest that a similar proportion of cells in the BJ/2222 cell line might be
productively infected, however this could only be determined by in situ hybridisation
of the OvHV-2 infected cell lines using probes for genes known to be expressed in
lytic or latent infection. The BCP-1 cell line contains approximately 1% of cells
lytically infected with KSHV. The intensity of the lower band of linear DNA seen on
analysis of OvHV-2 infected bovine cells is similar to that seen on analysis of the
KSHV infected BCP-1 cell line, it may be that a similar proportion of cells in the
OvHV-2 infected bovine cell line contain replicating viral DNA, however further
analysis would be required to determine this.
There is a small possibility that some of the linear viral DNA was produced
by nicking of episomal DNA. Comparison of the OvHV-2 infected cells with the
same cell line treated with antiviral agents such as acyclovir would be required to
prove that this was not the case, however the fact that linear DNA was not detectable
in the same amounts in either the KSHV infected cell lines or in the cattle cell lines,
which were processed in exactly the same way as the rabbit cell lines, suggests that
the linear DNA in the cell lines is not an artefact. The strong evidence of substantial
amounts of linear viral DNA in rabbit cells lines prompted the analysis of these cell
lines for evidence of the expression of lytic cycle genes.
OvHV-2 infected cells were analysed for the presence of lytic viral transcripts
by northern blotting and RT-PCR. The expression of both immediate early viral
genes (ORF 57) and late viral genes (ORF 75) was shown in the OvHV-2 infected
rabbit cell line BJ/2222 by RT-PCR. It was not possible to detect the expression of
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OvHV-2 transcripts by northern analysis and treatment of the rabbit cell line BJ/2222
with TPA did not increase viral gene expression to the level of detection. It was not
possible to perform further analysis on the bovine cell line BJ/1035 as the cell line
died soon after completion of the Gardella gel analysis. Generally the OvHV-2
infected cell lines were short lived and the availability of OvHV-2 infected cell lines
for analysis was a constant constraint.
The expression of both the early gene ORF 57 and the late gene ORF 75 was
evidence that both early and late viral gene expression was taking place in some of
the OvHV-2 infected rabbit cells. Since the PCR primers did not span splice sites,
care was taken to ensure that the products were as a result of PCR amplification of
cDNA and not of contaminating genomic DNA. The samples were incubated with
DNasel before the reverse transcription reactions. A sample of each RNA was used
to set up an RT reaction without enzyme, so that any amplification products from this
reaction would show that the products were as a result of genomic DNA
contamination. Reverse transcription reactions performed using cytoplasmic RNA
were not successful. This was possibly due to the fact that this method of isolation
required the use of phenol : chloroform and contamination of RNA samples with
phenol can affect the reverse transcriptase enzyme, therefore subsequent RT
reactions were performed on RNA extracted by a different method.
The failure to detect expression of lytic cycle genes in OvHV-2 infected cell
by northern analysis suggests that levels of the lytic gene transcripts in the cell lines
were low. This could be because expression of ORF 57 and ORF 75 was low, or that
the transcripts had a very short half life and were not allowed to accumulate in large
amounts. The failure to increase expression of lytic cycle genes in OvHV-2 infected
cell lines to detectable levels is in contrast to KSHV infected cell lines and EBV
infected cell lines, which both show an increase in the proportion of cells undergoing
lytic gene expression by treatment with TPA (Renne et al., 1996b) (Fin et al., 1983).
Some HVS infected rabbit cell lines do not produce infectious virus, however the
expression of lytic transcripts can be increased by treament with TPA (Ablashi et al.,
1985). A HVS infected human T cell line which did not produce infectious virus was
found to increase the expression of transcripts of the transforming protein STP-C on
treatment with TPA, however the expression of lytic transcripts was not increased to
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detectable levels (Fickenscher et al., 1996). It is possible therefore that treatment of
OvHV-2 infected cell lines with TPA had effects on genes other than the lytic
transcripts examined. The probability of detecting viral transcripts by northern
analysis could have been increased by the use of poly A enriched RNA, however this
was not possible at the time because more OvHV-2 infected cells were not available.
Evidence of the expression of both early and late lytic viral genes in OvHV-2
infected rabbit cells suggested that the full lytic cycle might be taking place in some
cells, therefore the cells were examined for the presence of viral particles. It was not
possible to detect viral particles by transmission electron microscopy of fixed
OvHV-2 infected rabbit cells. Cell lysates from the OvHV-2 infected rabbit cell line
BJ/2222 were examined for the presence of viral particles. From these cell lines, a
herpesvirus capsid was visualised. This finding is significant as up until now it has
not been possible to detect the presence of any components of viral particles in
OvHV-2 infected cell lines. EM analysis of cell lysates was carried out as an
alternative method to direct EM of fixed cells, as this method is a way of
concentrating the cell contents. This makes detection of any virus particles more
feasible; therefore the method is particularly suited to cell lines in which only small
numbers of particles were present. The method was the same as that used to visualise
KSHV viral particles in the KSHV infected cell line BC-3 (Arvanitakis et al., 1996).
Although the electron micrograph clearly shows an icosahedral capsid typical
of a herpesvirus, the viral envelope is not obvious and it is possible that the image is
that of a non-enveloped particle. It is not known if this is an artefact of processing, or
if production of fully enveloped viral particles does not occur in OvHV-2 infected
rabbit cells. Although Gardella gel analysis seemed to suggest that substantial
amounts of linear DNA was present in OvHV-2 infected rabbit cell lines, the fact that
it was not possible to detect expression of either ORF 57 or ORF 75 by northern
analysis suggests that expression of lytic cycle genes is low. This might mean that
only a small proportion of cells are undergoing lytic cycle replication and production
of viral particles is low. Since a virus capsid has been visualised but no envelope, it
is also possible that DNA replication and expression of early and late viral genes
occurs, but the viral lytic cycle is not complete and production of mature enveloped
capsids does not occur. The fact that the OvHV-2 infected cells transmit disease,
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however suggests that the virus in the cells does retain the ability to undergo lytic
replication given the right conditions.
4.2 Generation of Sequence of the OvHV-2 Genome
Research into the pathogenesis of OvHV-2 has long been hampered by the lack of a
tissue culture system for growing the virus. This is in contrast to A1HV-1, which can
replicate in tissue culture cells and whose genome has been completely sequenced.
The fact that some OvHV-2 infected cell lines transmit disease suggested that the
complete viral genome was present in these cell lines and that these cell lines might
be a source from which the viral genome could be cloned. The OvHV-2 genome was
predicted to be similar in size to that of A1HV-1, therefore was expected to be
approximately 150kb in size. In order to sequence the OvHV-2 genome, a cosmid
library was constructed using genomic DNA extracted from the OvHV-2 infected
bovine cell line BJ/1035. The library was screened using an OvHV-2 specific probe,
which resulted in the identification of the first virus containing cosmid, named C75.
Walking probes were made based on the sequence at the ends of the virus containing
cosmids and a series of 5 cosmids was identified which spanned most of the viral
genome (Figure 3.2.3.1). At the left hand end of the genome the cosmid C8 extended
into 02. At the right hand end of the genome the cosmid C75 extended to the right of
ORF 09. It was not possible to obtain cosmid clones containing virus sequence to the
right of cosmid C75 or to the left of cosmid C8.
Cosmids were used as cloning vectors due to their large cloning capacity.
Vectors such as bacteriophage vectors are often used for construction of genomic
libraries, as they allow DNA fragments as large as 20kb to be cloned. Cosmid
vectors, however, are an improvement on bacteriophage vectors, in that they can
package inserted DNA of up to 40kb in size and therefore require the screening of a
smaller number of clones to identify the sequence of interest. Cosmid cloning has
been used in the past for genomic walking of eukaryotic DNA (Wahl et al., 1987)
and also in the sequencing of virus genomes. Cosmid cloning was used in the
sequencing of the turkey herpesvirus genome (Reilly & Silva, 1993a). The genome
of KSHV was identified by screening cosmid and phage libraries constructed using
DNA extracted from the KSHV infected cell line BC-1 (Russo et al., 1996). In both
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these examples, the viral DNA genome was cloned along with an excess of cellular
DNA. This illustrates that this approach is a valid way of sequencing viruses that do
not grow well in tissue culture.
The vector SuperCos 1MW had been modified for cloning in HSV. The
cloning site had been leplaced by a synthetic oligonucleotide sequence and the T7
and T3 bacteriophage promoter sequences were no longer present. These sequences
were present so that RNA walking probes could be synthesised against the sequence
of each end of the vector using bacteriophage DNA dependant RNA polymerases.
The lack of these sequences meant that walking probes were instead made by PCR
amplification of known sequence at each end of the cosmid insert. Sequencing of the
ends of the inserted DNA was therefore necessary. This however gave the advantage
that in most cases it confirmed that the new sequence was viral, before using this to
screen the library. False positive clones did prove a problem and probing the library
with the probe C75R amplified from a cosmid DNA template resulted in a false
positive clone which was later shown to be non viral. The problem was thought to
have been caused by the presence of the template cosmid in the probe. Ensuring that
template was removed from the PCR product to be used as a probe solved this
problem. This shows that the presence of sequence such as cosmid in the probe,
which would have homology to all cosmid sequences, can result in the generation of
false positives. The use of RNA probes synthesised by in vitro transcription can also
lead to problems with false positive clones, as all probes have sequence
complementary to cosmid at the 5' end.
This cosmid library generated contained 16,000 transformants. The
estimation of the average copy number of the viral genomes in OvHV-2 infected
cattle cell lines was 50 copies per cell. Assuming two copies of every cellular gene,
this meant that there was on average a 25 fold excess of unique viral sequences over
unique cellular sequences. It was calculated that 13,818 transformants would be
required to have a 99% chance of finding a viral sequence in the library. This meant
that the library should have been representative of each sequence. The fact that
screening the cosmid library resulted in the identification of clones covering a large
proportion of the viral genome indicated that the library was quite comprehensive,
however it was not possible to obtain clones to the right of the C75 clone, or to the
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left of the C8 clone. The BJ/1035 bovine cell DNA was used to construct the cosmid
library because this was shown to contain viral DNA predominantly in the circular
episomal form. Use of circular herpesviral DNA in cosmid cloning has resulted in
the identification of clones spanning the terminal repeats (Andrew Davison, Pesonal
Communication), this type of clone has, however, not been identified in this case.
There could be a number of reasons for the failure to extend the viral
sequence further towards the viral terminal repeat sequences. Bacterial clones
carrying recombinant cosmids grow at different rates and it is possible that a
proportion of clones did not grow well during amplification of the library. The
library was amplified to increase the number of bacteria carrying each transformant.
This is to ensure a stock of cosmid containing bacteria large enough to screen the
library several times. Amplification of cosmid libraries can be performed either by
replica plating and storage of the library on filters at -70°C (Hanahan & Meselson,
1980), or by transduction of the packaged cosmids into bacteria and growing the
bacteria for a few generations in liquid culture. The cosmids were amplified in liquid
culture, as this protocol was supplied with the SuperCos 1 vector.
This method is easier and quicker than replicating the bacteria on filters,
however it can lead to a change in the composition of the library during replication,
as some cosmid containing bacteria grow better in the cultures than others. This is a
problem that would not have been encountered if the library was amplified by replica
plating. It is also possible that the inserted DNA in some clones was unstable.
Recombination between repeated elements as would be found in clones containing
terminal repeat sequence can lead to loss or rearrangement of cloned sequence.
Evidence that some cosmid containing clones were unstable was found on analysis of
C57 cosmid DNA (Section 3.2.1.5) when some cosmid clones seemed to digest to a
disproportionally large amount of vector DNA. This suggested that some bacteria
had lost their inserts whilst growing in culture. If this occurred during amplification
of the cosmid library it would lead to the loss of cosmid clones and the library having
a lower titre than the calculated titre.
Since screening the library using the C75R probe and the A2 probe resulted
in no new clones, alternative methods of extending the virus sequence were required.
It was hypothesised that the virus DNA extracted from the OvHV-2 infected bovine
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cell line contained the full virus sequence, therefore this DNA was used as a source
to extend the viral sequence beyond that obtained by cosmid cloning. DNA extracted
from the OvHV-2 infected bovine cell line BJ/1035 was used as a template for
splinkerette PCR. In the first round of splinkerette PCR, OvHV-2 DNA was digested
with one of 4 restriction enzymes, BamHI, Xbal, Hindlll, or fcoRI and ligated to a
"splinkerette" linker molecule. Splinkerette PCR amplification of the ligated Hindlll
digest using primers designed to extend the sequence from 02 resulted in the
generation of clone splinkl. This clone was 1.2kb in size and extended to the left of
the cosmid clone C8. Sequence analysis of clone splinkl showed that it contained the
remainder of the 02 virus sequence continuing from clone C8. PCR amplification of
the BamHI digested DNA using a primer designed to extend sequence from the new
splinkl sequence resulted in the generation of clone splink2. This clone was 900bp in
size. Sequence analysis showed that although this clone did not contain sequence
homologous to known viral sequences, the sequence overlapped with splinkl.
PCR amplification of the BamHI digested OvHV-2 DNA using a primer
designed to amplify sequence from the right hand end of cosmid C75R resulted in
the 200bp clone splinkC75R. Sequence analysis of SplinkC75R showed that the
sequence overlapped with the end of cosmid C75R, however the sequence did not
have any homology with known virus sequences. Attempts to extend sequence
beyond the splink2 sequence at the left hand end and the splinkC75R sequence at the
right hand end, by splinkerette PCR using the original four OvHV-2 DNA digests
was not successful. Splinkerette PCR was therefore repeated using DNA digested
with the enzymes Sail, ZtasHII, Xmal, Bglll and Nhel. No new virus clones were
obtained using these digests. The technique of splinkerette PCR advanced the known
OvHV-2 sequence approximately 2.1kb at the left hand end of the genome, towards
the terminal repeats and 200bp at the right hand end of the genome. None of the
clones contained terminal repeat sequence, however.
The technique of splinkerette PCR was used because it enabled use of the
OvHV-2 genomic DNA to extend the sequence generated by cosmid cloning. The
use of "splinkerette" linker molecules enabled PCR amplification of stretches of
DNA where sequence information was only available at one end. Splinkerette PCR
was originally used for genome walking (Devon et al., 1995). The vectorette and
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splinkerette methods have been used for the isolation of end fragments of length up
to 3kb from YAC recombinants (Riley et al., 1990) and in PCR walking (Arnold &
Hodgson, 1991).
Splinkerette PCR was used rather than vectorette PCR because the technique
has been modified to minimise amplification from unligated linker molecules. This
was a major cause of non-specific amplification in vectorette PCR. The disadvantage
of using splinkerette PCR for genome walking as compared to cosmid cloning is that
the walking steps taken are much smaller, however since it was estimated that the
remaining sequence to the terminal repeats at each end of the genome may be as little
as lkb this was not a major concern. It was considered that once the sequence of one
terminal repeat unit has been obtained, the number of terminal repeats could then be
estimated by Southern blotting.
This method of cloning is dependant on the existence of the restriction site of
choice within a reasonable distance of the known sequence, such that this sequence
can be amplified by PCR. When new PCR products could not be amplified from the
original four DNA digests used (BamHl, EcoRl, Hindlll, Xbal), it was hypothesised
that this was because the sequence to be amplified was GC rich terminal repeat
sequence and did not contain many restriction sites for the enzymes used to digest
the genomic DNA. The five additional enzymes used to digest the OvHV-2 genomic
DNA (fissHII, NheI, Xmal, Sail, Bglll) were used because their recognition sites
were GC rich and therefore it was expected that they might cut in the terminal repeat
sequence. It was considered that the most likely reason that no products were
generated by PCR amplification using these enzymes was a lack of restriction sites
close enough to the known sequence.
The PCR amplification was carried out using Taq DNA polymerase and it is
possible that the distance to the restriction sites was too great for amplification using
this enzyme, therefore amplification using an enzyme designed for the amplification
of long templates, such as the Expand Long Template PCR System (Roche) might
have resulted in the generation of new products. It is not possible to use positive
controls for this technique of PCR, therefore it was not possible to optimise the
conditions for use of the primers. The primers were designed to have similar
annealing temperatures and repetitive sequence was avoided when designing the
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primers, to avoid the formation of primer dimers. The PCR program used was a
combined "hotstart" and "touchdown" program, as used by (Devon et al., 1995). The
"hotstart" part of the program was designed to reduce mis-priming at the start of the
PCR cycle and has been shown to improve the yield of in amplification of low copy
number templates (Chou et al., 1992). The touchdown part of the program was
designed to prevent spurious priming during amplification and minimise the need to
optimise PCR reactions (Don et al., 1991). This PCR program had been successful in
the first two rounds of PCR; therefore the use of a long PCR enzyme and digests
with different restriction enzymes may have been a way to obtain further products.
The availability of OvHV-2 genomic DNA from the BJ/1035 cattle cell line was
limited, however, as the cell line had died, therefore this was a further constraint.
The use of splinkerette PCR advanced the OvHV-2 sequence approximately
2.1kb at the left hand end of the genome and 200bp at the right hand end of the
genome. Failure to advance further and the lack of OvHV-2 DNA for further enzyme
digestions prompted the use of a different approach to extend the sequence. It has
been shown by Gardella gel analysis that the viral DNA in the OvHV-2 infected
bovine cell line BJ/1035 was predominantly in the circular episomal configuration
(Section 3.1.2), therefore long distance PCR was used to try to extend the sequence
over the terminal repeats from the right hand end of the genome to the left. The PCR
reactions were performed using the Expand Long Template PCR system. Initial PCR
amplification using an annealing temperature of 65°C and an extension time
extending from 20 to 25 minutes did not result in the generation of any PCR product.
Repeat of this PCR reaction using internal primers, a reduced annealing temperature
of 62°C, an increased extension of up to 30 minutes and an increased magnesium
concentration, resulted in a high molecular weight smear of PCR product. A repeat of
the PCR reaction again using internal primers resulted in a number of bands, the
largest of which was approximately 1.3kb in size. This 1.3kb band and a 650bp band
were cloned into a TA vector and sequenced, however the sequence did not overlap
with existing virus sequence and had homology to cellular DNA sequences. It was




Gammaherpesvirus genomes contain variable numbers of terminal repeat
sequences. HVS contains 30 - 35 copies of a 1.5kb terminal repeat sequence
(Albrecht et al., 1992a) and A1HV-1 contains 20 - 25 copies of a repeated sequence
of approximately l.lkb. It was estimated from the layout of the A1HV-1 genome that
the distance from the known sequence of OvHV-2 into the terminal repeat sequence
may have been less than lkb at each end of the genome. The total distance over the
terminal repeats may therefore have been from 25 - 30kb. It was anticipated that the
l.lkb and 650bp products were too small to contain products of a PCR amplification
reaction spanning the terminal repeats, however it was hypothesised that it may have
been possible to obtain short products if a viral genome containing only one terminal
repeat sequence was amplified.
It was known that PCR amplification of genomic DNA over 12kb and
especially over 20kb requires extensive optimisation in terms of template quality,
magnesium concentration, denaturation conditions and nucleotide concentration. The
elongation times used should have been adequate, as it was recommended by the
manufacturer of the Expand Long Template PCR System that an elongation time of
20 minutes should have been adequate to amplify up to 30kb, whilst an extension
time of 30 minutes was recommended to be adequate to amplify up to 40kb.
Template quality is very important in long distance PCR. The high molecular weight
DNA used as a template for PCR amplification was analysed by gel electrophoresis
and was of high quality, however high molecular weight DNA does shear easily and
sheared template may have been a reason why it was not possible to amplify over the
terminal repeats.
Increasing the magnesium concentration in repeats of first round PCR did not
result in a visible PCR product and these PCR reactions were not repeated using
internal primers due to time constraints. The first round of PCR amplification must
have resulted in the generation of a small amount of non-specific PCR amplification
products. The reduction in annealing temperature may have improved the conditions
for their amplification in the second round of PCR using internal primers. If time had
allowed, further attempts at long distance PCR would have been carried out using a
more logical optimisation protocol, since using a different PCR protocol for PCR
amplification of the original reaction meant that it was unclear if repetition using the
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same conditions as in the first round would have resulted in the production of a
specific amplification product.
A number of approaches have been used for generation of new OvHV-2 virus
sequence, however it has not been possible to complete the virus sequence up to the
viral terminal repeats. Further attempts at completing the virus sequence might
involve re-optimisation of PCR across the viral terminal repeats, or repeat of
splinkerette PCR using different enzymes for digestion of the OvHV-2 genomic
DNA. Another approach would be to use a method that does not rely on the existence
of the correct restriction site. This could be possible if PCR amplification of linear
viral DNA was performed. This would require the use of blunt ended ligation of
splinkerette linker molecules to linear OvHV-2 genomic DNA which might be
expected to be found in OvHV-2 infected rabbit cell lines.
4.3 Sequence Analysis of The OvHV-2 Genome
It was shown by cross hybridisation with A1HV-1 DNA that the agent causing
SA-MCF is highly related to A1HV-1 (Bridgen & Reid, 1991). Comparison of the
recently derived sequence of OvHV-2 glycoprotein B (gB) with the gB sequence of
other herpesviruses also suggested that OvHV-2 and A1HV-1 were related, but
distinct herpesviruses (Dunowska et al., 2001). Analysis of the OvHV-2 sequence
cloned from cosmids has confirmed these assumptions. The total OvHV-2 sequence
cloned was 127,800bp. The conserved open reading frames are arranged collinear to
HVS, in a similar manner to A1HV-1. The fact that many of the A1HV-1 "A" genes,
which were considered to be unique to A1HV-1 are also conserved in OvHV-2
confirms the relatedness of the two viruses. Since the full sequence of A1HV-1 was
published, sequence from the porcine herpesvirus PLHV-1 has also been published
(Goltz et al., 2002). This virus also contains homologues of the A1HV-1 "A" genes,
indicating that these three viruses are highly related. All the OvFIV-2 ORFs with a
homologue in A1HV-1 show the greatest similarity to A1HV-1, however ORF9
(DNA polymerase) shows highest homology with ORF9 of Caprine herpesvirus-2
(CprHV-2) (Li et al., 2001b). This is the only open reading frame of CprHV-2 that




The open reading frame 02 is similar to A2 of A1HV-1 and both ORFs are
predicted to be spliced. The 02 gene contains a leucine zipper motif, therefore may
function as a transcriptional regulator. The 03.5 gene is located in the same position
as the A1HV-1 gene A4. Both ORFs are predicted to contain signal sequences,
however the ORFs are not homologous and the possible function is unknown. The
block of ORFs from 0RF6 to 9 are all highly conserved and encode genes involved
in viral DNA replication. All the ORFs involved in viral DNA replication are
generally highly conserved, especially among rhadinoviruses. Many of the capsid
and tegument proteins are also highly conserved, for example the capsid protein vp23
encoded by ORF 26 shares 83% amino acid identity with A1HV-1 and 48% with
HVS. The gB and terminase genes are highly conserved and are used for
phylogenetic analysis of herpesviruses.
In common with A1HV-1 and PLHV-1 the genome of OvHV-2 contains a gap
between ORF 11 and 17, which does not contain any predicted open reading frames.
This region in KSHV and HVS contains homologues of cellular genes. In KSHV it
contains cellular homologues such as an IL-6 homologue and homologues of the
macrophage inhibitory proteins MIPI and II. In HVS 0RF14 encodes a putative
transactivator related in sequence to the Mis genes of mice (Albrecht et al., 1992a)
and ORF 15 is related to the complement regulatory protein CD59. The area between
ORF 69 and ORF 73 also contains no open reading frames in A1HV-1, however in
OvHV-2 in contains the predicted open reading frame 08.5. This ORF is predicted to
encode a 390 amino acid protein, but its possible function is unknown. Non-coding
areas in non-repetitive regions of herpesvirus genomes are unusual, however they are
also found in the genome of EHV-2 (Telford et al., 1995). Large regions between
ORFs 9 and E5, ORFs 13 and 17 and the region between the IL-10 homologue E7
and the right hand end of the genome contain relatively few genes. The genome of
OvHV-2 contains two putative tegument proteins at ORF 75 and ORF 3, which are
homologous to formylglycineamide ribotide amidotranferase (FGARAT), an enzyme
catalysing the fourth step in the de-novo synthesis of purine bases (Barnes et al.,
1994). FGARAT homologues are present at these positions in A1HV-1, HVS,
BoHV-4 and EHV-2, however EBV and KSHV encode just one copy.
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Similarly to other gammaherpesviruses, OvHV-2 contains homologues to
cellular genes. ORF 02.5 is not present in A1HV-1 and is predicted to encode an
IL-10 homologue. The other gammaherpesviruses encoding IL-10 homologues are
EBV (BCRF1) (Vieira et al., 1991) and EHV-2 (E7) (Telford et al., 1995). IL-10
homologues are also found in other DNA viruses such as ORF virus (Fleming et al.,
1997) and in other herpesviruses such as human cytomegalovirus (Kotenko et al.,
2000) and rhesus cytomegalovirus (Lockridge et al., 2000). IL-10 was first known as
cytokine synthesis inhibitory factor (CSIF). Cellular IL-10 has both
immunosuppressive and immunostimulatory activities (reviewed by Moore et al.,
2001). It inhibits the synthesis of pro-inflammatory cytokines such as TNFa, IL-1B,
IFNy, GM-CSF and IL-6 (Fiorentino et al., 1991) from monocytes and macrophages
and also inhibits expression of MHC class II molecules on monocytes. This therefore
inhibits antigen presentation by these cells. IL-10 can act as a stimulatory factor for
immature and mature thymocytes, mast cells and B cells (Ding et al., 2000). The
IL-10 homologue of EBV is 90% homologous to human IL-10 and is thought to have
been acquired from the host. EBV IL-10 acts as a predominantly immunosuppressive
cytokine, inhibiting cytokine synthesis by monocytes and ieducing antigen specific
human T cell proliferation by reducing expression of MHC class II (de Waal Malefyt
et al., 1991).
The translated sequence of 02.5 is homologous to both viral and cellular
IL-10 protein sequences (Figure 3.2.3.4), however the sequence seems more
divergent from cellular IL-10 sequences than either the EBV IL-10 homologue or the
ORF IL-10 sequence. The sequence has only 44% homology with the Ovine cellular
IL-10 sequence. This is in contrast to the EBV IL-10, which as mentioned is 90%
homologous to the human cellular sequence. ORF IL-10 is 80% homologous to ovine
IL-10 (Fleming et al., 1997). This IL-10 homologue has retained some of the
immunostimulatory activities of cellular IL-10 and can induce proliferation of both
thymocytes and mast cells. The HCMV IL-10 homologue is only 27% homologous
to cellular IL-10 sequences however it has been shown to have immunosuppressive
activity (Spencer et al., 2002). The functional activity of IL-10 proteins is localised
to specific regions of the protein (Gesser et al., 1997) and the immunostimulatory
activity has been localised to a single amino acid (Ding et al., 2000). The differences
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in activity and homology of viral IL-10 molecules as compared to host 1L-10 show
how the sequences have diverged over time in response to the viral requirements in
the host.
Cellular IL-10 genes contain four introns. The OvHV-2 IL-10 is predicted to
be spliced and contains 5 predicted exons, in a similar way to cellular sequences.
This is in contrast to EBV IL-10, which is not spliced. The predicted splice sites in
the OvHV-2 IL-10 homologue are in the same positions as in human IL-10,
indicating that these splice sites may be used in vivo. It will be of great interest to
investigate if these splice sites are used, as this IL-10 homologue would be the only
viral IL-10 homologue retaining the intron-exon structure of the cellular gene. The
IL-10 homologues of both human and rhesus cytomegalovirus also contain introns
(Ligure 4.1). The HCMV IL-10 contains two introns, however there is no intron
between exons 2 and 3 or between exons 4 and 5. The rhCMV IL-10 contains three
introns. The only difference from the splicing arrangement of cellular IL-10 is that
there is no intron between exons 2 and 3. It was suggested by Lockridge et al.,
(2000) that intron-exon arrangement of the CMV IL-10 homologues results from the
acquisition of a cellular IL-10 gene by a progenitor CMV followed by sequence
variation and loss of introns during speciation. This could suggest that the OvHV-2
IL-10 is a relatively recent acquisition and that introns may be lost in time. The
OvHV-2 IL-10 homologue, if functional, could play an important role in aiding
persistence of OvHV-2 in the host, possibly by reduction in the host inflammatory
response and reduction in presentation of OvHV-2 antigens to the host by down
regulation of MHC class II expression. It was observed by Schock et al., (1998) that
OvHV-2 infected bovine cell lines express IL-10. RT-PCR analysis of these cell lines
using primers specific for OvHV-2 IL-10 would be necessary to determine of the cell
lines express viral IL-10.
The genome of OvHV-2 encodes two bcl-2 homologues, located at 04.5 and
09. The ORE 04.5 has also been recently identified in the same position in A1HV-1,
although it was not identified in the original complete sequence. The ORE is
homologous to E4 of EHV-2, E4 of PLHV-l(Goltz et al., 2002) and BALL1 of EBV
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IL-10 1 I 2 I 3 I 4
The intron-exon structures of the viral IL-10 homologues of Simian
cytomegalovirus (CMV), human cytomegalovirus (HCMV), Epstein-
Barr virus (EBV) and OvHV-2 are shown as compared to human
cellular IL-10 (cIL-10). The exons are shown as coloured boxes and
the exons numbered 1 to 5. The introns are shown as lines joining
the exons together. Cellular IL-10 contains 5 exons, whilst in simian
CMV IL-10, exons 2 and 3 are joined together. In HCMV IL-10
exons 2 and 3, and exons 4 and 5 are joined together. The intron-




(Bellows et al., 2002). The 09 gene shares 50% amino acid identity with A9 of
A1HV-1 and is homologous to a number of cellular bcl-2 sequences. All
gammaherpesviruses sequenced so far encode viral bcl-2 homologues, including
HVS (ORF 16), KSHV (ORF 16), MHV-68 (Mil) and BoHV-4 (ORF 16). The bcl-
2 homologues of HVS (Nava et al., 1997), KSHV (Cheng et al., 1997) and MHV-68
(Roy et al., 2000) have been shown to be functional and it is thought that bcl-2
homologues are therefore important to the viral life cycle. EBV encodes two bcl-2
homologues, encoded by BHRF1 and BAFF1.
BHRF1 of EBV is an early lytic cycle gene that inhibits apoptosis induced by
a variety of stimuli and it is thought that it may prevent cell death during viral
replication (Henderson et al., 1993). BALF1 has been found to lack anti-apoptotic
function, but acts to negatively regulate the EBV anti-apoptotic protein BHRF1
(Bellows et al., 2002). Bcl-2 homologues are defined by the presence of one or more
bcl-2 homology (BH) domains as well as a C terminal hydrophobic domain.
ClustalW analysis showed that 04.5 contains conserved BH domains, confirming
this protein as a bcl-2 homologue. The divergence of the non-primate BALF1
proteins from the primate proteins was illustrated by ClustalW analysis and probably
reflects differences in the host. It is not known if the bcl-2 homologues of OvHV-2
are functional. It is possible, however that the 04.5 gene of OvHV-2 might
negatively regulate the activity of the bcl-2 homologue 09 in the same way that
BALF1 of EBV negatively regulates the activity of BHRF1.
05 encodes a putative G protein-coupled receptor protein and is homologous
to A5 of A1HV-1, E6 of PLHV-1 and to E6 of EHV-2. The E6 gene of EHV-2 is the
third putative G protein-coupled receptor protein in EHV-2. Although it has seven
membrane spanning domains and sequence motifs characteristic of G protein
coupled receptor, it does not have high homology to other G protein coupled
receptors. No positional homologues of 05 are found in HVS or in KSHV, although
G protein-coupled receptor homologues are found in these viruses at ORF 74.
The ORF 74 gene of HVS encodes a functional IL8 receptor (Ahuja &
Murphy, 1993) and similarly, the ORF 74 gene of KSHV binds a range of
chemokines and has been shown to induce cell proliferation (Arvanitakis et al.,
1997). The KSHV ORF 74 gene also exhibits transforming activity in 3T3 cells and
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is tumourigenic in nude mice, therefore it is thought to be important in KSHV
pathogenesis and oncogenesis. GPCR homologues are therefore thought to be
important in induction of host cell proliferation by gammaherpesviruses. The E6
gene of PLHV-1 was expressed in the lymph nodes of pigs with post transplantation
lymphoproliferative disease (Goltz et al., 2002), therefore the gene could be of
importance in the pathogenesis of this disease. The 05 ORF of OvHV-2 might
therefore be of importance in the induction of the proliferation of LCLs in culture,
and in the induction of lymphoproliferation in vivo as is found in MCF.
The arrangement of the genes 06, 07 and 08 is the same as in A1HV-1. The
genes A6 and A7 have also been identified in the genome of PFHV-1. 06 of OvHV-
2 is predicted to be spliced and encodes three exons. It has been shown that A6 of
PFHV-1 is expressed as a spliced transcript in the same way as is predicted for 06.
The arrangement of this region is similar in EBV and the ORFs 07 and 08 are in an
analogous position to the EBV gene BFFF1, which encodes the envelope
glycoprotein gp350 (Hummel et al., 1984). ORF 07 encodes a putative signal
peptide, whilst 08 is predicted to encode a glycoprotein. The 07 and 08 ORFs are
predicted to be spliced together to form a complete membrane glycoprotein similar to
gp350. In a similar function to gp350, the 07/08 protein may act as a receptor for
OvHV-2 viral entry into host cells.
The 03 open reading frame encodes a semaphorin homologue, as does A3 of
A1HV-1 (Ensser & Fleckenstein, 1995). Semaphorins are a large family of secreted
and transmembrane signalling proteins that regulate axonal guidance in the
developing nervous system (Goshima et al., 2002). Semaphorins are also of possible
importance in the immune system, as the transmembrane protein CD 100 is a class 4
semaphorin expressed by T and B lymphocytes, NK cell, monocytes, and
macrophages. CD 100 is thought to be involved in B cell development and in T cell
activation. Other viruses such as the pox viruses vaccinia virus (Comeau et al., 1998)
and fowlpox (Afonso et al., 2000) also encode semaphorin homologues. The
vaccinia virus semaphorin homologue A39R binds a receptor found on lymphocytes
and induces cytokine production and intracellular adhesion molecule-1 (ICAM-1)
up-regulation in monocytes. 03 is homologous to both viral and cellular semaphorins
and could have a role in host immune regulation by OvHV-2.
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The sequence of OvHV-2 is similar to that of A1HV-1, reflecting the
similarities in the disease caused by the two viruses and the fact that although the
natural host of the viruses differs, both OvHV-2 and A1HV-1 can cause malignant
catarrhal fever in the same susceptible hosts. OvHV-2 contains a number of genes
that may be important in disease pathogenesis, including those that are included in
the genome of A1HV-1 (and some in PLHV-1) such as the semaphorin homologue
encoded by ORF 03, the two bcl-2 homologues encoded by ORF 04.5 and ORF 09
and the potential G protein-coupled receptor encoded by ORF 05. These indicate
that in common with other rhadinoviruses the induction of cell proliferation, the
promotion of infected cell survival and evasion of the host immune response may be
important in the pathogenesis of OvHV-2 infection.
The inclusion of a viral IF-10 homologue potentially provides OvHV-2 with
another way of avoiding the host immune response in early viral replication. It
remains to be seen however, if these potentially useful genes are functional in
OvHV-2 in vivo. It would be interesting to investigate the possible function of the yet
uncharacterised genes 03.5 and 08.5, which are unique to OvHV-2 and therefore
also of possible importance in viral pathogenesis. The sequencing of this large
portion of the OvHV-2 genome provides a starting point for further studies on the
pathogenesis of OvHV-2. The availability of the sequence means that antibodies can
be raised to viral proteins to study the cellular localisation and possible function and
the completion of the sequence would provide a starting point for the production of
recombinant viruses to enable the study disease pathogenesis in the in vivo rabbit
model system.
4.4 Characterisation of the 07 and 08 open reading frames
4.4.1 Analysis of The Expression of 07/08 in OvHV-2 Infected Rabbit
LCLs
The open reading frames 07 and 08 were identified close to the centre of the
OvHV-2 genome, in a position analogous to that of gp350/220 of EBV. Gp350/220
functions as a receptor for EBV entry into host cells and it was hypothesised that 07
and 08 might have a similar function in OvHV-2. Work was undertaken to further
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characterise the expression of 07 and 08 in OvHV-2 infected cell lines, in order to
gain an insight into the possible function of 07 and 08. It was hypothesised that 07
and 08 might be spliced together to form domains of one glycoprotein, therefore
initial experiments aimed to determine if this was the case. The cellular localisation
of 07 and 08 were also studied using an anti-08 antibody raised in rabbits, and
using an anti-haemagglutinin antibody to study expression of a haemagglutinin
epitope tagged 07/08 construct.
Sequence analysis of the 07/08 region was performed in order to predict the
basic properties of the 07/08 product as a starting point for experimental analysis.
Comparison of the translated sequence with other protein sequences showed that the
07 and 08 proteins had greatest homology with A7 and A8 of A1HV-1, however the
sequence also had homology with A7 and A8 of the porcine gammaherpesvirus
PLHV-1, showing that these three viruses are highly related. The areas of homology
with A7 and A8 were located in distinct blocks, suggesting these areas might be
important functionally. The predicted 07 open reading frame was preceded by two
possible TATA sequences, but no putative polyadenylation sites were identified. The
predicted 08 open reading frame was not preceded by any putative promoter
sequences, however a potential polyadenylation signal was identified downstream of
the open reading frame. This suggested that the 07 and 08 open reading frames
might be spliced together and expressed on the same transcript. The predicted 07
and 08 open reading frames were not in frame with each other. In addition, the end
of the 08 sequence was not in frame with the start of 08, therefore splicing would be
required for an 07/08 protein to be expressed from these open reading frames.
Analysis of the sequence identified the presence of multiple potential splice sites in
the 07 and 08 sequence, some of which could be used to splice the sequences
together.
The 07 and 08 translated sequences contained potential N and O
glycosylation sites. Hydropathicity analysis revealed a predicted hydrophobic
domain in the N terminal region of the 07 protein and on the C terminal region of the
08 protein. The 07 protein also contained a predicted signal cleavage site. The
presence of a putative signal sequence on the N terminus of 07 and a putative
membrane anchor sequence on the C terminus of 08 suggested that the two ORFs
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might be domains of one virion glycoprotein. It was hypothesised therefore from this
analysis that the 07 and 08 ORFs formed separate domains of a glycoprotein. The
predicted 07/08 glycoprotein contained an N terminal signal sequence, a C terminal
membrane anchoring sequence and glycosylated 08 ectodomain. The ectodomain
also contained proline, serine and threonine rich regions.
The predicted features of the 07/08 gene product are those of a type I virion
glycoprotein. A glycoprotein gene is present in this position in all rhadinovirus
genomes sequenced so far. All encode a hydrophobic signal sequence, a serine and
threonine rich ectodomain, a hydrophobic membrane anchor and a short cytoplasmic
tail. The open reading frame of gp350 is spliced and the protein gp220 is expressed
in the same frame as gp350. The KSHV equivalent gene, K8.1 is also expressed as
two differentially spliced transcripts termed K8.1a and K8.18. The transcripts share
the same splice donor but employ different splice acceptor sites.
The predicted features of 07/08 were used as a basis for experimental work
to further characterise the open reading frames. Since the 07 and 08 open reading
frames were predicted to be expressed on the same transcript and multiple ways of
splicing of the transcript were predicted, the expression of 07 and 08 encoding
transcripts was analysed. Expression of the RNA encoding the putative 07/08
glycoprotein in OvHV-2 infected rabbit cell lines was analysed by northern blotting.
Northern analysis of total RNA was performed using an OvHV-2 08 probe,
expression of an 08 transcript was not detectable in the cell lines by northern
analysis and treatment of the OvHV-2 infected rabbit cell lines with sodium butyrate
did not increase expression to the level of detection. Probing the membrane with a
probe for the housekeeping gene GAPDH showed that this transcript was easily
detectable. Northern analysis of poly A RNA extracted from an OvHV-2 infected
rabbit cell line was performed, however it was still not possible to detect expression
of 08. It was however possible to detect expression of 08 in RNA extracted from a
cell line transfected with a plasmid encoding 07 and 08, which was analysed
alongside the BJ/880 RNA as a positive control.
The inclusion of positive controls in the northern analysis showed that the
failure to detect expression of 08 by northern analysis was because levels of 08
transcripts in the OvHV-2 infected cell lines were low and not because there was no
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RNA on the membrane. It may be that levels of transcripts were low because
expression was low, or because the transcripts were unstable and were rapidly
degraded once produced. Sodium butyrate is very efficient at increasing viral lytic
gene expression in KSHV, however the fact that this did not have any detectable
effect in OvHV-2 infected rabbit cell lines suggests that removal of transcriptional
repression by chromatin condensation is not sufficient to increase expression of lytic
cycle genes to the level of detection.
The low levels of 08 transcripts in OvHV-2 infected rabbit cells suggested
that more sensitive methods of detection of the transcripts were required; therefore
RT-PCR analysis of the expression of 07 and 08 was performed. The primers used
for PCR amplification were designed to amplify the area between the predicted start
of the 07 open reading frame and the predicted end of the 08 open reading frame. It
was hypothesised that PCR amplification of the area between these two primers
would be successful if the 07 and 08 open reading frames were spliced together as
predicted. This region was defined as the "full length" 07/08 RT-PCR product.
It was not possible to detect the full length 07/08 RT-PCR product by
analysis of total RNA extracted from the OvHV-2 infected rabbit cell line BJ/880.
RT-PCR analysis of the 07/08 region using primers designed to amplify smaller
defined areas of 07 and 08 confirmed expression of all five regions of 07 and 08
amplified. Two of the primer pairs spanned regions predicted to be spliced, these
were the region from 07 to 08 and the region at the end of 08. The RT-PCR product
from amplification of the region from 07 to 08 was not easily detectable by agarose
gel electrophoresis. Southern analysis of this transcript using the cosmid C57 as a
probe confirmed the size of this RT-PCR product and the lack of product in the
control sample that omitted reverse transcriptase enzyme. The RT-PCR products
were the same length as RT-PCR products produced by analysis of genomic DNA.
This meant that there was no evidence of splicing of the 07/08 RNA. RT-PCR
analysis of poly A RNA extracted from an OvHV-2 infected rabbit cell line
identified expression of the 07/08 RNA as a full-length transcript, however the size
of this RT-PCR product was the same as the product from amplification of genomic
DNA. This suggested that the transcript was not spliced.
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The RT-PCR product spanning the area from the 07 ORF to the 08 ORF was
difficult to detect compared to PCR products spanning other regions of 07 and 08,
this may be because the PCR reaction was inefficient. The fact that a product was
detected however, was evidence that 07 and 08 are expressed on the same RNA
transcript. The detection of expression of the full length cDNA encoding 07 and 08
by analysis of poly A RNA was further evidence that 07 and 08 are expressed on
the same mRNA. In both cases the cDNAs detected were of the same length as
product from PCR amplification of positive control genomic DNA, therefore there
was a possibility that the products were a result of contamination of the RNA
samples with genomic DNA. This is unlikely however, as RNA samples were treated
with DNasel before analysis and control RNA samples without RT enzyme used for
PCR amplification did not result in the amplification of any PCR product.
Sequencing of the full length RT-PCR product resulting from amplification of
poly A RNA would have confirmed that this cDNA did encode 07 and 08, however
this was not possible as attempts to clone this cDNA into a sequencing vector were
not successful. The amplification of this product was however reproducible and a
positive control of genomic DNA resulted in the same product under the same
conditions. This suggests that the product is likely to be the correct 07/08 product
and not a spurious PCR product. This work has provided two lines of evidence that
the 07 and 08 open reading frames are expressed on the same transcript, however
there was no evidence that the transcript was spliced in the OvHV-2 infected rabbit
cell lines. Low levels of expression of the 07/08 transcript made analysis in this cell
line difficult and it is possible that spliced mRNAs encoding and 07/08 protein are
produced, but were below detectable levels.
4.4.2 Expression of 07/08 RNA In Transfected Cell Lines
The analysis of 07/08 expression in OvHV-2 infected rabbit cell lines was made
difficult by the low levels of expression of 07 and 08 in these cell lines. In order to
increase expression of 07 and 08, two different expression constructs containing a
haemagglutinin (HA) tagged 07/08 under the control of a CMV promoter were
transfected into mammalian cell lines. A HA tagged expression construct of 07 and
08 was made because commercially available antibodies could be used to detect
expression of a haemagglutinin epitope tagged protein.
260
CHAPTER 4 DISCUSSION
Transfection of the 07/08 construct pVR07/8HA into HEK293 cells resulted
in the expression of 07/08 RNA transcripts that were detectable by northern
analysis. RNA species of size approximately 2.2kb, 2.4kb and 3kb were observed.
RT-PCR analysis of the RNA resulted in a major band of approximate size 2.2kb, a
product of size 3kb and a number of smaller products. Cloning of the RT-PCR
product into a TA vector for sequencing resulted in the identification of two different
spliced 07/08 cDNAs. The cDNA 07/8-293.11 contained one splice from within the
08 ORF. This splicing pattern meant that the beginning and end of the 08 protein
were in frame, however there were stop codons in the cDNA between the predicted
07 and 08 open reading frames.
The cDNA 07/8-293.6 contained a splice within the 08 ORF. This used the
same 3' splice acceptor site as seen in 07/8-293.11, however an alternative splice
donor site 129 bp 3' to the site used in 07/8-293.11 was used. A splice was also seen
within the 07 ORF and a splice in the area between the predicted 07 and 08 open
reading frames. Similarly to 07/8-293.11, this cDNA contained stop codons between
the 07 and 08 open reading frames, however 08 open reading frame was spliced
such that the spliced open reading frame was maintained and did not contain stop
codons. None of the cDNAs sequenced seemed to have the potential to encode an
07/08 protein due to the presence of translational stop signals between the 07 and
08 sequences.
It was hypothesised that there could be a number of reasons for incorrect
splicing of the 07/08 construct. The vector pVR1255 contained a CMV intron A
sequence, which has been shown to increase expression of cloned genes (Huang &
Gorman, 1990, Xu et al., 2001). It was suspected however that the intron A sequence
in the vector pVR1255 might affect splicing, therefore the construct was cloned into
the vector pcDNA3.1 Myc-His. This vector directed expression under the control of a
CMV promoter, however it did not contain intron sequences. This construct was used
for all subsequent transfections. It was also hypothesised that splicing of the 07/08
construct could be regulated by cell-type specific factors. Cell type specific
regulation of splicing is well documented in the regulation of the expression of
cellular genes (Xu et al., 2002), such as the gene encoding the lymphocyte protein
CD45 (Virts & Raschke, 2001) and is found in expression of the HCMV immediate
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early gene region (Kerry et al., 1995). In order to address the possibility of tissue
specific splicing, the construct pcDNA07/8HA was transfected into the mouse B cell
line A20. This cell line was chosen as OvHV-2 has been shown to infect
lymphocytes and has been suggested to infect B lymphocytes in sheep (Baxter et al.,
1997). RT-PCR analysis of RNA extracted from transfected A20 cells resulted in
major RT-PCR products of the same size of 2.2kb. Since this was the same size as
the products identified on analysis of transfected HEK293 cells, it was concluded
that additional splicing to that found in HEK293 cells had not taken place and that
splicing of the 07/08 construct was still not correct for expression of an 07/08
protein. This result suggests that B lymphocyte cell specific factors are not required
for splicing of the 07/08 construct. The question of the possibility of cell type
specific splicing may not have been completely addressed by this experiment
however, as the target cell of OvHV-2 has not been definitively proved. It has been
shown that for A1HV-1 in rabbits T lymphocytes are infected (Mushi & Rurangirwa,
1981, Rurangirwa & Mushi, 1982), and it has also been suggested that the target cell
for OvHV-2 is the large granular lymphocyte (Reid et al., 1984). In order to
completely address this question transfection of T lymphocytes with the 07/08
construct would be necessary.
It was also hypothesised that species-specific factors may be involved in the
correct splicing of the 07/08 construct. Species-specific control of splicing is not
well documented in control of viral gene expression, but is seen in cellular genes
such as p53 (Laverdiere et al., 2000). It is also found in expression of the gene
encoding ATP1 IB, a P-type ATPase (Halleck et al., 2002). OvHV-2 is not known to
infect human or murine cells, therefore in order to address the possibility of species
specific splicing, the MDBK cell line was transfected.
Transfection of the 07/08 construct pcDNA07/8HA into MDBK cells
resulted in the expression of 07/08 RNA which was detected by northern analysis as
one RNA species of size approximately 2.4kb. RT-PCR analysis of the RNA resulted
in a large product of size approximately 2.2kb and several smaller products. Cloning
and sequencing of the 2.2kb band identified two different cDNAs that were both
spliced. MDBK4, 6 and 12 were the same sequence as the cDNA 07/8-293.11,
containing the same large splice within the 08 ORF. MDBK3 contained the same
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splice within 08 as MDBK4, 6 and 12. This cDNA also was spliced at the end of 07.
The splice donor site was located close to the end of the predicted 07 open reading
frame and the splice acceptor site was in the region between 07 and 08. These two
spliced cDNAs also resulted in 07/08 open reading frames containing stop codons.
The first splice donor at position 42 and the second splice acceptor at position 466,
are used as splice donor and acceptors in the clone 07/8-293.6. It is possible that
splice pattern observed in 07/8-293.6 is an intermediate found before the complete
splice from 42 to 466 found in MDBK3.
Similarly to the cDNAs identified in HEK293 cells, none of the cDNAs
identified from transfection of MDBK cells represented RNA transcripts that could
be translated into a complete 07/08 protein, due to the presence of translational stop
codons between 07 and 08. This suggested that bovine cell specific factors were not
required for splicing of the 07/08 construct. The transcripts expressed in MDBK
cells did appear different than those found in transfected HEK293 cells, as no RNA
species corresponding to the length of an unspliced transcript was found in MDBK
cells, whereas in HEK293 cells, transcripts of varying sizes up to approximately 3kb
in size were identified. It may be therefore that splicing of the transcript was more
efficient in MDBK cells and a higher proportion of transcripts are spliced.
The fact that transcripts encoding both 07 and 08 could be identified in
transfected cell lines is evidence that the 07 and 08 sequences are expressed from
the same transcript in this system, however the results shown by the splicing patterns
are less conclusive. Transfections into two different cell types using two different
expression constructs resulted in the identification of cDNAs with the same splicing
pattern in 08. The intronic sequence spliced from 08 in the two different splice
variants was closely correlated with the area of 08 that was not homologous to A8.
This suggested that the conserved sequence is functionally important, and the same
region is spliced from the A8 sequence of A1HV-1. Mutations in the intronic
sequence would not affect the function of the protein, as long as the splice donor and
acceptor sites and the branch point were conserved. This suggests therefore that this
pattern of splicing in 08 could be found in viral gene expression in vivo. The 07
sequence contains a distinct area that is homologous to A7 and it may be that in the
same way, the region of 07 not homologous to A7 is spliced from the sequence. No
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putative splice donor sites in the region at the end of the area of 07 homologous to
A7 were identified using the NetGene program, however a number of GT motifs,
which could act as splice donor sequences were present in the region.
Transfection of the 07/08 sequence alone is an artificial situation and it is
possible that virus specific factors are required for correct splicing of the 07/08
construct. A possible viral protein involved in splicing is the ORF 57 protein. ORF
57 is homologous to the HSV protein ICP27. In HVS, ORF 57 has been shown to be
involved in redistribution of the SC-35 and snRNPU2 components of the
spliceosome (Cooper et al., 1999). It is thought that this may be a way of down
regulation of expression of intron containing viral genes. This gene product may also
be involved in regulation of splicing, therefore future experiments would involve
co-transfection of ORF 57 and 07/08. Splicing has also been shown to be linked to
the promoter driving expression of the spliced gene, as splicing of the fibronectin
gene differed when driven by different promoters (Cramer et al., 1997). It is thought
that the effect of splicing regulators is modulated by the promoter (Cramer et al.,
1999). It is possible therefore that splicing of the 07/08 construct would have been
different if the 07/08 sequence had been under the control of a different promoter
than CMV.
In summary, the fact that transcripts encoding both 07 and 08 are expressed
in transfected cells is further evidence that 07 and 08 can be expressed on the same
transcript in some situations. The fact that in both splices identified in the 08 open
reading frame, the intron spliced out was closely correlated with the area of 08 not
homologous to A1HV-1 suggests that the conserved region is functionally important.
It also suggests that this pattern of splicing might also be found in A8 of A1HV-1.
The splicing pattern that might be used to express a protein translated from the 07
and 08 open reading frames has not been determined, as all splices preceding the 08
open reading frame resulted in the introduction of stop codons. It is hypothesised that
the 08 open reading frame might be spliced close to the end of the region of
homology with 07. Future approaches to test this hypothesis would involve the
cotransfection of ORF 57 with 07/08 and possibly testing the 07/08 construct
under the control of a different promoter.
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4.4.3 Analysis of 07/08 Protein Expression By Immunofluorescence
Immunofluorescence analysis of the 07/08 transfected MDBK cells was carried out
using an anti-haemagglutinin antibody to identity the cellular localisation of the
07/08 protein in transfected cells. Although no transcripts were identified that were
likely to encode an 07/08 protein, it was possible that undetected transcripts were
translated into 07/08 protein. Immunofluorescence analysis of the triple HA tagged
07/08 construct in 07/8 HA transfected MDBK cells did not result in detection of
expression of the 07/08 protein, although fluorescence of the two control expression
constructs JkHA and IRF7HA was identified in the paraformaldehyde fixed samples.
Haemagglutinin epitope tagging was chosen as a method of detecting the
07/08 protein because it was known to be reliable and good commercially available
antibodies could be used for detection of the 07/08 protein. The influenza
haemagglutinin epitope tag placed at the 3' end of an expressed protein has been
found not to affect protein function or expression (Sells & Chernoff, 1995). A triple
haemagglutinin tag was used as this has been found to increase sensitivity of
detection (Nakajima & Yaoita, 1997). Efforts were underway to raise an antibody to
08 in rabbits and it was expected that results from the study of transfection of the
07/08 construct might correlate with results from study of the anti-08 antibody in
OvHV-2 infected cells.
Visualisation of the control HA tagged plasmids suggested that the antibodies
were working and the fixation of the cells was being carried out correctly. Since the
HA tag was located at the 3' end of the 07/08 construct, expression of a full length
07/08 protein was required for detection of the expression using the anti-HA
antibody. Failure to detect the 07/08 protein using the anti-HA antibody suggests
that the putative full length 07/08 protein was not expressed in the 07/08
transfected cells. This is likely to be due to the fact that the 07/08 encoding cDNAs
detected in 07/08 transfected cells were not spliced in a way that maintains a
complete 07/08 open reading frame, therefore a full-length protein could not be
translated from these transcripts.
It was hypothesised that correctly spliced RNAs may be present in the cells at
levels undetectable by RT-PCR and that these RNAs may be translated into
detectable amounts of HA tagged 07/08, however this does not seem to be the case.
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Studies of the expression of the 07/08 protein seem to confirm that the spliced
RNAs detected cannot be translated into an 07/08 protein and splicing of the 07/08
RNA to result in an in-frame 07 and 08 open reading frame would be required for
expression of the protein. Due to the location of the HA tag at the 3' end of the
construct, only expression of the full-length protein could be detected. An antibody
raised against 07, or the use of a 5' HA tagged construct would be necessary to
detect expression of proteins from the 07/08 open reading frame that did not contain
the 3' end of 08.
4.4.4 Generation of an Anti-08 Antibody in Rabbits
Efforts were made to raise an antibody to 08 in rabbits in order to study the cellular
location and expression of the 08 protein in OvHV-2 infected cells. A 207 amino
acid region of OvHV-2 08 was expressed as a GST fusion protein in E. coli, in order
to immunise rabbits. The 08-GST fusion protein was found to be insoluble and was
therefore purified from bacteria as an inclusion body preparation. The inclusion body
preparation was then used to immunise rabbits. Sera from the immunised rabbits
were tested for the presence of antibodies to the 08-GST fusion protein by western
blotting analysis and were found to contain antibodies specific for the 08-GST
fusion protein. The immune rabbit serum was used in immunofluorescence analysis
of OvHV-2 infected rabbit cells.
A large proportion of the cells analysed displayed positive fluorescence as
compared with that observed using pre-immune rabbit sera. The fluorescence pattern
observed was intracellular and some cells appeared to display fluorescence round the
cell surface. Control non-infected rabbit lymphoblasts were subjected to
immunofluorescence analysis using the pre-immune and immune rabbit sera.
Moderate levels of fluorescence were seen on a number of cells incubated with both
the immune and non-immune sera. Fluorescence was also observed in a small
number of cells incubated with PBS followed by the secondary anti-rabbit FITC.
The fact that the 08-GST fusion protein was insoluble meant that it was not
possible to purify the fusion protein from the rest of the bacterial proteins by affinity
chromatography on immobilised glutathione. This was not too problematic however,
as an inclusion body preparation can contain over 90% pure foreign protein and SDS
PAGE analysis of the inclusion body preparation showed that although it did contain
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other bacterial proteins, it was composed mostly of the 08-GST fusion protein.
Protocols are documented involving the re-folding and solubilisation of inclusion
body preparations, however inclusion body preparations containing denatured
proteins are known to invoke good antibody responses, therefore further purification
of the inclusion body preparation was considered to be unnecessary.
The fluorescence observed following incubation of the OvHV-2 infected cells
was preliminary data suggestive that a large proportion of cells of the BJ/880
OvHV-2 infected rabbit cell line were expressing the 08 protein. Although
fluorescence was observed after incubation with pre-immune serum, this was not of
the same intensity as that seen after incubation with the immune serum. The
fluorescent staining observed in the PHA treated lymphoblasts, although only seen in
a small number of cells, must however be considered.
A number of problems could arise as a result of using a rabbit antibody for
indirect immunofluorescence analysis of rabbit cells. The secondary antibody used
was an anti-rabbit FITC, therefore this could cause non-specific fluorescence by
binding to any rabbit immunoglobulin present on the cells. This would be of
particular relevance to the non-infected control lymphocytes, as these cells were
likely to include B as well as T lymphocytes and B lymphocytes would carry rabbit
immunoglobulin on their surface. The rabbit immunoglobulins in the rabbit sera
would bind to Fc receptors, which would be present in and on the surface of rabbit B
cells. Both these problems would cause non-specific fluorescence in the rabbit
lymphocytes and binding of the anti-rabbit FITC to rabbit immunoglobulin might
have been the cause of the fluorescence observed on incubation of the rabbit
lymphocytes with PBS and the anti-rabbit FITC. It was originally intended to use the
immune rabbit serum for immunofluorescence analysis of OvHV-2 infected bovine
cell lines as well as rabbit cell lines, however a bovine cell line was not available at
the time of analysis.
The cellular localisation of the 07/08 protein was predicted to be similar to
that of other viral envelope glycoproteins such as EBV gp350 and MHV-68 gpl50,
therefore a cell surface and Golgi pattern of expression was expected. The
fluorescence pattern observed could be consistent with this, however further
localisation of the fluorescence using organelle specific staining would be necessary
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to determine the cellular localisation of the 08 protein. Evidence of expression of 08
in a high proportion of OvHV-2 infected rabbit cells is consistent with the fact that
OvHV-2 infected rabbit cells transmit virus very efficiently, as the 08 protein is
predicted to be important in viral infectivity.
In order to determine the molecular weight of the 07/08 protein, western
blotting analysis was performed on lysates of OvHV-2 infected rabbit cell line using
the rabbit anti-08 immune serum. Three bands were identified in samples incubated
with immune serum but not in samples identified with pre immune serum. In samples
incubated at serum concentrations of 1/100, 1/200 and 1/500, a band was present at
approximately 53KDa and two similar sized bands were present at approximately 37
and 38KDa.
The size of the proteins identified is considerably smaller than the size that
would be predicted for an 07/08 protein. The predicted size of the 07/08 protein
was predicted to be approximately 80 - 98KDa depending on how the 08 open
reading frame was spliced. The actual molecular weight observed is likely to be
higher as the protein is predicted to be glycosylated. The predicted product of the
unglycosylated 08 open reading frame alone is 52 - 84KDa depending on how the
transcript is spliced. It is unlikely therefore, that the proteins detected represent the
07/08 protein. It is possible that the 53KDa band might represent an 08 protein.
This might be identified following cleavage of the signal sequence from the N
terminal end of the 07/08 protein. It may also be that 08 is expressed as a single
protein without 07, however sequence analysis did not identify a promoter sequence
preceding 08 or a signal sequence in the protein. The locus on the genome occupied
by the 08 ORF would predict that the protein encodes a membrane glycoprotein,
which would be expected to contain a signal sequence.
Further analysis would be required to determine the molecular weight of the
putative 07/08 glycoprotein. Further optimisation of this system including the use of
non-infected control cells would be required to determine the molecular weight of
the 07/08 protein using the anti-08 immune serum. It was expected that the use of
anti-haemagglutinin antibody on western analysis of cells transfected with a
haemagglutinin tagged 07/08 construct would confirm results obtained using the
anti-08 antiserum, however this method of analysis was also not successful.
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4.4.5 Study of The Antibody Response to 08 in Sheep and Cattle
Sheep are thought to be the natural host of OvHV-2 and it is known that they
transmit disease to susceptible hosts. It is hypothesised therefore that OvHV-2
undergoes lytic replication in sheep. It has been shown by immunoblotting analysis
that sheep sera react to A1HV-1 polypeptides (Herring et al., 1989); this suggests that
sheep develop an antibody response to some OvHV-2 proteins. The glycoprotein
gp350 is the major antigenic determinant of EBV and absorption of immune sera
from EBV infected patients with gp350 greatly reduces their virus neutralising
capacity (Thorley-Lawson & Poodry, 1982). In addition the KSHV glycoprotein
K8.1 is recognised by human sera on western blotting analysis of KSHV infected
cells. Both these glycoproteins are in an analogous position in the genome to
OvHV-2 08, therefore it was reasonable to expect that infected sheep might raise an
antibody response to 08.
In order to determine if sheep develop antibodies to the 08 protein, sera from
adult sheep, lambs, MCF recovered cattle and uninfected cattle were tested for the
presence of antibodies to the 08-GST fusion protein by western blotting analysis. All
sera appeared to react weakly with a 52 KDa band at the position of the GST fusion
protein, however the fact that uninfected cattle reacted indicated that the band was
caused by non-specific binding of the sera to the 08-GST fusion protein. This meant
that there was no evidence that MCF recovered cattle, or adult sheep, have specific
antibodies to the region of 08 tested.
Sheep sera reacted to A1HV-1 antigens when used at a dilution of 1/40
(Herring et al., 1989). Serum concentrations in these experiments were initially 1/50.
Sera were also tested at a concentration of 1/20 and 1/10, however no specific
antibody binding was seen. The presence of non-specific antibody binding by the
sera used was a problem in these experiments and the non-specific binding may have
masked a weak antibody response. Various approaches to reduce the non-specific
antibody binding were attempted. These included titration of the secondary and
tertiary antibodies, use of Tween 80 at a concentration of 0.5% in both the blocking
and the hybridisation buffer and use of a "high salt" hybridisation and blocking
buffer, however these methods did not reduce the non-specific binding. The non-
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specific antibody binding was however, quite weak and it was considered that this
did not detract from the fact that none of the sera contained specific antibodies to the
section of 08 tested.
The lack of antibody response to the 08 protein could be for a number of
reasons. It is not known if OvHV-2 viral replication occurs in MCF affected cattle, as
they do not transmit disease to other animals, therefore cattle may not develop
antibodies to 08 for this reason. If viral replication does occur in OvHV-2 infected
sheep it may be that this occurs only at low levels insufficient to stimulate a
detectable antibody response. This however seems unlikely since, as mentioned,
Herring et al., (1989) demonstrated the presence of antibodies in sheep sera which
cross-reacted with a number of A1HV-1 antigens and it was assumed that these
antibodies were directed against OvHV-2 antigens.
It may be that the region of 08 chosen for expression is not an antigenic
determinant of 08 during infection. The region of 08 chosen for expression as a
GST fusion protein was predicted to contain antigenic sites (Figure 3.3.1.10), and
contained predicted N and O glycosylation sites (Figure 3.3.1.4 & 5). These features
indicated that the region might be located outside the viral envelope and possibly
expressed on the surface of OvHV-2 infected cells, however the prediction may have
been incorrect. It is possible that a different region of 08 may have been recognised
by the sera. It is also possible that the 08 protein itself is not found in the viral
envelope in a similar manner to EBV gpllO, which is found in large amounts in the
nuclear membrane, but only in small amounts in the viral envelope (Gong & Kieff,
1990). Further experiments to clarify the situation would therefore involve
expression of a different region of the 08 protein, or possibly expression of the
whole of the putative ectodomain region in order to raise antibodies to different
regions of the 08 protein.
4.5 Conclusions
The study of OvHV-2 pathogenesis remains of importance, as the virus is the cause
of MCF in the UK and worldwide. MCF is a devastating disease that is reported
sporadically, however outbreaks of economic importance are reported with
reasonable frequency. The identification of Caprine herpesvirus-2 as a cause of MCF
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provides another member of the family of MCF causing viruses and comparative
study of the mechanisms of pathogenesis of these viruses will be of great interest.
This work describes significant advances in the study of OvHV-2
pathogenesis. Cloning and sequencing of much of the virus genome has confirmed
OvHV-2 as a gammaherpesvirus similar to A1HV-1. It has also been established that
despite being similar to A1HV-1, OvHV-2 contains significant differences that
confirm that this is a gammaherpesvirus distinct from A1HV-1. OvHV-2 and A1HV-1
have been shown to be similar to the porcine gammaherpesvirus PLHV-1. Further
sequence data of PLHV-1 would be expected to reveal interesting similarities
between these three viruses.
The sequence data will prove to be a valuable resource for further study of
OvHV-2 and will enable the generation of reagents for further study of virus
pathogenesis, such as antibodies and in situ hybridisation probes to study in vivo
expression of viral genes. Little is known about the in vivo sites of virus persistence
and replication, either in MCF affected animals or in the natural host, the sheep. The
genes at the left hand end of the virus genome are expected to be of significant
interest as by comparison with other gammaherpesvirus genomes, they are likely to
be important in viral pathogenesis. Establishing if the IL-10 homologue encoded by
ORF 02.5 is functional will be of particular interest. Work on the OvHV-2 infected
lymphoblastoid cell lines has established important data regarding the mode of viral
persistence in these cell lines. The finding of evidence of viral replication in OvHV-2
infected rabbit cell lines was followed by the first visualisation of an OvHV-2 capsid.
Study of the 07 and 08 open reading frames provided evidence that these
two open reading frames are expressed on the same transcript as predicted, and
immunofluorescence analysis using anti-08 sera raised in rabbits resulted in
preliminary data indicating that the 08 protein is expressed in a large proportion of
cells in OvHV-2 infected rabbit lymphoblastoid cell lines. This work has provided a
starting point for further study of this region.
The lack of a productive tissue culture system for OvHV-2 still remains a
problem in the study of this virus. Although evidence of productive cycle replication
was demonstrated in rabbit cell lines, the failure to detect transcripts by northern
analysis suggests that levels of OvHV-2 transcripts in these cell lines are low. All
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OvHV-2 infected lymphoblastoid cell lines were quite short lived, and the
availability of cells for analysis was a constraint in some areas of the work. Defining
conditions that allow in vitro productive replication of this virus would be very
useful for the study of OvHV-2 gene expression. Of importance now in OvHV-2
research will be the completion of the viral genome sequence and the establishment
of better in vitro systems for virus culture. The completion of the virus sequence will
be a starting point to gain an insight into the pathogenesis of a gammaherpesvirus
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Ovine herpesvirus 2 lytic cycle replication and
capsid production
Jane Rosbottom,1 Robert G. Dalziel,1 Hugh W. Reid2 and James P. Stewart1
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Ovine herpesvirus 2 (OvHV-2) causes malignant
catarrhal fever in cattle, pigs and deer. We have
observed intact circular and linear OvHV-2 ge¬
nomes in infected T cell lines derived from cows and
rabbits. Bovine T cell lines were predominantly
latently infected but rabbit T cell lines supported
OvHV-2 productive cycle gene expression and virus
capsids were demonstrated for the first time.
Malignant catarrhal fever (MCF) is a severe, usually fatal,
lymphoproliferative and inflammatory syndrome of domestic
cattle, pigs, deer and certain other susceptible ruminants such
as bison. Cases of MCF in cattle usually occur sporadically.
However, periodically limited epizootic outbreaks occur
(Hamilton, 1990) where losses can be substantial. MCF is also
the most important virus disease of farmed deer. The disease is
mainly caused by either of two bovid gammaherpesviruses
that persist subclinically in their natural host. These viruses are
highly related to each other and to other gammaherpesviruses
such as Kaposi's sarcoma-associated herpesvirus (KSHV),
Epstein—Barr virus (EBV) and murine gammaherpesvirus
(MHV-68). Alcelaphine herpesvirus 1 (AlHV-1) naturally
infects wildebeest and is the source of wildebeest-associated
MCF in Africa (Plowright el al„ 1960). Domestic sheep are the
reservoir of infection for the other main form of the disease,
sheep-associated MCF (SA-MCF). The SA-MCF agent, ovine
herpesvirus 2 (OvHV-2), is antigenically closely related to
AlHV-1 (Herring el al„ 1989; Rossiter, 1981, 1983). Limited
sequence analysis of the genome corresponding to part of
ORF75 shows that OvHV-2 also shares homology at the
DNA level with AlHV-1 and other gammaherpesviruses
(Baxter el al„ 1993; Bridgen & Reid, 1991).
The detection ofDNA in diseased animals and inapparently
infected sheep has confirmed that OvHV-2 is the aetiological
Author for correspondence: James Stewart. Present address: Centre
for Comparative Infectious Diseases, The University of Liverpool, Dept
of Medical Microbiology and Genitourinary Medicine, Duncan Building,
Daulby Street, Liverpool L69 3GA, UK.
Fax + 44 151 706 5805. e-mailj.p.stewart@liv.ac.uk
agent involved in SA-MCF (Baxter et al„ 1993; Li et al„
1998; Muller-Doblies et al., 1998; Wiyono et al., 1994).
OvHV-2 DNA can be found in epithelial tissues and B cells
from sheep (Baxter et al., 1997). However, in SA-MCF-affected
ruminants, virus DNA has only been observed in hyperplastic
T cells (Baxter et al., 1993; Bridgen & Reid, 1991). These T cells
can grow in culture into lines and will transmit disease back to
cattle as well as to experimental animals such as rabbits and
hamsters (Burrells & Reid, 1991; Buxton et al., 1984, 1988). In
turn, T cell lines can subsequently be isolated and passaged
from these secondary hosts (Reid et al., 1983).
AlHV-1 has been isolated, completely sequenced and will
productively infect epithelial cell lines in culture (Ensser et al.,
1997; Plowright et al., 1960). In contrast, research on OvHV-
2 has been hampered by the lack of reagents and a consistent
failure to isolate the virus and define a productive cell culture
system. The aim of this work was to ascertain the nature of
OvHV-2 genomes in T cell lines and to define a productive
culture system for OvHV-2. Here, we show that infected rabbit
T cell lines support aspects of the virus productive cycle.
To identify cells supporting productively replicating
OvHV-2, we analysed infected T cell lines by CardcIIa (in jitu
lysis) gel electrophoresis and Southern blotting exactly as
described previously (Gardella et al., 1984; Usherwood et al.,
1996). This technique discriminates linear from covalently
closed circular (CCC) viral genomes which are characteristic of
cells supporting either productive or latent herpesvirus
infection respectively. OvHV-2-infected T cell lines were
derived from an affected cow (BJ/1035) or affected rabbits
(BJ/2222, BJ/2223) as described previously (Buxton et al.,
1985). The control cell lines, Sll (Usherwood et al., 1996) and
BCP-1 (Boshoff et al., 1998), are latently infected with the
related MHV-68 and KSHV respectively. Equal numbers
(2 x 106) of cells were loaded onto each lane of the gel. A
Southern blot of the gel was probed simultaneously with 32P-
Iabelled DNA fragments derived from the OvHV-2 ORF75,
the MHV-68 gpl50 gene (Stewart et al., 1996) and the KSHV
K13 gene. The results are shown in Fig. 1. Sll (MHV-68-
infected) and BCP-1 (KSHV-infected) cells contained both
CCC and linear genomes but Sll cells contained a higher
proportion of linear relative to circular genomes. Indeed, the
amount of linear genomes in BCP-1 cells was on the borderline
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Fig. 1. Gardella gel analysis of lymphoid cell lines. Cells were lysed in situ
in the agarose gel and then electrophoresed and analysed by Southern
blotting. Cell lines used were as indicated above the tracks. The blot was
probed simultaneously with 32P-labelled probes specific for MHV-68,
KSHV and OvHV-2 followed by autoradiography. The positions of
covalently closed circular (CCC) and linear viral DNA are indicated at the
left. Asterisks indicate the positions of linear DNA in two cases that were
visible on the autoradiograph but did not reproduce photographically.
of detection (shown by asterisk). This corresponds to a
relatively high level of spontaneous reactivation (up to 20% of
cells) in Sll (Usherwood et al., 1996), compared with BCP-1
where the level of spontaneous reactivation is only 1—2% of
cells (Talbot et al., 1999). An OvHV-2-infected bovine T cell
line (BJ/1035) contained predominantly circular genomes and
a barely detectable level of linear genomes (shown by asterisk).
In contrast, two OvHV-2-infected rabbit T cell lines (BJ/2222
and BJ/2223) contained comparatively large amounts of linear
genomes with only a relatively small amount of circular
genome apparent. These results strongly suggested that the
OvHV-2-infected bovine line that we studied contained
predominantly latently infected cells, whereas the two rabbit
lines contained latently infected cells but also a relatively large
proportion of cells that might be undergoing productive
replication.
To determine whether infected rabbit T cells supported
OvHV-2 gene expression normally associated with the
productive cycle, we performed RT-PCR analysis. Total RNA
was extracted from a rabbit T cell line (BJ/2319) or uninfected
rabbit lymphoblasts using an RNeasy kit (Qiagen) and then
Fig. 2. RT-PCR analysis of OvHV-2-infected rabbit T cell line. RNA was
extracted from cells and analysed by RT-PCR using primers specific for
GAPDH and ORF75 as indicated above the gel. Products were
electrophoresed through 2% agarose gels containing ethidium bromide
and visualized using a UV transilluminator. Reactions were performed in
the presence (RT+ ) or absence (RT —) of reverse transcriptase as well as
in the absence of template (C-VE). Positive controls (C+VE) of infected
cell DNA and mouse cell cDNA were included for the ORF75 and GAPDH
primers respectively. Molecular mass determinations were made using a
DNA ladder (1 kb plus, Life Technologies) as indicated (Mr). The positions
of relevant markers are shown at the left.
1 pg was reverse-transcribed using a combination of random
hexamer primers (Roche) and Superscript II RT (Life Tech¬
nologies) as described previously (Roy et al., 2000). RT
products were amplified by PCR as described previously
(Usherwood et al., 2000), using 40 cycles and primers specific
for gIyceraldehyde-3-phosphate dehydrogenase (GAPDH;
sense 5' CCTTCATTGACCTCAACTACAT, antisense 5'
CCAAAGTTGTCATGGATGACC) and OvHV-2 ORF75
(sense 5' GCTTCAGCTTACTCCCTTTAC, antisense 5'
TCAATCAGGTTCAGGTTTACAG). ORF 75 in the related
EBV and MHV-68 is a late productive cycle gene (Hudson et
al., 1985; B. Ebrahimi, personal communication) and is therefore
an indicator of productive cycle gene expression. As shown in
Fig. 2, a product of the correct size (400 bp) was amplified
using GAPDH primers from positive control mouse cDNA
and the OvHV-2-infected cell cDNA. No products were seen
in control reactions where either RT (RT—) or template (C—)
was omitted. Likewise, products 540 bp in length were
amplified using ORF75 primers from positive control OvHV-
2-infected cell DNA and OvHV-2-infected cell cDNA, but not
from negative control samples or uninfected rabbit cells (not
shown). Thus, ORF75 was expressed in the OvHV-2-infected
rabbit T cell line. This shows that gene expression normally
associated with the productive cycle was occurring in the
rabbit T cell line. This concurs with the detection of linear
genomes in infected rabbit T cell lines.
We surmised that if rabbit T cells contained linear virus
DNA and expressed a gene associated with the productive
cycle in other gammaherpesviruses then they might produce
virus particles. In an initial screen, infected bovine and rabbit T
cell lines were examined by transmission electron microscopy.
However, after inspection of several hundred cells from
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Fig. 3. Transmission electron micrograph of an OvHV-2 particle. Infected
rabbit T cells were lysed, the virus pelleted and then visualized by
negative staining using transmission electron microscopy.
different preparations of each type of cell line we were unable
to detect viral particles. We therefore adopted an alternative
approach based upon the concentration of viral particles by
pelleting that had proved successful for certain KSHV-infected
cell lines. Infected cells were lysed by freeze—thawing and viral
pellets were prepared and examined by transmission electron
microscopy exactly as described by Arvanitakis et al. (1996).
Fig. 3 shows that characteristic herpesvirus capsids were
observed in extracts from infected rabbit T cells. These
appeared to be reminiscent of A-type capsids that do not
contain viral DNA and are non-infectious. Thus, infected rabbit
T cells not only display markers of the productive cycle but
also produce visible capsids. However, the lack of mature
capsids and particles argues that the majority of cells are
undergoing an abortive productive cycle.
Previous results had implied that OvHV-2-infected T cell
lines were capable of producing infectious viral particles
because they were capable of causing MCF after experimental
transfer into rabbits and hamsters (Burrells & Reid, 1991; Bux¬
ton et al., 1984, 1988). While the results presented here
represent a significant advance in OvHV-2, research in
delineating cell lines that support gene expression that is
normally associated with the productive cycle, they still fall
short of defining an amenable, fully productive culture system.
The presence of linear genomes in cells infected by other
gammaherpesviruses is directly correlated with the presence of
cells undergoing full productive replication. There are clearly
significant numbers of linear viral genomes and evidence of
productive cycle gene expression in infected rabbit T cells.
However, neither gives an indication of the proportion of cells
involved and RT—PCR gives no idea of the levels of gene
expression. The inability to detect viral particles in intact cells
argues for one of two conclusions. Firstly, that only a very
small percentage of cells is undergoing productive replication
resulting in particles or, alternatively, that there are a larger
percentage of cells undergoing a productive cycle that is
largely abortive with respect to particle production. These
limitations aside, the delineation of cell types maintaining
either latency or aspects of the productive cycle will enable the
study of these phases of the virus life-cycle in more detail, in
particular the delineation of antigens associated with each
phase. However, the key to the analysis of this virus is the
determination of the complete DNA sequence of the genome.
The definition of an in vitro culture system supporting
productive infection provides the substrate for such a sequenc¬
ing project.
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